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CHAPTER 1. INTRODUCTION 
Thei e is increasing evidence of the importance of vitamin E (VE) in the 
human and animal world. In body tissues, VE acts as a potent radical chain-
breaking antioxidant, protecting biological membranes against free radical damage. 
In this way, VE maintains cellular integrity, decreases lipid peroxidation, and 
increases disease resistance. 
Vitamin E is routinely supplemented in turkey diets, usually at concentrations 
that exceed the National Research Council (NRC, 1984, 1994) recommended 
concentration, 12 lU of VE [as dl-a-tocopheryl acetate (dl-aTACT)]/kg of diet. 
However, despite seemingly adequate VE supplementation, there are reported 
cases of encephalomalacia and other VE deficiency signs in flocks of young 
turkeys during the first 2 or 3 weeks (wk) of life. 
Just after hatch, during a period characterized by general rapid 
development, young poultry have limited capacity to utilize nutrients provided in the 
diet. Specifically, a-tocopheroi (ciTOC) concentrations decrease markedly in 
plasma and livers of turkey poults during the first 2 wk of life. This decrease 
occurs irrespective of dietary manipulations to maintain adequate VE 
supplementation. In the past few years, conflicting reports for other species 
(Horwitt et al., 1972; Hidiroglou and Charmley, 1990) opened the question of 
whether liver or plasma oTOC were adequate indicators of oTOC status of turkey 
poults during the first few weeks after hatching. The research presented in this 
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dissertation addresses the following questions: 1) is the dietary requirement of VE 
for young turkeys greater than 12 lU of dl-aTACT/kg of diet? 2) is it possible to 
improve the aTOC status of poults by using different sources, routes, or 
concentrations of supplemental VE than those used currently? 3) are plasma or 
liver aTOC adequate indicators of aTOC status of poults? 4) do different tissues of 
the poults accumulate aTOC at similar rates? 5) is the VE administered to poults 
through different routes transported In blood in a similar way? and 6) do high 
dietary concentrations of vitamin A (VA) negatively influence the absorption and 
utilization of VE by turkey poults? 
In Experiment 1, the effect of supplementing different concentrations of VE 
and VA, as well as the effect of injecting VE to turkey poults were determined on 
performance, weight of specific tissues, and aTOC concentrations in plasma and 
selected tissues. The tissues studied were abdominal adipose tissue, breast 
muscle {Pectoralis superficialis), small intestine, leg muscle {Biceps femoralis), 
iiver, and uropygial gland. Correlation coefficients relating aTOC of the tissues 
studied to plasma aTOC concentration and to liver aTOC concentration also were 
calculated to determine whether plasma or liver aTOC could be used as indicators 
of aTOC status of young poults. 
In Experiment 2, the efficacy of two different dietary sources (dl-aTACT and 
d-aTOC) and an injectable form (d-aTOC) of VE to improve the aTOC status of 
poults was compared. The efficacy of the different VE sources studied was 
3 
evaluated by the performance of the poults, the aTOC concentration of 
erythrocytes, plasma, and liver, and the concentration of triglycerides in plasma. 
Ability of the liver to undergo lipid peroxidation, susceptibility of the erythrocytes to 
hemolysis by a peroxidative agent, and muscle damage, as indicated by plasma 
creatine kinase values, were measured as additional indicators of VE status of 
poults. 
In Experiment 3, the effects of different dietary concentrations of dl-aTACT, 
and of an early high dose of VE (given by subcutaneous injection, or in the 
drinking water) were determined. The effects of the treatments were measured by 
determining poult performance, concentration of qTOC in erythrocytes, plasma, 
liver, and selected tissues, i.e., adrenal glands, bursa of Fabricius, lungs, and 
pancreas, and by measuring the susceptibility of erythrocytes to hemolysis by a 
peroxidizing agent. The concentration of aTOC in three plasma lipoprotein 
fractions was also measured to determine whether VE administered by different 
routes is transported in blood in a similar way. 
The literature review that follows provides information on: 1) the intestinal 
development of the newly hatched turkey, 2) VE, 3) VE requirements, 4) VE 
supplementation, and 5) indicators of VE status. 
4 
CHAPTER 2. LITERATURE REVIEW 
Intestinal Development of the Newly Hatched Turkey 
The development of the gastrointestinal tract begins early in embryonic life. 
However, it is not until the late stages of embryonic development that chicks and 
poults utilize part of their digestive-absorptive capabilities to obtain nourishment. 
The residual yolk is the primary source of nourishment for chickens and turkeys 
just before, and for a few days (d) after hatching. However, this source of 
nutrients is depleted within 4 or 5 d posthatch. Sell et at. (1991) observed a 
decreased residual yolk weight of turkeys after Day 26 of incubation, and that 
residual yolk became depleted by 4 d after hatching. In chickens, Murakami et al. 
(1992) reported similar changes in yolk weight with age. 
Just after hatch, birds need to develop the ability to absorb and utilize 
dietary nutrients. To achieve that objective, the gastrointestinal tract of poults 
needs to develop physically and functionally during the first few days after hatching. 
This development has been reported for both turkeys (Sell et al., 1991) and 
chickens (Katanbaf et al., 1988). Sell et al. (1991) observed an accelerated growth 
of the gastrointestinal organs of poults, compared with that of the whole body from 
2 to 4 d prior to hatch until 6 to 8 d of age. Katanbaf et al. (1988) found that the 
relative weight (expressed as a percentage of empty body weight) of supply organs 
(I.e., lungs, proventriculus, liver, esophagus, small intestine, heart) of chickens 
increased during the first 10 d of life, whereas that of demand organs (breast, 
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wings, legs, feathers) increased only after 10 d of age. 
The functional development of the gastrointestinal tract of poultry needs to 
be fully achieved within a few days after hatch. This way, the animal will be able to 
utilize carbohydrates, proteins, and lipids that are essential nutrients in their new 
diets. Changes in activities of intestinal and pancreatic enzymes have been 
described in detail for chickens (Nitsan et al., 1991a, 1991b; Nir et a/., 1993) and 
turkeys (Sell et al., 1991). 
In the pancreas, activities of amylase increased in chickens between 1 and 
10 d of age, and then remained the same through 15 d, whereas those of trypsin 
and lipase increased markedly from 1 to 10 d of age, and continued to increase 
afterwards (Nir et al., 1993). However, the activity of each enzyme increased in a 
different manner. Increases in activity of amylase per gram of broiler increased 3-
fold, whereas those of trypsin and lipase increased 5- to 6-fold for the period 
studied (Nir et al., 1993). Results published by Nitsan et al. (1991a, 1991b) agree 
with those reported by Nir et al. (1993), and indicate that the pancreas of chickens 
develops rapidly following hatch. Results published by Sell et al. (1991) indicate 
that pancreatic enzymes of turkeys undergo a similar development to that of 
pancreatic enzymes of chickens early in life. Amylase, lipase, and trypsin activities 
(/imoles of substrate hydrolyzed/mg protein hourly) increased nearly 6-, 10-, and 
7-fold, respectively, from hatching to 6 d posthatching. These changes agree with 
those reported by Krogdahl and Sell (1989), who observed that pancreatic amylase 
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in poults was low at hatch, and then increased rapidly through 21 d after hatch. 
Krogdahl and Sell (1989) also reported that lipase activity in poults at hatch was 
nearly 30% of the activity at 56 d of age, declined between 4 and 14 d of age, and 
then increased steadily up to 56 d of age. Similar results were published by 
Escribano et al. (1988). 
Activities of enzymes of the intestinal mucosa also increase markedly shortly 
after hatch. Low maltase and sucrase activities in the intestine of hatching 
chickens have been reported (Siddons, 1969). Similarly, low sucrase and 
isomaltase activities in the intestinal mucosa of newly hatched poults have been 
described (Sell et al., 1989). Sell et al. (1989) found that activities of these 
enzymes during the first days after hatching increased at a slower rate than those 
observed by Siddons (1969) in chicks. Also working with poults. Angel et al. 
(1990) reported a marked decrease in maltase and sucrase activities from Day 1 to 
Day 7, followed by an increase until 25 d of age. Vilaseca (1993) reported a similar 
decrease in maltase activity during the first week of life of turkey poults, followed by 
an increase thereafter. Vilaseca (1993) also reported that intestinal alkaline 
phosphatase activity followed a similar pattern to that observed for maltase activity, 
decreasing between 1 and 9 d of age, and increasing aften^/ards. 
In summary, there seems to be a period after hatch when the functioning of 
digestive enzymes (pancreatic and intestinal) increases at a slow rate in chickens 
and turkeys. 
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Nutrient utilization is also relatively poor for chickens and turkeys during the 
first weeks of life. Research with turkeys (Sell et al., 1991, ISU, Ames, lA 50011, 
personal communication) indicates that utilization of dietary fat, protein, and dry 
matter increased markedly between 5 and 7 d posthatching. Also in poults, Soto-
Salanova et al. (1991) reported that the metabolizable energy of diets was lowest 
between Days 4 and 7 posthatching. Furthermore, the determined 21-d-
metabolizable energy value of the diet was still considerably less than the value 
calculated from ingredient reference values. Wiseman and Salvador (1989) 
reported for chickens a marked increase in the metabolizable energy of fats from 
1.5 wk to 3.5 wk of age, and a steady increase thereafter. In the instance of fat, 
numerous reports have indicated that poultry have a poor ability to digest fat early 
in life. Carew et al. (1972) observed that digestibility of tallow was low in the chick 
during the first 7 d after hatching (40%), and increased from 8 to 15 d of age 
(79%). Similarly, Polin and Hussein (1982) found an increased fat digestion in 
chicks from 62.4% at 7 d of age, to 82% at 21 d of age. Whitehead and Fisher 
(1975) observed that the absorbability of maize oil, tallow, and lard by turkeys 
increased markedly with age. 
The limited ability of poultry to utilize dietary fats efficiently during the first 
weeks after hatching may have a negative impact in the utilization of fat-soluble 
nutrients, such as VE. In chickens, Dudin and Dvinskaya (1983) observed a 
decrease in the absorption of aTOC during the first 20 d after hatch, and an 
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increase in the oxidation of orTOC to a-tocopheryl quinone in the tissues during the 
first 10 d after hatching. Mezes (1988) attributed this decrease to early postnatal 
development (up to 6 d of age), and he stated that liver aTOC content of young 
chicks remained at the same low level up to 35 d of age. In turkeys, Soto-
Salanova et ai (1993) observed a rapid decline in liver and plasma aTOC from 1 to 
9 d of age, despite relatively high (100 lU of dl-oTACT) VE in the diet. This early 
decrease of aTOC in poults has been confirmed by several researchers (Mallarino, 
1992; Sell et a!., 1994; Applegate, 1995). Bartov (1983) reported a lower capacity 
of turkeys to absorb otTOC, compared to chickens. Furthermore, turkeys were 
found to have an increased production of glucuronide compounds by the liver, 
compared with chickens, giving rise to aTOC metabolites directly discharged with 
the feces (Sklan et al., 1982). Whether the limited utilization of fat and VE are 
directly interrelated remains unknown. 
The immune system plays a vital role in the development of the 
gastrointestinal tract, helping the intestine to act as a barrier between the 
environment and the body. However, the immune system of poultry is immature at 
the time of hatching, and this observation has been confirmed by several reports 
(Jeurissen et al., 1989; Piquer et al., 1991; Schat and Myers, 1991). Piquer et al. 
(1991) observed a very low concentration of immunoglobulin A in intestine of poults 
until 9 d after hatch, followed by a marked increase until 29 d of age. 
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Vitamin E 
Vitamin E is the generic term for two groups of naturally occurring fat-soluble 
compounds, the tocopherols and the tocotrienols (Kasperek, 1980). In the 
tocopherols, the phytyl side chain attached to the chroman nucleus is saturated 
(a-, i9-, 1', and 5-tocopherol), whereas the tocotrienols (a-, 7-, and 5-
tocotrienol) have three double bonds in the phytyl side chain (Bjorneboe et al., 
1990). The most biologically active of these compounds is aTOC (Wilson, 1983), 
with the active site being the 6-hydroxyl group (Burton and Ingold, 1981; Wilson, 
1983). a-Tocopherol acts by inhibiting the peroxidation of membrane lipids, and 
the extent of its protection is related to the quantity of aTOC present in 
membranes. 
Absorption of VE is dependent upon normal lipid digestion and absorption; 
therefore, it will depend on adequate pancreatic function, biliary secretion, micellar 
formation, and penetration across intestinal membranes (Bjorneboe et al., 1990). 
Dietary VE is released from associated proteins by proteolytic enzymes and acidity 
in the stomach, and dissolved in fat globules, which, by the action of bile and 
pancreatic juice, are transformed into micelles. Once pancreatic lipases hydrolyze 
triglycerides (TG) into long chain fatty acids and monoglycerides, bile salts act 
upon them as detergents, cofactors for enzymes, and are also involved in the 
formation of mixed micelles. Tocopherol within micelles is mostly in the alcohol 
form, its absorption being enhanced by dietary lipids, especially medium chain fatty 
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acids. In contrast, retinoic acid (Bier! eta!., 1981) and polyunsaturated fatty acids 
(Gallo-Torres et al., 1971b) reduce the absorption of tocopherols. a-Tocopherol is 
absorbed by a passive diffusion process from the small intestine to the enterocyte. 
However, the transport of aTOC through the epithelial cell is not well understood, 
and it is thought to require several stages (Gallo-Torres, 1980; Diplock, 1985). In 
poultry, aTOC is incorporated into portomicrons for transport to the liver for 
storage and distribution (Gallo-Torres, 1980). 
The absorption efficiency of tocopherols and tocopherol esters is relatively 
poor (Simon et al., 1956; Gallo-Torres, 1980), the remainder being excreted in 
feces. Despite the greater uptake of 7-tocopheroi (7TOC) than that of aTOC 
because of its predominance in common feedstuffs, 7TOC averages only 15% of 
the concentration of aTOC (Behrens and Madere, 1985). However, no 
discrimination occurs between forms of VE such as aTOC and 7TOC (Traber and 
Kayden, 1989), or between RRR- and SRR-aTOC (Traber et al., 1990a; Traber et 
al., 1992a) during absorption and chylomicron secretion. Because of its 
hydrophobicity, VE requires a special transport system in aqueous environments of 
the plasma, extracellular space, and cell cytoplasm (Dutta-Roy et al., 1994). 
However, it does not have a special carrier protein in plasma and is transported in 
plasma by lipoproteins such as high density lipoproteins (HDL), low density 
lipoproteins (LDL), very low density lipoproteins (VLDL), and chylomicrons 
(CM)(Bjornson et a!., 1976). The vitamin is released from the enterocyte into the 
11 
lymph and bloodstream within the CM and VLDL. Chylomicrons and VLDL are TG-
rich lipoproteins that are in charge of transporting dietary fats and newly absorbed 
VE from the intestine to the liver (Gallo-Torres, 1970; Traber et al., 1986). 
Chylomicrons are catabolized in the circulation by lipoprotein lipase (LPL), which 
hydrolyzes core TG, releasing fatty acids. Because this process reduces the size 
of the CM core, excess surface is created. Surface components, such as 
cholesterol and phospholipids, are then transferred to HDL. During CM catabolism 
VE is found in all the circulating lipoproteins (Traber et al., 1988; Traber et al., 
1990a). Probably, VE is transferred to HDL, and from there, is further transferred 
to other lipoproteins (Traber et al., 1992b). This transfer process is not 
discriminatory, as RRR- and SRR-aTOC and 7TOC are similarly present in all of the 
lipoproteins at early time points (up to 12 h) following oral administration of these 
deuterium-iabeled tocopherols (Traber et al., 1988; Traber et a!., 1990a; Traber et 
al., 1992a). Some transfer of VE to tissues occurs during CM catabolism, 
mediated by LPL. !t occurs parallel to fatty acid transfer, and is dependent on 
binding of LPL to the cell surface (Traber et al., 1985). Tissues such as adipose 
tissue, muscle, or brain, that receive most of their lipids during the delipidation 
cascade, also receive VE as a result of LPL activity. 
Dietary lipids and VE are delivered to the liver by CM remnants (Cohn et al., 
1988). Then, they are repackaged by the liver and secreted into the plasma in 
VLDL These lipoproteins have a TG-rich core, and apolipoprotein B-100 as major 
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apolipoprotein. It has been demonstrated that VLDL are secreted preferentially 
enriched in RRR-oTOC (Traber et a!., 1990b), whereas the other isomers are 
excreted through the biliary canaliculi (Traber and Kayden, 1989). Thus, the liver, 
not the intestine, discriminates between tocopherols (Traber and Kayden, 1989; 
Traber, 1994). An aTOC binding protein (TBP,) of molecular mass 30 kDa, which 
specifically binds aTOC, has been isolated in the cytosol of liver of different species 
(Kaplowitz et a!., 1989; Sato et a!., 1991; Yoshida et a/., 1992). This TBP^ is 
thought to be responsible for specific incorporation of aTOC into nascent VLDL 
(Traber, 1994). Having some homology with the retinaldehyde binding protein of 
the retina (Sato et a!., 1993), the TBP, is expressed exclusively in the hepatocytes, 
and is absent from other tissues such as heart, spleen, or lung (Yoshida et al., 
1992). This TBP, is responsible for discrimination between the homologues by 
facilitating the transfer of aTOC from lysosomes to the endoplasmic reticulum for 
VLDL synthesis (Kayden and Traber, 1993). This would explain why the 7 
homologue, although efficiently absorbed, only accounts for 10 to 15% of plasma 
tocopherol. 
Plasma becomes preferentially enriched in RRR-aTOC as a result of VLDL 
catabolism (Traber et al., 1990a). During the conversion of VLDL to LDL in the 
circulation, a portion of the RRR-aTOC remains with the core lipids, and some is 
transferred to HDL. Equilibration of RRR-oTOC between LDL and HDL occurs 
because these two lipoproteins readily exchange aTOC without the assistance of 
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any transfer protein (Granot et al., 1988). Similar exchange has been reported 
between lipoproteins and erythrocytes. Lipoprotein lipase has been shown to enter 
cells via the specific high affinity LDL receptor. Since LDL functions as a transfer 
for aTOC, the LDL receptor mechanism also mediates the delivery of aTOC to cells 
(Dakshinamurti and Chauhan, 1994). However, there are other parallel 
mechanisms for aTOC uptake by cell membrane, since LDL receptor deficiency 
does not impair oTOC uptake (Cohn and Kuhn, 1989). A TBP (TBPg) has been 
identified and partially characterized from human erythrocytes and adrenal 
membranes (Kitabchi etal., 1980; Kitabchi and Wimalasena, 1982). The 
erythrocyte membrane contains aTOC as the major lipid-soluble chain-breaking 
antioxidant. Dutta-Roy et al. (1994) suggest a possible role of TBPg in aTOC 
uptake in these membranes. 
Little information is available about the transport of aTOC from cellular to 
intracellular membranes. The existence of a low molecular weight TBPg in the rat 
liver cytoso! has been demonstrated recently (Dutta-Roy et al., 1993a, 1993b). This 
14 kDa TBP2 specifically binds aTOC, but not the 7 or 5 homologues. It is likely 
that it acts by increasing the solubility of aTOC in the cytoplasm, enhancing its 
diffusion from the plasma membrane to the intracellular membrane-bound 
organelles. Since the 30 kDa TBP^ exists only in the liver, it is possible that this 
TBP^ is responsible for the secretion of aTOC into nascent VLDL, maintaining 
plasma levels of aTOC. The 14kDa TBP2, instead, would be responsible for 
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intracellular distribution and metabolism of aTOC in all tissues, including liver. The 
primary hepatic oxidation product of qTOC is a-tocopheryl quinone (Chow, 1985). 
This compound is further reduced to hydroquinone, conjugated with glucuronic 
acid and excreted in the bile, or degraded in the kidneys to a-tocopheronic acid, 
followed by conjugation and elimination in urine. Dimers and trimers have also 
been detected {Draper and Csallany, 1969). Draper and Csallany (1969) defined 
these dimers and trimers as terminal oxidation products of aTOC, formed in vivo as 
the result of reactions with lipid free radicals. 
Liver (Bjorneboe etal., 1986), skeletal muscle (Machlin and Gabriel, 1982), 
and adipose tissue (Traber and Kayden, 1987) are the tissues with greatest 
capacity to store aTOC. The adrenal glands accumulate more aTOC per gram of 
tissue than any other tissue (Dakshinamurti and Chauhan, 1994), and this may be 
due to a specific TBPg existent in this tissue (Kitbachi et al., 1980). Lungs and 
spleen are also relatively high in aTOC (Bjorneboe et al., 1986), indicating the 
importance of aTOC in protection against lung injury due to hyperoxia and the 
maintenance of immune response (Boxer, 1986). Testes and cerebrum contain 
less aTOC per gram of tissue than most other organs, and, therefore may be more 
prone to VE deficiency, resulting in signs such as reproductive failure (Evans and 
Bishop, 1922) and neurological disfunction (Kayden and Traber, 1986). The 
cerebral cortex has the highest and cerebellum the lowest concentration of aTOC 
in rat brain (Bjorneboe et al., 1986). 
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Vitamin E Requirements 
In the current NRC (1994) publication, the value given as the VE requirement 
of starting turkeys is the same as that reported by Scott (1953) and Scott et al. 
(1965) when the dietary selenium concentration was .1 mg/kg. This requirement 
was based on growth response, appearance of enlarged hocks and gizzard 
myopathy of male and female turkeys. The requirement was established as 12 lU 
of VE (as dl-aTACT)/kg of diet. One lU of VE is the activity of 1 mg of synthetic dl-
aTACT, .735 mg of d-aTACT, .671 mg of d-aTOC, or .909 mg of dl-aTOC. 
Additional requirements for the turkey breeder hen (Jensen and McGinnis, 1957) 
were established as 24 !U of VE/kg of diet, based on hatchability data, and an 
increase of aTOC content of eggs. However, these values were based on the level 
that avoided deficiency symptoms, rather than the one that would ensure optimal 
performance. It is known the VE affects many physiological functions, including the 
defense mechanism of the body, acting as an antioxidant and cell membrane 
stabilizing agent to protect the body from free radical-induced damage. One of the 
problems encountered in assessing VE requirements is the infrequent occurrence 
of clinical signs of deficiency. Although these vary considerably with species, the 
targets are in general the neuromuscular, vascular, and reproductive systems 
(Dutta-Roy etal., 1994). The classical diseases associated, at least in part, with an 
insufficiency in VE in the growing poultry are nutritional encephalomalacia, 
exudative diathesis, muscular dystrophy, and enlarged hocks (in the turkey) (Austic 
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and Scott, 1984). 
There are reports in the recent literature indicating the existence of 
encephalomalacia in 3- to 4-wk-old poults (Jortner et al., 1985; Klein et at., 1994), 
even in the presence of adequate (75.9 lU/kg) VE supplementation in the diet 
(Klein et al., 1994). One of the reasons for this increased susceptibility to VE 
deficiency diseases of young poults could be the marked decline observed in 
plasma and liver aTOC of poultry during early posthatching development. Dudin 
and Dvinskaya (1983) observed a decreased absorption of aTOC in chickens 
during the first 20 d of life, and an increased oxidation of aTOC to a-tocopheryl 
quinone in tissues during the first 10 d after hatching. These results were 
confirmed by Mezes (1988), who attributed this decrease to early postnatal 
development. Mezes (1988) reported that chicken liver aTOC levels remained low 
until 35 d of age. A similar early decrease in body aTOC stores has been 
observed for turkeys. Mecchi et al. (1956), Marusich et al. (1975), and Sklan et al. 
(1982) found that turkeys had a poorer ability than chickens to accumulate aTOC 
in their tissues. This was attributed to a decreased intestinal absorption of aTOC 
by turkeys, especially early in life, combined with an increased secretion of 
glucuronides (Sklan et al., 1982). More recently, Soto-Salanova (1991) and 
Mallarino (1992) observed a marked decrease in plasma and liver aTOC of young 
turkeys fed 12 lU of VE/kg of diet during the first 21 d after hatching. Dietary 
supplementation with 100 (Soto-Salanova, 1991), 150 (Applegate, 1995), or 800 
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(Mallarino, 1992) lU of VE/kg of diet only partly alleviated the depletion in tissue 
qTOC observed in young turkeys. Adding a bile salt (800 mg of sodium 
taurocholate/kg of diet), a synthetic antioxidant (500 mg of ethoxyquin/kg of diet), 
or using different concentrations (12 or 100 lU/kg) of a water-soluble VE (Soto-
Salanova et ai, 1993) did not have any effect on plasma or liver aTOC 
concentration. Even the use of a source of easily digested fat (coconut oil) did not 
change the pattern of decline observed in tissue aTOC of poults shortly after hatch 
(Soto-Salanova and Sell, 1995). 
Vitamin E is closely related to other components of the diet, including 
polyunsaturated fatty acids, antioxidants, sulfur amino acids, selenium, and other 
fat-soluble vitamins, and its requirement will vary according to the presence and/or 
absence of these factors in the diet. 
Factors Affecting Requirement: Vitamin A 
Since the early reports of Davis and Moore (1941) indicating a positive effect 
of adding VE to high VA diets, the nutritional interactions between these two 
vitamins have been studied extensively, with inconclusive results. McCuaig and 
Moztok (1970) observed that the negative effects of excessive VA on performance 
and viability of chickens were partly counteracted by the addition of 100 ID or more 
of VE/kg of diet. Similar results were observed recently by Weiser et al. (1991). In 
this study, Weiser et al. (1991) found that the adition of 60, 120, and 240 mg of 
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VE/kg of diet did not affect liver retinol stores, but mitigated the decrease in dry 
bone mass and tibia breaking strength caused by high dietary concentrations of 
VA (10,000 to 120,000 lU/kg of diet). The use of normal concentrations of dietary 
VE (20-30 lU/kg) or vitamin D3 (75-750 /ig/g) could not alleviate the negative effect 
that high doses of VA (33-63 mg/kg) had on performance and lipid digestibility of 
chicks (Vahl and and Klooster, 1987). 
Pellett et at. (1994) studied the interaction between VE and VA in protection 
against oxidative damage in chicks. These authors fed chicks diets containing 0 or 
50 lU of VE/kg, and 0, 30, or 100 mg of VA/kg for 3 wk, and observed that VE 
protected chicks against heme oxidation and lipid peroxidation (as measured by 
the production of thiobarbituric acid reactive substances, TBARS). Increased VA 
not only failed to protect chicks against hemichrome formation or TBARS, but also 
decreased retention of hepatic aTOC and increased production of TBARS and 
hemichrome. Lowered plasma concentrations of aTOC with increasing dietary 
concentrations of VA (10 to 50,000 !U/kg) had been reported by Frigg and Broz 
(1984). However, these authors found that intravenous injection of VE decreased 
the negative effect of VA, compared with supplementing the VE in the diet. These 
results confirmed those published by Sklan and Donoghue (1982) with chicks, 
indicating that the interaction between the two vitamins could occur in the 
gastrointestinal tract, prior to absorption. Sklan and Donoghue (1982) 
demonstrated that the interactions between VE and VA involved an enhanced 
19 
oxidation of dietary VE before reaching the absorption sites, an enhanced aTOC 
clearance from plasma by increased catabolism of tocopheryl glucuronides, and 
changes in enzymes involved in protection of cells against oxidative damage. 
Vitamin E Supplementation 
Sources 
Biological potencies of various VE compounds have been established 
primarily using the rat fetal resorption assay, with the following relationships; 1 mg 
dl-aTACT, 1.00 lU; 1 mg d-aTACT, 1.36 lU; 1 mg dl-a-tocopheryl succinate, 1.21 
ID; and 1 mg of d-a-tocopheryl succinate, .89 lU. However, recent VE 
bioavailability studies across animal species raised questions on the reliability of 
those established potencies (Ingold ef a/., 1987). Horwitt et al. (1984) studied the 
bioavailability of d-aTACT and dl-aTACT for humans. These authors reported that 
d-aTACT was 2.62 times more potent than dl-aTACT in increasing serum aTOC 
concentration 24 h after ingestion of a single oral dose of either source (d-aTACT 
or dl-aTACT) of the vitamin. It seems that tissues functioning in absorption and 
distribution of aTOC are stereoisomer discriminative, the discrimination being in 
favor of the natural form of VE. These results are supported by data published by 
Ferslew et al. (1993). Ferslew et al. (1993) tested the plasma and red blood cell 
(RBC) pharmacokinetics and bioavailability of the natural source (d-aTOC) and the 
synthetic (dl-aTOC) estereoisomers of aTOC after a single oral administration (400 
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mg) to humans. Plasma and RBC aTOC concentrations were greater for d-aTOC-
than for dl-aTOC-supplemented subjects, from 10 to 96 h postadministration. In 
cattle, Hidiroglou et al. (1988) compared the efficacy of four VE sources given 
orally to beef cows, dl-aTOC, d-aTOC, dl-oTACT, or d-aTACT. Cattle 
supplemented orally with 1,000 ID of d-aTOC or d-aTACT had higher serum aTOC 
levels than those supplemented with dl-aTOC or dl-aTACT. Hidiroglou and 
McDowell (1987) and Hidiroglou and Karpinski (1988) also reported that the natural 
form of the vitamin was more efficient than the synthetic form in increasing tissue 
aTOC levels of sheep after oral or intramuscular administration of VE. Recently, 
Chung et al. (1992) fed pigs 16, 48, or 96 lU of two different dietary VE sources, d-
oTOC, or dl-aTACT for 35 d after weaning. These authors found that, when VE 
was supplemented as d-aTOC, serum aTOC concentrations were consistently 
higher. Chung et al. (1992) stated that dietary d-aTOC may be more effectively 
absorbed and retained by weanling swine than dl-aTACT. They attributed the 
difference in serum aTOC to a limit in pancreatic esterase and (or) bile in the 
weanling pig for dl-aTACT hydrolysis and absorption. They also suggested a 
biological activity of 2.44 lU/mg of the alcohol relative to the acetate form of the 
vitamin for weanling swine. These data are in agreement with results obtained with 
fish. Hung et al. (1982) studied the uptake, transport, and distribution of dl-aTACT 
and d-aTOC by rainbow trout after administration of a single oral radioactive dose. 
Comparisons of plasma ^H and ^''C radioactivity suggested that the uptake of d-
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aTOC was 6 to 8 times greater than that of dl-aTACT during the first 4 h, and 2 to 
3 times greater between 8 and 64 h. 
The predominant source of VE supplementation in animal feeds has been dl-
aTACT. However, other commercial preparations, such as succinates and 
nicotinates, are also available. When dl-oTACT and dl-o-tocopheryl nicotinate 
(Gallo-Torres and Miller, 1971; Gallo-Torres et al., 1971a) were administered to 
rats, tissues preferentially selected dl-aTACT over dl-a-tocopheryl nicotinate. This 
occurred irrespective of route of administration of the two sources of VE, oral 
(Gallo-Torres etal., 1971a), or intravenous (Gallo-Torres and Miller, 1971). When 
the same sources of VE, dl-aTACT and dl-a-tocopheryl nicotinate, wtre 
supplemented to sheep (Hidiroglou and Charmley, 1991), there was a preferential 
incorporation of the tissues in favor of dl-aTACT, irrespective of route of 
administration of VE (intraruminal, or intraperitoneal). 
Different response methods have been used to assess the bioavailability of 
different dietary sources of VE for poultry. Dam and Sondergaard (1964) 
compared the effectiveness of the different tocopherol esters in prevention of 
encephalomalacia, and found a bioefficiency for d-aTACT of 168%, compared with 
that of dl-aTACT. Scott and Desai (1964) used the model of the muscular 
dystrophic chicken and observed a biopotency somewhat lower (146%). Using the 
chick liver storage bioassay, Matterson and Pudelkiewicz (1974) reported a 
bioefficiency of 121% for d-aTACT. Combs (1978) compared the natural alcohol, 
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d-aTOC, and dl-aTACT, and reported similar efficiency for d-aTOC and dl-aTACT if 
they were fed at dietary concentrations less than (or equal to) 40 mg of dl-
tocopheryi equivalents/kg of diet. Hakkarainen et al. (1984) used the prevention of 
encephalomalacia, and the liver and plasma storage of aTOC assays to establish 
the biopotency of the natural VE isomers in barley compared with that of dl-aTACT. 
These authors found a biopotency of 37% for the total VE in barley. More recently, 
Jakobsen et al. (1993) examined the biological activity of a mixture of d-a, d-7, and 
d-5TACT, and compared it with that of dl-aTACT. The results were dependent on 
the response parameters chosen, but were more favorable for the dl-aTACT form 
of the vitamin. Fuhrmann et al. (1994) used the hemolysis test and microsomal 
pentane production to assess the biopotency of the d-a, d-7, and d-5TACT in 
comparison with dl-aTACT. These authors, in contrast to what had been observed 
by Jakobsen et al. (1993), reported a bioefficiency of 134 to 137% of d-aTACT, of 
15.8 to 18.2% of d-7TACT, and of 4% of d-5TACT in comparison with dl-aTACT. 
Soto-Salanova et al. (1993) compared the efficacy of dl-aTACT and d-a-tocopheryl 
polyethylene glycol 1,000 succinate (TPGS) to improve aTOC status of young 
poults. These authors reported that the water-soluble form of VE (TPGS) did not 
have any effect on aTOC content of plasma or liver of 1- to 21-d-poults, whereas 
increasing dietary concentration of dl-aTACT from 12 to 100 !U/kg of diet 
increased liver and plasma aTOC from 1 to 21 d of age. Similar results were 
published for pigs (Ewan, 1990), and sheep (Hidirogou and Ivan, 1991), but some 
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reports for humans (Traber et al., 1986; Sokol et al., 1987) and captured wild 
animals (Papas, 1989, Eastman Chemical Division, P.O. Box 431, Kingsport, TN 
37662, personal communication) suggested that TPGS was an excellent source of 
VE under the conditions studied. This indicates that the response to the different 
sources of VE seems to be species dependent. Recently, Waibel et al. (1994) 
compared the activity of miceilized d-aTOC, micellized dl-aTACT, and dl-aTACT in 
young turkeys as indicated by serum and liver storage levels of aTOC. These 
authors reported that both micellized forms, d-aTOC and dl-aTACT, showed 
equivalent biopotency at the levels used in the experiment (10 and 25 lU/kg of 
diet). These forms also were more potent than dietary dl-aTACT at 25 lU/kg of 
diet. Moreover, the use of micellized d-aTOC in the drinking water resulted in a 
more marked increase in liver and serum aTOC as compared with any of the other 
treatments. Similar results were published by Wills and Rodick (1993) with 
chickens. In contrast, the use of different emulsifiable, nonemulsifiable, and 
micellized sources of dietary VE in sheep (Ochoa et al., 1992) resulted in similar 
serum and tissue concentrations of aTOC. 
Routes 
One of the problems in estimating the proper doses of VE supplementation 
for optimal performance and protection against disease is that biopotency of VE 
depends greatly on the method of administration (Hidiroglou et al., 1970). The 
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most common form of supplementing VE to poultry is through the diet. To the 
author's knowledge, there is very limited information, if any, on the parenteral 
adminstration of VE to chickens or turkeys. A recent study by Waibel et al. (1994) 
compared the efficacy of adding a micellized form of d-aTOC in the feed or in the 
drinking water of turkeys from 1 to 26 d of age. These authors reported a greater 
increase in liver and plasma aTOC when micellized d-aTOC was supplemented in 
the water than when it was added in the diet. 
Parenteral administration of VE has been commonly used in different species 
because no.losses are expected due to gastrointestinal absorption. Therefore, the 
advantage is based on a 100% bioavailability of the vitamin. Hidiroglou (1986) 
compared different routes of VE administration to sheep, and reported that 
intravenous administration of a single physiological dose of VE ensures a much 
higher VE specific activity in most tissues than using other routes such as 
intramuscular, oral, or intraruminal. In a follow-up study, Hidiroglou and Karpinski 
(1987) established that biological bioavailability of these four routes for sheep 
followed the descending order intravenous, oral, intraruminal, and intramuscular, in 
contrast, Judson et al. (1991) reported that, if the parenteral VE was given 
subcutaneously (and as dl-aTACT), oral administration was more effective than the 
injection to increase aTOC in liver and plasma of sheep. Hidiroglou and Charmley 
(1991) compared the intraruminal and the intraperitoneal routes to administer dl-
aTACT to sheep, and reported that the intraperitoneal route was more effective 
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than the intraruminal to increase aTOC stores in sheep. This was attributed to the 
mesenteric lymph vessels of the peritoneum, which will give easy access of aTOC 
to the bloodstream. 
Parenteral administration of a single high dose of VE has been commonly 
reported in the literature as a means of producing a rapid increase in aTOC stores 
of different species. Moreover, this form of supplementing VE has been 
demonstrated to be suitable for therapeutic treatment of VE deficiency in different 
species. Intramuscular injection of VE to black rhinoceros (Dierenfeld and Citino, 
1989) rapidly increased plasma oTOC, as compared with dietary VE 
supplementation. The dose injected in the experiment conducted by Dierenfeld 
and Citino (1989) was 5,760 lU/animal, which can be considered therapeutic. 
Similar results were published by Meydani et al. (1982) for owl monkeys, in which 
hemolytic anemia was decreased by injectable, but not by oral forms of VE. 
Intramuscular injection of a single dose of VE also has been reported to be 
successful in sheep (Hidiroglou and Karpinski, 1991) and pigs (Batra and 
Hidiroglou, 1994). Schwalbe et al. (1992) administered VE intravenously to 
premature infants deficient in VE, and reported a rapid response in plasma aTOC. 
Concentrations 
There are many reports in the literature illustrating the effect of different 
concentrations of supplemental VE on performance, tissue aTOC storage, and 
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protection of aTOC against disease of poultry. Most reports indicate, however, that 
there is little effect of VE supplementation on growth of turkeys. One hundred 
(Soto-Salanova eta!., 1993), 150 (Sell etal., 1994; Applegate, 1995), 300 (Sell et 
al., 1994), or 360 (Franchini et a!., 1990b) lU of added dietary VE failed to produce 
any changes in the weight of turkeys, compared with feeding low concentrations of 
VE. Soto-Salanova (1991) reported an increase in the weight of 1- to 21-d-old 
poults after feeding them diets supplemented with 100 lU of VE/kg of diet, and 
2,000, 5,000, or 8,000 lU of VA/kg of diet. Moreover, Soto-Salanova (1991) 
observed that the beneficial effect of including 100 lU of VE in the diet partly 
alleviated the decrease in weight produced by the high doses of dietary VA. Data 
reported by Mallarino (1992) indicated that adding 800 lU of VE/kg to the diet of 1-
to 21-d-old poults increased the weight of the turkeys, as compared with adding 12 
ID of VE/kg of diet. The dose administered by Mallarino (1992) can be considered 
pharmacological. The effects of feeding chicks a diet supplemented with massive 
amounts of VE were studied extensively by several researchers. March et al. 
(1973) reported a depressed thyroidal uptake and release of ^^^1 in chicks 
consuming a diet containing 200 lU of VE/kg. The same authors observed 
reduced growth, skeletal mitochondria, respiration rate, bone calcification, and 
hematocrit values of chickens fed 2,200 lU of VE/kg of diet. This high VE diet also 
caused reticulocytosis and increased prothrombin time, indicating a disturbance in 
the metabolism of vitamin K as a result of excessive VE intake. Ten thousand lU of 
27 
VE/kg of diet reduced calcium and phosphorus in blood plasma, dry fat-free bone, 
bone ash, bone calcium, and bone phosphorus (Murphy et al., 1981) of chicks fed 
different concentrations of vitamin D. However, the effect of excessive dietary 
intake of VE on performance of poultry has been inconsistent. No depression in 
growth was reported after feeding a diet with excessive VE to chickens (McCuaig 
and Motzok, 1970; Murphy et al., 1981). In contrast, a marked reduction in growth 
after feeding 2,000 or 4,000 lU of VE/kg of diet to chickens was reported by March 
etal. (1973) and Nockels etal. (1976), respectively. 
The use of increasing concentrations of dietary VE to increase aTOC in the 
body tissues has been documented for a variety of species. Hassan and 
Hakkarainen (1990) observed a linear relationship between increasing dietary 
concentrations of VE and aTOC levels in plasma of chickens. These results were 
confirmed by Sheehy et al. (1991). These authors fed chickens diets 
supplemented with 5 to 180 mg of VE/kg of diet, and observed parallel increases 
in plasma and tissue aTOC. In turkeys, Csallany et al. (1988) reported an increase 
in liver aTOC when dietary VE was increased from 0 to 10, or 300 lU of VE/kg of 
diet, irrespective of source of dietary fat (animal fat, hydrolyzed animal-vegetable 
fat, or soybean oil). Also, a linear increase of liver and plasma aTOC of turkeys 
was observed by Sell et al. (1994) after feeding 0, 25, 50, 75, 100, or 150 iU of 
VE/kg of diet. Similar increases were observed when dietary VE was increased to 
100 (Soto-Salanova, 1991; Soto-Salanova etal., 1993), 150 (Appelgate, 1995), or 
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800 (Mallarino, 1992) lU/kg of diet. Dogs (Piilai et a/., 1993), fish (Frigg et al., 
1990; Furones et al., 1992; Bai and Gatlin III, 1993), humans (Lehmann et al., 
1988), pigs (Asghar et al., 1991a: Chung et al., 1992), rats (Machlin and Gabriel, 
1982; Lehmann, 1981) and sheep (Hidiroglu and Charmley, 1990; Judson et a!., 
1991) exhibited similar behaviour when their diet was supplemented with increasing 
concentrations of dietary VE. 
Reports published by Heinzerling et al. (1974), Tengerdy and Nockels 
(1975), and Tengerdy and Brown (1977) indicated that dietary concentration? 
between 150 and 300 lU of VE/kg were effective in protecting chickens against E. 
coll infection. Recently, Qureshi et al. (1993) gave 1,10, and 250 times the NRC 
(1984) recommended levels of dietary VE to turkey poults, and observed an 
improvement in humoral and cell-mediated immune response as a consequence of 
an increased VE supplementation. These results corroborate those published by 
Franchini et al. (1990a). 
Indicators of Vitamin E Status 
Several different response criteria can be used to determine the qTOC 
status of an animal. However, the results obtained may vary depending on the 
response being evaluated, because not all response criteria estimate the same 
aTOC status. 
a-Tocopherol is widely distributed throughout the body and is most 
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concentrated in cell fractions rich in nnennbranes, such as microsomes and 
mitochondria. When VE is withdrawn from the diet, the rate of depletion of aTOC 
varies from tissue to tissue, being rapid in plasma, liver and heart, slower in skeletal 
muscle, and very slow in adipose tissue, brain, and nerves. However, one of the 
problems encountered when assessing the aTOC status of a species is that clinical 
signs observed in marginal or deficient individuals are often subtle, or may be 
absent; thus, the need for sensitive tests to provide a clinical diagnosis is therefore 
evident. Morrisey et al. (1993) classified the methods employed to assess VE 
status as static measurements, or functional tests. The first group of tests include 
the assay of aTOC concentration in different tissues. These are specific for VE 
status, and are generally employed in clinical practice. A second group of 
diagnostic methods includes the in vitro hemolysis tests, and the determination of 
biological changes which occur in connection with the lesions found in the skeletal 
muscle, liver, or heart of a marginal or deficient animal (i.e, production of cytotoxic 
aldehydes, alcohols, pentane, ethane, conjugated dienes, etc). A third group 
includes tests of specific enzymes. Enzyme assays are sensitive, a rise in the 
activity of an specific enzyme in plasma can usually be found before any 
pathological changes or clinical signs are observed. However, factors such as 
level of protein in the feed, physical exercise, and specially the age of the animals, 
can cause changes in activities of enzymes in plasma; thus, changes in plasma 
enzymes may not be related specifically to VE status. 
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Plasma and Liver a-Tocopherol 
ot-Tocopherol is widely distributed in the human and animal body, and is 
mainly stored in liver and adipose tissue (Gallo-Torres, 1980). Early studies used 
plasma and liver aTOC as an index of the aTOC intake and status. Bieri (1972) 
found that plasma and liver aTOC varied directly with the concentration of dietary 
VE. The relationship observed was linear between plasma and liver aTOC 
concentration in rats and the logarithm of the dietary VE concentration. Machlin 
and Gabriel (1982) reported that liver was the major storage organ for available 
aTOC. Since then, several authors have used liver and/or plasma aTOC as 
indicators of aTOC status in different species. Liver aTOC was used for chickens 
(Sheehy et al., 1991), pigs (Jensen ef a/., 1990; Chung et ai, 1992), trout (Furones 
ef al., 1992), and turkeys (Sklan et al., 1982; Csallany et al., 1988; Soto-Salanova 
et a!., 1993), whereas plasma aTOC was used in calves (Reddy et a!., 1987), 
chickens (Hakkarainen et al., 1984; Hassan and Hakkarainen, 1990), humans 
(Dimitrov et al., 1991), mink (Tyoponnen et al., 1984), and pigs (Jensen et al., 
1990). However, results obtained by some other authors (Hidiroglou and 
Charmley, 1990) suggested that plasma aTOC may not be a reliable index of 
aTOC intake or status, and that liver, or some other tissue, may represent better 
the actual oTOC status of an animal. 
The validity of using plasma aTOC as an indicator of adequate aTOC status 
was first questioned in 1972. Horwitt et al. (1972) found that, in humans, plasma 
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aTOC increased in response to an increase in the level of plasma lipids. Similar 
results were confirmed later for humans by Horwitt et al. (1984), and for rats 
(Lehmann, 1981). As a result, these authors proposed that the plasma aTOC/lipid 
ratio, and not plasma aTOC, should be used as the indicator of aTOC status. 
Simultaneously, Lehmann (1981) observed that qTOC content of platelets was 
independent of the lipid content in plasma. In fact, platelet oTOC content 
accurately reflected changes in dietary VE, and this observation led Lehmann 
(1981) to propose the use of platelet aTOC, and not plasma aTOC or the plasma 
aTOC/lipid ratio as the best indicator of the status of aTOC in rats. Vatassery et 
al. (1983) published similar findings for humans. These authors observed a linear 
relationship between platelet aTOC content and the amount of VE consumed, at 
least until the intake reached 1,800 lU/d. 
Red blood cells have also been used as an indicator of aTOC intake or 
status. A linear increase of RBC aTOC in response to dietary VE has been 
reported for cattle (Roquet et al., 1992; Sconberg et al., 1993), guinea pigs (Kelly er 
al., 1992), rats (Lehmann, 1981; Behrens and Madere, 1990), and sheep (Fry et 
al., 1993). 
In avian species, plasma and/or liver aTOC have been used as indicators of 
VE biopotency and status (Marusich et al., 1975; Bartov, 1983; Hakkarainen etal., 
1984; Csallany et al., 1988; Sheehy et al., 1991; Soto-Salanova, 1991; Soto-
Salanova et al., 1993). A linear response of plasma and liver aTOC in response to 
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dietary VE supplementation has been reported by Hakkarainen et at. (1984) and 
Sheehy et a/. (1991) in chickens, and by Franchini et al. (1990b) and Crisetig et al. 
(1991) in turkeys. 
Erythrocyte Hemotysis 
An increased fragility of the RBC to in vitro oxidative stresses has also been 
associated with an inadequate VE status. The hemolysis test reflects the impaired 
resistance of cell membranes against peroxidative damage (Mino et al., 1985). 
Erythrocytes are major targets of oxyradical attack, because they are rich in 
polyunsaturated fatty acids, and are continuously exposed to high oxygen tension. 
Furthermore, the hemoglobin and iron they contain are powerful catalysts of 
oxidative reactions (Fraga et al., 1990). An insufficient intake of aTOC leads to 
oxidative changes in the fatty acids of the erythrocyte membrane (Hamada et al., 
1982), making them more susceptible to hemolysis. 
The hemolysis test is based on th'i measurement of the resistance of RBC 
membranes against stress imposed by agents such as dialuric acid, hydrogen 
peroxide, or t-butyl hydroperoxide (BHP). The method was first developed by 
Rose and Gyorgy (1950), who observed that RBC of rats receiving adequate 
amounts of VE were completely protected against the hemolyzing effect of dialuric 
acid, whereas those of VE-deficient rats were not. Mino et al. (1981) reported 
similar results after feeding rats a VE-deficient diet for 7 wk. These authors found 
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that erythrocytes of rats whose minimum RBC and plasma aTOC levels were 40 
and 180 /ig/dL, respectively, were resistant against hemoly^'s by dialuric acid. 
Instead, complete hemolysis was detected in rats having RBC aTOC values of less 
than 20 ^g/dL Brownlee et al. (1977) stated that lipid peroxidation and hemolysis 
of RBC of VE-deficient rats were concurrent rather than consecutive events. They 
suggested that the hydroxyl radical, generated from the intracellular decomposition 
of hydrogen peroxide, was the hemolytic agent, whereas lipid peroxidation was 
produced by superoxide, which was also generated from hydrogen peroxide. 
Recently, Eicher et al. (1994) used hydrogen peroxide-induced hemolysis to 
confirm VE deficiency in rats. Hemolysis values increased from 4.2% in VE-
adequate rats to 92.6% in VE-depleted rats. 
Applegate (1995) observed in poults that susceptibility of RBC of 1- to 22-d-
pouits to hemolysis was much greater for poults fed diets with no supplemented 
VE than for poults fed 150 lU of dl-aTACT/kg of diet. Moreover, RBC hemolysis 
was highly correlated with liver and plasma qTOC concentration from 13 to 22 d of 
age. Fischer et al. (1970) reported that erythrocytes of young chicks on a VE-
deficient diet were more prone to lysis with hydrogen peroxide solution than RBC 
of poults fed a VE-supplemented diet. More recently, Fuhrmann et al. (1994) 
observed a high degree of hemolysis of RBC of chicks fed diets supplemented with 
less than 22 mg of dl-aTACT/kg of diet. Concurrently, encephalomalacia was 
observed in chicks fed 2.75 mg or less of dl-aTACT/kg of diet. 
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Differences in the susceptibility of erythrocytes of different species to 
hemolysis have been reported when BHP was used as the peroxidative agent. 
Smith et al. (1988) found that chicken erythrocytes were more susceptible to 
hemolysis than human, bovine, or pig red cells (Smith and Nunn, 1986). Smith et 
al. (1988) attributed the different susceptibility to the different erythrocyte 
membrane structure of the species mentioned. Chicken RBC had a higher linoleic, 
and a lower oleic content than RBC of humans, pigs, or cattle. Moreover, adding 
undialyzed plasma to erythrocytes treated with BHP markedly decreased hemolysis 
of chicken RBC, whereas the addition of dialyzed plasma had little effect on 
erythrocyte hemolysis (Smith et al., 1988). The low concentration of ceruloplasmin 
found in chicken plasma may have been another factor contributing to the lack of 
protection of chicken RBC against hemolysis, compared to the other species 
studied. 
ThiQbarbi&jric Acid Reactive Substances 
The susceptibility of an animal to oxidative damage depends on the balance 
between oxidative stress and antioxidant defense capacity. Of the antioxygenic 
nutrients that play a role in protecting cells against oxidative damage, aTOC is the 
most important, having the ability to scavenge free radicals, delaying or preventing 
the chain reactions that occur in lipid peroxidation. According to Urano et al. 
(1990), the hydroxyl group of aTOC is hydrogen bonded to the carbonyl group of 
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a fatty acid ester in the phospholipids of bilayer liposomes, and in this way the 
aTOC molecule is held close to the surface of membranes formed by the 
unsaturated fatty acid moiety of phospholipids. This position in the membrane 
would enable the aTOC molecule to act as a radical chain-breaking antioxidant, 
and as stabilizing agent, restricting the mobility of components of the biological 
membranes. In fact, this notion was further supported by the findings of Nardini et 
al. (1993), who reported that, once the dietary requirement for VE of rats was 
satisfied, an increased consumption of polyunsaturated fatty acids from vegetable 
oils did not enhance lipid peroxidation in physiological conditions. In practical 
conditions, it is possible to measure the aTOC status on the basis of the degree of 
lipid peroxidation, which can be done by quantifying secondary products of lipid 
peroxidation, such as malondialdehyde, alcohols, pentane, ethane, and conjugated 
dienes. Although malondialdehyde is only a secondary product of lipid 
peroxidation, its measurement by the TEARS assay gives a good estimation of the 
lipid peroxidation that has ocurred in the system under study. 
Lipid peroxidation in vitro has been associated with a decreased aTOC 
status of poultry. In turkeys, Csallany et al. (1988) found an inverse relationship 
between hepatic aTOC and TEARS values in the muscle of 14-wk-old turkeys (r=-
.94), after feeding them diets supplemented with 0, 10, or 300 lU of VE/kg. 
Applegate (1995) observed a decreased production of TEARS in livers of turkeys 
fed 150 lU of VE/kg from 1 to 22 d of age. The same author found that liver 
36 
TBARS were inversely correlated with plasma and liver aTOC only after 13 d of 
age. Sheehy et al. (1993) obsen/ed a reduction in the production of TBARS in 
plasma of chicks fed diets supplemented with 50 lU of VE/kg, compared with 
those receiving no supplemental VE. Furthermore, the low aTOC levels measured 
in plasma of chicks receiving no supplemental VE reduced the supply of aTOC to 
the tissues, which resulted in an increased susceptibility of thigh and breast 
muscles to lipid peroxidation. Sheehy et al. (1993) stated that high dietary VE and 
high tissue aTOC were associated with a greater stability of tissues to lipid 
peroxidation. Similarly, RBC TBARS of chicks fed 0 lU of VE/kg were much higher 
than those of chicks receiving 50 mg of VE/kg of diet (Pellett et al., 1994). 
The production of tissue TBARS has been studied for a variety of species. 
Decreased TBARS as dietary concentration of VE increased has been generally 
reported, supporting the idea of VE having a protective effect against oxidative 
damage. Muscle TBARS were decreased in cattle (Arnold et al., 1992; Arnold et 
al., 1993; Walsh et al., 1993), poultry (Marusich et al., 1975; Csallany et al., 1988; 
Franchini et al., 1990b; Bartov and Frigg, 1992; Sheehy et al., 1993), sheep (Fry et 
al., 1993), swine (Monahan etal., 1992), and trout (Frigg et al., 1990) as increasing 
concentrations of supplemental VE were provided to the animals. Meydani et al. 
(1988) studied the susceptibility of lipid components of neuronal tissue of rats to 
radical reactions and peroxidation after feeding them diets supplemented with 30 or 
200 lU of VE/kg. The cerebellum was the region of the brain that accumulated the 
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lowest aTOC concentration of all brain segments analyzed. However, increasing 
dietary VE from 30 to 200 lU/kg of diet markedly increased aTOC concentration in 
the cerebellum, and decreased cerebellum susceptibility to lipid peroxidation 
(Meydani ef a/., 1988). The cerebellum was most susceptible to lipid peroxidation, 
probably due to its high content in iron and phospholipids with polyunsaturated 
fatty acids, and to the high rate of oxygen consumption exhibited by this region of 
the brain. 
En2ymes 
The levels of certain enzymes in plasma are thought to represent an 
equilibrium between the rate of release from the cells and the rate of removal from 
the blood. An increase in the activity of a tissue enzyme in blood can usually be 
detected before any pathological changes or clinical signs are observed in the 
tissue, and indicate the existence of tissue damage. However, enzyme tests to 
indicate aTOC status in an animal should be used as a companion indicator. iViost 
enzymes are distributed universally throughout the body, and thus, an increase in 
their activity in plasma is not always a specific indicator of aTOC status. However, 
combined with clinical indications and pathological findings, they are a useful 
criterion if an accurate diagnosis is to be made. Several enzymes have been used 
to determine aTOC status in different species, and the results have been 
controversial (Tollersrud, 1973; Reddy ef a/., 1987; Franchini efa/., 1990b; Asghar 
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etal., 1991a). 
Little information exists on the use of changes in the activity of plasma 
enzymes to assess VE status of poultry. Franchini et al. (1990b) reported no 
changes in the activity of plasma alkaline phosphatase (AP) of turkeys with 
increasing concentrations of dietary VE (30 to 360 ppm). However, AP was 
increased in plasma of chickens fed 325 ppm of dietary VE (Franchini et al., 1988). 
These authors proposed that this increased plasma AP activity indicated a more 
active cell multiplication and a better cell metabolism in chickens receiving 
adequate VE. Jakobsen et al. (1993) reported a decrease in the activities of 
plasma aspartate amino transferase (GOT) and creatine kinase (CK) with increased 
supplementation of dietary VE. They also reported that both dietary forms of VE 
used, a mixture of d-o, 6-y, and d-5TACT, and dl-aTACT, were effective in 
decreasing these enzymes. 
In pigs, Hyldgaard-Jensen (1973) reported that damage to the skeletal 
muscle, liver, or heart (tissues primarily affected by VE deficiency in pigs) could be 
located by an examination of the lactate dehydrogenase (LDH) enzyme pattern in 
plasma. A concurrent increase in plasma CK of VE-deficient pigs would indicate 
muscular dystrophy, whereas elevated plasma levels of GOT, glutamate 
dehydrogenase, or ornithine carbamyl transferase would be an indication of liver 
necrosis. Hyldgaard-Jensen (1973) suggested the combination of these enzyme-
tests to improve the sensitivity of the analysis, and to establish the magnitude of 
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the damage in a specific tissue. Toilersrud (1973) evaluated changes In the 
activities of several serum enzymes [GOT, alanine aminotransferase (GPT), 
isocitrate dehydrogenase (ICD), and LDH] in control and VE-deficient pigs. High 
levels of serum GOT and GPT of VE-deficient pigs indicated myocardial injury, 
whereas the increased levels of ICD indicated liver damage due to VE deficiency. 
Duthie et at. (1989) reported a decrease in the leakage of OK and pyruvate kinase 
(PK) from muscle to plasma of stress-susceptible pigs when their diets were 
supplemented with approximately 20 times the normal VE requirement (200 vs 10 
lU/kg of diet). However, Asghar et al. (1991a) failed to detect changes in the 
activities of LDH, OK, and GOT in plasma of pigs fed increasing concentrations of 
dietary VE (10, 100, and 200 lU/kg of diet). 
Whereas increased activities of LDH, OK, or GOT in plasma of VE-deficient 
calves (Reddy et al., 1987; Sconberg et al., 1993), rats (Sokol et al., 1991), sheep 
(Horton eta!., 1978; Stevenson and Jones, 1989; Walsh etal., 1993), and swine 
(Ruth and van VIeet, 1974) have been reported. Fry et al. (1993) did not detect any 
increase in the activity of plasma CK of sheep fed VE deficient diets for 12 wk. In 
trout challenged with an enteric pathogen {Yersinia ruckeri), there was a decrease 
in plasma PK activity with increasing concentrations of dietary VE (7 to 86, or 806 
lU/kg), which indicated a protective effect of dietary VE against tissue damage 
caused by the disease (Furones et al., 1992). 
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CHAPTERS. EXPERIMENT 1 
Materials and Methods 
Five hundred and forty 1-d-old, Nicholas Large White male turkey poults 
were obtained from a commercial hatchery. Fifteen poults were distributed to each 
of thirty-six pens so that the average poult weight was approximately the same in 
each pen. Each of nine treatments was randomly assigned to four pens. 
Eight of the treatments resulted from the factorial combination of two dietary 
vitamin E (VE) concentrations, two dietary vitamin A (VA) concentrations, and two 
concentrations of injected VE. Poults were fed corn-soybean meal diets containing 
12 (LED) or 300 (HED) lU of added dl-a-tocopheryl acetate^ (dl-aTACT)/kg of diet, 
or were subcutaneously injected in the dorsal area of the neck at Day 1, and in the 
area of the breast at Days 7 and 14, with amounts of dl-a-tocopherol^ (dl-aTOC) 
approximately equivalent to the amount poults would consume if their diet was 
supplemented with 12 (LEI) or 300 (HE!) of VE/kg. Trying to minimize differences 
due to the injection per se, the source of injectable VE was diluted with the 
injectable carrier^ so as to contain the appropriate amount of VE in the volume 
injected at each age, .15 mL at Day 1, .25 mL at Day 7, and .50 mL at Day 14. 
^Rovimix® E-50, 500 lU of dl-a-tocopheryl acetate/g. Hoffmann-La Roche, Inc. 
Nutley, NJ 07110 
^Rocavif^-E-Roche, 250 lU of dl-a-tocopherol/mL. Hoffmann-La Roche, Inc. 
Nutley, NJ 07110 
^Placebo vehicle. Hoffmann-La Roche, Inc. Nutley, NJ 07110 
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The actual amount of VE injected to poults in the LEI group was 1.5 lU at Day 1, 
2.5 lU at Day 7, and 5 lU at Day 14, whereas poults in the HEl group received 37.5 
lU at Day 1, 62.5 iU at Day 7, and 125 lU at Day 14. For the overall period, LEI 
and HEl poults received 9 and 225 IU of dl-aTOC/poult, respectively. The four VE 
treatments were used in a complete factorial arrangement with two dietary 
concentrations of VA [5,000 (LA) and 15,000 (HA) IU of retinyl acetate/kg of diet]. 
During the 21-d experimental period, poults in four additional pens were injected 
with the carrier of the injectable VE. Poults in this ninth treatment were injected at 
Days 1, 7, and 14 with a volume of carrier equal to the volume of dl-oTOC injected 
to poults receiving the LEILA, LEIHA, HEILA, and HEIHA treatments. This 
treatment was used to assess any influence of the carrier on the results of the 
experiment. 
During the experiment, turkeys were housed in electrically heated battery 
brooders'^. Temperature inside the pens was maintained at 35 C for the first week 
of experiment, at 32 C during the second week, and at 29 C until the end of the 
trial. Room temperatures ranged between 23 and 25 C during the 21-d period. 
Feed and water were provided for ad libitum consumption throughout the 
experiment. 
Turkeys in all treatments were fed a typical corn-soybean meal starter diet. 
All diets were formulated to meet or exceed the NRC (1984) recommended nutrient 
''Petersime, Gettysburg, OH 45328 
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concentrations for a turkey starter diet, except for VE, and were calculated to be 
isocaloric (2,900 kcal ME^/kg) and isonitrogenous (28.5% protein). Composition of 
the diets is shown in Table 3.1. 
Feed samples from each diet were taken at the time of mixing, and stored at 
4 C until analyzed for dry matter, ash, protein, and fat. An extra sample from each 
diet was also taken at mixing time, and stored at -20 C for VE analysis. Feed 
samples used for proximate analysis were ground to pass through a 1.0 mm mesh 
sieve. Dry matter was determined by drying the samples in a forced draft oven at 
72 C until constant weight was achieved. Ash was determined by placing the 
samples in a muffle oven at 600 C for 24 h. The macro-Kjeldahl procedure 
(Association of Official Analytical Chemists, AOAC, 1980, section 2.057) was used 
to determine nitrogen concentration. To obtain protein percentage, nitrogen values 
were multiplied by 6.25 (AOAC, 1980, section 14.068). Fat concentration in the 
feed was determined by the ether extract procedure (AOAC, 1980, section 7.056). 
Tocopherol isomers and TACT were extracted from the diets with acetone in a 
Soxhiet extractor, evaporated to dryness and redissolved in hexane, and then, 
separated and quantitated by high performance liquid chromatography (HPLC) 
(Cort et a!., 1983). Calculated and determined analyses of the diets are shown in 
Tables 3.2 and 3.3, respectively. 
Body weight (BW) and feed intake (F!) of the poults were measured at 1, 3, 
5, 7, 14, and 21 d of age. Feed efficiency (FE) was calculated as the F1 to BW 
TABLE 3.1. Ingredient composition of the corn-soybean meal diets^ 
Ingredient LEDLA LEDHA HEDLA HEDHA LEILA LEIHA HEILA HEIHA 
/ f t / \  
Corn 37.86 37.66 37.57 
V/o; 
37.37 37.87 37.67 37.87 37.67 
Soybean meal 53.63 53.63 53.63 53.63 53.63 53.63 53.63 53.63 
Dicalcium 
phosphate 2.34 2.34 2.34 2.34 2.34 2.34 2.34 2.34 
Limestone 1.46 1.46 1.46 1.46 1.46 1.46 1.46 1.46 
Animal-vegetable 
fat 3.83 3.83 3.83 3.83 3.83 3.83 3.83 3.83 
Mineral premix^ .30 .30 .30 .30 .30 .30 .30 .30 
Vitamin premix^ .30 .30 .30 .30 .30 .30 .30 .30 
Premix E'* .012 .012 .30 .30 
Premix A® .10 .30 .10 .30 .10 .30 .10 .30 
DL-methionine .168 .168 .17 .17 .17 .17 .17 .17 
^ Basal corn-soybean meal diets, to which vitamin E was added as 12 (LEDLA and LEDHA) or 300 
(HEDLA and HEDHA) lU of dl-a-tocopheryl acetate/kg of diet, and vitamin A was added as 5,000 (LEDLA, 
HEDU\, LEILA, and HEILA) or 15,000 (LEDHA, HEDHA, LEIHA, and HEIHA) lU of retinyl acetate/kg of diet. 
^Supplied per kilogram of diet: manganese, 70 mg; zinc, 40 mg; iron, 37 mg; copper, 6 mg; 
selenium, .15 mg; sodium chloride, 2.60 g. 
^Supplied per kilogram of diet: cholecalciferol, 1,500 ID; vitamin 11 vitamin K 
(menadione sodium bisulfite), 1.8 mg; riboflavin. 2.7 mg; pantothenic acid, 7 mg; niacin, 75 mg; 
choline, 509 mg; folic acid, .55 mg; biotin, 75 /xg. 
(cont.) 
''Supplied per kilogram of diet: dl-a-tocopheryl acetate, 12 lU when used at .012%; and 
300 iU when used at .30% of the diet. 
^Supplied per kilogram of diet: retinyl acetate, 5,000 IU when used at .10%; and 15,000 IU 
when used at .30% of the diet. 
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TABLE 3.2. Nutrient composition of the corn-soybean meal diets 
Calculated analysis Basal diet 
Dry matter, % 90.60 
MEn, kcal/kg 2,900.00 
Protein, % 28.50 
Ether extract, % 5.50 
Total sulfur amino acids, % 1.05 
Methionine, % .61 
Lysine, % 1.75 
Calcium, % 1.20 
Available phosphorus, % .60 
Sodium, % .12 
Chloride, % .22 
Potassium, % 1.20 
Selenium, mg/kg .22 
Zinc, mg/kg 72.40 
Iron, mg/kg 582.00 
Vitamin A\ lU/kg 5,040.00 
Cholecalciferol, lU/kg 1,500.00 
Vitamin E^ lU/kg 10.00 
Riboflavin, mg/kg 4.90 
Pantothenic acid, mg/kg 24.00 
Niacin, mg/kg 96.00 
Choline, mg/kg 2,099.00 
Linoleic acid, % 2.30 
^Calculated analysis for vitamin A: 5,040 lU when used at .10% of the diet, and 
15,090 when used at .30% of the diet. 
^Calculated analysis for vitamin E: 22 ID when used at .012%; and 310 lU 
when used at .30% of the diet. 
TABLE 3.3. Determined composition of the corn-soybean meal diets^ 
LEDLA LEDHA HEDLA HEDHA LEILA LEIHA HEILA HEIHA 
Dry matter, % 88.75 88.90 88.91 89.06 88.16 88.82 88.50 89.10 
Protein, % 29.80 29.04 28.73 29.04 29.44 29.15 28.60 28.77 
Ether extract, % 5.62 5.64 6.29 6.01 5.26 5.62 5.60 5.72 
Ash, % 6.72 6.62 6.87 6.84 6.14 6.60 6.33 6.61 
Vitamin E, lU/kg 19.96 15.55 234.14 220.32 8.81 7.01 6.81 6.64 
^ Basal corn-soybean meal diets, to which vitamin E was added as 12 (LEDLA and LEDHA) or 300 
(HEDLA and HEDHA) lU of dl-a-tocopheryl acetate/kg of diet, and vitamin A was added as 5,000 (LEDLA, 
HEDLA, LEILA, and HEILA) or 15,000 (LEDHA, HEDHA, LEIHA, and HEIHA) lU of retinyl acetate/kg of diet. 
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gain ratio for each of the periods studied. At 1 d of age, 18 poults were randomly 
selected for sampling to obtain baseline data (six pooled samples). Subsequently, 
two poults were selected at random from each pen for sampling at 3, 5, 7, 14, and 
21 d of age. 
Blood was obtained by jugular venipuncture by using heparinized syringes 
(200 U heparin/mL). Blood samples were stored in crushed ice (4 C) until 
centrifugation. Then, blood was centrifuged at 1,500 x g for 15 minutes, and 
plasma was aspirated with a Pasteur pipette, transferred to tubes, and frozen at -20 
C for subsequent aTOC determination. Plasma aTOC concentration was 
determined by the method described by Cort et at. (1983). Plasma (2 mL) was 
deproteinized with absolute ethanol (3 mL), and tocopherols were extracted with 
hexane (1 mL). Tocopherol concentrations were determined by HPLC, with 
fluorescence retention at 294 nm excitation wavelength and 323 nm emission 
wavelength. The mobile phase was 3.5% tetrahydrofuran (vol/vol) in hexane, with 
a flov/ rate of 2.2 mL/min. The sample extracted in hexane was injected directly 
into the HPLC. a-Tocopherol was identified and quantitated by the comparison of 
retention times and peak areas with aTOC standards. 
After blood samples were taken, turkey poults were killed by Halothane®^ 
inhalation and the following tissues were excised: abdominal adipose tissue (ADT), 
breast muscle [Pectoralis superficialis), small intestine (SI), leg muscle {Biceps 
^Halocarbon Laboratories, North Augusta, SC 29841 
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femoralis), liver, and uropygial gland. Portions of ADT were taken from the external 
lateral area of the body cavity, and only a sample was used for aTOC analysis. 
Small intestine samples were flushed with saline solution (containing .89% NaCl). 
All tissue samples were frozen in liquid nitrogen, weighed, and stored at -20 C until 
prepared for aTOC determination. At 7, 14, and 21 d of age, tibia of turkeys was 
excised for ash and fat determination. 
Tissue samples were thawed at room temperature, and .05 to 2 g 
(depending on the age of the poults and the amount of aTOC expected) were 
homogenized in 10 mL (wt/vol) of phosphate-EDTA buffer (pH 7.0). Tissue 
tocopherols were then determined by HPLC by processing 2 mL of the tissue 
homogenate as described earlier for plasma. 
Statistical analysis of data obtained within each age was performed 
according to the General Linear Model (GLM) procedure of SAS® (SAS Institute, 
1985) to determine main effects of route of administration of VE (RT), concentration 
of VE, and concentration of VA, and the interaction among these three factors. 
Regression analyses were done to determine the relationships between plasma 
aTOC and aTOC in ADT, breast muscle, SI, leg muscle, liver, and uropygial gland. 
Similarly, analyses were done to determine the relationships between liver aTOC 
and aTOC in ADT, breast muscle, SI, leg muscle, and uropygial gland. Correlation 
coefficients were derived by taking the square root of the r-square values. The arc 
sine transformation was used before analysis of data expressed as a percentage. 
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Results 
Body weight of poults, separated for each treatment group or by main effect 
means, is presented in Tables 3.4 and 3.5, respectively. Body weight averaged 66, 
120, 236, and 418 g/poult at 1, 7, 14, and 21 d of age across all treatment groups 
(Table 3.4). Concentration of VE affected (P < .008) BW only at 21 d of age, 
although poults receiving the HE treatments (300 lU of VE/kg of diet, or its 
equivalent in the injection) had numerically greater BW than those receiving the LE 
treatments from 3 to 21 d of age (Table 3.5). Giving the VE by subcutaneous 
injection had a negative impact on BW at all ages. Poults receiving the injection 
treatments were lighter than those receiving the dietary treatments at 3 (P < .09), 5 
(P < .009), 7 (P < .001), 14 (P < .001), and 21 (P < .001) d of age. At 21 d of 
age, the increase in BW of poults caused by subcutaneous injection of HE was 
greater than that caused by injecting LE, but only when diets contained LA. This 
resulted in a VE by RT (P < .04) interaction at the end of the experiment. 
Concentration of supplemental VA did not affect BW of the poults until 21 d 
of age. At this time, poults receiving 15,000 III of VA/kg of diet were heavier (P < 
.001) than poults fed 5,000 lU of VA/kg of diet. Dietary HA increased 21-d BW of 
HED, LEI, and HEl treatment groups, but decreased BW of LED groups, resulting 
in VE by VA (P < .007), RT by VA (P < .001) and VE by RT by VA (P < .001) 
interactions at 21 d of age (Table 3.5). 
Feed intake of poults averaged 523 g for the 21-d period across all 
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TABLE 3.4. Body weight of poults as influenced by vitamin E provided in the 
diet or by subcutaneous injection, and by dietary vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
Vy/ 
LEDLA 66 80 104 124 257 463 
LEDHA 66 79 101 120 252 451 
HEDLA 66 84 105 125 254 458 
HEDHA 67 82 105 126 243 468 
LEILA 66 80 98 108 197 298 
LEIHA 66 80 100 119 241 419 
HEILA 66 79 101 118 219 386 
HEiHA 66 80 99 116 223 403 
SEM^ 1 2 3 10 10 
Probabilities 
Treatment .12 CD
 
b
 
.003 .001 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.5. Main effect means of body weight of poults as influenced by 
vitamin E provided in the diet or by subcutaneous injection, 
and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
(.y/ puuii; 
By vitamin E concentration (VE) 
LE (12 lU/kg) 66 80^ 101 118 237 408 
HE (300 lU/kg) 66 81 102 121 235 429 
By vitamin E route (RT) 
Diet 66 81 104 124 252 460 
Injection 66 80 99 115 220 377 
By vitamin A concentration (VA) 
LA (5,000 iU/kg) 66 80 102 119 232 402 
HA (15,000 IU/kg) 66 80 101 120 240 435 
Probabilities 
VE .11 .44 .17 .80 .006 
RT .09 .009 .001 .001 .001 
VA .86 .63 .48 .28 .001 
VE * RT .02 .65 .94 .56 .04 
VE * VA .72 .90 .44 .13 .007 
RT * VA .28 .51 .22 .03 .001 
VE * RT * VA .99 .22 .07 .24 .001 
Voults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEl treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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treatment groups (Table 3.6). There was no effect of concentration of VE on Fl (P 
> .05) during the 21-d experiment (Table 3.7). Instead, the route of VE 
administration had a marked effect on Fl for each age-period studied, and from 1 
to 21 d of age. Subcutaneous injection of VE to turkeys decreased (P < .007) Fl 
from 1 to 7, 7 to 14, 14 to 21, and from 1 to 21 d of age (Table 3.7), compared 
with dietary supplementation of VE. At 21 d of age, poults in the dietary treatments 
had consumed 575 g of feed, whereas those in the injected treatments had 
consumed only 472 g. Dietary concentration of VA did not have a main effect (P > 
.05) on Fl of the poults throughout the experiment (Table 3.7). However, from 14 
to 21 d of age, giving 15,000 lU of VA/kg of diet (HA treatments) decreased Fl of 
LED, HED, and HEI groups, but increased Fl of LEI-treated poults, resulting in VE 
by VA (P < .02), RT by VA (P < .02), and VE by RT by VA (P < .007) interactions 
during that period. For the overall period, increasing dietary VA concentration from 
5,000 to 15,000 lU/kg of diet decreased Fl of those poults fed VE (either 
concentration), increased Fl of LE-injected poults, and had no effect on Fl of HE-
injected turkeys. This inconsistency resulted in VE by VA (P < .07), RT by VA (P 
< .004), and VE by RT by VA (P < .008) interactions from 1 to 21 d of age. 
Feed efficiency data for the 21-d period are separated by main effect means 
in Table 3.8, or for each treatment group in Table 3.9. There was a marked effect 
of the treatments on FE at all ages (Table 3.9). Poults receiving 300 lU of VE/kg 
of diet or its equivalent in the injection (HE treatments) used feed more efficiently (P 
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TABLE 3.6. Feed intake of poults as influenced by vitamin E provided in the 
diet or by subcutaneous injection, and by dietary vitamin A 
Period 
Treatment^ 1 to 7 d 7 to 14 d 14 to 21 d 1 to 21 d 
(g/poult) 
LEDLA 72 193 311 575 
LEDHA 68 187 295 550 
HEDLA 74 188 328 590 
HEDHA 73 190 321 583 
LEILA 67 153 207 427 
LEIHA 67 179 275 521 
HEILA 66 159 245 470 
HEIHA 65 174 231 469 
SEIVI^ 3 7 11 14 
Probabilities 
Treatment .16 .002 .001 .001 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-Q-tocopherol (LE! and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.7. Main effect means of feed intake of poults as Influenced by 
vitamin E provided in the diet or by subcutaneous injection, 
and by dietary vitamin A 
Period 
Main effects of treatment^ 1 to 7 d 7 to 14 d 14 to 21 d 1 to 21 d 
-(g/poult)-
By vitamin E concentration (VE) 
LE(12lU/kg) 69^ 178 272 518 
HE (300 lU/kg) 69 178 281 528 
By vitamin E route (RT) 
Diet 72 190 314 575 
Injection 66 166 239 472 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) 70 173 273 515 
HA (15,000 lU/kg) 68 182 280 531 
Probabilities 
VE .69 .95 .24 .34 
RT .007 .001 .001 .001 
VA .58 .07 .34 .12 
VE * RT .19 .88 .12 .17 
VE * VA .84 .84 .02 .07 
RT * VA .51 .03 .02 .004 
VE * RT * VA .66 .35 .007 .008 
Voults received 12 or 300 lU of vitamin E/kg, as dietary di-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
di-G-tocopherol (LEI and HE! treatments, respectively), and were fed 5,000 or 
15,000 ID of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.8. Main effect means of feed efficiency (feed:gain) of poults as 
influenced by vitamin E provided in the diet or by subcutaneous 
injection, and by dietary vitamin A 
Period 
Main effects of treatment^ 1 to 7 d 7 to 14 d 14 to 21 d 1 to 21 d 
-(g/g)-
By vitamin E concentration (VE) 
LE(12IU/kg) 1.35^ 1.51 1.65 1.55 
HE (300 lU/kg) 1.27 1.45 1.52 1.45 
By vitamin E route (RT) 
Diet 1.26 1.44 1.54 1.47 
Injection 1.36 1.52 1.62 1.54 
By vitamin A concentration (VA) 
LA (5,000 iU/kg) 1.35 1.52 1.67 1.56 
HA (15,000 lU/kg) 1.27 1.44 1.50 1.44 
Probabilities 
VE .001 
RT .001 
VA .002 
VE * RT .005 
VE * VA .006 
RT * VA .001 
VE * RT * VA .001 
.02 .006 .001 
.01 .08 .003 
.005 .001 .001 
.01 .001 .001 
.11 .04 .004 
.02 .02 .001 
.10 .03 .002 
Voults received 12 or 300 iU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 IU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.9. Feed efficiency (feed:gain) of poults as influenced by vitamin E 
provided in the diet or by subcutaneous injection, and by dietary vitamin A 
Period 
Treatment^ 1 to 7 d 7 to 14 d 14 to 21 d 1 to 21 d 
(g/g) 
LEDLA 1.25 1.45 1.53 1.46 
LEDHA 1.27 1.43 1.48 1.43 
HEDU^ 1.25 1.46 1.61 1.51 
HEDHA 1.24 1.44 1.55 1.47 
LEILA 1.60 1.72 2.03 1.83 
LEI HA 1.28 1.46 1.56 1.48 
HEILA 1.29 1.48 1.49 1.45 
HEIHA 1.28 1.42 1.41 1.39 
SEM^ .03 .04 .06 .03 
Probabilities 
Treatment .001 .001 .001 .001 
Voults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocoplieryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
di-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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< .02) than those receiving 12 lU of VE/kg of diet or its Injected equivalent (LE 
treatments) from 1 to 21 d of age (Table 3.8). At all times, FE was impaired (P < 
.08) by injection of VE. The negative effect of the VE injection was more marked 
for the LE group than for the HE group, resulting in a VE by RT interaction (P < 
.01) at all ages studied. Adding 15,000 lU of dietary VA/kg improved (P < .005) 
FE from 1 to 21 d of age, compared with adding 5,000 lU of VA/kg of diet. The 
beneficial effect of including 15,000 lU of VA/kg of diet was more marked for the 
turkeys In the LE groups than for those in the HE groups, resulting in a VE by VA 
interaction for the periods 1 to 7 d (P < .006), 14 to 21 d (P <.04), and 1 to 21 d 
(P <.004). Also, adding 15,000 ID VA/kg of diet improved FE of VE-injected 
turkeys, as compared with adding 5,000 ID VA/kg, and this resulted in a RT by VA 
interaction (P < .02) for all periods studied (Table 3.8). At each age-period, poults 
in the LEILA treatment groups (those receiving the equivalent to 12 ID of VE/kg by 
subcutaneous injection, and 5,000 lU of VA/kg of diet) had the poorest FE, 
compared with poults In any other treatment. I.e, FE of LEILA-treated poults 
averaged 1.60, 1.72, 2.03, and 1.83 from 1 to 7, 7 to 14, 14 to 21, and 1 to 21 d, 
respectively, whereas averaged FE for all other treatment groups for the same age-
periods was 1.27, 1.45, 1.52, and 1.46, respectively. Most likely, it was mainly the 
LEILA treatment that accounted for all the differences observed in the FE data. 
Plasma aTOC concentration of poults decreased for all treatment groups 
from 1 to 14 d of age (Table 3.10). From an average of 15.02 /^g/mL at Day 1, 
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TABLE 3.10. Concentration of a-tocopherol in plasma of poults as influenced 
by vitamin E provided in the diet or by subcutaneous injection, 
and by dietary vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
VMy/i"w 
LEDLA 15.02 16.16 7.75 5.68 1.64 1.96 
LEDHA 15.02 13.69 18.98 5.62 1.50 1.43 
HEDLA 15.02 19.43 19.22 12.58 12.74 28.12 
HEDHA 15.02 19.38 13.98 10.15 13.15 15.67 
LEILA 15.02 25.41 14.43 10.48 3.24 3.74 
LEIHA 15.02 20.45 11.72 6.18 2.29 2.41 
HEILA 15.02 158.85 49.33 28.91 8.71 8.92 
HEIHA 15.02 128.38 49.21 27.95 7.90 8.43 
SEM^ 21.56 4.42 1.82 1.17 .89 
Probabilities 
Treatment .001 .001 .001 .001 .001 
^Poults received 12 or 300 ID of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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plasma aTOC values ranged from 1.50 /jg/mL for the LEDHA group to 13.15 
^g/mL for HEDHA group at Day 14. Plasma aTOC concentrations decreased until 
21 d of age for the LEDHA group, but increased in varying degrees for poults in all 
other treatment groups (Table 3.10). By the end of the 21-d period, plasma of 
poults fed 12 lU of VE/kg of diet carried the lowest, and those fed 300 ID VE/kg of 
diet carried the highest aTOC concentrations of all treatment groups. 
Increasing the concentration of supplemental VE from 12 to 300 lU/kg of 
diet (or the equivalent by injection) increased (P < .001) plasma aTOC at all ages 
(Table 3.11). By 21 d of age, plasma of HE-supplemented poults carried an 
average of 15.28 fig of aTOC/mL, whereas that of LE-supplemented turkeys 
carried only 2.38 ^ig/mL. The route of VE supplementation also had a marked 
effect on plasma oTOC concentration from 1 to 21 d of age. Subcutaneous 
injection of VE at Day 1 increased (P < .001) plasma aTOC concentration at 3, 5, 
and 7 d of age, compared with dietary supplementation of VE (Table 3.11). The 
effect of injection was reversed after 7 d of age, and VE injection at Day 7 and Day 
14 resulted in a decreased aTOC concentration in plasma at 14 (P < .05) and 21 
(P < .001) d of age, compared with dietary VE supplementation. The magnitude of 
the response of plasma aTOC concentration to increasing concentrations of 
supplemented VE was different depending on the route of VE administration and 
this resulted in a VE by RT interaction (P < .002) from 1 to 21 d of age. In these 
instances, the increase in plasma aTOC caused by injection of the high dose of VE 
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TABLE 3.11. Main effect means of concentration of a-tocopherol in plasma of 
poults as influenced by vitamin E provided in the diet or by 
subcutaneous injection, and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
(Mg/mL) 
By vitamin E concentration (VE) 
LE (12 lU/kg) 15.02 18.93^ 13.22 6.99 2.17 2.38 
HE (300 lU/kg) 15.02 81.01 32.93 19.90 10.62 15.28 
By vitamin E route (RT) 
Diet 15.02 17.16 14.98 8.51 7.26 11.80 
Injection 15.02 82.77 31.17 18.38 5.53 5.87 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) 15.02 54.96 22.68 14.41 6.58 10.68 
HA (15,000 lU/kg) 15.02 44.98 23.47 12.48 6.21 6.98 
Probabilities 
VE .001 .001 .001 .001 .001 
RT .001 .001 .001 .05 .001 
VA .52 .80 .15 .66 .001 
VE * RT .001 .001 .001 .002 .001 
VE * VA .68 .28 .85 .84 .001 
RT * VA .57 .49 .59 .54 .001 
VE * RT * VA .63 .14 .28 .90 .001 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 !U of retiny! acetate/kg of diet (LA or MA treatments, respectively). 
^Means of four pens per treatment. 
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(225 ID of dl-aTOC/poult for the overall period, equivalent to 300 lU of VE/kg of 
diet) was greater than that caused by feeding HE through 7 d. However, the 
opposite was true for plasma aTOC concentration at 14 and 21 d. There was no 
effect of dietary concentration of VA on plasma aTOC concentration until 21 d of 
age. At this time, poults fed 5,000 lU of VA/kg of diet (LA treatments) carried more 
aTOC in their plasma (P < .001) than those receiving 15,000 lU of VA/kg of diet 
(HA treatments). The magnitude of the decrease in plasma aTOC concentration 
with increasing concentrations of dietary VA differed according to the concentration 
and the route of administration of supplemented VE. Dietary HA decreased plasma 
aTOC to the greatest extent with the HED treatment groups, but had relatively little 
effect on plasma aTOC with the LED, LEI, and HEl groups. This resulted in VE by 
VA, RT by VA, and VE by RT by VA interactions (P < .001) at 21 d of age (Table 
3.11). 
Due to the inconsistent effect of route of administration of VE on plasma 
aTOC concentration, and since there was no effect of dietary VA concentration on 
plasma aTOC until 21 d of age, data were summarized for the dietary VE 
treatments, according to VE concentration and across VA treatments, and these 
data are depicted in Figure 3.1. Changes of plasma aTOC concentration with age 
were significant (P < .003) for both dietary treatments (12 and 300 lU of VE/kg). 
Plasma aTOC concentration of LE-fed turkeys decreased markedly from 1 (15.02 
/ig/mL) to 14 (1.57 /^g/mL) d of age, and increased slightly (1.69 /ig/mL) by 21 d 
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Figure 3.1. Changes in plasma a-tocophero! concentration of poults fed 12 (LE) 
or 300 (HE) lU of vitamin E/kg of diet with age. Each bar is the 
mean of 8 pens summarized across vitamin A treatments. Changes 
with age were best described by a linear model (P < .003) for LE 
poults, and by a quadratic model (P < .002) for HE poults. Plasma 
a-tocopherol concentration (y) of LE and HE groups at age x was 
y=17.34-1.01x (r^=.46) and y=17.20+.08x-.11x^ (r^=.26), respectively 
63 
of age, whereas that of HE-fed poults decreased slightly from 1 to 7 d of age 
(15.02 /ig/mL at Day 1 to 11.37 /xg/mL at Day 7). and increased afterwards (21.90 
/ig/mL at 21 d of age). Changes with age (x) of plasma qTOC concentration (y) 
were best described by a linear model for the LE-poults (P < .003) (y = 17.34-1.01 x, 
r^=.46), and by a quadratic model for the HE-turkeys (P < .002) (y = 17.20+.08x-
.11x^ r2=.26). 
Samples of ADT and breast muscle {Pectoralis superficialis) tissues were 
collected only on a qualitative basis. Thus, no quantitative data of the weight of 
those two tissues will be presented in the present experiment. Data for the weight 
of SI, leg muscle {Biceps femoralis), liver, and uropygial gland are summarized 
separately for each treatment (Tables 3.12, 3.14, 3.16, and 3.18, respectively), or 
by main effect means (Tables 3.13, 3.15, 3.17, and 3.19, respectively). The effects 
of the treatments on the weight of these tissues were meager and inconsistent 
throughout the 21-d experiment, and they were mainly due to interactions rather 
than to main effects. By 21 d of age, however, subcutaneous injection of VE to 
turkeys decreased (P < .02) weight of SI (Table 3.13), leg muscle (Table 3.15), and 
liver (Table 3.17), compared with dietary supplementation of VE. 
Q-Tocopherol concentration of ADT of poults is summarized in Tables 3.20 
and 3.21. Adipose tissue of poults contained 15.0 jug of aTOC/g at 1 d of age. 
Then, aTOC stores in ADT decreased in varying degrees between 3 and 7 d of 
age, and increased again to 21 d of age, depending on the treatment (Table 3.20). 
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TABLE 3.12. Weight of small intestine of poults as influenced by vitamin E 
provided in the diet or by subcutaneous injection, 
and by dietary vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
vy; 
LEDLA 1.4 3.8 6.0 8.9 21.6 32.1 
LEDHA 1.4 3.9 5.9 7.6 21.7 31.7 
HEDLA 1.4 4.2 6.3 9.3 21.2 31.9 
HEDHA 1.4 4.4 5.8 9.2 21.6 31.3 
LEILA 1.4 4.1 5.6 8.2 17.3 22.4 
LEIHA 1.4 3.8 6.0 8.4 20.9 29.9 
HEILA 1.4 3.9 5.8 8.2 18.7 26.8 
HEiHA 1.4 3.8 5.7 7.4 20.4 25.9 
SEM^ .2 .4 .5 1.7 1.8 
Probabilities 
Treatment .53 .93 .14 .52 .007 
Voults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
di-a-tocopherol (LEI and HEl treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.13. Main effect means of weight of small intestine of poults as 
influenced by vitamin E provided in the diet or by subcutaneous 
injection, and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
(g) 
By vitamin E concentration (VE) 
LE(12lU/kg) 1.4 3.9^ 5.9 8.3 20.4 29.0 
HE(300IU/kg) 1.4 4.0 5.9 8.5 20.5 29.0 
By vitamin E route (RT) 
Diet 1.4 4.1 6.0 8.8 21.5 31.7 
Injection 1.4 3.9 5.8 8.0 19.3 26.3 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) 1.4 4.0 5.9 8.7 19.7 28.3 
HA (15,000 lU/kg) 1.4 4.0 5.9 8.1 21.2 29.7 
Probabilities 
VE .39 .94 .50 .95 .96 
RT .29 .39 .06 .08 .001 
VA .79 .76 .17 .24 .30 
VE * RT .12 .81 .07 .75 .87 
VE * VA .75 .44 .99 .73 .12 
RT * VA .23 .40 .61 .31 .15 
VE * RT * VA .72 .98 .15 .64 .13 
Voults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 !U of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.14. Weight of leg muscle {Biceps femoraJis) of poults as influenced 
by Vitamin E provided in the diet or by subcutaneous injection, 
and by dietary vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
vy; 
LEDUK .19 .25 .38 .40 .73 1.49 
LEDHA .19 .27 .34 .35 .62 1.47 
HEDLA .19 .28 .44 .37 .73 1.61 
HEDHA .19 .24 .26 .39 .69 1.50 
LEILA .19 .23 .38 .33 .61 .92 
LEIHA .19 .26 .41 .36 .74 1.38 
HEILA .19 .25 .36 .37 .74 1.33 
HEIHA .19 .25 .35 .32 .82 1.42 
SEM^ .02 .05 .02 .08 .07 
Probabilities 
Treatment .59 .38 .23 .59 .001 
^Poults received 12 or 300 ID of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-or-tocophero! (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.15. Main effect means of weight of leg muscle {Biceps femoralis) of 
poults as influenced by vitamin E provided in the diet or by subcutaneous 
injection, and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
(g) 
By vitamin E concentration (VE) 
LE (12 lU/kg) .19 .26^ .38 .36 .68 1.32 
HE (300 lU/kg) .19 .25 .35 .36 .74 1.46 
By vitamin E route (RT) 
Diet .19 .26 .35 .38 .69 1.52 
Injection .19 .25 .38 .35 .73 1.26 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) .19 .25 .39 .37 .70 1.34 
HA (15,000 lU/kg) .19 .27 .34 .36 .72 1.44 
Probabilities 
VE .97 .52 .76 .22 .006 
RT .33 .52 .06 .49 .001 
VA .75 .17 .67 .78 .04 
VE * RT .76 .72 .98 .52 .13 
VE * VA .10 .20 .86 .94 .03 
RT * VA .28 .11 .98 .11 .002 
VE * RT * VA .62 .50 .02 .55 .15 
^Poults received 12 or 300 iU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-ot-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 iU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.16. Liver weight of poults as influenced by vitamin E provided in the 
diet or by subcutaneous injection, and by dietary vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
LEDLA 1.6 3.1 4.1 4.1 6.8 10.4 
LEDHA 1.6 3.1 3.8 4.1 6.5 10.9 
HEDLA 1.6 3.7 4.2 4.3 6.8 11.7 
HEDHA 1.6 3.4 3.8 4.4 6.7 10.7 
LEILA 1.6 3.2 3.9 3.8 5.8 8.6 
LEIHA 1.6 3.2 3.9 4.1 6.6 10.8 
HEILA 1.6 3.1 3.6 4.4 6.3 10.3 
HEIHA 1.6 3.3 4.0 4.1 7.0 9.8 
SEM^ .1 .2 .2 .5 .6 
Probabilities 
Treatment .06 .51 .63 .84 .07 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopiieryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEl treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.17. Main effect means of liver weight of poults as influenced by 
vitamin E provided in the diet or by subcutaneous injection, 
and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
(g) 
By vitamin E concentration (VE) 
LE(12IU/kg) 1.6 3.1^ 3.9 4.0 6.4 10.2 
HE(300IU/kg) 1.6 3.4 3.9 4.3 6.7 10.6 
By vitamin E route (RT) 
Diet 1.6 3.3 4.0 4.2 6.7 10.9 
Injection 1.6 3.2 3.8 4.1 6.4 9.9 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) 1.6 3.3 3.9 4.2 6.4 10.3 
HA (15,000 lU/kg) 1.6 3.2 3.9 4.2 6.7 10.6 
Probabilities 
VE .02 .97 .14 .43 .31 
RT .27 .31 .39 .46 .02 
VA .83 .72 .94 .49 .50 
VE * RT .05 .44 .99 .64 .88 
VE * VA .67 .77 .51 .97 .02 
RT * VA .09 .06 .87 .25 .21 
VE * RT * VA .26 .38 .21 .83 .51 
Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 !U of rstinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.18. Weight of uropygial gland of poults as influenced by vitamin E 
provided in the diet or by subcutaneous injection, 
and by dietary vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
vy; 
LEDLA .020 .032 .048 .067 .139 .309 
LEDHA .020 .042 .037 .047 .153 .309 
HEDLA .020 .034 .051 .055 .124 .346 
HEDHA .020 .042 .038 .055 .154 .306 
LEILA .020 .032 .044 .048 .135 .265 
LEIHA .020 .038 .042 .055 .146 .312 
HEILA .020 .043 .044 .058 .126 .312 
HEiHA .020 .033 .055 .052 .178 .318 
SEM^ .006 .005 .006 .020 .019 
Probabilities 
Treatment .61 .16 .31 .60 .23 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopineryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-0!-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.19. Main effect means of weight of uropygial gland of poults as 
influenced by vitamin E provided in the diet or by subcutaneous 
injection, and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
(g) 
By vitamin E concentration (VE) 
LE (12 lU/kg) .020 .036^ .043 .054 .143 .299 
HE (300 lU/kg) .020 .038 .047 .055 .146 .320 
By vitamin E route (RT) 
Diet .020 .038 .044 .056 .142 .317 
injection .020 .036 .047 .053 .146 .302 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) .020 .035 .047 .057 .131 .308 
HA (15,000 lU/kg) .020 .039 .043 .052 .158 .311 
Probabilities 
vyE 
.62 .20 .80 .85 .11 
RT .78 .39 .50 .77 .24 
VA .39 .30 .24 .07 .81 
VE * RT .83 .48 .50 .51 .72 
VE * VA .22 .44 .66 .32 .13 
RT * VA .20 .02 .19 .73 .08 
VE * RT * VA .34 .28 .05 .64 .99 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEi treatments, respectively), and were fed 5,000 or 
15,000 !U of retiny! acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.20. Concentration of a-tocopherol in abdominal adipose tissue of 
poults as influenced by vitamin E provided in the diet or 
by subcutaneous injection, and by dietary vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
LEDLA 15.0 2.8 3.1 4.2 18.4 30.2 
LEDHA 15.0 3.1 3.1 5.9 13.6 9.6 
HEDLA 15.0 2.6 3.0 4.6 13.4 11.3 
HEDHA 15.0 5.1 3.6 3.4 5.7 9.4 
LEILA 15.0 2.9 3.6 4.1 12.1 21.7 
LEIHA 15.0 2.3 3.3 5.1 14.0 13.0 
HEILA 15.0 7.5 4.5 9.8 222.1 90.5 
HEIHA 15.0 10.2 5.3 16.8 246.5 178.5 
SEM^ 1.1 .7 2.7 39.4 38.9 
Probabilities 
Treatment .001 .24 .03 .001 .05 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.21. Main effect means of concentration of a-tocopherol in 
abdominal adipose tissue of poults as influenced by vitamin E 
provided in the diet or by subcutaneous injection, 
and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
(Mg/g) 
By vitamin E concentration (VE) 
LE (12 lU/kg) 15.0 2.8^ 3.3 4.8 14.5 18.6 
HE (300 lU/kg) 15.0 6.4 4.1 8.7 121.9 72.4 
By vitamin E route (RT) 
Diet 15.0 3.4 3.2 4.5 12.8 15.1 
Injection 15.0 5.7 4.2 9.0 123.7 79.9 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) 15.0 3.9 3.5 5.7 66.5 38.4 
HA (15,000 lU/kg) 15.0 5.2 3.8 7.8 70.0 52.6 
Probabilities 
VE .001 .09 .06 .001 .06 
RT .006 .06 .03 .001 .04 
VA .11 .53 .28 .90 .61 
VE * RT .002 .20 .02 .001 .03 
VE * VA .09 .36 .69 .86 .30 
RT * VA .82 .99 .33 .73 .36 
VE * RT * VA .74 .83 .25 .82 .48 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatnnents, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 ID of retiny! acetate/kg of diet {UK or HA treatments, respectively). 
^Means of four pens per treatment. 
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Giving 300 lU of VE/kg of diet (or its injected equivalent) increased (P < .09) ADT 
otTOC concentration (Table 3.21) at all ages studied, compared with feeding 12 lU 
of VE/kg (or the equivalent injection)(Table 3.21). Also, subcutaneous injection of 
VE at 1, 7, and 14 d of age increased (P < .06) aTOC stores in ADT from 3 to 21 
d of age. Vitamin E-fed turkeys had 15.1 /ig of aTOC/g of ADT at 21 d of age, 
whereas VE-injected turkeys stored 79.9 ng/g (Table 3.21). The increase in ADT 
aTOC with increasing concentrations of supplemental VE was more marked when 
the VE was supplemented by subcutaneous injection than when it was 
supplemented in the diet, and this resulted in a VE by RT interaction at 3 (P < 
.002), 7(P < .02), 14 (P <.001), and 21 (P < .03) d of age. There was no effect of 
increasing dietary VA concentration from 5,000 to 15,000 lU/kg of diet on aTOC 
stores of ADT at any of the ages studied. 
Figure 3.2 displays data corresponding to aTOC stored in ADT of poults, 
summarized for the two dietary VE treatments (12 and 300 lU of VE/kg of diet), 
averaged across VA treatments. Concentration of aTOC in ADT of LE- and HE-fed 
turkeys changed with age (P < .04 and P < .001, respectively), decreasing from 1 
to 3 or 5 d of age, and increasing afterwards to 21 d of age. Abdominal adipose 
tissue oTOC stores of poults fed 12 ID of VE/kg increased from 2.95 ixg/g at Day 
3 to 19.89 iig/g at 21 d of age, whereas those of poults fed 300 ID of VE/kg 
increased from 3.32 ng/g at Day 5 to 10.34 ng/g at Day 21. Changes of ADT 
aTOC concentration (y) with age (x) were best described by a cubic model for 
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Figure 3.2. Changes in abdominal adipose tissue a-tocopherol concentration of 
poults fed 12 (LE) or 300 (HE) lU of vitamin E/kg of diet with age. 
Each bar is the mean of 8 pens summarized across vitamin A 
treatments. Changes with age were best described by a cubic model 
for LE (P < .02) and HE (P < .001) treatments. Abdominal adipose 
tissue a-tocopherol concentration (y) of LE and HE groups at age x 
was y = 18.43-6.07x+.69x^-.02x^ (r^ = .32) and y = 18.07-5.39x+.55x^ 
-.02x^ (r^=.56), respectively 
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both the LE- (P < .02)(y = 18.43-6.07x+.69x^-.02x^, r^ = .32) and the HE- (P < .001) 
(y = 18.07-5.39x+.55x2 -.02x^ r^ = .56) groups. 
Data presented in Tables 3.22 and 3.23 show the aTOC concentration of 
breast muscle (Pectoralis superficialis) of poults. Concentration of aTOC in breast 
muscle averaged 11.18 ng/g at Day 1, and decreased for most treatment groups 
until the end of the experiment (Table 3.22). There was a marked effect of the 
treatments (P < .002) on aTOC concentration of breast muscle, starting at 5 d of 
age. By 21 d of age, aTOC concentration in breast muscle of LEDHA-poults was 
.53 ng/g, whereas HEILA- and HEIHA- poults had aTOC concentrations in their 
breast muscle of 43.97 and 114.49 iig/g, respectively (Table 3.22). 
Increasing VE supplementation from 12 to 300 lU/kg of diet (or the 
equivalent by injection) increased (P < .008) aTOC concentration in breast muscle 
from 5 to 21 d of age (Table 3.23). By the end of the experiment, LE-turkeys 
stored 4.63 fig of aTOC/g of breast muscle, whereas HE-turkeys stored as much 
as 41.31 /ig/g at 21 d of age. Subcutaneous injection of turkeys with VE at 1, 7, 
and 14 d of age increased (P < .003) aTOC stores of breast muscle, starting at 5 
d of age. Vitamin E-injected poults had 43.88 /xg of aTOC/g of breast muscle by 
21 d of age, whereas VE-fed turkeys had only 2.00 ng/g. Injecting the equivalent 
of 300 ID of VE/kg of diet was more beneficial than feeding poults 300 lU of VE/kg 
of diet, and this resulted in a VE by RT interaction (P < .01) from 5 to 21 d of age 
for breast muscle aTOC concentration (Table 3.23). There was no effect of 
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TABLE 3.22. Concentration of o-tocopherol in breast muscJe {Pectoraiis 
superficiaJis) of poults as influenced by vitamin E provided in the 
diet or by subcutaneous injection, and by dietary vitamin A 
Age 
Treatment^ 1 d 3d 5 d 7 d 14 d 21 d 
vf^y/ y; 
LEDLA 11.18 9.03 2.73 2.48 1.08 .89 
LEDHA 11.18 7.48 5.18 2.02 .89 .53 
HEDLA 11.18 5.76 6.63 3.72 3.13 4.45 
HEDHA 11.18 5.80 4.83 3.11 2.43 2.30 
LEILA 11.18 7.35 6.39 4.94 6.51 7.88 
LEIHA 11.18 13.43 3.93 2.91 11.52 9.20 
HEILA 11.18 6.85 26.72 14.03 39.67 43.97 
HEIHA 11.18 12.02 33.73 25.31 45.36 114.49 
SEM^ 3.75 2.95 2.31 5.62 17.87 
Probabilities 
Treatment .77 .001 .001 .001 .002 
Voults received 12 or 300 !U of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HE! treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.23. Main effect means of concentration of a-tocopherol in breast 
muscle {Pectoralis superficialis) of poults as influenced by vitamin E 
provided in the diet or by subcutaneous injection, and by 
dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
VM'y/ y; 
By vitamin E concentration (VE) 
LE(12IU/kg) 11.18 9.32^ 4.56 3.09 5.00 4.63 
HE(300IU/kg) 11.18 7.61 17.98 11.54 22.65 41.31 
By vitamin E route (RT) 
Diet 11.18 7.02 4.84 2.83 1.88 2.00 
Injection 11.18 9.91 17.69 11.80 25.77 43.88 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) 11.18 7.25 10.62 6.29 12.60 14.30 
HA (15,000 lU/kg) 11.18 9.68 11.92 8.34 15.05 31.63 
Probabilities 
VE .52 .001 .001 .001 .008 
RT .29 .001 .001 .001 .003 
VA .37 .54 .22 .54 .18 
VE * RT .78 .001 .001 .001 .01 
VE * VA .95 .54 .06 .99 .19 
RT * VA .24 .64 .13 .47 .15 
VE * RT * VA .82 .11 .05 .94 .17 
^Poults received 12 or 300 lU of vitamin E/kg. as dietary dl-a-tocophery! 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 ILI of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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increasing dietary VA concentration (P > .05) from 5,000 to 15,000 lU/kg of diet 
on breast muscle aTOC throughout the 21-d period. 
Q-Tocopherol concentration of breast muscle of poults fed different VE 
concentrations (12 or 300 lU/kg of diet) changed markedly with age (P <.001) 
(Figure 3.3). Breast muscle aTOC concentration of LE-fed turkeys decreased from 
11.18 fig/g at Day 1 to .71 ixg/g at Day 21, whereas that of HE-fed turkeys 
decreased from Day 1 (11.18 ^lg/g) to Day 14 (2.78 iig/g), and then increased 
slightly by 21 d of age (3.38 iig/g). Changes of breast muscle qTOC 
concentration (y) with age (x) were significant (P < .001), and were best described 
by a quadratic model for the LE- (y = 14.34-2.87x+.20x^, r^ = .67), and HE-
(y = 12.64-2.31 x+.17x^ r^=.62) fed poults. 
Small intestines of 1-d-old poults had 4.74 /xg of aTOC/g for a total of 4.60 
Atg (Tables 3.24 to 3.27). a-Tocopherol concentration in SI decreased steadily for 
LEDLA, LEDHA, LEILA, and LEIHA treatments until 21 d of age, but increased for 
HEDLA and HEDHA treatments for the same period. Instead, Si aTOC 
concentration increased, and then decreased to the initial levels for HEILA and 
HEIHA treatments (Table 3.24). Total aTOC in SI increased for all treatments 
during the 21-d period (Table 3.26). a-Tocopherol in SI was responsive (P < .003) 
to the treatments throughout the trial (Tables 3.24 and 3.26). a-Tocopherol of SI of 
poults was increased (P < .001) by increasing supplemental VE concentration from 
12 to 300 lU/kg of diet (or the injected equivalent) at all ages (Tables 3.25 and 
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Figure 3.3. Changes in breast muscle a-tocopherol concentration of poults fed 12 
(LE) or 300 (HE) iU of vitamin E/kg of diet with age. Each bar is the 
mean of 8 pens summarized across vitamin A treatments. Changes 
with age were best described by a quadratic model (P < .001) for LE 
and HE poults. Breast muscle a-tocopherol concentration (y) of LE 
and HE groups at age x v/as y=14.34-2.87x+.20x^, (r^=.67) and 
y=12.64-2.31x+.17)? (r^=.62), respectively 
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TABLE 3.24. Concentration of a-tocopheroi in small intestine of poults as 
influenced by vitamin E provided in the diet or by subcutaneous 
injection, and by dietary vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
LEDLA 4.74 3.16 3.43 3.36 2.28 2.18 
LEDHA 4.74 2.90 3.42 2.85 2.07 1.79 
HEDLA 4.74 7.88 8.47 9.10 10.55 14.25 
HEDHA 4.74 6.61 6.21 6.77 9.02 9.76 
LEILA 4.74 3.43 3.90 4.25 1.70 2.34 
LEIHA 4.74 3.58 3.87 3.82 2.35 2.08 
HEILA 4.74 21.08 10.75 10.63 5.44 4.98 
HEIHA 4.74 19.04 13.43 12.06 4.31 5.58 
SEM^ 1.28 1.61 .96 .44 .50 
Probabilities 
Treatment .001 .001 .001 .001 .001 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryi 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HE! treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.25. Main effect means of concentration of a-tocopheroi in small 
Intestine of poults as influenced by vitamin E provided in the 
diet or by subcutaneous injection, and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
(/^g/g) 
By vitamin E concentration (VE) 
LE (12 lU/kg) 4.74 3.27^ 3.66 3.57 2.10 2.10 
HE (300 lU/kg) 4.74 13.65 9.71 9.64 7.33 8.64 
By vitamin E route (RT) 
Diet 4.74 5.14 5.38 5.52 5.98 6.99 
Injection 4.74 11.78 7.99 7.69 3.45 3.74 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) 4.74 8.89 6.64 6.84 4.99 5.94 
HA (15,000 iU/kg) 4.74 8.03 6.73 6.37 4.44 4.80 
Probabilities 
VE .001 .001 .001 .001 .001 
RT .001 .03 .004 .001 .001 
VA .35 .94 .50 .09 .004 
VE * RT .001 .07 .08 .001 .001 
VE * VA .38 .92 .99 .02 .03 
RT * VA .92 .29 .17 .33 .001 
VE * RT * VA .74 .29 .19 .72 .002 
"•poults received 12 or 300 lU of vitamin E/kg, as dietary dl-o-tocopheryi 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEl treatments, respectively), and were fed 5,000 or 
15,000 !U of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.26. Total a-tocopherol in small intestine of poults as influenced by 
vitamin E provided in the diet or by subcutaneous injection, 
and by dietary vitamin A 
Age 
Treatment'' 1 d 3 d 5 d 7 d 14 d 21 d 
LEDLA 4.6 10.5 20.2 29.3 48.2 69.3 
LEDHA 4.6 9.6 19.9 21.3 44.5 55.6 
HEDLA 4.6 28.6 51.8 82.6 220.2 448.5 
HEDHA 4.6 23.5 34.2 60.3 189.8 298.8 
LEILA 4.6 11.5 21.3 32.5 27.3 49.7 
LEIHA 4.6 11.6 22.0 31.3 47.4 61.0 
HEILA 4.6 65.5 58.7 83.0 100.3 129.6 
HEIHA 4.6 64.1 76.1 83.5 86.5 143.1 
SEM^ 4.7 8.7 6.4 9.6 13.9 
Probabilities 
Treatment .001 .003 .001 .001 .001 
^Poults received 12 or 300 ID of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.27. Main effect means of total a-tocopherol in small intestine of 
poults as influenced by vitamin E provided in the diet or by 
subcutaneous injection, and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
im) 
By vitamin E concentration (VE) 
LE (12 lU/kg) 4.6 10.8^ 20.8 28.6 41.9 58.9 
HE (300 !U/kg) 4.6 45.5 55.2 78.1 149.2 255.0 
By vitamin E route (RT) 
Diet 4.6 18.1 31.5 48.4 125.7 218.0 
Injection 4.6 38.2 44.5 58.3 65.4 95.9 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) 4.6 29.0 38.0 57.6 99.0 174.3 
HA (15,000 lU/kg) 4.6 27.2 38.0 49.1 92.0 139.6 
Probabilities 
VE .001 .001 .001 .001 .001 
RT .001 .04 .04 .001 .001 
VA .59 .99 .07 .31 .002 
VE * RT .001 .07 .46 .001 .001 
VE * VA .67 .98 .40 .03 .002 
RT * VA .73 .16 .16 .15 .001 
VE * RT * VA .84 .18 .48 .79 .002 
Voults received 12 or 300 ID of vitamin E/kg, as dietary dl-a-tocopiieryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-Q-tocopherol (LEI and HE! treatments, respectively), and were fed 5,000 or 
15,000 !U of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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3.27). The route of administration of VE also affected (P < .04) aTOC of SI of 
poults during the 21-d period. Giving VE to the turkeys by subcutaneous injection 
increased oTOC concentration and total aTOC of SI at 3 (P < .001), 5 (P < .04), 
and 7 (P < .04) d of age, compared with supplementing VE in the diet. However, 
this effect was reversed after Day 7, and poults supplemented with dietary VE had 
more (P < .001) aTOC in their SI at 14 and 21 d of age than those injected with 
VE (Tables 3.25 and 3.27). The increase in SI aTOC with increasing 
concentrations of injected VE was greater than that caused by increasing dietary 
VE through 7 d. However, the opposite was true for SI aTOC at 14 and 21 d. 
This inconsistency resulted in a VE by RT interaction (P < .08) at all ages for SI 
aTOC concentration, and at 3 (P < .001), 5 (P < .07), 14 (P < .001), and 21 (P < 
.001) d of age for SI total aTOC. Dietary VA concentration did not affect aTOC of 
SI until 21 d of age. At this time, poults consuming 15,000 lU of VA/kg of diet had 
less (P < .004) aTOC in their SI than those consuming 5,000 lU of VA/kg of diet 
(Tables 3.25 and 3.27). Increasing dietary VA concentration decreased SI aTOC of 
VE-fed poults, but increased aTOC in SI of VE-injected turkeys. Besides, the 
magnitude of the decrease of Si aTOC of VE-fed poults was greater than that of 
the increase of VE-injected turkeys. This resulted in VE by VA (P < .03), RT by VA 
(P < .001), and VE by RT by VA (P < .002) interactions at 21 d of age for both SI 
aTOC concentration (Table 3.25) and SI total oTOC (Table 3.27). 
Data corresponding to aTOC of SI of turkeys fed 12 or 300 lU of VE/kg of 
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diet are summarized in Figures 3.4 and 3.5. Concentration of aTOC in Si of 
turkeys fed 12 lU of VE/kg of diet (LE) decreased (P < .001) from 1 to 21 d of 
age, whereas tiiat of turkeys fed 300 lU of VE/kg of diet (HE) increased (P < .001) 
during the 21-d trial (Figure 3.4). Changes of SI aTOC concentration (y) with age 
(x) of LE-fed turkeys were significant (P < .005), and were best described by a 
quadratic model (y=4.72-.41x+.02x^, r^ = .65), whereas those of HE-fed turkeys 
were best described by a linear model (P < .001)(y=4.35+.89x, r^=.60). Total 
aTOC in SI of VE-fed turkeys increased (P < .001) from 1 to 21 d of age, 
irrespective of concentration of dietary VE (Figure 3.5). One-d-old poults had a 
total of 4.74 fig of aTOC in their SI, and total aTOC in SI of 21-d-old turkeys 
ranged between 62.47 (LE) and 373.63 (HE) fig. Changes in total SI aTOC (y) 
with age (x) were best described by a linear model (P < .001) for LE-fed turkeys 
(y=-.08+4.02x, r^=.93), and by a quadratic model (P < .006) for HE-fed poults 
(y = 1.04+4.67x+.87x2, r^=.92). 
Leg muscle {Biceps femoralis) of 1-d-old poults contained 19.20 fig of 
aTOC/g for a total of 3.96 fxg of aTOC per leg muscle (Tables 3.28 to 3.31). 
Concentration of aTOC in leg muscle decreased until 21 d of age for all treatment 
groups (Table 3.28). Total oTOC in leg muscle also decreased until 21 d of age 
for poults in LEDLA, LEDHA, LEILA, and LEIHA treatments (2.50, 2.33, 2.53, and 
2.67 fig of aTOC, respectively), but increased for poults in HEDLA, HEDHA, HEILA, 
and H El HA treatments (9.30, 5.91, 7.66, and 8.14 ^g of aTOC, respectively) (Table 
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Figure 3.4. Changes in small intestine o-tocopherol concentration of poults fed 12 
(LE) or 300 (HE) !U of vitamin E/kg of diet with age. Each bar is the 
mean of 8 pens summarized across vitamin A treatments. Changes 
with age were best described by a quadratic model (P < .005) for LE 
poults, and by a linear model (P < .001) for HE poults. Small 
intestine a-tocopheroi concentration (y) of LE and HE groups at age x 
was y=4.72-.41x+.02x^ (r^=.65) and y=4.35 + .89x (r^=.60), 
respectively 
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Figure 3.5. Changes in small intestine total a-tocopherol of poults fed 12 (LE) or 
300 (HE) lU of vitamin E/kg of diet with age. Each bar is the mean of 
8 pens summarized across vitamin A treatments. Changes with age 
were best described by a linear model (P < .001) for LE poults, 
and by a quadratic modei (P < .006) for HE poults. Small intestine 
total c-tocopherol (y) of LE and HE groups at age x was y=-.08 
+4.02X (r^=.93) and y = 1.04 + 4.67x+.87x^ (r^=.92), respectively 
89 
TABLE 3.28. Concentration of a-tocopherol in leg muscle {Biceps femoralis) 
of poults as influenced by vitamin E provided in the diet or 
by subcutaneous injection, and by dietary vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
LEDLA 19.20 7.85 5.30 5.78 2.60 1.67 
LEDHA 19.20 5.45 5.61 6.21 2.45 1.59 
HEDLA 19.20 7.20 5.67 6.92 4.09 5.81 
HEDHA 19.20 9.67 5.88 6.15 4.32 3.95 
LEILA 19.20 11.47 6.37 7.67 3.12 2.80 
LEI HA 19.20 6.18 5.07 6.54 3.09 1.94 
HEILA 19.20 8.48 12.64 17.92 6.91 5.85 
HEIHA 19.20 8.76 15.41 19.46 7.73 5.84 
SEM^ 1.80 1.06 1.42 .39 .59 
Probabilities 
Treatment .37 .001 .001 .001 b
 
o
 
—
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^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.29. Main effect means of concentration of a-tocopheroi in leg 
muscle {Biceps femoralis) of poults as influenced by vitamin E 
provided in the diet or by subcutaneous injection, 
and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
By vitamin E concentration (VE) 
LE (12 lU/kg) 19.20 7.74^ 5.59 6.55 2.81 2.00 
HE (300 lU/kg) 19.20 8.53 9.90 12.61 5.76 5.36 
By vitamin E route (RT) 
Diet 19.20 7.54 5.62 6.27 3.37 3.26 
Injection 19.20 8.72 9.87 12.90 5.21 4.11 
By vitamin A concentration (VA) 
Lk (5,000 lU/kg) 19.20 8.75 7.50 9.57 4.18 4.03 
HA (15,000 lU/kg) 19.20 7.52 7.99 9.59 4.40 3.33 
Probabilities 
VE .54 .001 .001 .001 .001 
RT .36 .001 .001 .001 .05 
VA .34 .52 .98 .44 .11 
VE * RT .44 .001 .001 .001 .79 
VE * VA .05 .20 .72 .28 .58 
RT * VA .33 .75 .85 .53 .53 
VE * RT * VA .89 .18 .34 .67 .13 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LE! and HEI treatments, respectively), and were fed 5,000 or 
15,000 !U of retiny! acetate/kg of diet (LA or HA xreaiments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.30. Total a-tocopherol in leg muscle {Biceps femoralis) of poults as 
influenced by vitamin E provided in the diet or by subcutaneous 
injection, and by dietary vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
LEDLA 3.96 1.97 1.92 2.29 1.86 2.50 
LEDHA 3.96 1.51 1.89 2.17 1.53 2.33 
HEDLA 3.96 1.99 2.45 2.53 2.90 9.30 
HEDHA 3.96 2.36 1.53 2.42 2.93 5.91 
LEILA 3.96 2.63 2.37 2.49 1.85 2.53 
LEI HA 3.96 1.58 2.04 2.30 2.13 2.67 
HEILA 3.96 2.10 4.75 6.71 5.08 7.66 
HEIHA 3.96 2.13 5.29 6.12 6.33 8.14 
SEM^ .44 .58 .41 .28 .71 
Probabilities 
Treatment .66 .001 .001 .001 .001 
Voults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.31. Main effect means of total a-tocopherol in leg muscle {Biceps 
femoralis) of poults as Influenced by vitamin E provided in the diet 
or by subcutaneous injection, and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
By vitamin E concentration (VE) 
LE (12 lU/kg) 3.96 1.92^ 2.06 2.10 1.84 2.51 
HE (300 lU/kg) 3.96 2.15 3.51 4.45 4.31 7.76 
By vitamin E route (RT) 
Diet 3.96 1.96 1.95 2.36 2.30 5.01 
Injection 3.96 2.11 3.61 4.41 3.85 5.25 
By vitamin A concentration (VA) 
VA (5,000 lU/kg) 3.96 2.18 2.87 3.51 3.92 5.50 
HA (15,000 lU/kg) 3.96 1.90 2.69 3.25 3.23 4.77 
Probabilities 
VE .48 .002 .001 .001 .001 
RT .64 .001 .001 .001 .63 
VA .37 .65 .40 .14 .16 
VE * RT .50 .003 .001 .001 .92 
VE * VA .13 .99 .74 .11 .16 
RT * VA .46 .48 .64 .03 .05 
VE * RT * VA .85 .29 .73 .46 .09 
Voults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HE! treatments, respectively), and were fed 5,000 or 
15,000 !U of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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3.30). There was a marked effect of the treatments (P < .001) on leg muscle 
OfTOC, starting at 5 d of age (Tables 3.28 and 3.30). Giving 300 lU of VE/kg of 
diet (or the equivalent injection) increased (P < .002) aTOC concentration (Table 
3.29) and total aTOC (Table 3.31) of leg muscle of poults from 5 to 21 d of age, 
compared with giving 12 lU of VE/kg (or the equivalent injected). Also, 
administering VE by subcutaneous injection at 1, 7, and 14 d of age increased (P 
< .001) aTOC stores of leg muscle of poults at 5, 7, and 14 d of age, compared 
with giving VE in the diet. By 21 d of age, VE-injected poults still had higher (P < 
.05) aTOC concentration in their leg muscle than those receiving the VE in their 
diet (Table 3.29). Although total aTOC in leg muscle of VE-injected turkeys was 
still numerically higher than that of VE-fed poults (5.25 and 5.01 ^g, respectively) 
by 21 d, the difference was not significant at this age (Table 3.31). The increase in 
leg muscle aTOC with increasing concentrations of supplemental VE was more 
marked if the VE was given by subcutaneous injection than if it was given in the 
diet, resulting in a VE by RT interaction (P < .001) at 5, 7, and 14 d of age (Tables 
3.29 and 3.31). There was no effect of dietary VA (P > .05) on leg muscle aTOC 
throughout the 21-d period. 
a-Tocopherol content in leg muscle of poults receiving 12 or 300 lU of 
VE/kg of diet is depicted in Figures 3.6 and 3.7. Concentration of aTOC of LE-
and HE-fed turkeys decreased markedly (P < .001) with age (Figure 3.6). Leg 
muscle aTOC concentration of LE-fed poults decreased from 1 to 21 d of age 
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Figure 3.6. Changes in leg muscle a-tocopherol concentration of poults fed 12 
(LE) or 300 (HE) lU of vitamin E/kg of diet with age. Each bar is the 
mean of 8 pens summarized across vitamin A treatments. Changes 
with age were best described by a cubic model (P < .001) for LE 
and HE poults. Leg muscle a-tocopherol concentration (y) of LE and 
HE groups at age x was y=19.88-4.32x+.34x^-.01x^ (r^=.65) and 
y=20.81-4.40x+.35x^-.01x^ (r^=.62), respectively 
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Figure 3.7. Changes in leg muscle total a-tocopherol of poults fed 12 (LE) or 300 
(HE) lU of vitamin E/kg of diet with age. Each bar is the mean of 8 
pens summarized across vitamin A treatments. Changes with age 
were best described by a quadratic model for LE (P < .008) and HE 
(P < .001) poults. Leg muscle total a-tocopherol (y) of LE and HE 
groups at age x was y=3.71-.53x+.04x^ (r^=.20) and y=3.82-.46x 
+ .03x^ (r^=.70), respectively 
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(19.20 ng/g at Day 1, and 1.63 ng/g at Day 21), whereas that of HE-fed poults 
decreased until 14 d of age (4.21 /xg/g), and Increased slightly by 21 d of age 
(4.88 Mg/g)- Changes of leg muscle aTOC concentration (y) with age (x) were 
best described by a cubic model (P < .001) for LE- (y= 19.88-4.32x+.34x^-.01x^, 
r^ = .65) and HE- (y=20.81-4.40x+.35x^-.01x^ r^ = .62) fed turkeys. 
Total aTOC in leg muscle of VE-fed poults also changed (P < .001) with age 
(Figure 3.7). By 21 d of age, LE-fed turkeys had 2.41 /zg of aTOC in their leg 
muscle, whereas HE-fed turkeys had as much as 7.61 jug at the same age. 
Changes in leg muscle total aTOC (y) with age (x) were best described by a 
quadratic model for LE- (P < .008)(y=3.71-.53x+.04x^, r^=.20) and HE- (P < 
.001)(y=3.82-.46x+.03x^, r^=.70) treated poults. 
Liver aTOC was responsive to treatments during the 21-d experiment 
(Tables 3.32 to 3.35). Livers of 1-d-old poults had 97.4 /xg of aTOC/g for a total of 
158.9 ng of aTOC per liver (Tables 3.32 and 3.34). Liver aTOC concentration 
increased for all treatment groups from 1 to 3 d of age, and then, decreased in 
varying degrees, depending on the treatment, until 21 d of age (Table 3.32). At 
this time, aTOC concentration in liver of LEDHA-poults was only 1.2 /xg/g, whereas 
that of poults in the HEDLA group was 28.7 ng/g. Poults in HEILA and HEIHA 
treatments stored 982.3 and 1,038.1 ng of aTOC/g of liver by 3 d of age, but, by 
the end of the experiment, they had only 10.1 and 10.3 /xg of aTOC/g of liver, 
respectively (Table 3.32). Total aTOC in liver also increased from 1 to 3 d of age. 
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TABLE 3.32. Concentration of a-tocopherol in liver of poults as influenced by 
vitamin E provided in the diet or by subcutaneous Injection,and by dietary 
vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
LEDLA 97.4 130.5 41.8 39.0 2.1 1.6 
LEDHA 97.4 125.4 62.5 27.9 1.8 1.2 
HEDLA 97.4 112.2 100.7 68.2 23.4 28.7 
HEDHA 97.4 140.2 88.2 50.0 18.4 21.2 
LEILA 97.4 214.2 79.6 49.2 2.9 3.2 
LEI HA 97.4 158.0 60.7 43.0 2.8 2.8 
HEILA 97.4 982.3 400.9 142.9 11.4 10.1 
HEIHA 97.4 1,038.1 369.9 103.5 8.8 10.3 
SEM^ 76.9 47.2 22.7 1.9 2.0 
Probabilities 
Treatment .001 .001 .02 .001 .001 
^Poults received 12 or 300 ID of vitamin E/I<g, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HE! treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.33. Mean effect means of concentration of a-tocopherol in liver of 
poults as influenced by vitamin E provided in the diet or by 
subcutaneous injection, and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
VMy/ y; 
By vitamin E concentration (VE) 
LE (12 iU/kg) 97.4 157.0^ 61.2 39.8 2.4 2.2 
HE (300 IU/kg) 97.4 568.2 240.0 91.2 15.5 17.6 
By vitamin E route (RT) 
Diet 97.4 127.1 73.3 46.3 11.4 13.2 
Injection 97.4 598.4 227.8 84.7 6.5 6.6 
By vitamin A concentration (VA) 
LA (5,000 IU/kg) 97.4 359.8 155.8 74.8 9.9 10.9 
HA (15,000 IU/kg) 97.4 365.4 145.4 56.1 8.0 8.9 
Probabilities 
VE .001 .001 .004 .001 .001 
RT .001 .001 .02 .001 .001 
VA .92 .76 .25 .14 .16 
VE * RT .001 .001 .12 .001 .001 
VE * VA .51 .74 .54 .19 .25 
RT * VA .92 .67 .80 .63 .17 
VE * RT * VA .72 .88 .69 .68 .17 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocophery! 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEl treatments, respectively), and were fed 5,000 or 
15,000 !U of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.34. Total a-tocopheroi in liver of poults as influenced by vitamin E 
provided in the diet or by subcutaneous injection, and by dietary vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
LEDLA 158.9 404.7 173.0 161.4 13.7 16.6 
LEDHA 158.9 371.9 241.3 111.9 11.4 13.1 
HEDLA 158.9 413.4 430.7 288.6 154.0 335.3 
HEDHA 158.9 463.2 342.6 215.4 122.7 229.0 
LEILA 158.9 673.3 306.6 184.3 17.1 27.1 
LEIHA 158.9 506.0 237.4 169.3 17.4 30.4 
HEILA 158.9 3,023.2 1,459.0 600.2 74.4 98.2 
HEIHA 158.9 3,455.0 1,496.6 422.2 60.6 101.4 
SEM^ 222.8 188.6 90.7 15.7 22.8 
Probabilities 
Treatment .001 .001 .01 .001 .001 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LE! and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.35. Main effect means of total a-tocopherol in liver of poults as 
influenced by vitamin E provided in the diet or by subcutaneous 
injection, and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
(Mg) 
By vitamin E concentration (VE) 
LE (12 lU/kg) 158.9 489.0^ 239.6 156.7 14.9 21.8 
HE (300 lU/kg) 158.9 1,838.7 932.2 381.6 102.9 191.0 
By vitamin E route (RT) 
Diet 158.9 413.3 296.9 194.3 75.4 148.5 
Injection 158.9 1,914.4 874.9 344.0 42.4 64.3 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) 158.9 1,128.6 592.3 308.6 64.8 119.3 
HA (15,000 lU/kg) 158.9 1,199.0 579.5 229.7 53.0 93.5 
Probabilities 
VE .001 .001 .002 .001 .001 
RT .001 .001 .03 .006 .001 
VA .66 .92 .23 .30 .12 
VE * RT .001 .001 .10 .002 .001 
VE * VA .29 .93 .47 .34 .12 
RT * VA .70 .98 .79 .66 .08 
VE * RT * VA .42 .63 .59 .74 .12 
Voults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocoplieryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEi and HE! treatments, respectively), and were fed 5,000 or 
15,000 !U of retinyl acetate/kg of diet (L^ or HA treatments, respectively). 
^Means of four pens per treatment. 
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especially for poults in the HEILA and HEIHA treatments. However, by 21 d of 
age, total liver aTOC had decreased for most treatment groups, and only poults in 
the HEDLA and HEIHA treatments had more aTOC in their livers than at Day 1 
(Table 3.34). There was a marked effect (P < .02) of the treatments on liver aTOC 
stores, starting at 3 d of age (Tables 3.32 and 3.34). Poults receiving 300 lU of 
VE/kg of diet (or the equivalent injection)(HE) stored more (P < .004) aTOC in 
their livers from 3 to 21 d of age than those receiving 12 lU of VE/kg (or the 
injected equivalent)(LE)(Tables 3.33 and 3.35). Giving VE by subcutaneous 
injection also increased (P < .001) liver aTOC stores at 3 and 5 d of age, 
compared with giving the VE in the diet. At 7 d of age, VE-injected poults still had 
more aTOC in their livers (P < .03) than those receiving the VE in the diet. 
However, at 14 and 21 d of age, poults fed VE stored more aTOC in their livers (P 
< .006) than those receiving the vitamin by subcutaneous injection (Tables 3.33 
and 3.35). The increase in liver oTOC (concentration and total amount) with 
increasing concentrations of supplemental VE was greater for VE-injected turkeys 
than for VE-fed poults until 7 d. The opposite was true at 14 and 21 d of age. 
These inconsistencies resulted in a VE by RT interaction (P < .002) at 3, 5, 14, and 
21 d of age (Tables 3.33 and 3.35). There was no effect of increasing dietary VA 
concentration from 5,000 to 15,000 lU/kg of diet on liver aTOC. 
Data presented in Figures 3.8 and 3.9 show that aTOC stored in livers of 
poults receiving 12 or 300 lU of VE/kg of diet changed (P < .001) with age. Liver 
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Figure 3.8. Changes in liver a-tocopherol concentration of poults fed 12 (LE) or 
300 (HE) !U of vitamin E/kg of diet with age. Each bar is the mean of 
8 pens summarized across vitamin A treatments. Changes with age 
were best described by a quadratic model for LE (P < .001) and HE 
(P < .004) poults. Liver a-tocopherol concentration (y) of LE and HE 
groups at age x was y = 133.71-15.11x+.29x^ (r^=.73) and y= 112.64 
+ .65x-1.17>^ (r^ = .71), respectively 
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Figure 3.9. Changes in liver total a-tocopherol of poults fed 12 (LE) or 300 
(HE) iU of vitamin E/kg of diet with age. Each bar is the mean of 8 
pens summarized across vitamin A treatments. Changes with age 
were best described by a cubic model for LE (P < .004) and HE (P < 
.001) poults. Liver total a-tocopherol (y) of LE and HE groups at age 
X was y=216.13+30.18x-6.18x^+.20x^ (r^=-63) and y=148.29 + 97.35x 
-12.79>r+.40x^ (r^=.43), respectively 
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aTOC concentration of LE-fed poults increased from 1 to 3 d of age, and then, 
decreased markedly to 21 d of age (97.50 /ig/g at Day 1, and 1.39 /ig/g at Day 
21)(Figure 3.8). For HE-fed turkeys, liver aTOC concentration increased until 3 d, 
decreased until 14 d of age, and then, increased slightly by 21 d of age. Changes 
in liver aTOC concentration (y) with age (x) were best described by a quadratic 
model for both LE- (P < .001)(y = 133.71-15.11x + .29x^ r^ = .73) and HE- (P < 
.004)(y=112.64 +.65x-1.17x^ r^ = .71) fed turkeys. Total aTOC in liver followed a 
similar pattern to that observed for liver aTOC concentration (Figure 3.9). Changes 
of total aTOC in liver (y) with age (x) were significant (P < .001), and were best 
described by a cubic model for LE- (P < .004)(y=216.18+30.18x-6.18x^+.20x^, 
r2=.63) and HE- (P < .001)(y = 148.29+97.35x-12.79x^+.40x^ r^ = .43) fed poults. 
a-Tocopherol content of uropygial gland of 1 to 21-d-old turkeys is depicted 
in Tables 3.36 to 3.39. Uropygial gland of poults contained 147.0 ng of aTOC/g 
for a total of 1.77 jug per gland at Day 1 (Tables 3.36 and 3.38). At Day 3, 
uropygial gland aTOC concentration of HEILA- and HEIHA-poults increased 
slightly, but, by 21 d of age, aTOC concentration in uropygial gland had decreased 
markedly across all treatment groups (Table 3.36). Total aTOC of uropygial gland 
decreased from 1 to 3 d of age for most treatments, but increased thereafter 
(Table 3.38). 
Poults in the HE treatments had more aTOC in their uropygial gland (P < 
.001) than those in the LE treatments throughout the 21-d experiment (Tables 3.37 
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TABLE 3.36. Concentration of a-tocopherol in uropygial gland of poults as 
influenced by vitamin E provided in the diet or by subcutaneous 
injection, and by dietary vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
LEDLA 147.0 140.1 40.8 36.3 16.1 10.0 
LEDHA 147.0 73.1 59.1 52.1 14.8 5.1 
HEDLA 147.0 96.6 82.8 55.9 50.5 65.9 
HEDHA 147.0 89.9 71.6 45.2 45.2 35.9 
LEILA 147.0 109.8 53.7 55.8 19.8 13.4 
LEIHA 147.0 122.9 53.5 45.7 18.9 8.8 
HEILA 147.0 192.9 137.8 131.7 65.1 33.9 
HEIHA 147.0 178.0 134.8 125.1 42.5 35.4 
SEM^ 30.1 16.3 12.6 6.6 3.8 
Probabilities 
Treatment .10 .001 .001 .001 .001 
Moults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
di-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyi acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.37. Main effect means of concentration of a-tocopherol in uropygial 
gland of poults as influenced by vitamin E provided in the diet or by 
subcutaneous injection, and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
By vitamin E concentration (VE) 
LE (12 lU/kg) 147.0 111.4^ 51.8 47.5 17.4 9.3 
HE (300 lU/kg) 147.0 139.8 106.8 89.5 50.8 42.8 
By vitamin E route (RT) 
Diet 147.0 99.9 63.6 47.4 31.6 29.2 
Injection 147.0 150.9 94.9 89.6 36.6 22.9 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) 147.0 134.9 78.8 69.9 37.9 30.8 
HA (15,000 lU/kg) 147.0 116.0 79.8 67.0 30.3 21.3 
Probabilities 
VE .20 .001 .001 .001 .001 
RT .02 .01 .001 .30 .03 
VA .39 .93 .75 .12 .002 
VE * RT .06 .02 .001 .83 .001 
VE * VA .71 .49 .52 .18 .09 
RT * VA .41 .83 .55 .38 .007 
VE * RT * VA .31 .57 .41 .35 .008 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.38. Total a-tocopherol in uropygial gland of poults as influenced by 
vitamin E provided in the diet or by subcutaneous injection, 
and by dietary vitamin A 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
LEDLA 1.77 1.33 1.25 1.62 1.69 2.56 
LEDHA 1.77 1.10 1.17 1.10 1.68 1.45 
HEDLA 1.77 1.16 1.69 2.12 5.06 20.93 
HEDHA 1.77 1.13 1.33 1.65 5.31 9.91 
LEILA 1.77 1.13 1.45 1.72 2.16 3.22 
LEIHA 1.77 1.16 1.34 1.55 1.84 2.51 
HEILA 1.77 2.39 3.43 4.82 6.44 8.46 
HEIHA 1.77 2.83 4.04 4.30 6.12 9.81 
SEM^ .26 .45 .29 .64 .99 
Probabilities 
Treatment .001 .001 .001 .001 .001 
^Poults received 12 or 300 iU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEi treatments, respectively), and were fed 5,000 or 
15,000 IU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.39. Main effect means of total a-tocopherol in uropygial gland of 
poults as influenced by vitamin E provided in the diet or by 
subcutaneous Injection, and by dietary vitamin A 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
im) 
By vitamin E concentration (VE) 
LE(12IU/kg) 1.77 1.18^ 1.30 1.50 1.84 2.44 
HE(300IU/kg) 1.77 1.88 2.62 3.22 5.73 12.28 
By vitamin E route (RT) 
Diet 1.77 1.18 1.36 1.62 3.44 8.71 
Injection 1.77 1.88 2.57 3.10 4.14 6.00 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) 1.77 1.50 1.95 2.57 3.84 8.79 
HA (15,000 lU/kg) 1.77 1.56 1.97 2.15 3.74 5.92 
Probabilities 
VE .001 .001 .001 .001 .001 
RT .001 .001 .001 .13 .001 
VA .76 .96 .05 .82 .001 
VE * RT .001 .004 .001 .39 .001 
VE * VA .41 .73 .71 .89 .01 
RT * VA .33 .46 .71 .63 .001 
VE * RT * VA .79 .45 .63 .88 .001 
Voults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryi 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 !U of retiny! acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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and 3.39). Subcutaneous injection of VE increased (P < .02) aTOC in uropygial 
gland at 3, 5, and 7 d of age, compared with dietary supplementation of VE. At 14 
d of age, this effect was reversed and, by 21 d of age, VE-fed poults had more 
aTOC (P < .03) in their uropygial gland than those injected with VE (Tables 3.37 
and 3.39). From 1 to 7 d of age, the HE treatment was more effective in increasing 
uropygial gland aTOC when given by subcutaneous injection than when 
supplemented in the diet, and this resulted in a VE by RT interaction (P < .06) at 3, 
5, and 7 d of age. However, after 7 d this pattern of response was reversed, and 
this inconsistency resulted in a VE by RT interaction (P < .001) by 21 d of age 
(Tables 3.37 and 3.39). 
Dietary VA did not affect aTOC in uropygial gland (P > .05) until 21 d of 
age. At this time, poults fed 15,000 lU of VA/kg of diet had less (P < .002) 
uropygial gland aTOC than those fed 5,000 lU of VA/kg. Dietary HA decreased 
uropygial gland aTOC to the greater extent with the HED treatment groups, but 
had little or no effect on uropygial gland aTOC with the LED, LEI, and HEI 
treatment groups. This inconsistency resulted in VE by VA, RT by VA, and VE by 
RT by VA interactions (P < .09) at 21 d of age (Tables 3.37 and 3.39). 
Figures 3.10 and 3.11 contain data corresponding to the aTOC content of 
uropygial gland of poults fed LE (12 lU of VE/kg) and HE (300 lU of VE/kg) diets. 
a-Tocopherol concentration of uropygial gland of poults changed markedly (P < 
.001) with age (Figure 3.10). As had been observed previously for other tissues. 
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Figure 3.10. Changes in uropygial gland Q-tocopherol concentration of poults fed 
12 (LE) or 300 (HE) lU of vitamin E/kg of diet with age. Each bar is 
the mean of 8 pens summarized across vitamin A treatments. 
Changes with age were best described by a quadratic model (P < 
.001) for LE and HE poults. Uropygial gland a-tocopherol 
concentration (y) of LE and HE groups at age x was y=186.20-35.87x 
+ 2.48x^ (r^ = .62) and y = 167.29-28.74x+2.12x^ (r^=.55), respectively 
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Figure 3.11. Changes in uropygial gland total a-tocopherol of poults fed 12 (LE) or 
300 (HE) ID of vitamin E/kg of diet with age. Each bar is the mean of 
8 pens summarized across vitamin A treatments. Changes with age 
were best described by a linear model (P < .001) for LE poults, and 
by a quadratic model (P < .001) for HE-poults. Uropygial gland total 
Q-tocopheroi (y) of LE and HE groups at age x was y = 1.69-.18x 
(r^=.31) and y = 1.31+.02x-.01>r (r^=.78), respectively 
1,12 
uropygial gland aTOC concentration decreased from 1 to 21 d of age for poults 
receiving 12 lU of VE/kg of diet, whereas it decreased until 14 d of age, and then 
increased to 21 d of age for poults receiving 300 lU of VE/kg. Changes in 
uropygial gland aTOC concentration (y) with age (x) were best described by a 
quadratic model for LE- (P < .001)(y = 186.20-35.87x+2.48x^ r^=.62), and HE- (P 
< .001)(y=167.29-28.74x+2.12x^ r^=.55) supplemented poults. 
Total aTOC of uropygial gland changed also (P <.001) with age (Figure 
3.11). It decreased from Day 1 to Day 3 (HE) or Day 5 (LE), and then increased 
steadily until 21 d of age. Changes in total aTOC of uropygial gland (y) with age 
(x) were significant (P < .001) and linear for LE-fed poults (y = 1.69-.18x, r^=.31), 
and quadratic for HE-fed poults (y = 1.31+.02x-.01x^, r^ = .78). 
Data presented in Tables 3.40 to 3.43 show the correlation coefficients 
relating aTOC of selected tissues to plasma aTOC concentration (Tables 3.40 and 
3.42) and to liver aTOC concentration (Tables 3.41 and 3.43) of poults from 1 to 21 
d of age. Adipose tissue aTOC concentration was poorly correlated with plasma 
(Table 3.40) and liver (Table 3.41) aTOC concentration at all ages studied, a-
Tocopherol concentration of breast muscle, SI, leg muscle and liver were highly 
correlated with plasma aTOC concentration at 7, 14, and 21 d of age, whereas that 
of uropygial gland was highly correlated at 14 and 21 d of age (Table 3.40). Breast 
muscle and SI aTOC concentrations were highly correlated with liver oTOC 
concentration from 7 to 21 d of age, but leg muscle and uropygial gland aTOC 
113 
TABLE 3.40. Correlation coetlicients relating plasma a-tocopheroi 
concentration^ to a-tocopherol concentration of selected 
tissues of poults fed diets containing 12 or 300 lU 
of supplemental vitamin E per kg of diet 
Age 
Tissue^ 1 d 3 d 5 d 7 d 14 d 21 d 
(correlation coefficient)^-
Adipose tissue .28 .22 .06 .20 .32 .24 
Breast muscle .46 .43 .69 .82 .72 .93 
Small intestine .48 .57 .22 .95 .89 .79 
Leg muscle .11 .48 .16 .57 .72 .90 
Liver .03 .04 .28 .64 .87 .95 
Uropygial gland .12 .59 .06 .21 .87 .96 
^Plasma o-tocopherol concentration (/xg/mL) of two poults per pen, eight pens 
per dietary vitamin E treatment, per day. 
tissue a-tocopherol concentration ( i ig/g) of two poults per pen, eight pens 
per dietary vitamin E treatment, per day. 
^If correlation coefficient values are equal or higher than .50, probability of 
observing a significant correlation will be P < .05. 
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TABLE 3.41. Correlation coefficients relating liver a-tocopherol 
concentration^ to a-tocopherol concentration of selected 
tissues of poults fed diets containing 12 or 300 lU 
of supplemental vitamin E per kg of diet 
Age 
Tissue^ 1 d 3 d 5 d 7 d 14 d 21 d 
(correlation coefficient)^-
Adipose tissue .10 .46 .22 .21 .38 .25 
Breast muscle .49 .37 .52 .62 .70 .86 
Small intestine .72 .09 .68 .65 .94 .93 
Leg muscle .31 .33 .20 .42 .72 .82 
Liver . - . -
Uropygial gland .26 .06 .34 .21 .90 .87 
\iver a-tocopherol concentration [ng/g) of two poults per pen, eight pens per 
dietary vitamin E treatment, per day. 
tissue a-tocopherol concentration ( f ig/g) of two poults per pen, eight pens 
per dietary vitamin E treatment, per day. 
^If correlation coefficients are equal or higher than .50, probability of observing 
a significant correlation will be P < .05. 
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TABLE 3.42. Correlation coefficients relating plasma a-tocopherol 
concentration^ to total a-tocopherol of selected tissues of 
poults fed diets containing 12 or 300 lU of supplemental 
vitamin E per kg of diet 
Age 
Tissue^ 1 d 3d 5 d 7 d 14 d 21 d 
(correlation coefficient)®-
Small intestine .11 .40 .21 .91 .88 .97 
Leg muscle .28 .45 .11 .44 .86 .91 
Liver .08 .13 .26 .69 .87 .94 
Uropygial gland .12 .24 .14 .77 .96 .96 
^Plasma a-tocopherol concentration (/zg/mL) of two poults per pen, eight pens 
per dietary vitamin E treatment, per day. 
^otal tissue a-tocopherol { f ig) of two poults per pen. eight pens per dietary 
vitamin E treatment, per day. 
®lf correlation coefficient values are equal or higher than .50, probability of 
observing a significant correlation will be P < .05. 
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TABLE 3.43. Correlation coefficients relating liver a-tocopherol 
concentration^ to total a-tocopherol of selected tissues 
of poults fed diets containing 12 or 300 lU of 
supplemental vitamin E per Kg of diet 
Age 
Tissue^ 1 d 3d 5 d 7 d 14 d 21 d 
(correlation coefficient)^-
Small intestine .38 .08 .76 .65 .93 .94 
Leg muscle .09 .23 .04 .09 .79 .83 
Liver .99 .86 .96 .99 .97 .99 
Uropygial gland .26 .20 .78 .54 .90 .88 
^Liver a-tocopherol concentration (ng/g) of two poults per pen, eight pens per 
dietary vitamin E treatment, per day. 
^otal tissue a-tocopherol {iig) of two poults per pen, eight pens per dietary 
vitamin E treatment, per day. 
^If correlation coefficient values are equal or higher than .50, probability of 
observing a significant correlation will be P < .05. 
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concentrations were correlated with liver qTOC concentration only at 14 and 21 d 
of age (Table 3.41). Total aTOC of all tissues studied were highly correlated to 
plasma aTOC concentration after 7 d of age (Table 3.42). Total aTOC of SI, liver, 
and uropygial gland also were highly correlated with liver aTOC concentration from 
5 to 21 d of age, whereas leg muscle total aTOC was correlated with liver aTOC 
concentration starting at Day 14 (Table 3.43). 
Percentage of fat in tibia of poults increased from 7 to 14 d of age, 
irrespective of treatments (Table 3.44). Tibia fat averaged 4.34, 8.01, and 11.67% 
at 7, 14, and 21 d of age, respectively. Poults in the LEILA group had the highest 
percentage of fat in tibia at all ages (6.72, 14.48, and 18.32% at 7, 14, and 21 d of 
age, respectively). Tibia fat was affected by treatments at all ages (P < .05)(Table 
3.44). However, the effect of the treatments was inconsistent throughout the 21-d 
period (Table 3.45). The higher (P < .004) percentage of tibia fat of poults fed 
5,000 lU of VA/kg of diet than that of poults fed 15,000 iU of VA/kg of diet at the 
end of the experiment was probably due to the high percentage of fat in tibia of 
poults in the LEILA treatment, as indicated by the VE by VA by RT interaction (P < 
.02). 
Data presented in Tables 3.46 and 3.47 show the percentage of ash in tibia 
of poults from 7 to 21 d of age. As had been observed with the percentage of fat 
in tibia of poults, tibia ash increased from 7 to 21 d of age (45.08% at Day 7, 
51.28% at Day 21) (Table 3.46). But, neither concentration nor route of 
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TABLE 3.44. Percentage of fat in tibia of poults as influenced by vitamin E 
provided in the diet or by subcutaneous injection, and by dietary vitamin A 
Age 
Treatment^ 7 d 14 d 21 d 
/o/\ 
LEDLA 3.77 
V/o; 
6.55 9.86 
LEDHA 4.12 7.92 9.19 
HEDLA 3.50 6.70 15.68 
HEDHA 5.14 8.58 9.14 
LEILA 6.72 14.48 18.32 
LEI HA 3.23 7.05 9.46 
HEILA 5.68 7.02 11.74 
HEIHA 2.52 5.77 10.00 
SEM^ .90 1.28 1.80 
Probabilities 
Treatment .05 .002 .02 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-or-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEI treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.45. Percentage of fat in tibia of poults as influenced by vitamin E 
provided in the diet or by subcutaneous injection, and by dietary vitamin A 
Age 
Main effects of treatment^ 7d 14 d 21 d 
By vitamin E concentration (VE) 
LE (12 lU/kg) 4.46^ 9.00 11.27 
HE (300 !U/kg) 4.21 7.02 11.64 
By vitamin E route (RT) 
Diet 4.13 7.44 10.97 
Injection 4.54 8.58 11.98 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) 4.92 8.69 13.60 
HA (15,000 lU/kg) 3.75 7.33 9.45 
Probabilities 
VE 
RT 
VA 
VE * RT 
VE * VA 
RT * VA 
VE * RT * VA 
.70 
.53 
.08 
.33 
.53 
.002 
.72 
.04 
.22 
.15 
.01 
.08 
.003 
.13 
.78 
.44 
.004 
.05 
.99 
.53 
.02 
Vouits received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous Injection of 
dl-a-tocopherol (LEI and HE! treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.46. Percentage of ash in tibia of poults as influenced by vitamin E 
provided in the diet or by subcutaneous injection, and by dietary vitamin A 
Age 
Treatment^ 7 d 14 d 21 d 
tQ/ \ 
LEDLA 44.9 49.7 51.5 
LEDHA 46.5 50.0 50.6 
HEDLA 45.5 48.9 51.9 
HEDHA 45.4 49.3 50.7 
LEILA 43.8 47.8 50.4 
LEIHA 45.8 48.6 51.0 
HEILA 44.9 48.2 51.5 
HEIHA 43.8 48.7 52.6 
SEM^ 1.2 1.0 .6 
Probabilities 
Treatment .75 .74 .25 
^Poults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryi 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HE! treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyi acetate/kg of diet (U\ or HA treatments, respectively). 
^Means of four pens per treatment. 
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TABLE 3.47. Percentage of ash in tibia of poults as influenced by vitamin E 
provided in the diet or by subcutaneous injection, and by dietary vitamin A 
Age 
Main effects of treatment^ 7 d 14 d 21 d 
By vitamin E concentration (VE) 
LE (12 lU/kg) 45.3^ 49.0 50.9 
HE(30G!U/kg) 44.9 48.8 51.7 
By vitamin E route (RT) 
Diet 45.6 49.5 51.2 
Injection 44.6 48.3 51.4 
By vitamin A concentration (VA) 
LA (5,000 lU/kg) 44.8 48.6 51.3 
HA (15,000 lU/kg) 45.4 49.1 51.2 
Probabilities 
VE .66 .72 .09 
RT .24 .10 .64 
VA .52 .48 .78 
VE * RT .91 .47 .24 
VE * VA .17 .91 .84 
RT * VA .86 .79 .04 
VE * RT * VA .72 .91 .64 
Voults received 12 or 300 lU of vitamin E/kg, as dietary dl-a-tocopheryl 
acetate (LED and HED treatments, respectively), or by subcutaneous injection of 
dl-a-tocopherol (LEI and HEl treatments, respectively), and were fed 5,000 or 
15,000 lU of retinyl acetate/kg of diet (LA or HA treatments, respectively). 
^^y!eans of four pens per treatment. 
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administration of VE, nor dietary concentration of VA had any effect (P > .05) on 
tibia ash during the 21-d experimental period. At 21 d of age, dietary HA 
decreased tibia ash of VE-fed poults, but increased that of VE-injected turkeys, 
resulting in a RT by VA (P < .04) interaction at the end of the trial (Table 3.47). 
Discussion 
Results from the current experiment indicate that subcutaneous injection of 
dl-aTOC to 1-, 7-, and 14-d-old poults had a negative impact on performance and 
aTOC status of poults during the first 3 wk of life. Poults injected with VE 
(equivalent to feeding diets with 12 or 300 lU/kg, respectively) were smaller by 5 d 
of age than their counterparts fed diets containing 12 or 300 lU/kg, and this 
difference in BW became greater as poults aged to 21 d of age. Injection of poults 
was done in the area of the neck at Day 1, and in the breast area at Days 7 and 
14. The decision to change the injection site was due to the lesions observed in 
the neck area upon necropsy at 7 d of age. Moreover, pale firm areas covering 
the area of injection of VE given at Days 7 and 14 could be observed at 14 and 21 
d of age, 1 wk after administration, in the area of the breast. The injection was 
intended to be subcutaneous, but in some of the poults, the injection had been 
administered intramuscularly in the breast. Tissues were not analyzed 
histologically, but the macroscopic damage seemed severe enough to be 
detrimental on performance of the poults. Poults receiving the carrier of the vitamin 
E (placebo pens, data not shown) showed no indication of damage in the injection 
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site, although BW of carrier-injected poults was reduced 5% at 3, 5, 7, and 14 d of 
age, and 11% at 21 d of age, compared with that of VE-fed poults. It is possible 
that the carrier was partly responsible for the poorer performance of VE-injected 
turkeys during the trial. To the author's knowledge, there are no data available in 
the literature about parenteral administration of VE to turkeys at any age, and 
reports indicating any damage of parenteral administration of VE to other species 
are scarce. Judson et al. (1991) administered dl-aTACT to sheep by 
subcutaneous injection. These authors detected a bolus under the skin near the 
injection site for at least 7 d, suggesting a low availability of the subcutaneously 
injected vitamin due to the retention of the dose at the injection site. Dickson et al. 
(1986) gave several vitamin E preparations (and the oil carrier) by intramuscular 
injection to sheep. Sheep in all injected VE treatments (even 1 mL injections) had 
microscopic muscle lesions, and severe histopathological changes in the injected 
areas. Besides, the iliac lymph glands were larger in size, and contained more VE 
in the side that had been injected with the vitamin. Probably, VE compounds 
irritated the tissues at the site of injection, and were taken up by local drainage 
lymph glands, and stored there for considerable periods. Barak et al. (1986) 
reported similar results with intramuscularly VE-injected human babies. They also 
described soft-tissue calcification in subcutaneous and muscular tissue at the 
injection sites. Babies were injected with a dosage of 100 mg/kg/d, a relatively 
high dose of VE. In contrast, intramuscular injection of VE has been used widely 
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with no detrimental effect on premature infants (Schwalbe etal . ,  1992), black 
rhinoceros (Dierenfeld and Citino, 1989), sheep (Hidiroglou and Karpinski, 1987) 
and swine (Carrion and Soto-Salanova, 1993, ISU, Ames, lA 50011, personal 
communication). In the current experiment, consideration must be given to the fact 
that the volume chosen to inject in 1-d-old poults might have been too high (.15 
mL, 1.5 or 37.5 lU of dl-aTOC/poult to LE and HE poults, respectively). However, 
there were no published specifications available about the adequate doses to 
administer to poultry of any age. 
Body weight of poults was affected by VE injection starting at 5 d of age, 
and by VE and dietary VA concentration only at 21 d of age. As explained above, 
injection of .15 mL of the equivalent to either 12 or 300 lU/kg of d-aTOC produced 
a negative reaction in the body of the poults, that translated into a decreased BW 
by 48 h after VE administration. This decrease in BW was probably secondary to 
interferences of the injected VE with metabolic processes. It is possible that 
homeostatic mechanisms were unable to adjust for the alterations induced by the 
injected vitamin. Statistical analysis of 21-d data indicated that there were main 
effects of VE and VA whereby BW of poults receiving the higher concentrations of 
each vitamin was increased. Route of VE administration also affected poult growth, 
with the injection of VE reducing 21-d BW. Interpretation of these main effects, 
however, is complicated by the interactions observed. There is no doubt of the 
adverse effects of injection, although the magnitude of these effects were greater 
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when LA diets (5,000 lU/kg) were fed, indicating that extra dietary VA alleviated 
part of the effects of the injection. Increasing supplemental VE from 12 to 300 
lU/kg of diet (or the equivalent injected) in the presence of LA also alleviated part 
of the injection effect, resulting in a significant 3-way interaction. A review of BW 
data showed that the interactions involving injection of VE contributed to the 
statistical main effects of VE and VA, thus causing a relatively false impression that 
increasing the dietary concentration of either vitamin improved 21-d BW. However, 
a comparison of the mean BW of poults from treatment groups not receiving 
injections (463, 451, 458, and 468 g/poult) demonstrated no effect of dietary 
concentration of VE or VA. Effects of VE and VA supplementation have been 
reported previously, with conflicting results. In previous research in our own 
laboratory, Soto-Salanova (1991) fed 1- to 21-d-old turkeys diets containing 12 or 
100 lU of VE, and 2,000, 5,000, or 8,000 lU of VA/kg of diet. Soto-Salanova 
(1991) reported that 100 lU of VE/kg of diet decreased the reduction in BW 
caused by adding 5,000 or 8,000 lU/kg of VA to turkey diets. Similarly, McCuaig 
and Motzok (1970) reported that 10,000 lU/kg of diet or more of VE counteracted 
the negative effect on performance and viability of chicks due to excessive VA 
intake. In contrast, other authors (Vahl and Klooster, 1987; Abawi and Sullivan, 
1989; Weiser et a!., 1991) indicated no effect of increased VE supplementation on 
performance of chicks fed high VA diets. The lack of consistency of the effect of 
supplemental VE and VA on BW reported in the literature may be attributed to a 
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series of factors. Namely, species, breed, body reserve of the vitamins, absorption 
of the vitamins, level and source of dietary fat, etc, may markedly influence the 
interaction of these vitamins in the body tissues. Furthermore, the relative ratio in 
which these two vitamins were included in a diet might also change their effect on 
BW. 
Concentration of VE or VA did not affect F1 of poults during the current 
experiment, but subcutaneous injection of VE (either concentration) at Days 1, 7, 
and 14 decreased Fl of poults throughout the trial. Previously, Soto-Salanova 
(1991), feeding poults of the same age as those in the present experiment, 
observed an increased Fl of poults fed 100 lU of VE/kg of diet, compared with that 
of poults fed 12 ID of VE/kg. Mallarino (1992) also reported an increased Fl of 
poults fed 800 lU of VE/kg, compared with that of poults fed 12 lU of VE/kg. In 
contrast, Soto-Salanova et al. (1993) and Applegate (1995) failed to see any 
changes in Fl of 1- to 22-d-old poults with supplemental VE. Similarly, Murphy et 
al. (1981) did not observe any change in Fl after feeding chicks a diet with 10,000 
lU of VE/kg. In growing pigs, the effects of supplemental VE and VA on Fl have 
also been divergent. Asghar et al. (1991a) reported an increased Fl of weanling 
pigs fed diets containing 100 or 200 lU of VE/kg, compared with that of pigs fed 
10 lU of VE/kg. However, Hoppe et al. (1992) reported that no changes in Fl were 
observed after feeding growing pigs diets containing 54 lU of VE and 5,000, 
10,000, 20,000, or 40,000 lU of VA/kg. In the present trial, injection of VE 
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depressed F1 at all ages studied. The depression in F1 was more pronounced 
when poults were fed 5,000 lU of VA/kg of diet, indicating that the addition of 
15,000 lU of VA/kg of diet partly alleviated the effects of the injection. Also, the 
the adverse effect of the HE injection was partly alleviated when the LA diet was 
fed, resulting in a 3-way interaction. No information is available on the effect of 
parenteral administration of VE to turkeys, or chickens, but no adverse effects of 
VE injection on Fl of pigs (Carrion and Soto-Salanova, 1993, ISU, Ames, lA 50011, 
personal communication) or of sheep (Judson eta!., 1991) were reported. 
Feed efficiency data from the current trial show that all treatments had a 
marked effect on FE of poults from 1 to 21 d of age. There were main effects of 
VE and VA at all age-periods. Poults receiving the HE and HA treatments used 
feed more efficiently than those receiving the LE and LA treatments. Also, VE-
injected poults had a poorer FE than VE-fed poults throughout the trial. As was 
observed with the BW data, main effects of the treatments were modified by the 
interactions observed. Injection of VE impaired FE, especially that of poults fed 
5,000 ID of VA/kg of diet, suggesting a beneficial effect of including a higher 
concentration of dietary VA (15,000 lU/kg) in the diet. Also, supplementation of 
300 lU of VE/kg (or its equivalent in the injection) in the presence of 5,000 lU of 
VA/kg alleviated part of the effects of the injection, resulting in a 3-way interaction 
from 1 to 7, and 14 to 21 d, and for the overall period. The FE data show that the 
interactions involving VE injection were mainly responsible for the main effects of 
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VE and VA observed in the current experiment. 
Data published for laying hens (Butcher et al., 1993) and pigs (Asghar et al., 
1991a) showed that FE was improved by increasing supplemental VE. Butcher ef 
al. (1993) fed laying hens 10, 50, or 100 lU of VE/kg of diet. Hens receiving 50 or 
100 !U of VE/kg used feed more efficiently than those receiving 10 lU of VE/kg at 
14 and 18 wk of age. Pigs receiving 100 or 200 lU of VE/kg of diet had better FE 
than those fed 10 lU of VE/kg of diet during the growing period (Asghar et al., 
1991a). In contrast, previous reports for VE-supplemented poults (Soto-Salanova, 
1991; Mallarino, 1992; Applegate, 1995) reported no changes in FE of 1- to 22-d-
old poults with increasing VE supplementation. Moreover, FE of turkeys fed similar 
concentrations of VE/kg of diet as those used in the present trial (Sell et al., 1994) 
was not affected by dietary treatments by 42 d of age. Studies on the effect of 
increasing dietary VA concentration on FE of different species have been also 
inconclusive. Vahl and Klooster (1987) reported an impaired FE of chicks with 
increasing dietary concentrations of VA (3 to 63 mg/kg of diet). Similarly, Abawi 
and Sullivan (1989) observed that FE of chicks was impaired when they were fed 
increasing dietary concentrations of VA (10,000 to 100,000 iU/kg). in contrast, 
Weiser et al. (1991) found that increasing dietary VA from 10,000 to 15,000, 20,000, 
40,000, 80,000, or 120,000 IU/kg of diet did not affect FE of chickens during the 
first 29 d after hatching. Similar results were published by Hoppe et al. (1992) 
indicating that FE of growing pigs was not changed when VA content of their diets 
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increased from 5,000 to 10,000, 20,000, or 40,000 lU/kg of diet. 
Concentration of aTOC in plasma of poults in the present experiment 
changed with age, as reported previously for 1- to 21-d-old poults (Soto-Salanova, 
1991; Soto-Salanova et ai, 1993). The high content of aTOC carried by plasma of 
1-d-old poults indicates that there was an effective transfer of aTOC from hens to 
their progeny (Combs and Scott, 1979; Hassan et a/., 1990). Between 1 and 5 d 
of age, plasma aTOC of poults fed either concentration (12 or 300 lU/kg) of VE 
varied slightly. During this period, poults were still using aTOC from the egg yolk 
remaining in the abdomen after hatching. Egg yolk effectively supplies nutrients to 
poults 4 or 5 d after hatching (Sell et a/., 1991). From 5 d of age until 14, or 21 d 
of age, plasma aTOC of VE-fed poults varied depending on the dietary VE 
supplementation. Plasma aTOC of injected poults, in contrast, increased during 
the first week of age and then, decreased to different degrees until 21 d of age. 
These age-related changes in plasma aTOC agree with results published previously 
for turkeys (Mallarino, 1992; Sell etai, 1994; Applegate, 1995) and chickens 
(Mezes, 1988). Mallarino (1992), Sell et al. (1994), and Applegate (1995) described 
similar changes in plasma aTOC of turkeys during the first 2 wk of life, irrespective 
of VE supplementation. Differences detected in the concentration of aTOC in 
plasma of poults of the cited experiments at Day 14 can probably be attributed to 
the initial aTOC status of those poults. Day 1-aTOC, in turn, would be greatly 
influenced by the aTOC status of the hens from which poults were obtained. 
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Changes with age of plasma qTOC were linear for LE-fed turkeys, and 
quadratic for HE-fed turkeys. The linear decrease observed for the LE-fed turkeys 
supports the hypothesis that 12 lU of VE/kg of diet, the NRC (1984) recommended 
concentration for young turkeys, were not enough to maintain adequate aTOC 
levels in plasma of turkeys, whereas increasing dietary concentration of VE (300 
lU/kg) partly alleviated the depletion observed in plasma aTOC, especially between 
7 and 14 d of age. 
Increased plasma aTOC with increasing dietary VE supplementation has 
been reported for different species. Sklan et at. (1982) observed an increase in 
plasma aTOC of chickens and turkeys with increasing dietary concentrations of VE. 
These authors also observed that chickens were more responsive to dietary VE 
than turkeys. Increased plasma aTOC with supplemental VE has been reported for 
dairy calves (Reddy et al., 1987), chickens (Bartov and Frigg, 1992), cranes 
(Dierenfeld et al., 1993), monkeys (Machlin and Gabriel, 1982), pigs (Monahan et 
al., 1990), and trout (Frigg et al., 1990). In the current experiment, plasma aTOC 
of poults fed 300 lU of VE/kg of diet decreased between 1 and 7, or 14 d of age, 
but the magnitude of decrease was much smaller than that observed in poults fed 
12 lU of VE/kg of diet. These results suggest that daily dietary supplementation is 
a feasible way to maintain aTOC concentrations in plasma of young poults, 
thereby, enhancing their immune response (Oureshi et al., 1993). 
Subcutaneous injection of VE at Day 1 increased plasma aTOC of poults 
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during the first week of life, the increase being related to the concentration of VE 
used (1.5 or 37.5 lU of dl-aTOC/poult at Day 1, equivalent to 12 or 300 lU of 
VE/kg of diet, respectively). A rapid response of plasma aTOC to parenteral 
administration of VE has been reported for different species (Dierenfeld and Citino, 
1989; Hidiroglou and Karpinski, 1991; Carrion and Soto-Salanova, 1993, ISU, 
Ames, lA 50011, personal communication). In contrast to the results obtained 
during the first week, VE injection (either concentration) at Days 7 and 14 resulted 
in relatively low aTOC concentrations in plasma 1 wk after each injection (Days 14 
and 21). Reasons for this lack of response of plasma aTOC to VE injection are 
uncertain. Perhaps, during the period of time elapsed between the injection and 
the measurement of aTOC in plasma, the injected VE was cleared from the 
plasma. Although there are no data available on kinetics of VE injected into 
turkeys or chickens, results in pigs (Carrion and Soto-Salanova, 1993, ISU, Ames, 
lA 50011, personal communication) and sheep (Hidiroglou and Karpinski, 1987, 
1988, 1991) indicated that plasma oTOC peaked between 24 and 48 h following 
administration. In sheep (Hidiroglou and Karpinski, 1987, 1988, 1991), there was a 
lag period of variable duration (0 to 10 h), followed by rapid absorption and 
elimination. Another reason for the lack of response in plasma oTOC could be that 
the VE dose administered in the breast at Days 7 and 14 remained trapped at the 
injection site for a long period of time. This hypothesis agrees with the high oTOC 
content measured in breast muscle and ADT of injected turkeys at the end of the 
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experiment, and with the lesions observed in the injection area at 14 and 21 d. 
Increasing dietary concentration of VA from 5,000 to 15,000 lU/kg of diet 
decreased plasma aTOC concentration of 21-d poults. This negative effect of 
dietary VA on plasma aTOC had been reported previously in turkeys (Soto-
Salanova, 1991) and chickens (Combs and Scott, 1974; Sklan, 1983; Frigg and 
Broz, 1984; Weiser et al., 1991). Increased supplemental VA is known to reduce 
the availability of aTOC. This effect could be due to increased oxidation of aTOC 
prior to the digesta reaching the duodenum, decreased intestinal absorption, or 
increased turnover of aTOC in blood and tissues, with enhanced enterohepatic 
secretion of tocopheryl glucuronides (Sklan and Donoghue, 1982). Frigg and Broz 
(1984), working with chickens, showed that the negative effects of increased 
dietary concentration of VA on aTOC status were manifested prior to intestinal 
absorption, suggesting that the dosage of the two vitamins should not be 
considered independent of each other. 
In the present trial, the response of plasma aTOC of poults to dietary and 
parenteral administration of VE was age-related. During the first week of age, the 
rapid response of plasma aTOC to injection (especially of the equivalent to 300 
lU/kg of diet) suggests that parenteral administration of VE is a very effective route 
to maintain adequate plasma aTOC concentration of poults early in life, when 
poults are trying to adjust to a new metabolic situation. Thereafter, dietary 
supplementation of VE seems to be an adequate way of increasing and 
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maintaining plasma otTOC. More research is necessary to find the optimal 
concentration of dietary VE needed to maintain satisfactory plasma qTOC 
concentrations of poults during the first 3 wk of life. 
In the present experiment, the effects of the treatments on the weight of the 
tissues sampled, ADT, breast muscle {Pectoralis superficialis), SI, leg muscle 
{Tibilais cranealis), liver, and uropygial gland, were small and Inconsistent 
throughout the 21-d experiment. Concentrations of VE used to supplement poults 
during the 3 wk-period can be considered safe for turkeys, and no effects on 
weight of the tissues were expected. Reports in the literature indicating a change 
in tissue weight due to VE supplementation dealt with excessive amounts of 
supplemental VE. For example, McCuaig and Motzok (1970) reported that liver 
weights of 32-d-old chicks were increased when VE was included in the diet at 
10,000 iU/kg of diet. Similarly, Nockels et al. (1976) reported that relative liver 
weight of 5-wk-old chickens was increased when dietary VE was 4,000 lU or 
more/kg of diet. In turkeys, Mallarino (1992) reported a greater liver weight of 21-
d-old poults when dietary VE was increased from 12 to 800 IU/kg of diet, but did 
not find any effect of the dietary treatments on relative liver weight (expressed as a 
percentage of BW) from 1 to 21 d. Soto-Salanova (1991) observed no changes in 
liver weight of poults during the first 3 wk of life after increasing dietary VE from 12 
to 100 IU/kg, but reported a decrease in relative liver weight of poults receiving 
100 lU of VE/kg of diet, compared with that of poults receiving 12 IU/kg. In that 
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experiment, BW of 100 lU/kg-fed poults was greater than that of 12 lU/kg-fed 
poults until 21 d. It is likely that the differences observed in relative liver weight 
were due to the increased BW of those poults, and not to a real change in liver 
weight due to VE supplementation. Recently, Applegate (1995) fed 1-d-old turkeys 
diets supplemented with 0 or 150 lU of VE/kg of diet for 22 d. Applegate (1995) 
reported that VE supplementation did not affect weight or relative weight 
(expressed as percentage of BW) of liver and cerebellum of poults. Similarly, 
Jakobsen et al. (1993) observed no changes in the weight of liver, heart, 
cerebellum, kidney, and spleen of chickens with type or concentration of dietary 
VE. 
In the current trial, subcutaneous injection of VE decreased weight of SI, leg 
muscle, and liver by the end of the experimental period. These results parallel 
those reported above for BW, and they are most likely related to the negative effect 
that subcutaneous injection had on the BW of turkeys during the 21-d trial, which 
y/as explained previously. No reports on the effect that parenteral adminstration of 
VE has on tissue weight of turkeys are available in the literature, and reports for 
other species are scarce. Intramuscular injection of VE (Carrion and Soto-
Salanova, 1993, ISU, Ames, lA, personal communication) did not affect weight of 
liver, heart, kidney, pancreas, spleen, adrenal glands, lungs, or muscle of weanling 
pigs 14 d after injection (28 d postweaning). 
Adipose tissue is a major aTOC depot over long periods of time for dogs 
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(Pillai et al., 1993), humans (Traber and Kayden, 1987), mink (Tyopponen et a!., 
1984), guinea pigs (Machlin eta!., 1979), pigs (Jensen et al., 1990), and rats (Bieri, 
1972; Behrens and Madere, 1990). Characterized by an extremely slow turnover 
rate, ADT orTOC accumulates continuously with time (Bieri, 1972), suggesting that 
analysis of this tissue might provide a useful index of relatively long-term 
supplementation of VE (Machlin and Gabriel, 1982). In the present experiment, 
ADT aTOC decreased from 1 to 5 d of age, irrespective of treatment. Thereafter, 
there was a slow increase of aTOC in ADT of VE-fed poults, and a high increase in 
that of VE-injected turkeys, the increase being related to the concentration of 
supplemental VE. Changes with age of ADT aTOC were cubic for LE- and HE-fed 
turkeys, with a marked increase during the last week of the experiment, suggesting 
that aTOC was deposited in this tissue at a higher rate as the poults aged. 
However, there is no logical explanation for the greater accumulation of aTOC in 
ADT of LE-fed turkeys from 7 to 21 d of age, compared with that of HE-fed poults, 
or for the inconsistent effect of the VA treatments on ADT aTOC, especially at the 
end of the experiment. 
Mecchi et al. (1956) studied the deposition of aTOC in chickens and turkeys 
fed a diet with or without added VE. These authors found that chickens deposited 
aTOC in ADT more efficiently than turkeys in all the conditions studied. An 
increase of ADT aTOC with increasing concentrations of VE (dietary or injected) 
has been reported by Arnold et at. (1993) for cattle, Asghar et al. (1991b) and 
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Monahan et al. (1992) for pigs, and Hidlroglou (1986, 1987) and Hidiroglou and 
Charmley (1990) for sheep. Whether aTOC in ADT remains unused or is mobilized 
with time is still unknown. In a study with young and adult human females, Schafer 
et al. (1989) observed that old and young women had similar ADT aTOC reserves, 
indicating that aTOC was just not accumulated through life, but used either locally 
or mobilized to other sites. In contrast, Judson et al. (1991) failed to see any 
change in ADT oTOC of sheep given oral or subcutaneous doses of VE. Moolenar 
et al. (1973) suggested that aTOC gets stored in the different tissues as two 
different pools, a labile one which can be mobilized rapidly, and a fixed one which 
corresponds to membrane-bound aTOC, and that can not be mobilized easily. 
The latter one would be closely related to the membrane lipid composition, and 
would explain differences observed among the different species. 
Unlike had been observed for plasma and ADT aTOC, concentration of 
aTOC in breast muscle decreased until 21 d of age for most treatments. However, 
increasing dietary VE from 12 to 300 lU of VE/kg increased aTOC in breast 
muscle, starting at 5 d of age. Changes of breast aTOC with age were quadratic 
for LE- and HE-fed poults. Marusich et al. (1975) observed an increase in breast 
muscle aTOC of chickens and turkeys with increasing concentrations of dietary VE. 
However, efficiency of aTOC uptake was greater for chickens than for turkeys. 
Similarly, Lin et al. (1989) found increased aTOC in breast muscle of chicks with 
increasing dietary VE. These authors attributed the lower incorporation of oTOC in 
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white meat, compared with that of red meat, to a poorer developed vascular 
system, combined with a lower lipid content. The moderate increase in breast 
muscle aTOC when dietary VE increased from 12 to 300 lU of VE/kg of diet 
agrees with observations reported by Lin et a/. (1989) with chickens, and with 
previous reports indicating the relatively poor ability of turkeys to accumulate aTOC 
early in life (Sklan etai, 1982; Bartov, 1983). Jensen et at. (1990) suggested a 
direct relationship between muscle tissue aTOC and the need for antioxidant 
protection to explain the low aTOC accumulated in white muscle of pigs. 
Subcutaneous injection of VE in poults increased aTOC concentration of 
breast muscle, especially at the high dosage (225 lU of dl-aTOC for the overall 
period, equivalent to 300 lU of VE/kg of diet). However, these data must be 
interpreted cautiously, because breast muscle was the site of VE injection at Days 
7 and 14. At the beginning of this discussion, an explanation was given of some 
lesions observed in the breast area of the injected poults. It could very well be that 
the injected vitamin would have been administered intramuscularly in some of the 
turkeys. The variation observed in the breast muscle aTOC data supports this 
possibility. The relatively slow increase in breast aTOC for HE-injected turkeys 
after injection at Day 1 agrees with reports in the literature for other animals 
(Karpinski and Hidiroglou, 1990; Hidiroglou and Karpinski, 1991). Due to the lack 
of information on parenteral administration of VE to poultry, and the negative effect 
that VE injection had on performance of the poults in the current experiment, it 
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would be advisable to do more research on parenteral administration of VE to 
turkey poults before drawing any conclusions about the effect that VE injection has 
on breast muscle oTOC of turkey poults. 
Contrary to what was observed in other tissues, SI aTOC varied little with 
age, the variation being closely related to VE supplementation. Concentration of 
aTOC in SI of 1-d-old poults was low (4.74 Mg/g) and decreased quadratically until 
21 d of age for LE-fed poults, but increased linearly for HE-fed turkeys. Reasons 
for the low concentration of aTOC in SI of newly hatched poults are uncertain. 
Ramsey (1990, ISU, Ames, lA 50011, personal communication) observed a high 
rate of peroxidation in SI of 1-d-poults. During the first days posthatch, the 
digestive system of the poults is very active, trying to adjust to a new metabolic 
situation. During that period, SI aTOC would be rapidly consumed, and the early 
slow mobilization of aTOC from the liver, as reported by Mallarino (1992) and Soto-
Salanova et at. (1993), would partly explain the relative low concentrations of aTOC 
detected in this tissue at Day 1. 
a-Tocopherol concentration in SI of turkeys was relatively low during the 21-
d trial, irrespective of concentration or route of VE administration and of dietary VA. 
Similar results were reported by Ramsey (1990, ISU, Ames, lA 50011, personal 
communication), working with turkeys of the same age. This author also reported 
a markedly low rate of lipid peroxidation in SI of turkeys after Day 1. These data 
support the idea that, beginning 3 to 4 d after hatching, the SI may contain a 
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natural inhibitor of lipid peroxidation (Balasubramanian et al., 1988; Diplock et al., 
1988). Tappel (1974) had proposed the SI as an ideal location for cellular damage 
by lipid peroxidation. Therefore, it would be logical to have specific inhibitors of 
lipid peroxidation in that area, sparing qTOC, that would be available for internal 
organs going through rapid metabolic changes at the early stages of life. 
Total aTOC stored in SI increased from 1 to 21 d of age, irrespective of VE 
and VA supplementation. Changes in total SI aTOC with age were linear for LE-fed 
poults, and quadratic for HE-fed poults. These changes are similar to those 
observed in other tissues and show that SI was responsive to VE supplementation. 
Gallo-Torres and Miller (1971) observed a similar linear uptake of qTOC by SI of 
rats, which increased with time, and was higher after administration of dl-aTACT 
than after supplementation of dl-a-tocopheryl nicotinate. 
Subcutaneous injection at Day 1 of 37.5 iU of dl-orTOC/poult (equivalent to 
300 lU/kg of diet) increased aTOC in SI during the first week of age, but the effect 
of the injection decreased gradually with time, and, at 14 and 21 d of age, dietary 
VE was more effective than injected VE in increasing SI aTOC. The relatively low 
response of SI to supplemental VE agrees with the hypothesis that SI has a 
specific inhibitor of lipid peroxidation, thus sparing aTOC in favor of other tissues. 
The lack of response of SI oTOC to VE injection at Day 7 and Day 14 parallels that 
reported earlier for plasma. Either aTOC had been eliminated from Si at measuring 
time (1 wk after each injection, Days 14 and 21), or the injected VE had been 
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trapped at the injection site, remaining unavailable for the tissues. 
Including 15,000 ID of VA/kg in the diet of poults decreased SI aTOC, 
compared with giving 5,000 lU of dietary VA/kg only at 21 d of age. These results 
agree with those reported for liver aTOC of chickens (Frigg and Broz, 1984; Weiser 
et al., 1991) and turkeys (Soto-Salanova, 1991) fed high VA diets, and indicate that 
the negative interaction between VE and VA occurs ubiquitously in the body 
tissues. 
As was observed for the other muscle studied in the current experiment 
{breast muscle, Pectoralis superficialis), leg muscle {Biceps femoralis) aTOC 
decreased with age for most treatments. However, the decrease was not as 
pronounced as it had been observed in breast muscle aTOC. These findings 
agree with the hypothesis that red meat can accumulate more aTOC than white 
meat (Lin et al., 1989), probably due to a higher lipid content, and a better 
developed vascular system. Increasing dietary VE supplementation partly alleviated 
the decrease of aTOC observed in leg muscle, and this effect was more evident for 
the HE-fed poults, which accumulated the most qTOC in leg muscle by 21 d of 
age. A similar response of leg muscle aTOC to increasing dietary VE was reported 
for turkeys (Franchini et al., 1990b), chickens (Lin et al., 1989; Sheehy et al., 1991) 
and rats (Bieri, 1972). Franchini et al. (1990b) fed 1- to 140-d-old turkeys diets 
containing 30, 90, 180, or 360 ppm of dl-oTACT. These authors observed that the 
aTOC content of leg muscle and the stability of muscle fat increased proportionally 
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to the dietary concentration of VE. Years before, Marusich et al. (1975) had 
reported that the onset of meat rancidity (breast muscle) was delayed in turkeys 
fed, for 3 or 4 wk prior to slaughtering, a diet supplemented with 100-400 ppm of 
VE. In chickens, Lin et al. (1989) and Sheehy et al. (1991) reported an increased 
deposition of aTOC in leg muscle with VE supplementation. Sheehy et al. (1991) 
found such increase to be highly correlated with increasing dietary concentrations 
of VE (5 to 180 hq/q of diet). 
Subcutaneous injection of 37.5 lU of VE/poult at Day 1 increased aTOC in 
leg muscle of poults from 3 to 7 d of age. However, no further increases were 
observed. The relatively high aTOC content in leg muscle of HE-injected poults at 
the end of the experiment may be a result of the slow turnover rate of muscle 
aTOC, as was published for muscle of VE depleted and repleted rats (Bieri, 1972). 
The response of muscle tissue to supplemental VE has been documented for cattle 
(Hidiroglou et al., 1988; Arnold etal., 1993), pigs (Jensen et al., 1990; Asghar et 
al., 1991a; Chung et al., 1992), sheep (Hidiroglou et al., 1988), rats (Behrens and 
Madere, 1990), and trout (Hung et al., 1982). In all cases, there was a slow but 
continuous increase with increasing VE supplementation. In contrast, Pillai et al. 
(1993) observed that skeletal muscle of dogs fed increasing concentrations (0, 74, 
or 114 mg/kg) of dl-aTACT accumulated aTOC at a faster rate, similar to that 
observed by heart muscle. Given the direct relationship observed between dietary 
VE, muscle aTOC content, and muscle oxidative stability (Frigg et al., 1990; Gatlin 
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III etai, 1992; Bai and Gatlin III, 1993; He and Lawrence, 1993), the increased leg 
muscle qTOC of HE-poults at 21 d of age obsen/ed in the current trial suggests 
that poults are responsive to VE supplementation, and that this would be an 
effective form to protect muscle tissue from lipid peroxidation. Moreover, results of 
leg muscle otTOC agree with those observed in other tissues during the present 
trial, indicating that increasing dietary VE during the first days of life is a non 
invasive and rapid method to increase aTOC stores of young poults. 
The concentration of aTOC in liver varied with the age of the poults. 
Concentration of orTOC in liver of poults at Day 1 averaged 97.4 /ig/g, or 158.9 nq 
when expressed as total aTOC stored in the liver. a-Tocopherol liver stores 
increased from 1 to 3 d of age, irrespective of treatment. This increase reflects the 
utilization of aTOC stored in the egg yolk of the poults and chicks just after hatch 
(Sell eta!., 1991; Murakami et al., 1992). A similar increase was reported by 
Mallarino (1992), working with poults of the same age as those used in the current 
trial. Liver aTOC decreased markedly from 3 to 14 d of age for all treatments, and 
then decreased or increased slightly, depending on the treatment, between 14 and 
21 d of age. These age-related changes have been previously reported for turkeys 
(Soto-Salanova, 1991; Sell et al., 1994; Applegate, 1995), chickens (Mezes, 1988), 
and pigs (Chung et al., 1992). Reasons for the marked decrease of liver aTOC 
during the first 2 or 3 wk of life are uncertain. First, turkeys have a relatively poor 
ability to accumulate aTOC in their tissues (Sklan et al., 1982). Second, during the 
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early posthatching period, the digestive system of poults is in a developing stage 
(Sell et aL, 1991). Sell et al. (1991) reported that most intestinal and pancreatic 
enzymes are not working at full capacity during the first few days of life. This 
suggests an inefficient absorption of nutrients (Sell et al., 1991, ISU, Ames, lA 
50011, personal communication), including qTOC, early in life. Third, liver has 
been proposed as the main organ with capacity to store aTOC for short periods of 
time (Bieri, 1972; Kelly et al., 1992). If that is the case, liver would mobilize its 
aTOC stores, i.e., at times of intense metabolic activity, to be used by organs and 
tissues that need the protecting antioxidant capacities of aTOC. 
Liver aTOC data show that high dietary VE (300 lU of VE/kg of diet) was 
more effective than any other treatment in increasing liver aTOC stores from 5 d to 
21 d of age, the effect being more marked as poults aged. The rapid response of 
liver aTOC to dietary VE supplementation has been widely reported. Increasing 
dietary VE from 12 to 100 lU/kg of diet increased aTOC in liver of turkeys of the 
same age as those used in the current trial (Soto-Salanova, 1991; Soto-Salanova et 
al., 1993). Other dietary concentrations of VE, ranging from 0 to 800 lU/kg, have 
been used with similar results in young turkeys (Csallany et al., 1988; Mallarino, 
1992; Sell et al., 1994; Waibel et al., 1994; Applegate, 1995), chicks (Sheehy et al., 
1991), pigs (Asghar et al., 1991a; Chung et al., 1992), and trout (Frigg et al., 1990; 
Furones et al., 1992). 
Subcutaneous injection at Day 1 of 37.5 lU of dl-aTOC/poult (equivalent to 
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300 lU/kg of diet) increased markedly liver aTOC stores during the first 48 h 
postinjection. The 3-d data show also the large capacity of the liver to store aTOC 
(1,038 fig/g or 3,455 /jg/liver for HEIHA poults). By 5 d of age, however, liver 
aTOC (expressed in /xg/g, or as /ig/liver) of VE-injected turkeys had decreased 
markedly, and continued to decrease until 14 or 21 d of age. These observations 
agree with those reported for plasma aTOC, indicating that there was no response 
of liver aTOC to VE injection at Day 7 and Day 14. As was proposed for plasma, it 
could be that injected VE was cleared from liver during the 7-d period that elapsed 
between the injection and the measurement of aTOC in the liver. Another reason 
to explain the lack of response of liver aTOC to VE injection could be that the 
vitamin was trapped at the injection site. This hypothesis was supported by the 
aTOC data of all tissues analyzed, and by lesions observed at the injection area at 
14 and 21 d. 
As was seen in the current trial, liver aTOC of pigs (Batra and Hidiroglou, 
1994), rats (Gallo-Torres and Miller, 1971), and sheep (Hidiroglou, 1986; Hidiroglou 
and Karpinski, 1987, 1988, 1991; Hidiroglou etal., 1990) was markedly increased 
after parenteral administration of VE, further supporting the theory that liver is a key 
organ in the storage, transport and utilization of aTOC. 
Dietary VA did not affect liver aTOC during the current trial. These results 
disagree with those observed earlier in our own laboratory, working with turkeys of 
the same age as those use herein. In that previous trial, Soto-Salanova (1991) 
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observed a decrease in liver aTOC when dietary VA was increased from 2,000 to 
5,000, or 8,000 lU/kg. Moreover, the inclusion of 100 lU of VE/kg in the diet of 
the turkeys partly alleviated the decrease in liver aTOC due to the high VA diets. It 
is not known why the greater concentrations of supplemental VE and VA used in 
the current trial (300 lU/kg of VE, and 15,000 lU of VA/kg of diet) failed to promote 
the same responses as in Soto-Salanova's trial. One reason could be the 
differences in the initial aTOC status of poults in both experiments. One-d-poults in 
Soto-Salanova's (1991) experiment had 35.01 jug/g of liver, or 57.61 /tg/liver, 
whereas those of the current trial had 97.4 ng/g, or 158.9 /xg/liver. It is possible 
that the better initial aTOC status of poults herein protected poults against the 
negative effect of higher doses of VA, as was reported for chickens (Vahl and 
Klooster, 1987; Pellett etaL, 1994). Had the experiment lasted longer, we might 
have seen some interaction between the two vitamins. 
Known also as the oil gland, or preen gland, the uropygial gland lies dorsally 
near the tip of the tail. !n the turkey, it consists of 2 lobes, with a separate duct 
opening into a narrow median slit on a distinct papilla (Lucas and Stettenheim, 
1972). The specific function of this gland is uncertain. It is a unique source of 
unusual lipids, especially monoester waxes, although there are also secretions of 
diester and triester waxes, glycerides, sterols, and hydrocarbons. Uropygial gland 
serves as a water-repellent agent (Weitzel, 1951), gives flexibility to the feathers 
(Elder, 1954), and controls the microflora of the plumage (Jacob and Ziswiler, 
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1982). It was believed to be a source of vitamin D. but this idea was rejected in 
1941, when Koch and Koch found that the uropygial gland of chickens was lacking 
or was exceedingly low in provitamin D. 
Uropygial gland of l-d-old poults had 147 /ig of aTOC/g, for a total of 1.77 
/ig/gland. Following a similar pattern to that observed in liver, uropygial gland 
aTOC decreased markedly with age, suggesting that this gland may be a short-
term storage organ of aTOC. Starting at 5 d of age, route and concentration of 
supplemental VE markedly influenced uropygial gland aTOC. Although uropygial 
gland oTOC of poults receiving the LE supplementation did not reach the low levels 
observed with liver aTOC at 14 and 21 d of age, increasing VE from 12 to 300 
lU/kg of diet (or its equivalent by injection) alleviated the depletion of aTOC in 
uropygial gland, and this effect became more evident as turkeys aged. 
The uropygial gland was also responsive to parenteral administration of VE. 
Subcutaneous injection of 37.5 lU of dl-aTOC/poult (equivalent to 300 lU of VE/kg 
of diet) at Day 1 increased uropygial gland aTOC from 1 to 7 d of age, and aTOC 
levels remained fairly high until 21 d of age. To the author's knowledge, there is 
no literature available on changes in the aTOC content of uropygial gland with VE 
supplementation in any species. The uropygial secretions of Galliformes (among 
whom the turkey is included) contain more polar lipids than those of most other 
species (Gamo, 1971), with unbranched fatty acids (of 18 C atoms), and threo- and 
erytho-alkane-2,3-diols. This high content of lipid material of the uropygial gland 
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may require extra aTOC to protect tiie gland against lipid peroxidation. Also, the 
similar pattern of changes of ctTOC in this gland to those observed in liver aTOC 
strongly suggests an active role of this gland, unknown to date, in aTOC 
metabolism. Lipid content of the uropygial gland was not analyzed in the present 
experiment, so we cannot draw any conclusion to that respect. However, it would 
be advisable to do more research on the potential function of this gland as a 
reservoir of aTOC in poultry. 
Since qTOC is widely distributed in human and animal tissues, the 
assessment of aTOC status may be determined by measuring the aTOC content in 
a specific tissue, which is then assumed to represent the whole body. Plasma and 
liver have been used as the most common indicators of aTOC status (Bartov, 
1983; Bartov and Bornstein, 1977; Sklan and Donoghue, 1982). In the present 
study, aTOC content of all tissues studied (expressed in /ig/g, or as /ig/tissue), 
with the exception of adipose tissue, was highly correlated with plasma and liver 
aTOC concentration, starting at 7 d of age. The low correlation observed during 
the first week of life could be expected. During that time, poults are still using their 
aTOC stores in liver and egg yolk, that had been accumulating before hatch (Noble 
and Cocchi, 1990; Noble et al., 1993). a-Tocopherol concentration of ADT was 
poorly correlated with plasma and liver aTOC concentration at all ages studied. 
This is not surprising, since ADT is characterized by a slow turnover rate of aTOC 
(Machlin and Gabriel, 1982) that seem to vary independently of the rest of the 
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tissues, in contrast, liver and plasma accumulate and mobilize aTOC at a much 
faster rate, and they are very responsive to VE supplementation. Most tissues, 
liver and plasma included, are thought to contain a labile pool of aTOC, which can 
be mobilized rapidly. Both plasma and liver oTOC have been found to be excellent 
indicators of this circulating aTOC available at the tissue level, and of availability of 
dietary VE. Similarly to what was seen in the current trial, Bieri (1972) reported that 
plasma aTOC of rats was highly correlated with aTOC of all tissues studied, except 
that of adipose tissue. And similar results were published for guinea pigs (Machlin 
et a!., 1979) and pigs (Jensen ef a/., 1990). 
The high correlation reported here between plasma and liver aTOC, and 
aTOC in breast and leg muscles, SI, liver, and uropygial gland agrees with early 
reports for chickens (Bartov and Bornstein, 1977; Sklan et al., 1982; Hassan and 
Hakkarainen, 1990) and turkeys (Marusich et al., 1975; Sklan et al., 1982; Soto-
Salanova, 1991). Plasma and/or liver have been used to indicate the aTOC status 
of a variety of species, such as chicks (Hakkarainen et al., 1984), mink 
(Tyopponen et al., 1984), and turkeys (Soto-Salanova, 1991; Waibel et al., 1994; 
Applegate, 1995). But, in fact, reports in the literature indicating the validity of 
using plasma or liver aTOC as indicators of VE status have been controversial. 
Hassan and Hakkarainen (1990) observed that plasma, whole blood, and RBC 
aTOC were all reliable indexes of the aTOC status of chickens. Similarly, Sheehy 
et al. (1991) found that plasma was a good index of aTOC status of lung, liver and 
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heart of chickens receiving increasing concentrations (5 to 180 ng/g) of dietary VE. 
Recently, Sheehy et al. (1993) reported a high correlation between plasma aTOC 
and thigh and breast muscle aTOC of chicks. In 1980, Gallo-Torres suggested that 
plasma aTOC may not be a sensitive indicator of aTOC stores, but that it was an 
excellent indicator of circulating aTOC available at the tissue level, and of the 
availability of dietary VE. Results published by Jensen et al. (1990) for pigs 
corroborate this idea. Jensen et al. (1990) found that liver and plasma aTOC 
reflect the immediate nutritional status of VE, whereas adipose and skeletal muscle 
aTOC reflect the long-term nutritional history. In rats, Eicher et al. (1994) used 
plasma aTOC levels and RBC hemolysis to confirm VE deficiency of rats. In 
contrast, Hidiroglou and Charmley (1990) and Hidiroglou and Karpinski (1991) 
observed that plasma was not a reliable index of aTOC status of sheep, after 
dietary (Hidiroglou and Charmley, 1990) or intramuscular (Hidiroglou and Karpinski, 
1991) supplementation of VE. These results disagree with those published by Fry 
et al. (1993) for VE-deficient sheep. These authors found plasma oTOC to be a 
good indicator of aTOC status in skeletal muscle, heart muscle, adrenal glands, 
adipose tissue, liver and RBC. 
The validity of using plasma oTOC as an adequate indicator of aTOC status 
for humans was first questioned by Honwitt et al. (1972). Honwitt et al. (1972, 1984) 
suggested that in humans, the plasma aTOC/lipid ratio was a better indicator of 
aTOC status than plasma aTOC. Similar results have been published by Roem et 
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al. (1990) for blue tilapia. Roem et al. (1990) recommended that VE requirement 
for blue tilapia would be expressed as a function of dietary lipid level. However, 
Dimitrov et al. (1991) reported that, although the ratio of oTOC/choiesterol can be 
more accurate than plasma aTOC levels to determine the cfTOC status of humans, 
using the cited ratio did not alter significantly the pattern of changes in plasma 
when pharmacological doses were administered. Composition of the diets 
consumed by the subjects under study should be considered before drawing any 
conclusion. When a standardized diet, with specific lipid composition was used, 
minor differences in plasma lipid composition should be expected (Chung et al., 
1992). Species differences may account also for some of the discrepancies in the 
results. Reports published for chickens (Crisetig et al., 1993), sheep (Fry et al., 
1993), and turkeys (Franchini et a!., 1990b; Crisetig et al., 1991) indicated that 
plasma lipids of these animals were not affected by dietary VE supplementation. 
Since the reports published by Horwitt et al. (1972), alternative indicators of 
aTOC status have been proposed. In humans, Vatassery et al. (1983) and 
Lehmann et al. (1988) found that platelets were the most accurate indicator of VE 
status. Ogihara et al. (1985) and Morita et al. (1989), instead, proposed RBC as 
the best index for physiologically available aTOC localized in biomembranes. 
Lehmann (1981) used platelets to indicate the aTOC status of rats, whereas Mino 
et al. (1981) used RBC aTOC to indicate the aTOC status of VE-deficient rats. 
Kelly et al. (1992) found that RBC aTOC was the best indicator of VE status of 
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guinea pigs during the perinatal period. Finally, RBC hemolysis has been used as 
the most sensitive indicator of aTOC status, especially in VE deficiency, for different 
species (Rose and Gyorgy, 1950; Horwitt etal., 1972; Mino et al., 1981; Stevenson 
and Jones, 1989; Eicher et al., 1994). 
Results from the current experiment confirm previous reports for turkeys 
(Bartov, 1983; Franchini etal., 1990b; Soto-Salanova, 1991; Applegate, 1995) 
indicating that plasma and/or liver are good indicators of aTOC status of turkey 
poults after 7 d of age. However, more research is needed to establish which is 
the best indicator of aTOC status under the specific conditions of the study under 
way. 
Percentage of fat in the tibia of poults increased from 7 to 21 d of age, 
irrespective of treatment. A review of the tibia fat data indicates that the effects of 
the treatments on tibia fat were sporadic, and seem to be related to the increased 
tibia fat of LEILA turkeys during the experiment. There was an indication that HA-
fed poults had less tibia fat than LA-fed poults, especially at 21 d of age. Instead, 
tibia ash was not affected by any of the treatments at any age. The combined 
results of tibia fat and ash show that there was no clear effect of the treatments on 
these parameters at any age. This is not surprising, since the concentrations of VE 
and VA used in the current trial can be considered safe for turkeys, never reaching 
the high concentrations reported by some other authors. In 29-d-old chickens, 
Weiser et al. (1991) reported a decreased dry bone mass and tibia breaking 
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Strength when chicks received massive doses of VA (20,000 to 300,000 iU/kg of 
feed). These authors also reported that the negative effect of excessive VA on tibia 
mass and strength was mitigated by VE supplementation (30 to 120 mg/kg of 
diet). In contrast, Blair et al. (1992), working with pigs, failed to observe any 
relationship between dietary VA (increased until 100 times the NRC estimated 
requirement) and the incidence of clinical osteochondrosis. Reports in the 
literature indicating changes in bone calcification with VE used excessive amounts 
of the vitamin (March et al., 1973; N/lurphy et al., 1981). For example. Murphy et al. 
(1981) observed a lower percent bone ash, calcium, and phosphorus with 
excessive VE supplementation (10,000 lU of dl-aTACT/kg of diet). 
In summary, results from the present experiment indicate that dietary 
supplementation of 300 ID of VE/kg of diet was effective in increasing aTOC stores 
of poults in all tissues studied, ADT, breast and leg muscle, SI, liver, and uropygial 
gland. Liver and plasma aTOC can be considered as excellent indicators of aTOC 
status of young turkeys after the first week after hatching. Vitamin E injection 
markedly increased aTOC stores of the poults during the first week of life, but had 
little effect thereafter. This, and the negative effect observed on performance of the 
injected poults during the 3 wk-period strongly suggest the need for more research 
to decide if parenteral administration of VE to poults is an adequate route of VE 
supplementation, and, if it is, what are the doses recommended to improve the 
health status of the poult just after hatch. The great concentration of aTOC in the 
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uropygial gland of poults found in the current trial opens the question of whether 
this gland may be used as a reservoir of aTOC by the turkeys during embryonic 
life, or after hatch, and why aTOC is stored in such gland. More research is 
needed to answer these questions. 
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CHAPTER 4. EXPERIMENT 2 
Materials and Methods 
Six hundred 1 -d-oid male turkey poults (Nicholas Large White) were 
obtained from a commercial hatchery. Twenty poults were placed in each of thirty 
pens so that the average poult weight was approximately the same in each pen. 
Each of seven treatments was randomly assigned to four pens, and an eighth 
treatment was randomly assigned to two pens. 
Six of the treatments were the result of a factorial arrangement of three 
concentrations and two sources of dietary vitamin E (VE). Turkeys in these 
treatments received 12 (LACT), 80 (MACT), or 150 (HACT) lU of dl-a-tocopheryl 
acetate^ (dl-QtTACT)/kg of diet, or were supplemented with 12 (LOL), 80 (MOL), or 
150 (HOL) lU of d-a-tocopherol^ (d-Q!TOC)/kg of diet. The seventh treatment 
(INOL) consisted of a single subcutaneous injection of d-aTOC^ at 1 d of age. 
Poults in this treatment were subcutaneously injected In the dorsal area of the neck 
with 25 ID of d-oTOC, this amount being approximately equivalent to the amount 
poults would consume if their diet was supplemented with 150 lU of VE/kg during 
^Rovimix® E-50, 500 lU of dl-a-tocopheryl acetate/g. Hoffmann-La Roche, Inc. 
Nutley, NJ 07110 
^Emcelle Tocopherol, 500 ID of d-a-tocopherol/mL. Stuart Products. Bedford, TX 
76021 
\'ital E"'-500, 500 lU of d-a-tocopherol/mL. Schering-Plough Animal Health. 
Kenilworth, NJ 07033 
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their first week of life. Poults in the INOL treatment also received 12 ID of dl-
aTACT/kg of diet throughout the 21-d experiment. During the first week of the 
experiment, two additional pens were injected with the carrier" of the injectable VE. 
Poults in this eighth treatment were subcutaneously injected at 1 d of age in the 
dorsal area of the neck with a volume of carrier equal to the volume of d-aTOC 
injected to poults receiving the INOL treatment. This treatment was used to assess 
any influence of the carrier on the results of the experiment, and was eliminated 
from the experiment at the end of the first week of trial. 
During the experiment, turkeys were allotted to 59 x 69 cm floor pens, which 
were bedded with clean litter. Room temperatures ranged between 23 and 25 C 
during the 21-d period. Pen temperature was kept at 35 C until poults were 7 d 
old, at 32 C until they were 14 d of age, and at 29 0 thereafter. Feed and water 
were provided for ad libitum consumption throughout the experiment. 
Poults in all treatments were fed a typical corn-soybean meal starter diet. All 
diets were formulated to meet or exceed the NRC (1984) recommended nutrient 
concentrations for a turkey starter diet, and were calculated to be isocaloric (2,850 
kcal ME^/kg) and isonitrogenous (28.5% protein). Composition of the diets is 
shown in Table 4.1. 
Feed samples from each diet were taken at mixing time, and stored at 4 C 
until analyzed for dry matter, ash, protein, and fat. An extra sample from each diet 
Vital E Placebo. Schering-Plough Animal Health. Kenilworth, NJ 07033 
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TABLE 4.1. Ingredient composition of the corn-soybean meal diets^ 
Ingredient LACT MACT HACT 
LOL MOL HOL 
INOL 
/«/ \ 
Corn 36.47 
V/oy 
33.75 30.95 
Soybean meal 55.38 55.38 55.38 
Dicalcium phosphate 2.33 2.33 2.33 
Limestone 1.45 1.45 1.45 
Animal-vegetable fat 3.11 3.11 3.11 
Mineral premix^ .30 .30 .30 
Vitamin premix^ .30 .30 .30 
Vitamin E premix"* .48 3.20 6.00 
DL-methionine .18 .18 .18 
^LACT, !NOL, MACT, and HACT treatments were supplemented with 12, 12, 80, 
and 150 ID of dl-a-tocopheryl acetate/kg of diet, respectively; LOL, MOL, and HOL 
treatments were supplemented with 12, 80, and 150 lU of d-a-tocopherol/kg of 
diet, respectively. 
^Supplied per kilogram of diet: manganese, 70 mg; zinc, 40 mg; iron, 37 mg; 
copper, 6 mg; selenium, .15 mg; sodium chloride. 2.60 g. 
^Supplied per kilogram of diet; vitamin A (retinyl acetate), 5,000 lU; 
cholecalciferol, 1,500 ID; vitamin vitamin K (menadione sodium 
bisulfite), 1.8 mg; riboflavin, 2.7 mg; pantothenic acid, 7 mg; niacin, 75 mg; choline, 
509 mg; folic acid, .55 mg; biotin, 75 ng. 
'^Adjusted at the expense of corn to supply: 12, 12, 80, and 150 lU of dl-a-
tocopheryi acetate for LACT, INOL, MACT, and HACT treatments, respectively; and 
12, 80, and 150 lU of d-a-tocopherol for LOL, MOL, and HOL treatments, 
respectively. 
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was also taken at the time of mixing, and stored at -20 C for VE analysis. To run 
proximate analysis on those feed samples stored at 4 C, samples were ground to 
pass through a 1.0 mm mesh sieve. Dry matter was determined by drying the 
samples in a forced draft oven at 72 C until they reached constant weight. To 
determine ash, samples were placed in a muffle oven at 600 C for 24 h. Nitrogen 
concentration was determined by the macro-Kjeldahl procedure (Association of 
Official Analytical Chemists, AOAC, 1980, section 2.057). Nitrogen values obtained 
were multiplied by 6.25 to calculate the protein percentage (AOAC, 1980, section 
14.068). Fat concentration in the feed was determined by ether extraction (AOAC, 
1980, section 7.056). Tocopherol isomers and dl-aTACT were extracted from the 
diets with acetone in a Soxhiet extractor, evaporated to dryness and redissolved in 
hexane, and then, separated and quantitated by high performance liquid 
chromatography (HPLC)(Cort et al., 1983). Calculated and determined analyses of 
the diets are shown in Tables 4.2 and 4.3, respectively. The differences between 
calculated and determined analyses for VE values were probably due to the long 
time of storage of the samples, and the poor efficiency of the extraction method. 
Body weight (BW) and feed intake (Fl) of the poults were monitored at 1, 3, 
5, 7, 14, and 21 d of age. Feed efficiency (FE) was calculated as the Fl to BW 
gain ratio for each of the periods studied. On the first day of the experiment, 20 
poults were randomly selected for sampling to obtain zero-time data (five pooled 
samples). Subsequently, one or two poults (depending on the age of the poults) 
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TABLE 4.2. Nutrient composition of the corn-soybean meal diets 
Calculated analysis Basal diet 
Dry matter, % 90.20 
MEn, kcal/kg 2,850.00 
Protein, % 28.50 
Ether extract, % 5.20 
Total sulfur amino acids, % 1.05 
Methionine, % .60 
Lysine, % 1.70 
Calcium, % 1.20 
Available phosphorus, % .60 
Sodium, % .12 
Chloride, % .22 
Potassium, % 1.20 
Selenium, mg/kg .22 
Zinc, mg/kg 73.00 
Iron, mg/kg 579.00 
Vitamin A, lU/kg 5,040.00 
Cholecalciferol, lU/kg 1,500.00 
Vitamin E, lU/kg^ 21.80 
Riboflavin, mg/kg 5.00 
Pantothenic acid, mg/kg 23.80 
Niacin, mg/kg 96.10 
Choline, mg/kg 2,140.00 
Linoleic acid, % 2.00 
^Basal corn-soybean meal diet, to which vitamin E was added as 12, 12, 80, 
and 150 ID of dl-a-tocopheryl acetate/kg of diet for treatments LACT, INOL, MACT, 
and HACT, respectively; and 12, 80, and 150 ID of d-a-tocopherol/kg of diet for 
treatments LOL, MOL, and HOL, respectively. 
^Calculated analysis for vitamin E: 22 lU for treatments LACT, INOL, and LOL; 
90 lU for treatments MACT and MOL; and 160 ID for treatments HACT and HOL. 
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TABLE 4.3. Determined composition of the corn-soybean meai diets^ 
LACT MACT HACT LOL MOL HOL 
Dry matter, % 90.99 90.68 91.06 90.66 90.92 90.88 
Protein, % 28.29 29.96 29.54 28.43 27.90 30.83 
Ether extract, % 4.75 4.52 4.83 4.30 5.32 4.54 
Ash, % 7.16 6.89 7.02 7.18 7.22 6.91 
Vitamin E, iU/kg 12.94 37.30 71.25 6.61 25.99 45.79 
^Basal corn-soybean meal diets, to which vitamin E was added as 12, 12, 80, 
and 150 lU of dl-a-tocopheryl acetate/kg of diet for treatments LACT, MACT, and 
HACT, respectively; and 12, 80, and 150 lU of d-a-tocopherol/kg of diet for 
treatments LOL, MOL, and HOL, respectively. 
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were selected at random from each pen for sampling at 3, 5, 7, 14, and 21 d of 
age. 
Blood was obtained by jugular venipuncture by using heparinized syringes 
(200 U heparin/mL). Blood samples were subsequently separated into three 
subsamples. The first subsample, consisting of 1 mL of whole blood, was used to 
determine the susceptibility of the erythrocytes to oxidative stress. Hemolysis of 
the red blood cells (RBC) was induced by using t-butyl hydroperoxide (BHP), at a 
concentration of 400 /iM, as the oxidative agent (Smith et al., 1988). The second 
subsample consisted of 2 mL of whole blood and was used to collect RBC for 
qTOC determination. For that purpose, blood was centrifuged at 1,500 x g for 15 
minutes, plasma was separated, and the packed RBC were washed three times 
with isotonic buffer (pH 7.4) (Hassan and Hakkarainen, 1990), and stored frozen at 
-20 C until RBC aTOC analysis. The third subsample was stored in crushed ice (4 
C) until centrifugation and then, centrifuged at 1,500 x g for 15 minutes. The 
plasma was aspirated v/ith a Pasteur pipette and samples were stored frozen at -20 
C in separate tubes until analyzed. One hundred nL of sample were used to 
determine the activity of the enzyme creatine phosphokinase (CK) in plasma. For 
that purpose, a commercial CK kit® was used. Adenosine-5'-diphosphate and 
phosphocreatine were used as substrates, and the production of free creatine 
formed by action of CK was measured by a colorimetric method at 520 nm. The 
^Sigma Chemical Co, St Louis, MO 63178 
161 
amount of color formed was proportional to CK activity (Hughes, 1962). Another 
subsample of 100 /xL was used to determine the content of triglycerides (TG) in 
plasma. A commercial TG kit® was used for a colorimetric determination. The 
intensity of color produced was directly proportional to the TG concentration of the 
sample, and this color was measured colorimetrically at 500 nm (Bucolo and David, 
1973). Another plasma subsample was kept frozen at -20 C for subsequent aTOC 
determination. 
Plasma aTOC concentration and concentration of aTOC in RBC were 
determined by the method described by Cort et at. (1983). Plasma and RBC (2 
mL) were deproteinized with absolute ethanol (3 mL), and tocopherols were 
extracted with hexane (1 mL). Tocopherol concentrations were determined by 
HPLC, with fluorescence retention at 294 nm excitation wavelength and 323 nm 
emission wavelength. The mobile phase was 3.5% tetrahydrofuran in hexane, with 
a flow rate of 2.2 mL/min. The sample extracted in hexane was injected directly 
into the HPLC. a-Tocopherol was identified and quantitated by the comparison of 
retention times and peak areas with aTOC standards. 
After blood samples were taken, turkey poults were killed by Halothane®^ 
inhalation and livers were excised at 1, 3, 5, 7, 14, and 21 d of age. Before 
freezing, .4 g samples of livers of poults were used immediately after sampling to 
®Sigma Chemical Co, St Louis, MO 63178 
''Halocarbon Laboratories, North Augusta, SC 29841 
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determine lipid peroxidation in vitro. Liver lipid peroxidation was measured by 
determination of the production of thiobarbituric acid reactive substances (TBARS) 
in vitro (Baiasubramanian etal., 1988) at 1, 5, 7, 14, and 21 d of age. Also, yolk 
sac and yolk sac contents were excised and collected at 1 d of age. Samples 
were weighed, frozen in liquid nitrogen, and stored at -20 C until prepared for 
aTOC determination. 
Tissue samples were thawed at room temperature, and .05 to 2 g 
(depending on the age of the poults and the amount of aTOC expected) were 
homogenized in 10 mL (wt/vol) of phosphate-EDTA buffer (pH 7.0). Tissue 
tocopherols were then determined by HPLC by processing 2 mL of the tissue 
homogenate as described earlier for RBC and plasma. 
Statistical analysis within each age was performed according to the General 
Linear Model (GLM) procedure of SAS® (SAS Institute, 1985) to determine the 
effect of treatment. Single-degree of freedom, orthogonal contrasts were done 
when significant (P < .05) effects of treatments were observed. The six contrasts 
were done to compare each of the dietary treatments with the INOL treatment. A 
two-way analysis of variance by using the GLM procedure of SAS® was also done 
to determine main effects of concentration and source of dietary VE, and their 
interaction. The arc sine transformation was used before analysis of data 
expressed as a percentage. 
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Results 
Body weight of poults was not affected (P > .05) by any of the treatments 
from 1 to 21 d of age (Table 4.4). Twelve lU of either dl-aTACT or d-aTOC/kg of 
diet supported growth adequately as compared with feeding 80 or 150 lU of either 
VE source/kg. There was no influence of injecting 25 IU of d-aTOC at Day 1 on 
BW of poults throughout the 21-d period (Table 4.4). Body weight of the turkeys 
averaged 456 g at 21 d of age across all treatment groups. 
At 14 d of age, poults in all treatments were diagnosed with an enteric 
disease. Poults were infected with a rotavirus (type D), the infection lasting until 
the end of the experimental period. This enteric disease produced diarrhea and 
reduced Fl, and might have affected performance and some of the traits measured 
during the trial. 
Supplementation of the diet with three concentrations (12, 80, and 150 lU/kg 
of diet) and two sources (dl-aTACT and d-aTOC) of VE did not affect (P > .05) Fl 
of poults at any of the ages studied (Table 4.5). Poults injected with 25 iU of d-
aTOC at 1 d of age consumed as much feed (P > .05) as did poults receiving any 
of the dietary treatments (Table 4.5). 
There were no significant effects of the treatments on FE in the current 
study, with the exception of the 14 to 21-d period (Table 4.6). Poults fed 12 IU of 
dl-aTACT /kg of diet (LACT treatment) utilized feed more efficiently (P < .03) during 
the last week of the experiment than poults receiving any other treatment. 
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TABLE 4.4. Body weight of poults as influenced by vitamin E provided in the 
diet or by subcutaneous injection 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
Vy/ 
LACT 52 69 83 104 225 469 
MACT 52 87 78 100 230 454 
HACT 52 70 82 103 234 467 
LOL 52 68 80 99 223 441 
MOL 52 69 81 101 231 455 
HOL 52 69 80 100 230 452 
INOL 52 68 80 100 224 447 
SEM^ 1 2 2 5 9 
Probabilities 
Treatment .39 .63 .59 .74 .31 
Voults were fed 12, 80 or 150 lU of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-QfTOC)(LOL, MOL, and 
HOL treatments, respectiveiy)/kg of diet, or received 25 !U of d-oTOC at Day 1 by 
subcutaneous injection (INOL). 
^Means of four pens per treatment. 
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TABLE 4.5. Feed intake of poults as influenced by vitamin E provided in the 
diet or by subcutaneous Injection 
Period 
Treatment^ 1 to 7 d 7 to 14 d 14 to 21 d 1 to 21 d 
(g/poult) 
LACT 64 169 334 568 
MACT 61 176 333 569 
HACT 63 166 336 565 
LOL 60 165 323 548 
MOL 63 167 329 559 
HOL 60 161 328 549 
INOL 60 165 322 547 
SEM^ 1 4 6 10 
Probabilities 
Treatment .30 .30 .58 .45 
^Poults were fed 12, 80 or 150 IU of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-aTOC)(LOL, MOL, and 
HOL treatments, respectiveiy)/kg of diet, or received 25 ID of d-aJOC at Day 1 by 
subcutaneous injection (INOL). 
^Means of four pens per treatment. 
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TABLE 4.6. Feed efficiency (feed:gain) of poults as influenced by vitamin E 
provided in the diet or by subcutaneous injection 
Period 
Treatment^ 1 to 7 d 7 to 14 d 14 to 21 d 1 to 21 d 
19/9) 
LACT 1.24 1.42 1.37 1.36 
MACT 1.26 1.35 1.49 1.42 
HACT 1.23 1.27 1.44 1.36 
LOL 1.29 1.33 1.48 1.41 
MOL 1.27 1.29 1.47 1.39 
HOL 1.26 1.24 1.48 1.38 
INOL 1.25 1.33 1.45 1.39 
SEM^ .03 .06 .02 .01 
Probabilities 
Treatment .72 .55 .03 .09 
LACT vs INOL 
MACT vs INOL 
HACT vs INOL 
LOL vs INOL 
MOL vs INOL 
HOL vs INOL 
.03 
^Poults were fed 12, 80 or 150 !U of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-aTOC)(LOL, MOL, and 
HOL treatments, respectjveiy)/l<g of diet, or received 25 lU of d-aTOC at Day 1 by 
subcutaneous injection (INOL). 
^Means of four pens per treatment. 
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Cumulative FE for the 21-d period averaged 1.38 across ail treatment groups, and 
was not affected (P > .05) by any of the dietary treatments or by d-aTOC injection 
CTable 4.6). 
Susceptibility of erythrocytes of poults to hemolysis changed markedly with 
age. From an initial low value of 9.5% at 1 d of age, RBC susceptibility to 
hemolysis increased for all treatment groups until 5 d of age (average 46%), 
irrespective of VE supplementation (Table 4.7). Starting at 5 d of age, RBC 
hemolysis was deeply affected by treatments, decreasing with increasing dietary 
VE in most cases to 21 d of age. The magnitude of the decrease depended on 
the route, source, and concentration of the VE supplement, and on the age of the 
poults. The effect of dietary VE supplementation as dl-oTACT or d-aTOC on 
erythrocyte susceptibility to hemolysis is presented in Table 4.8. Data show that 
RBC hemolysis was decreased by increasing the concentration of either source of 
VE from 12 to 80, or 150 !U/kg of diet. Percentage of erythrocyte hemolysis of 
poults fed 80 or 150 !U of either source of VE/kg of diet was numerically lower 
than that of poults receiving 12 lU of VE/kg at all ages, and it was significantly 
lower at 3 (P < .02), 7 (P < .004), 14 (P < .009), and 21 (P < .02) d of age. By 
the end of the experiment, 42.2% of the RBC of poults fed 12 lU of VE/kg of diet 
were susceptible to hemolysis, whereas only an average of 9.5% of those of poults 
receiving 80 or 150 iU/kg of diet were susceptible to oxidative damage. 
There was no effect of the source of dietary VE used in the present study on 
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TABLE 4.7. Susceptibility to hemolysis ot erythrocytes of poults as 
influenced by vitamin E provided in the diet or by 
subcutaneous injection 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
/o/ \ 
LACT 9.5 28.2 65.0 
V/o; 
61.2 55.8 45.6 
MACT 9.5 19.6 51.8 28.7 36.0 8.0 
HACT 9.5 11.2 45.4 17.6 19.4 11.2 
LOL 9.5 23.4 50.1 65.0 76.4 38.7 
MOL 9.5 14.6 50.8 35.4 17.3 7.8 
HOL 9.5 18.0 42.0 23.1 12.6 10.4 
INOL 9.5 18.5 14.5 16.6 15.9 8.5 
SEM^ 5.2 10.2 13.6 18.8 13.8 
Probabilities 
Treatment .11 .03 .02 .03 .09 
LACT vs INOL .001 .01 .06 .02 
MACT vs INOL .009 
HACT vs INOL .02 
LOL vs INOL .01 .004 .006 .08 
MOL vs INOL .01 
HOL vs INOL .04 
^Poults were fed 12, 80 or 150 ID of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-aTOC)(LOL, MOL, and 
HOL treatments, respectively)/kg of diet, or received 25 lU of d-aTOC at Day 1 by 
subcutaneous injection (INOL). 
^Means of four pens per treatment. 
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TABLE 4.8. Main effect means of susceptibility to hemolysis of erythrocytes 
of poults as influenced by different concentrations and sources of 
vitamin E provided in the diet 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
/O/ \ 
By concentration (Cone) 
°J 
L (12 lU/kg) 9.5 25.8 57.9 63.1 66.1 42.2 
M (80 lU/kg) 9.5 17.1 51.3 32.0 26.6 7.9 
H (150 lU/kg) 9.5 14.6 43.7 20.4 16.0 10.8 
By source 
ACT (Acetate) 9.5 19.6 54.3 35.8 37.1 21.6 
OL (Alcohol) 9.5 18.7 47.6 41.2 35.4 19.0 
SEM^ 5.1 11.0 13.9 19.9 14.9 
Probabilities 
Cone .02 .37 .004 .009 .02 
Source .78 .41 .52 .99 .73 
Cone * Source .23 .71 .99 .46 .91 
^Poults were fed 12, 80 or 150 lU of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-aTOC)(LOL, MOL, and 
HOL treatments, respectively)/kg of diet. 
^Means of four pens per treatment. 
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the susceptibility of RBC to hemolysis from 1 to 21 d of age (P > .05)(Table 4.8). 
However, supplying 25 lU of d-aTOC by subcutaneous injection at 1 d of age 
markedly decreased RBC susceptibility to hemolysis starting at 5 d of age (Table 
4.7). At this time, poults in all dietary treatment groups had a high percentage of 
their RBC (average 51%) susceptible to oxidative damage, as compared with poults 
in the INOL group (14.5%). The beneficial effect of d-aTOC injection gradually 
decreased until 21 d of age. At 7, 14, and 21 d of age, INOL treatment was more 
effective than LACT (P < .01, P < .06, and P < .02, respectively) and LOL (P < 
.004, P < .006, and P < .08, respectively) treatments in decreasing erythrocyte 
hemolysis. However, giving 80 or 150 lU of either dl-otTACT or d-aTOC/kg of diet 
to poults was as effective as d-aTOC injection to prevent RBC oxidative damage 
from 7 to 21 d of age. 
a-Tocopherol concentration in RBC of 1-d-old poults averaged .83 /zg/mL 
(Table 4.9). From 1 to 14 d of age, there was a general decrease in RBC aTOC 
concentration, irrespective of dietary VE, and then, concentration of aTOC in RBC 
increased until 21 d of age for all dietary treatment groups. There was a significant 
effect (P < .05) of concentration of dietary VE on RBC aTOC content from 5 to 21 
d of age. Erythrocytes of poults fed 80 or 150 lU of either source of VE (dl-aTACT 
or d-aTOC)/kg of diet contained more aTOC than those of poults fed 12 lU/kg at 
all ages. By 21 d of age, RBC aTOC concentration of poults fed 12, 80, and 150 
lU of VE/kg of diet was .17, .65, and .80 /xg/mL, respectively. There was no effect 
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TABLE 4.9. Main effect means of concentration of a-tocopherol in red blood 
cells of poults as influenced by different concentrations and 
sources of vitamin E provided in the diet 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
By concentration (Cone) 
L (12 lU/kg) .83 .72 .66 .57 .08 .17 
M (80 lU/kg) .83 .73 .75 .79 .37 .65 
H (150 lU/kg) .83 .79 .78 .93 .64 .98 
By source 
ACT (Acetate) .83 .75 .73 .72 .35 .59 
OL (Alcohol) .83 .74 .72 .80 .38 .62 
SEM^ .03 .05 .04 .06 .04 
Probabilities 
Cone .12 .05 .001 .001 .001 
Source .52 .77 .01 .57 .34 
Cone * Source .17 .40 .29 .82 .12 
Voults were fed 12, 80 or 150 lU of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-Q:TOC)(LOL, MOL, and 
HOL treatments, respectively)/kg of diet. 
^Means of four pens per treatment. 
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of source of dietary VE on RBC aTOC concentration until 7 d of age. At this time, 
poults fed d-aTOC had greater (P < .01) aTOC content in RBC compared with 
those fed dl-aTACT, irrespective of concentration. By 14 d of age, this effect had 
disappeared, and no further effect of the source of dietary VE could be detected 
until the end of the experiment. 
Injection of the poults with 25 ID of d-aTOC at 1 d of age increased (P < 
.001) RBC aTOC concentration at 3, 5, and 7 d of age (Table 4.10). Poults in the 
INOL treatment group still had greater concentrations of aTOC in RBC than poults 
in the LACT and LOL treatment groups at 14 (P < .001) and 21 (P < .08) d of age. 
However, at 14 d of age, RBC of those poults fed 150 IU (HACT and HOL 
treatments) of either source of VE/kg of diet had higher (P < .01) aTOC 
concentrations than those of injected turkeys (INOL treatment). By 21 d of age, 
feeding 80 or 150 ID of dl-aTACT or d-aTOC/kg of diet was more effective (P < 
.001) than supplying 25 ID of d-aTOC by subcutaneous injection at 1 d of age in 
maintaining high concentrations of aTOC in RBC. 
Plasma aTOC decreased from 1 to 14 d of age for poults in all dietary 
treatments (Table 4.11). a-Tocopherol concentration averaged 11.21 /ig/mL of 
plasma at Day 1, reached the lowest concentrations at Day 14, averaging 3.20 
/ig/mL, and increased slightly by 21 d of age (average 3.73 //g/mL). However, 
increasing dietary VE concentration from 12 to 80, or 150 lU/kg of diet increased 
(P < .02) plasma aTOC at all ages, starting at 3 d of age. Supplementing VE in 
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TABLE 4.10. Concentration of a-tocopherol in erythrocytes of poults as 
influenced by vitamin E provided in the diet or by 
subcutaneous injection 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
LACT .83 .70 .66 .56 .09 .18 
MACT .83 .73 .78 .72 .34 .67 
HACT .83 .83 .75 .88 .62 .91 
LOL .83 .74 .66 .58 .08 .16 
MOL .83 .72 .71 .85 .40 .64 
HOL .83 .74 .80 .98 .66 1.05 
INOL .83 4.84 2.78 1.59 .40 .29 
SEM^ .22 .22 .09 .06 .04 
Probabilities 
Treatment .001 .001 .001 .001 .001 
LACT vs INOL .001 .001 .001 .001 .08 
MACT vs INOL .001 .001 .001 .001 
HACT vs INOL .001 .001 .001 .01 .001 
LOL vs INOL .001 .001 .001 .001 .05 
MOL vs INOL .001 .001 .001 .001 
HOL vs INOL .001 .001 .001 .004 .001 
Voults were fed 12, 80 or 150 lU of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-Q!TOC)(LOL. MOL, and 
HOL treatments, respectively)/kg of diet, or received 25 ID of d-aTOC at Day 1 by 
subcutaneous injection (INOL). 
^Means of four pens per treatment. 
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TABLE 4.11. Main effect means of concentration of a-tocopherol in plasma of 
poults as influenced by different concentrations and sources of 
vitamin E provided in tlie diet 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
VH'y/ y; 
By concentration (Cone) 
L(12IU/kg) 11.21 6.36 4.60 2.29 3.02 2.29 
M (80 lU/kg) 11.21 6.77 5.07 4.63 3.11 4.31 
H (150 lU/kg) 11.21 8.69 6.05 5.94 3.45 4.60 
By source 
ACT (Acetate) 11.21 7.30 5.07 3.89 3.28 3.85 
OL (Alcohol) 11.21 7.24 5.42 4.67 3.11 3.61 
SEM^ .69 .41 .34 .15 .47 
Probabilities 
Cone .008 .008 .001 .02 .001 
Source .92 .31 .01 .17 .54 
Cone * Source .36 .58 .56 .06 .001 
^Poults were fed 12, 80 or 150 ID of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-aTOC)(LOL, MOL, and 
HOL treatments, respectively)/kg of diet. 
^Means of four pens per treatment. 
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the diet as d-ctTOC increased (P < .01) plasma aTOC concentration at 7 d of age, 
compared with adding VE in the diet as di-aTACT. Thereafter, this effect was 
reversed, and was different depending on the concentration of dietary VE. This 
resulted in a concentration by source interaction at 14 (P < .06) and 21 (P < .001) 
d of age (Table 4.12). 
Injection of 25 ID of d-aTOC at Day 1 increased (P < .001) plasma qTOC 
concentration until 7 d of age, compared with supplementation of VE in the diet 
(Table 4.12). By 14 d of age, however, plasma aTOC of INOL poults had 
decreased markedly, and HACT-fed poults carried greater (P < .003) oTOC 
concentration in their plasma than did INOL-injected turkeys. At the end of the 
experiment, INOL poults had similar concentration of aTOC in their RBC as poults 
fed 12 lU of either source of VE/kg of diet. 
Data presented in Table 4.13 show that activity of CK in plasma was not 
affected by any of the treatments during the 21-d experimental period. Activity of 
CK in plasma, measured by the number of micrograms of creatine formed per 
mililiter per minute, averaged 1,611 ^g/mL/min at Day 1. There was a marked 
increase in the activity of CK in plasma at 14 d of age, irrespective of treatment. 
This increase was most likely related to the enteric infection (caused by rotavirus 
D) that poults contracted by 14 d of age. By 21 d of age, however, this effect had 
disappeared and CK activity in plasma averaged 1,548 /ig/mL/min across all 
treatment groups. 
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TABLE 4.12. Concentration of a-tocopherol in plasma of poults as influenced 
by vitamin E provided in the diet or by subcutaneous injection 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
LACT 11.21 5.94 4.62 2.10 2.89 2.44 
MACT 11.21 6.70 4.94 4.18 3.26 5.46 
HACT 11.21 9.27 5.64 5.39 3.69 3.65 
LOL 11.21 6.78 4.59 2.47 3.15 2.13 
MOL 11.21 6.85 5.20 5.08 2.96 3.15 
HOL 11.21 8.11 6.46 6.48 3.22 5.54 
INOL 11.21 20.94 15.97 7.76 3.05 3.35 
SEM^ .75 .46 .46 .14 .47 
Probabilities 
Treatment .001 .001 .001 .01 .001 
LACT vs INOL .001 .001 .001 _ 
MACT vs INOL .001 .001 .001 .004 
HACT vs INOL .001 .001 .002 .003 
LOL vs INOL .001 .001 .001 .08 
MOL vs INOL .001 .001 .001 
HOL vs INOL .001 .001 .06 .003 
Voults were fed 12, 80 or 150 IU of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-o-tocopherol (d-Q!TOC)(LOL, MOL, and 
HOL treatments, respectively)/kg of diet, or received 25 lU of d-oTOC at Day 1 by 
subcutaneous injection (iNOL). 
^Means of four pens per treatment. 
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TABLE 4.13. Activity of creatine kinase in plasma of poults as influenced by 
vitamin E provided in the diet or by subcutaneous injection 
Age 
Treatment^ 1 d 3d 5 d 7 d 14 d 21 
I'll-/mil IJ 
LACT 1,611 1,510 1,415 2,036 9,542 1,308 
MACT 1,611 1,142 1,483 1,421 7,466 1,789 
HACT 1,611 1,632 1,058 1,510 6,808 1,844 
LOL 1,611 1,067 1,239 1,752 6,893 1,355 
MOL 1,611 1,292 973 2,593 5,561 1,637 
HOL 1,611 1,378 1,850 2,270 6,324 1,629 
INOL 1,611 1,242 1,185 1,705 10,417 1,276 
SEM^ 137 235 526 1,929 224 
Probabilities 
Treatment .10 20 .69 .56 .40 
Voults were fed 12, 80 or 150 ID of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-aTOC)(LOL, MOL, and 
HOL treatments, respectively)/kg of diet, or received 25 IU of d-aTOC at Day 1 by 
subcutaneous injection (INOL). 
^Means of four pens per treatment. 
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Supplementation of VE in the diet or by subcutaneous injection did not affect 
the concentration of TG in plasma from 1 to 21 d of age (Table 4.14). 
Concentration of TG in plasma increased from .65 mg/mL at Day 1 to 1.02 mg/mL 
at Day 3, irrespective of treatment. Plasma TG values decreased until Day 7, 
increased to 14 d of age, and decreased again for most treatment groups by the 
end of the experiment (average .83 mg/mL). 
The ttTOC/TG ratio in plasma of poults was affected (P < .004) by 
treatments at 3, 5, 7, and 21 d of age (Table 4.15). The aTOC/TG ratio in plasma 
of poults fed VE (either source or concentration) decreased from 1 d (average 17.7 
mg/g) to 14 or 21 d of age, depending of the treatment. Injection of poults with 25 
lU of d-aTOC at Day 1 markedly increased the aTOC/TG ratio in plasma at 3 (P < 
.001), 5 (P < .01), and 7 (P < .01) d of age, as compared with dietary 
supplementation of VE. At 14 d of age, however, plasma aTOC/TG ratio of INOL 
poults had decreased to levels similar to those observed for VE-fed poults, and, by 
21 d of age, poults in the HOL treatment had a greater (P < .01) aTOC/TG ratio in 
plasma than that of poults in any other treatment group. 
a-Tocopherol content of livers of poults during the 21-d experiment is shown 
in Tables 4.16 through 4.19. Livers of 1-d-old poults contained 143.6 /ig of 
aTOC/g of liver for a total of 208.2 Mg/liver (Tables 4.16 and 4.18). a-Tocopherol 
stored in liver of poults decreased markedly from 1 to 14 d of age for poults fed 
either source (dl-aTACT or d-aTOC) or concentration (12, 80, or 150 lU/kg) of VE. 
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TABLE 4.14. Concentration of triglycerides in plasma of poults as influenced 
by vitamin E provided in the diet or by subcutaneous injection 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
Viiiy/MiL.; 
LACT .65 .96 .70 .74 .94 .92 
MACT .65 .95 .61 .79 1.38 .94 
HACT .65 .98 .80 .89 1.23 .71 
LOL .65 1.14 .83 .95 .72 .83 
MOL .65 .96 .95 .92 1.01 .97 
HOL .65 1.16 .60 1.07 .88 .60 
INOL .65 1.00 .86 .85 1.14 .84 
SEM^ .14 .16 .11 .16 .17 
Probabilities 
Treatment .85 .65 .47 .14 .70 
^Poults were fed 12, 80 or 150 lU of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-QTOC)(LOL, MOL, and 
HOL treatments, respectively)/kg of diet, or received 25 lU of d-aTOC at Day 1 by 
subcutaneous injection (INOL). 
^Means of four pens per treatment. 
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TABLE 4.15. Alpha-tocopherol/triglyceride ratio in plasma of poults as 
influenced by vitamin E provided in the diet or by 
subcutaneous injection 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
v'y/ y; 
LACT 17.7 6.6 7.6 2.9 3.1 2.9 
MACT 17.7 7.4 8.8 5.6 2.4 6.2 
HACT 17.7 9.7 7.5 6.2 3.1 5.9 
LOL 17.7 6.0 6.2 2.9 5.7 3.7 
MOL 17.7 7.3 6.4 6.1 3.8 4.3 
HOL 17.7 7.8 11.8 6.1 4.2 9.5 
INOL 17.7 20.9 23.2 9.3 2.7 4.0 
SEM^ 1.1 2.8 .8 .9 1.2 
Probabilities 
Treatment .001 .004 .001 .19 .01 
LACT vs INOL .001 .001 .001 _ _  _ 
MACT vs INOL .001 .002 .005 
HACT vs INOL .001 .001 .01 
LOL vs INOL .001 .001 .001 
MOL vs INOL .001 .001 .01 
HOL vs INOL .001 .01 .01 .004 
Voults were fed 12, 80 or 150 lU of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-Q-tocopherol (d-aTOC)(LOL, MOL, and 
HOL treatments, respectively)/kg of diet, or received 25 ID of d-aTOC at Day 1 by 
subcutaneous injection (INOL). 
^Means of four pens per treatment. 
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TABLE 4.16. Main effect means of concentration of a-tocopherol in liver of 
poults as influenced by different concentrations and sources of 
vitamin E provided in the diet 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
VMy/ y; 
By concentration (Cone) 
L (12 iU/kg) 143.6 67.2 53.4 13.9 1.7 2.1 
M (80 lU/kg) 143.6 68.8 40.6 28.0 5.5 8.8 
H (150 IU/kg) 143.6 76.6 52.3 32.2 9.4 12.5 
By source 
ACT (Acetate) 143.6 65.6 48.7 26.7 5.8 7.6 
OL (Alcohol) 143.6 76.1 48.8 24.1 5.3 8.0 
SEM^ 8.4 8.6 5.6 1.0 .9 
Probabilities 
Cone .50 .28 .006 .001 .001 
Source .14 .98 .57 .49 .54 
Cone * Source .44 .63 .19 .64 .02 
Voults were fed 12, 80 or 150 IU of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-aTOC)(LOL, MOL, and 
HOL treatments, respectively)/kg of diet. 
^Means of four pens per treatment. 
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TABLE 4.17. Concentration of a-tocopherol in liver of poults as influenced by 
vitamin E provided in the diet or by subcutaneous injection 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
VMy/ y; 
LACT 143.6 66.5 56.8 16.5 1.9 2.2 
MACT 143.6 65.0 35.8 23.6 6.3 9.7 
HACT 143.6 65.3 53.4 40.1 9.3 10.7 
LOL 143.6 67.9 49.9 11.4 1.6 2.0 
MOL 143.6 72.6 45.3 32.5 4.7 7.8 
HOL 143.6 88.0 51.1 28.3 9.5 14.2 
INOL 143.6 295.0 167.5 37.8 4.7 3.5 
SEM^ 9.9 18.1 5.6 1.0 .8 
Probabilities 
Treatment .001 .001 .01 .001 .001 
LACT vs INOL .001 .001 .01 .05 
MACT vs INOL .001 .001 .09 .001 
HACT vs INOL .001 .001 .003 .001 
LOL vs INOL .001 .001 .003 .03 
MOL vs INOL .001 .001 .002 
HOL vs INOL .001 .001 .002 .001 
Poults were fed 12, 80 or 150 iU of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-aTOC)(LOL, MOL, and 
HOL treatments, respectively)/l<g of diet, or received 25 IU of d-aTOC at Day 1 by 
subcutaneous injection (!NOL). 
^Means of four pens per treatment. 
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TABLE 4.18. Main effect means of total a-tocopherol in liver of poults as 
influenced by different concentrations and sources of vitamin E 
provided in the diet 
Age 
Main effects of 
treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
By concentration (Cone) 
L (12 lU/kg) 208.2 179.5 178.3 49.5 10.4 23.8 
M (80 lU/kg) 208.2 186.4 122.6 89.2 37.2 100.4 
H (150 lU/kg) 208.2 236.9 163.2 118.0 59.8 145.3 
By source 
ACT (Acetate) 208.2 182.3 151.9 91.4 38.1 86.8 
OL (Alcohol) 208.2 219.5 157.6 79.7 33.5 92.5 
SEM^ 31.0 30.9 18.5 6.7 11.9 
Probabilities 
Cone .16 .20 .006 .001 .001 
Source .16 .82 .45 .42 .53 
Cone * Source .32 .57 .10 .79 .08 
Voults were fed 12, 80 or 150 ID of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-QTOC)(LOL, MOL, and 
HOL treatments, respectively)/kg of diet. 
^Means of four pens per treatment. 
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TABLE 4.19. Total a-tocopherol in liver of poults as influenced by vitamin E 
provided in the diet or by subcutaneous Injection 
Age 
Treatment^ 1 d 3 d 5 d 7 d 14 d 21 d 
VA»y/iivci; 
LACT 208.2 187.4 180.5 57.1 11.8 26.0 
MACT 208.2 162.9 101.1 73.0 42.1 108.2 
HACT 208.2 196.8 173.9 144.0 60.3 126.2 
LOL 208.2 171.7 176.1 41.8 9.0 21.7 
MOL 208.2 209.9 144.2 105.4 32.3 92.6 
HOL 208.2 276.9 152.5 91.9 59.3 164.4 
INOL 208.2 814.5 496.0 127.3 29.1 37.3 
SEM^ 33.2 52.3 18.6 6.4 11.0 
Probabilities 
Treatment .001 .001 .008 .001 .001 
LACT vs INOL .001 .001 .01 .07 _ 
MACT vs INOL .001 .001 .05 .001 
HACT vs INOL .001 .001 .002 .001 
LOL vs INOL .001 .001 .004 .04 
MOL vs INOL .001 .001 .002 
HOL vs INOL .001 .001 .003 .001 
^Poults were fed 12, 80 or 150 lU of dl-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-a-tocopherol (d-aTOC)(LOL, MOL, and 
HOL treatments, respectively)/kg of diet, or received 25 ID of d-aTOC at Day 1 by 
subcutaneous injection (INOL). 
^Means of four pens per treatment. 
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The magnitude of the decrease of liver aTOC concentration was 51, 66, 82, and 
90%, and that of total liver aTOC was 8, 26, 59, and 83% (average of all treatment 
groups) at 3, 5, 7, and 14 d of age. a-Tocopherol stores in liver, however, 
increased slightly by 21 d of age for all dietary treatments. Starting at 7 d of age, 
and until 21 d of age, dietary VE had a marked effect on the aTOC stored in liver 
of poults. Increasing the concentration of either source of dietary VE from 12 to 80 
or 150 lU/kg of diet increased aTOC in liver at 7 (P < .006), 14 (P < .001), and 21 
(P < .001) d of age (Tables 4.16 and 4.18). There was no effect of the dietary 
source of VE on liver aTOC stores during the 21-d experiment, although turkeys 
fed dl-aTACT (LACT, MACT, and HACT treatments) had numerically greater liver 
aTOC concentration and total amount than those fed d-aTOC (LOL, MOL, and 
HOL treatments). This trend was reversed by 21 d of age, with the effect of dl-
aTACT and d-oTOC being different depending on the dietary VE concentration. 
This inconsistency resulted in a concentration by source interaction for liver aTOC 
concentration (P < .02) and total liver aTOC (P < .08) at 21 d of age. 
Subcutaneous injection of 25 lU of d-aTOC at Day 1 markedly increased 
liver aTOC stores at 3 (P < .001) and 5 (P < .001) d of age (Tables 4.17 and 
4.19). By Day 7, INOL poults still had more oTOC in their livers than LACT (P < 
.01), MACT (P < .09), and LOL (P < .003) poults. As age increased, liver qTOC 
stores of INOL-injected turkeys decreased, and by 21 d of age, poults fed 80 or 
150 lU VE (either source)/kg of diet had greater (P < .002) liver oTOC 
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concentration (8.8 and 12.5 ng aTOC/g, respectively) than INOL poults (3.5 /ig/g) 
(Table 4.17). And the same was true for total otTOC in liver at 21 d of age (Table 
4.19). 
Lipid peroxidation in the liver, as measured by the TBARS assay, is depicted 
in Tables 4.20 and 4.21. Livers of 1-d-old poults were most susceptible to lipid 
peroxidation (5.10 nmol MDA/mg protein). The number of TBARS in liver 
decreased until 7 d of age, and then, increased to different degrees between 14 
and 21 d of age. Increasing dietary VE (either source) from 12 to 80 or 150 lU/kg 
of diet decreased (P < .005) liver TBARS at 7 d of age (Table 4.20). However, this 
effect disappeared by 14 d of age, and no further effect of dietary concentration of 
VE could be observed until the end of the experiment. There was no effect of 
source of dietary VE on liver TBARS. However, dl-aTACT-fed poults had lower lipid 
peroxidation values than those fed d-aTOC at all ages, except at 14 d of age. At 
this time, the effect of the dl-aTACT and d-aTOC was different depending on the 
dietary VE concentration, which resulted in a concentration by source interaction (P 
< .03). By 21 d of age, liver TBARS averaged 2.67 nmol MDA/mg protein across 
all dietary treatment groups. 
Injection of 25 ID of d-oTOC at 1 d of age had a slight and inconsistent 
effect on liver TBARS at 7 and 14 d of age (Table 4.21). By 21 d of age, the effect 
of the injection had disappeared and liver lipid peroxidation was similar for all 
treatment groups. 
187 
TABLE 4.20. Main effect means of lipid peroxidation, as measured by the 
TEARS assay, in liver of poults as influenced by different sources 
and concentrations of vitamin E provided in the diet 
Age 
Treatment^ 1 d 5 d 7 d 14 d 21 d 
(nmol MDA/mg protein) 
By concentration (Cone) 
L (12 lU/kg) 5.10 2.63 2.35 2.51 2.95 
M (80 lU/kg) 5.10 2.54 1.62 2.45 2.42 
H (150 lU/kg) 5.10 2.37 1.44 2.22 2.65 
By source 
ACT (Acetate) 5.10 2.49 1.75 2.54 2.64 
OL (Alcohol) 5.10 2.53 1.86 2.25 2.71 
SEM^ .32 .25 .23 .32 
Probabilities 
Cone .71 .005 .42 .27 
Source .88 .58 .14 .80 
Cone * Source .14 .48 .03 .87 
Voults were fed 12, 80 or 150 lU of dl-a-tocopheryt acetate (LACT, MACT, 
and HACT treatments, respectively) or d-Q-tocopherol (d-aTOC){LOL, MOL, and 
HOL treatments, respectively)/kg of diet. 
^Means of four pens per treatment. 
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TABLE 4.21. Lipid peroxidation, as measured by the TBARS assay, in liver of 
poults as influenced by vitamin E provided in thie diet or by 
subcutaneous injection 
Age 
Treatment^ 1 d 5 d 7 d 14 d 21 d 
(nmol MDA/mg protein) 
LACT 5.10 2.27 2.11 2.39 2.96 
MACT 5.10 2.83 1.65 2.97 2.29 
HACT 5.10 2.37 1.48 2.26 2.67 
LOL 5.10 2.99 2.58 2.63 2.95 
MOL 5.10 2.24 1.60 1.90 2.55 
HOL 5.10 2.36 1.40 2.18 2.63 
INOL 5.10 2.27 1.87 2.77 2.45 
SEM^ .34 .28 .21 .31 
Probabilities 
Treatment .57 .07 .03 .71 
LACT vs INOL _ _ 
MACT vs INOL 
HACT vs INOL 
LOL vs INOL .08 
MOL vs INOL .01 
HOL vs INOL . - .06 
^Poults were fed 12, 80 or 150 lU of di-a-tocopheryl acetate (LACT, MACT, 
and HACT treatments, respectively) or d-o-tocopherol (d-aTOC)(LOL, MOL, and 
HOL treatments, respectively)/kg of diet, or received 25 lU of d-aTOC at Day 1 by 
subcutaneous injection (!NOL). 
^Means of four pens per treatment. 
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Discussion 
Addition to the diets of 12, 80, or 150 ID of dl-oTACT (LACT, MACT, and 
HACT treatments, respectively), or d-aTOC (LOL, MOL, and HOL treatments, 
respectively), or subcutaneous injection of 25 ID of d-aTOC at Day 1 (INOL 
treatment) did not affect BW of the poults during the 21-d experiment. Reports of 
VE supplementation influencing growth performance have been contradictory. In 
turkeys, Sklan et al. (1982) found no changes in BW of 4-wk-old turkeys after 
supplementation of the diet with 0, 10, 50, and 250 !U of VE/kg. Soto-Salanova et 
al. (1993) indicated that supplementation of the diet with 100 lU of dl-aTACT/kg did 
not increase BW of poults, compared with including 12 lU of dl-oTACT/kg of diet 
during the first 3 wk of life. Similarly, Applegate (1995) observed no changes in 
BW of 1- to 22-d-old poults after supplementation of the diet with 0 or 150 IU of dl-
aTACT/kg. However, Soto-Salanova (1991) and Mallarino (1992), working with 
poults of the same age as those used in the current experiment, reported an 
increased BW with increasing dietary VE supplementation. Soto-Salanova (1991) 
fed poults diets containing 12 or 100 lU of dl-aTACT/kg, and 2,000, 5,000, or 8,000 
ID of vitamin A/kg, whereas Mallarino (1992) used therapeutic doses of VE (800 
lU/kg of diet). !n both instances, poults receiving the higher dietary concentrations 
of VE were heavier than poults receiving the NRC (1984) recommended dietary 
concentration for turkey poults (12 lU/kg). In chickens, published data dealing 
with changes in BW with VE supplementation has been also divergent. Decreased 
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(March eta!., 1973; Nockels et al., 1976) or unchanged (McCuaig and Motzok, 
1970; Murphy et al., 1981; Sklan et al., 1982; Bartov et al., 1991; Sheehy et a!., 
1991; Bartov and Frigg, 1992) BW of chickens with high dietary concentrations of 
VE has been reported in the literature. In other species, high dietary 
concentrations of VE have been reported to increase BW of calves (Reddy et al., 
1987), pigs (Asghar et al., 1991a), and rats (Meydani et al., 1986), and to maintain 
BW of calves (Arnold etal., 1992), laying hens (Butcher ef al., 1993), and trout 
(Furones et al., 1992). Finally, BW has been reported to decrease in VE-deficient 
trout (Frigg et al., 1990), but no changes in BW were detected in VE-deficient pigs 
(Jensen et al., 1990), or rats (Mino et al., 1981; Eicher et al., 1994). 
Information in the literature concerning the effect of different dietary sources, 
or different routes of VE administration on BW is scarce, and, in most cases, 
agrees with results reported herein. In the current research, no changes in BW of 
poults were observed with dietary supplementation of dl-aTACT or d-aTOC, or with 
the subcutaneous injection of d-aTOC at Day 1. Data published by Soto-Salanova 
et al. (1993) showed no effect of feeding 12 or 100 ID of either dl-aTACT or d-a-
tocopheryl polyethylene glycol 1,000 succinate (TPGS, a water-soluble form of VE) 
per kg of diet on BW of 21-d-old poults. Similarly, BW of weaning pigs was not 
modified after dietary supplementation with 16, 48 or 96 lU/kg of either dl-aTACT 
or d-aTOC (Chung et al., 1992). Six different sources of dietary VE (dl-aTACT in 
dry or liquid form, and in emulsifiable and nonemulsifiable form, dl-aTACT in 
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micellized liquid form, or d-aTOC in micellized form), also failed to modify BW of 
sheep after being fed at 1,000 lU/sheep during 56 d (Ochoa et al., 1992). Results 
from Experiment 1 showed a depression in growth after subcutaneous injection to 
1-, 7-, and 14-d-old poults of the equivalent to 12 or 300 lU of VE/kg of diet (9 or 
225 lU of dl-aTOC/poult, respectively). A different source of injectable VE was 
used in both experiments, dl-aTOC in Experiment 1, d-oTOC in the current trial. 
Moreover, the volume of VE injected per poult in Experiment 1 was .15 mL at Day 
1, .25 mL at Day 7, and .50 mL at Day 14, whereas poults in the current 
experiment were injected once (Day 1) with .05 mL of VE/poult. Differences in 
source and volume of VE injected may have been responsible for the differences in 
BW observed in the two trials. Subcutaneous injection of dl-aTACT (0, 15, 30, 60, 
or 120 mg/kg of live weight) to sheep (Judson et al., 1991) and intramuscular 
injection of several dl-aTACT and d-aTOC preparations to pigs (Carrion and Soto-
Salanova, 1993, ISU, Ames, lA 50011, personal communication) did not affect BW 
of the cited species throughout those experiments. 
As had been observed with BW, Fl of poults was not affected by any of the 
treatments throughout the trial. This observation is consistent with those of Soto-
Salanova et al. (1993) and Applegate (1995), but disagrees with those of Soto-
Salanova (1991) and Mallarino (1992) for poults of the same age as those used in 
the current experiment. Soto-Salanova (1991) used 100 lU of VE/kg of diet, 9 
times the NRC (1984) recommended levels for young turkeys, whereas Mallarino 
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(1992) used megadoses of VE (800 lU/kg of diet) to feed 1- to 21-d-old turkeys. 
Murphy et al. (1981) also used megadoses of dietary VE (10,000 lU/kg of diet) to 
feed 1- to 21-d-old chicks, but, unlike the results reported by Mallarino (1992), 
those authors failed to see any changes in Fi with supplemental VE. Asghar et al. 
(1991a) reported an increase in FI when 100 or 200 ID of VE/kg of diet were 
included in the rations of growing pigs. The lack of effect of a single subcutaneous 
injection of 25 lU of d-aTOC at Day 1 agrees with reports published by Judson et 
al. (1991) and by Carrion and Soto-Salanova (1993, ISU, Ames, lA 50011, personal 
communication), but disagrees with the depression in FI observed in Experiment 1. 
Again, the differences in source and volume of VE injected in both experiments 
may account for the different results reported for FI in Experiment 1 and 
Experiment 2. 
In the current experiment, FE was affected by treatments only from 14 to 21 
d of age. At this time, poults fed 12 lU of dl-aTACT/kg (LACT treatment) used 
feed more efficiently than poults in any other treatment. This transient beneficial 
effect of using 12 lU of dl-aTACT/kg of diet disagrees with data in the literature, 
and with results of Experiment 1. In Experiment 1, poults receiving the high doses 
of VE (300 lU/kg of diet, or its equivalent by injection) used feed more efficiently 
than those receiving the low-VE supplemented treatments. However, most authors 
have observed no effect of VE supplementation on FE (Soto-Salanova, 1991; 
Mallarino, 1992; Applegate, 1995), or an improved FE with increasing 
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concentrations of dietary VE (Asghar et al., 1991a: Butcher et a!., 1993). Asghar ef 
al. (1991a) reported an improved FE of growing pigs when diets were 
supplemented with 100 or 200 lU of VE/kg, compared with supplementing diets 
with 10 ID of VE/kg. Similarly, Butcher et al. (1993) observed a better FE for 14-
and 18-wk-old laying hens fed 50 or 100 lU of VE/kg of diet than that of those fed 
10 ID of VE/kg of diet. Unlike observations made in Experiment 1, injection of 
poults with 25 ID of d-aTOC/poult at Day 1 did not affect FE during the current 
trial. In Experiment 1, VE-injected poults showed a poorer FE during the 21-d trial, 
compared with VE-fed poults, whereas in the current experiment, injected poults 
performed as well as VE-fed poults. These results agree with those reported 
previously by Judson et al. (1991) with sheep, and by Carrion and Soto-Salanova 
(1993, ISU, Ames, lA 50011, personal communication) with pigs. In our current 
research, LACT-poults used feed more efficiently during the last week of the 
experiment than poults in any other treatment group. At this time, the entire flock 
contracted an enteric disease caused by rotavirus D. In avian species, and 
specifically in turkeys, common features of an infection by rotavirus D include acute 
diarrhea, enteritis, and, as a consequence, poor growth, and poor feed utilization 
(Reynolds, 1992). It is likely that the disease would have affected the flock 
unevenly, with some groups being more severely affected than others. If that were 
the case, one can only speculate that the FE data would represent a poorer FE of 
all other groups due to the disease, and not an improved FE of the LACT-treated poults. 
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Blood, and especially erythrocytes, may reflect the lability of the whole 
animal to oxidative conditions (Fraga et a!., 1990). The erythrocytes are the major 
targets of oxyradical attack because they are rich in polyunsaturated fatty acids, 
and are continuously exposed to high oxygen tension. In addition, hemoglobin 
and the iron it contains are powerful catalysts of oxidative reactions. Insufficient 
intake of tocopherols leads to oxidative damage of fatty acids of the erythrocyte 
membrane (Hamada et al., 1982), making them more susceptible to hemolysis. 
In the current research, RBC susceptibility to hemolysis increased until 5 d 
of age for all treatment groups, irrespective of VE supplementation, and then, 
decreased with increasing VE supplementation until 21 d of age. Similar results 
have been reported by Applegate (1995) in young turkeys fed diets supplemented 
with 0 or 150 lU of dl-aTACT/kg of diet. However, the highest percentages of 
hemolysis attained in the current experiment (76.4%) did not reach the values (90-
100%) reported by Applegate (1995). This should be expected since Applegate 
(1995) fed a diet containing 0 ID of supplemental VE, whereas poults in the current 
experiment were supplemented with at least 12 lU of VE (dl-aTACT or d-aTOC)/kg 
of diet. 
Changes in RBC susceptibility to hemolysis with supplemental VE have been 
widely reported in the literature for different species. Rose and Gyorgy (1950) and 
Mino et al. (1981) observed that RBC of rats receiving adequate amounts of VE 
were completely protected against hemolysis, whereas those of VE-deficient rats 
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were not. Rose and Gyorgy (1950) also reported a decreased susceptibility to 
hemolysis of RBC of newborn rats born from mothers that had been supplemented 
with 5 mg of VE/d during the gestation period. Brownlee et at. (1977) found that 
lipid peroxidation and hemolysis were concurrent events rather than consecutive 
events in RBC. They also reported that both RBC lipid peroxidation and RBC 
hemolysis were increased in VE-deficient rats. Eicher et al. (1994) used plasma 
aTOC levels and hydrogen peroxide-induced hemolysis to confirm VE-deficiency in 
rats. They observed an increase in hemolysis from 4.2% in VE-adequate rats, to 
92.6% in VE-depleted rats. Similar results were reported by Stevenson and Jones 
(1989) in sheep, and by Fuhrmann et al. (1994) in chicks. Fuhrmann et al. (1994) 
found decreased RBC susceptibility to hemolysis in 2- or 3-wk-old chicks being fed 
diets containing between 22 and 1400 mg dl-aTACT/kg of diet. 
Subcutaneous injection of d-aTOC at Day 1 was effective in protecting 
erythrocytes against BHP-induced hemolysis in the current study. Similar results 
with sheep have been published by Stevenson and Jones (1989). Those authors 
reported a decreased hemolytic sensitivity of VE-deficient sheep erythrocytes 24 h 
after resupplementation with a single subcutaneous injection of 300 ID of VE (as dl-
aTACT). 
The high aTOC content in RBC and plasma of newly hatched poults in the 
present experiment indicated an effective carry over from the hen to the egg (.83 
and 11.21 /xg/mL, respectively). One-d-old poults had 73.9 ng of aTOC/g of egg 
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yolk, which corroborates the findings of Noble et al. (1993) in chicks, indicating that 
orTOC accumulated in both the yolk sac membrane and the liver during the last 
days of embryonic development. Moreover, Piironen et at. (1991) studied the 
transfer of orTOC from feeds to eggs, and established that the transfer was efficient, 
and proportional to the biological activity of that specific aTOC stereoisomer (the 
more active an isomer, the more effectively stored). 
a-Tocopherol concentration in RBC and plasma of poults decreased 
markedly until 14 d of age, irrespective of dietary VE supplementation, and then, 
increased to various degrees until 21 d of age. This rapid decrease of RBC and 
plasma aTOC during the first 2 wk after hatching has been reported previously in 
chickens (Hassan and Hakkarainen, 1990). To the author's knowledge, there are 
no data available in the literature on RBC aTOC concentration of newly hatched 
turkeys. However, a similar decrease in plasma aTOC concentration of poults 
during the first 2 or 3 wk of life has been reported previously by Soto-Salanova 
(1991), Mallarino (1992), Soto-Salanova et ai. (1993), and Appiegate (1995). In 
chickens, Dudin and Dvinskaya (1983) reported a poor absorption of VE during the 
first 5 d of life, and a subsequent oxidation of aTOC to a-tocopheryl quinone in 
tissue. By 10 d of age, the oxidation process had decreased, and by 20 d of age, 
absorption of the vitamin had increased. In pigs, Chung et al. (1992) also 
observed an initial decline in serum aTOC, from weaning to 14 or 21 d afterwards, 
followed by an increase to 35 d after weaning. The fluctuation may be attributed to 
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the diet change that most newborns have to endure during the first days of life. 
This rapid decline of RBC and plasma aTOC during the early postnatal 
development may explain a higher susceptibility to VE deficiency diseases, as has 
been reported for growing chicks fed a low-VE diet after hatch (Hassan et a!., 
1985). In the present experiment, however, no signs of VE deficiency could be 
detected during the 21-d period. 
Supplementation of the diets with increasing concentrations (12, 80, or 150 
!U/kg) of dietary VE (dl-oTACT or d-aTOC) resulted in a continuous increase in 
cfTOC concentration in RBC and plasma, suggesting that both RBC and plasma 
were sensitive to changes in VE intake, and that their storage capacity was not 
saturated by the supplemental concentrations used. Moreover, the data showed 
that dietary VE supplementation was essential for poults during the first weeks of 
life to maintain adequate levels of VE in blood, regardless of their tissue reserves of 
qTOC at 1 d of age. A direct relationship between dietary VE supplementation and 
RBC and/or plasma cTOC concentration has been observed previously in chicks 
(Hakkarainen etal., 1984; Hassan and Hakkarainen, 1990; Sheehy etal., 1991), 
humans (Lehmann etal., 1988; Moritaefa/., 1989; Dimitrov ef a/., 1991), peregrine 
falcons (Dierenfeld et al., 1989), and rats (Lehmann, 1981; Mino et al., 1981). This 
seems to indicate that aTOC concentration of RBC and plasma are closely related 
to dietary VE intake. It would be feasible to improve the aTOC status of poults by 
increasing dietary VE concentration, thus improving the immune response of 
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turkeys as reported in the literature for chickens (Heinzerling et a/., 1974; Tengerdy 
and Nockels, 1975) and turkeys (Franchini etal., 1990a). Reports indicating the 
relative sensitivity of plasma and RBC aTOC to VE supplementation have been 
scarce, and conflicting. Behrens and Madere (1990) studied the response of RBC 
and plasma of rats to diets containing 0 or 1,360 lU of dl-oTACT/kg. These 
authors indicated that RBC showed a faster and more pronounced response to 
aTOC depletion than plasma. Instead, plasma responded quickly to repletion, 
being more sensitive than RBC to increased VE intake. Other reports indicated 
that RBC were a more sensitive indicator of qTOC intake and aTOC status than 
plasma in chicks (Hassan and Hakkarainen, 1990), guinea pigs (Kelly etal., 1992), 
humans (Lehmann etal., 1988), and rats (Mino etai, 1981). Results published by 
Hidiroglou and Charmley (1990) indicated that, in ruminants, plasma aTOC was not 
a reliable index of VE intake or VE status. These authors fed sheep increasing 
concentrations of dl-aTACT, from 30 to 200, 400, or 600 mg/sheep for 2 months. 
Blood aTOC in sheep increased with dietary VE supplementation, but the 
relationship between blood aTOC and dietary VE was not linear at high dietary VE 
concentrations, indicating that plasma aTOC was reaching saturation. 
Two different sources of dietary VE were tested in the present experiment to 
improve the qTOC status of poults during the first weeks of life, d-aTOC, and dl-
aTACT. Plasma and RBC aTOC analyses showed that dietary d-aTOC was more 
effective than dl-aTACT in increasing oTOC concentration in plasma and RBC of 
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poults only at 7 d of age, implying an enhanced absorption and biological potency 
of the natural alcohol form (d-oTOC) compared with the acetate form (dl-aTACT) at 
that age. The acetate moiety is hydrolyzed from dl-aTACT in the gut lumen. 
Emulsified by bile, dl-aTACT is then attacked by the esterase enzyme, yielding free 
aTOC, which is absorbed through the intestinal wall into the lymph (Gallo-Torres, 
1970). In poultry, specific activity of pancreatic enzymes such as lipase, trypsin, 
and amylase are low at hatching, and increase gradually during the first week of 
age (Sell et al., 1991). Specifically, lipase activity decreases between 6 and 8 d of 
age. This might have an impact in the poor utilization of dietary fats by poults 
during early growth (Sell et al., 1986), and also in the absorption and utilization of 
fat soluble vitamins. A low activity of the esterase enzyme during the first week 
after hatching would explain partially the decreased bioavailability of dl-aTACT at 
Day 7. From that time on, the digestive system of the poult is fully developed, and 
this agrees with the fact that no further differences between d-aTOC and di-aTACT 
could be detected until the end of the experiment. In the literature, most reports 
comparing natural and synthetic sources, and alcohol and ester forms of dietary 
VE indicate that the natural alcohol is the most effective form of VE to improve 
aTOC status of different species. Chung e( al. (1992) used the same dietary VE 
sources used in the current experiment (d-aTOC and dl-aTACT) to feed weaning 
pigs during 35 d. These authors found that d-aTOC was more effective than dl-
aTACT to increase tissue and serum aTOC at all ages. Similar results were 
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published by Hidiroglou and Karpinski (1988) in sheep, and by Ogihara et at. 
(1985) In rats. However, dl-aTACT has been proven to be more effective to 
improve animal oTOC status than some other dietary VE sources, such as IPGS 
(d-o-tocopheryl polyethylene glycol 1,000 succinate) (Hidiroglou and Ivan, 1991; 
Hidiroglou et al., 1992; Roquet et al., 1992; Soto-Salanova et al., 1993), dl-a-
tocopheryl nicotinate (Gallo-Torres and Miller, 1971; Hidiroglou et al., 1992), or dl-
a-tocopheryl succinate (Hidiroglou et al., 1992). When comparing natural and 
synthetic VE, most reports suggest a stereoselective discrimination, with the d-
aTOC form being preferentially selected by human and animal tissues, irrespective 
of route of administration of VE (Hidiroglou and McDowell, 1987; Ingold et al., 
1987; Hidiroglou and Karpinski, 1988; Hidiroglou et al., 1988; Hidiroglou et al., 
1992; Ferslew ef a/., 1993; Traber et al., 1993; Fuhrmann et al., 1994). 
In the present experiment, subcutaneous injection of 25 lU of d-aTOC at 
Day 1 was effective in increasing RBC and plasma aTOC concentration from 1 to 7 
d of age. These results agree with those reported in Experiment 1 for the first 
week after hatching. In the cited experiment, 1-d-old turkeys injected with 1.5 or 
37.5 lU of dl-aTOC (equivalent to 12 or 300 !U of VE/kg) had higher plasma aTOC 
concentrations than poults in any other treatment during the first week of age. 
Results in the literature indicating a faster and more effective distribution of aTOC 
compounds when administered via parenteral than when given in the diet are 
divergent. Intramuscular injection of 12.4 lU/kg body mass to black rhinoceros 
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resulted in a 10-fold increase in plasma aTOC 10 d after injection, compared with 
preinjection values, and with dietary dl-aTOC supplementation (Dierenfeld and 
Citino, 1989). In sheep, intravenous supplementation of d-aTOC resulted in greater 
availability of aTOC in plasma, compared with intramuscular, oral, or intraruminal 
VE supplementation (Hidiroglou and Karpinski, 1987). Instead, supplementation of 
200 lU of dl-aTOC/kg of diet to weanling pigs increased serum and tissue aTOC 
compared with intramuscular injection of 220 mg of dl-aTOC (Peplowski et a!., 
1981). Judson et al. (1991) found that dl-aTACT was slowly mobilized from the 
injection site when administered to sheep by subcutaneous injection. These 
authors reported that oral supplementation of dl-aTACT produced immediate 
changes in plasma oTOC concentration, whereas subcutaneous aTOC injection 
increased plasma and liver aTOC only 1 month after administration. These variable 
responses to VE parenteral supplementation might be related to the difficulty of 
controlling the resulting depot in the site of penetration of VE by the needle-
injection technique. Further differences in the absorption of the different VE 
compounds may be related to differences in the blood flow of the injection area, or 
the extent of absorption in that area, or both. 
Changes in the activity of certain enzymes in plasma can be used as an 
indicator of early membrane damage in biological systems, and thus, as early 
indicators of VE deficiency. Among the enzymes most commonly used, aspartate 
aminotransferase, CK, lactate dehydrogenase, and pyruvate kinase, CK is the most 
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specific to indicate muscle damage. In our current research, all treatment groups 
had been supplemented with VE, and that might explain why no effect of the 
treatments on CK activity in plasma was observed during the trial. These results 
agree with those reported by Asghar et al. (1991a) for pigs 5 to 14 wk of age, and 
with those reported by Fry et al. (1993) for sheep. Values of CK activity in plasma 
in the present experiment ranged from 973 to 2,593 lU (/xg/mL/min), except at 14 
d of age. These values are similar to those reported by Wilson et al. (1990), who 
measured CK activity in plasma of 10- to 16-wk-old healthy turkey breeder toms, 
but are lower than those published by Neufeld (1992). Neufeld (1992) measured 
plasma CK activity in 41-wk old turkey breeder hens, whereas turkeys in the 
current research were males and only 1 to 21 d of age. At 14 d of age, poults 
contracted an enteric disease (caused by rotavirus D), and activity of CK in plasma 
of poults in all treatment groups increased markedly (10 fold). This release of CK 
to plasma might indicate damage in the muscle cells. Increased plasma CK has 
been reported in clinically ill turkeys (salinomycin toxicosis)(Neufeld, 1992), in 
physically stressed cattle (Sconberg et al., 1993), and in VE-deficient calves (Reddy 
etai, 1987; Walsh etal., 1993), rats (Lehmann, 1981), sheep (Norton et al., 1978; 
Stevenson and Jones, 1989), and swine (Ruth and van VIeet, 1974; Duthie and 
Arthur, 1987). In the present experiment, increasing dietary VE supplementation 
(from 12 to 80, or 150 lU of dl-aTACT or d-orTOC/kg of diet), or giving a single 
subcutaneous injection of d-aTOC at Day 1 failed to decrease plasma CK activity, 
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even during a disease-stress situation. This observation is in contrast to the 
protective effect of VE against stress as reported for broiler chickens (Heinzerling et 
al., 1974; Tengerdy and Nockels, 1975; Mitchell eta!., 1994), cattle (Sconberg et 
ai, 1993), swine (Duthie eta!., 1989), and trout (Furones eta!., 1992). 
a-Tocopherol is widely distributed in animal tissues, with appreciable 
amounts stored in the liver (Jensen et al., 1990). The assessment of aTOC status 
in the different species may be determined by the direct measurement of the aTOC 
content in a specific tissue, which is then assumed to reflect the whole body oTOC 
status. Besides liver, concentration of aTOC in plasma was commonly used as an 
index of aTOC status in different species, including turkeys (Sklan et al., 1982), 
with the assumption that there was a direct relationship between plasma and tissue 
concentration of aTOC. However, there have been conflicting reports as to the 
validity of using plasma aTOC as an index of tissue aTOC in a variety of species. 
Because oTOC is transported in the circulatory fluids mainly bound to lipoproteins, 
as are cholesterol or TG, Horwitt et al. (1972) suggested that ratios of VE to these 
serum lipid components might more accurately reflect VE status. 
in the current experiment, levels of TG in plasma were not affected by the 
dietary intake of VE (dl-aTACT or d-aTOC), or by subcutaneous injection of d-
aTOC at 1 d of age, and were within the range of those published in the literature 
for adult turkeys (Franchini et al., 1990b; Crisetig et al., 1991; Kurima et al., 1994). 
To the authors' knowledge, there is no literature available on age-related changes 
204 
in plasma TG of 1- to 21-d-old turkeys. Franchini et al. (1990b) reported a steady 
increase in plasma TG of male turkeys from 28 d (40 mg/dL) to 140 d (83 mg/dL) 
of age. Instead, Crisetig et al. (1991) found no significant changes in plasma TG of 
turkeys until 90 d of age, and then, plasma TG values increased until 120 d of age, 
especially in female turkeys. In post-weaning pigs, Chung et al. (1992) reported 
serum TG fluctuations similar to those reported here for young turkeys. Those 
fluctuations most likely reflect the change in the fat content of the feed during this 
period, and the improved utilization of fatty acids with age. Published reports 
studying the effect of VE supplementation on plasma TG are contradictory. 
Lehmann (1981) observed increased lipid levels in plasma of rats as a 
consequence of dietary VE supplementation, the increase being mainly due to the 
increase in plasma TG (200%)(not in cholesterol or phospholipids) with increasing 
concentrations of dietary VE. Hov/ever, supplemental VE did not affect 
concentration of TG (or any other lipid) in plasma of chickens (Crisetig et al., 
1993), humans (Lehmann et al., 1988), pigs (Chung et al., 1992), sheep (Judson et 
al., 1991; Fry et a!., 1993), and turkeys (Franchini et al., 1990b: Crisetig et al., 
1991). 
Changes of the plasma aTOC/TG ratio with treatments in the present 
experiment paralleled those detected in aTOC concentration of plasma. These 
results could be expected, as no effect of VE supplementation was observed in 
plasma TG from 1 to 21 d of age. This observation agrees with data published by 
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Fry et al. (1993) for VE-depleted sheep. These authors reported that plasma and 
tissue aTOC were highly correlated, and that those correlations were not improved 
by expressing aTOC relative to either cholesterol or TG concentrations in plasma. 
Chung et al. (1992) fed 12, 48, or 96 lU of dl-aTACT or d-aTOC to weanling pigs 
for 35 d. These authors found serum aTOC and serum TG of weanling pigs not to 
be dependent on each other. However, in agreement with the early reports of 
Horwitt et al. (1972), experiments with humans and rats (Horwitt et al., 1984) 
suggested a greater variability in serum aTOC results due to serum lipids. 
However, Horwitt et al. (1972, 1984) did not use a standardized diet, with a known 
dietary lipid composition in all individuals studied, and differences in plasma lipids 
could be expected. Had those authors used a standard amount and type of 
dietary fat (as has been the case in the current research), the variability detected in 
plasma lipids may have decreased considerably, or may have disappeared. 
Liver aTOC concentration and total liver aTOC varied with the age of the 
poults. In the present experiment, aTOC concentration in liver of 1-d-old poults 
averaged 143.6 /ig/g, or 208.2 ng when expressed as total aTOC stored in the 
liver. Noble ef al. (1993) indicated that aTOC from the yolk sac accumulated in the 
liver during the last 5 d of embryonic development. Noble and Cocchi (1990) 
suggested that the particularly large concentration of aTOC within the liver just 
before hatching was a reflection of extremely high lipid accumulation by the end of 
the incubation period. By 5 d posthatch, liver aTOC stores had decreased. 
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irrespective of dietary VE supplementation, although the decrease during the first 5 
d after hatching was relatively slow. This was probably due to the utilization of the 
oTOC stores from the egg yolk remaining in the abdomen of the poults after 
hatching. Egg yolk supplies nourishment to poults during the first 3 to 4 d after 
hatching (Sell et al., 1991). 
Liver oeTOC decreased markedly between 7 and 14 d of age, and then, 
increased slightly until 21 d of age. These age-related changes in liver aTOC 
agree with results from Experiment 1, and with previous reports with turkeys (Soto-
Salanova, 1991; Mallarino, 1992; Soto-Salanova etal., 1993; Waibel etal., 1994; 
Applegate, 1995; Soto-Salanova and Sell, 1995). In liver, this high rate of depletion 
(that occurs irrespective of diet composition and VE supplementation) during the 
first 2 wk of life could indicate utilization, or indirect measurement of the 
involvement of the vitamin in metabolic processes that take place in the liver. It has 
been suggested that liver is the main storage organ for aTOC, and that liver helps 
to maintain plasma levels when intake becomes inadequate (Machlin and Gabriel, 
1982). Most likely, liver maintains plasma levels at times of nutritional and 
metabolic transition of poults, trying to fulfill a supply function for achieving early 
body development. Sklan et al. (1982) attributed low liver oTOC levels detected in 
turkeys to an early and high production of tocopheryl glucuronides. However, 
despite the low values of aTOC detected in liver of poults during the current 
experiment, no signs of VE deficiency could be detected. Probably, poults had 
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enough aTOC to meet their metabolic requirements, but not enough to build up 
storage in the liver. 
Increasing dietary concentration of VE (dl-aTACT or d-aTOC) from 12 to 80 
or 150 lU/kg of diet increased liver aTOC stores, starting at 7 d of age. This 
response of liver aTOC to VE supplementation has been reported previously for 
cattle (Arnold etal., 1992), chickens (Sklan et al., 1982; Sheehy et al., 1991), pigs 
(Jensen et al., 1990; Asghar et al., 1991a: Chung et a!., 1992), rats (Bieri, 1972), 
rhesus monkeys (Machlin and Gabriel, 1982), sheep (Hidiroglou and Charmley, 
1990), trout (Frigg et al., 1990; Furones et al., 1992), and turkeys (Marusich etal., 
1975; Sklan et al., 1982; Csallany etal., 1988; Soto-Salanova, 1991; Mallarino, 
1992; Soto-Salanova et al., 1993; Applegate, 1995). By 21 d of age, liver aTOC of 
poults fed 80 or 150 lU of VE/kg of diet were very similar, thus indicating that liver 
was reaching a stage of saturation. 
In the current experiment, liver aTOC of poults responded similarly to the 
two dietary sources used to feed turkeys from 1 to 21 d of age, dl-aTACT and d-
aTOC. This could be expected from the plasma and RBC data, where source of 
dietary VE affected aTOC concentration only at 7 d of age. Chung et al. (1992) 
found greater concentrations of aTOC in livers of weaning pigs fed d-aTOC than in 
those of pigs fed dl-aTACT. Hidiroglou et al. (1988) also reported greater liver 
aTOC concentrations in beef cattle after oral supplementation with d-aTOC than 
with dl-aTACT. In the current experiment, the lack of response of liver aTOC to the 
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two different dietary VE sources could be partly explained by a limited absorption 
of VE in turkeys early in life, and by a rapid excretion of tocopheryl glucuronides 
during the first 2 or 3 wk of life (Sklan et a!., 1982). Had the experiment lasted 2 or 
3 more weeks, the response of liver qTOC to the different VE sources might have 
been different. 
In the current trial, subcutaneous injection of d-aTOC at Day 1 increased 
aTOC stores in liver of poults during the first week of life. The effect of d-aTOC 
injection decreased gradually, and had disappeared by 21 d of age. A similar 
increase in liver aTOC stores after dl-aTOC subcutaneous injection had been 
observed in Experiment 1, indicating a high bioavailability of VE given parenteral. 
To the author's knowledge, there is no information available in the literature on 
parenteral administration of VE to turkey poults. However, injection of VE through 
different routes has been demonstrated to be highly effective in increasing aTOC 
stores in livers of different species. In sheep, intravenous administration of d-aTOC 
resulted in a high increase in liver aTOC 96 h post administration (Hidiroglou, 
1986). Similarly, intramuscular injection with different concentrations (20, 40, and 
60 mg/kg live wight) of dl-aTACT to sheep resulted in rapid absorption and 
storage by the liver, followed by a rapid elimination phase (Hidiroglou and 
Karpinski, 1991). However, subcutaneous injection of 15, 30, 60, or 120 lU/kg of 
dl-aTACT to sheep resulted in increased qTOC concentration in liver only 1 month 
after administration, suggesting a slow mobilization of the vitamin from the injection 
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site (Judson etal., 1991). 
In the present experiment, the increase in liver qTOC observed in injected 
poults by 3 d of age suggests that the vitamin had been rapidly mobilized from the 
injection site, and had reached the target tissues 48 h after administration. 
Susceptibility of animals to oxidative damage is dependent on the balance 
between oxidative stress and antioxidant defense capacity. Thus, the nutritional 
status with respect to various antioxygenic nutrients is an important protective 
factor against oxidative damage. Among those nutrients, VE has the ability to 
scavenge free radicals, thereby delaying or preventing the chain reaction that 
occurs in lipid peroxidation. In the current research, lipid peroxidation was 
assessed by measuring the concentration of TBARS in liver homogenates. The 
ability of liver homogenates to undergo lipid peroxidation in vitro has been shown 
to be inversely related to the aTOC status of animals (Bartov and Frigg, 1992; 
Applegate, 1995). 
Livers of 1-d-old poults were very susceptible to lipid peroxidation. Similar 
results were reported by Maiorino et al. (1989), and by Ramsey (1990, ISU, Ames, 
lA 50011, personal communication). Maiorino et al. (1989) suggested a delayed 
effect of VE in lipid peroxidation at Day 1 due to the low levels of glutathione and 
phospholipid hydroperoxide glutathione peroxidase. This would explain why, 
despite a high aTOC content (143.6 /ig/g for a total of 208.2 fig per liver), there 
was still a high rate of peroxidation in livers of 1 -d-old poults, as indicated by the 
210 
TEARS assay. 
High dietary and tissue aTOC concentrations are associated with greater 
stability to iron ascorbate-induced lipid peroxidation. In the present experiment, 7-d 
liver TEARS were decreased by increasing dietary concentration of VE (dl-oTACT 
or d-aTOC) from 12 to 80, or to 150 lU/kg of diet. These results agree with those 
reported by Combs and Scott (1974) and Pellett et al. (1994) in chicks, and by 
Applegate (1995) in turkeys. Decreased TEARS in tissues following increased VE 
supplementation has been reported extensively in the literature. Muscle TEARS 
were decreased as a consequence of increased vitamin E supplementation in cattle 
(Arnold et al., 1992; Arnold et al., 1993; Lanari et a!., 1993; Mitsumoto et al., 1993; 
Walsh et al., 1993), poultry (Marusich et al., 1975; Csallany et al., 1988; Lin et al., 
1989; Franchini et al., 1990b: Eartov et al., 1991; Bartov and Frigg, 1992; Sheehy 
et al., 1993), sheep (Fry et al., 1993), swine (Monahan et al., 1990; Asghar et al., 
1991b: Monahan eta!., 1992), and trout (Frigg et al., 1990). Similarly, VE 
supplementation resulted in decreased TEARS in chick plasma (Sheehy et al., 
1993), chick REC (Pellett et al., 1994), cow milk (Atwal et al., 1991), and rat brain 
(Meydani et al., 1988). 
In the current experiment, VE supplementation did not affect liver lipid 
peroxidation (measured by the production of TEARS) after 7 d of age. Nardini ef 
al. (1993) suggested that, once dietary requirement for VE is satisfied, factors that 
may promote lipid peroxidation, such as polyunsaturated fatty acid intake from 
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vegetable oils, do not enhance peroxidation in physiological conditions. Because 
there is a high degree of variation in the content of aTOC in the different tissues, it 
is likely that protection against oxidation in vivo may vary considerably from tissue 
to tissue. Results indicate that liver aTOC of 14-d poults fed 12 lU of VE (either 
source)/kg of diet averaged 10.4 iig per liver. We might assume that this amount 
of otTOC was enough to prevent the formation of TEARS in the liver, although other 
indicators of VE adequacy, such as RBC hemolysis or plasma aTOC, suggest that 
other tissues may be vulnerable to oxidation damage. 
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CHAPTER 5. EXPERIMENT 3 
Materials and Methods 
Three hundred and eighty-four 1-d-oid, Nicholas Large White male turkey 
poults were obtained from a commercial hatchery. Sixteen poults were distributed 
to each of twenty four pens so that the average poult weight was approximately the 
same in each pen. Each of the six treatments was randomly assigned to four 
pens. 
Four of the treatments resulted from the addition to the diet of four 
equidistant increments of dl-a-tocopheryl acetate^ (dl-aTACT), the concentrations 
being 12 (LLD), 46 (MLD), 81 (MHD), and 115 (HHD) !U/kg of diet. The fifth 
treatment (VHI) consisted of a single subcutaneous injection of d-a-tocopherol^ (d-
aTOC) at 1 d of age. Poults in this treatment were subcutaneously injected in the 
dorsal area of the neck with 50 ID of d-aTOC, the amount being approximately 
equivalent to the amount poults would consume if their diet was supplemented with 
300 lU of vitamin E (VE)/kg during their first week of life. Poults in the sixth 
treatment (VHW) received 50 ID of d-aTOC^ each in the drinking water from 3 to 
^Rovimix® E-50, 500 lU of di-a-tocopheryl acetate/g. Hoffmann-La Roche, Inc. 
Nutley. NJ 07110 
^Vital E™-500, 500 iU of d-a-tocopherol/mL. Schering-Plough Animal Health. 
Kenilworth, NJ 07033 
^Emcelle Tocopherol, 500 IU of d-a-tocopherol/mL. Stuart Products. Bedford, TX 
76021 
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10 d of age. This amount was also approximately equivalent to what the poults 
would consume if their diet would had been supplemented with 300 ID of VE/kg 
during their first week of life. Poults in the fifth and sixth treatment also recieved 12 
ID of d-TACT/kg of diet throughout the 21-d experiment. 
During the experiment, turkeys were housed in electrically heated battery 
brooders^. Pen temperature was maintained at 35 C for the first week of life, at 32 
C during the second week, and at 29 C until the end of the experiment. Room 
temperatures ranged between 23 and 25 C during the 21-d period. Feed and 
water were provided for ad libitum consumption throughout the experiment. 
Poults in all treatments were fed a typical corn-soybean meal starter diet. All 
diets were formulated to meet or exceed the NRC (1994) recommended nutrient 
concentrations for a turkey starter diet, and were calculated to be isocaloric (2,850 
kcal MEn/kg) and isonitrogenous (28.5% protein). The antibiotic virginiamycin was 
included in all diets during the 21-d period. An antibiotic, neomycin, was also 
added in the drinking water from Day 3 to Day 7 for all treatments. Composition of 
the diets is shown in Table 5.1. 
Feed samples from each diet were taken at the time of mixing and stored at 
4 C until analyzed for dry matter, ash, protein, and fat. An extra sample from each 
diet was also taken at mixing time, and stored at -20 0 for VE analysis. Feed 
samples to be subjected to proximate analysis were ground to pass through a 1.0 
Petersime, Gettysburg, OH 45328 
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TABLE 5.1. Ingredient composition of the corn-soybean meal diets 
Ingredient LLD MLD MHD HHD VHI VHW 
(%) 
Corn 36.03 34.75 33.42 32.14 36.03 36.03 
Soybean meal 55.53 55.46 55.39 55.32 55.53 55.53 
Dicalcium 
phosphate 2.26 2.26 2.27 2.27 2.26 2.26 
Limestone 1.62 1.62 1.62 1.62 1.62 1.62 
Animal-vegetable 
fat 3.24 3.23 3.22 3.21 3.24 3.24 
Mineral premix^ .30 .30 .30 .30 .30 .30 
Vitamin premix^ .30 .30 .30 .30 .30 .30 
Vitamin E 
premix^ .48 1.84 3.24 4.60 .48 .48 
DL-methionine .19 .19 .19 .19 .19 .19 
Virginiamycin'* .05 .05 .05 .05 .05 .05 
^Supplied per kilogram of diet: manganese, 70 mg; zinc, 40 mg; iron, 37 mg; 
copper, 6 mg; selenium, .15 mg; sodium chloride, 2.60 g. 
^Supplied per kilogram of diet: vitamin A (retinyl acetate), 5,000 IU; 
cholecalciferol, 1,500 IU; vitamin B,2> ^9! vitamin K (menadione sodium 
bisulfite), 1.8 mg; riboflavin, 2.7 mg; pantothenic acid, 7 mg; niacin, 75 mg; choline, 
509 mg; folic acid, .55 mg; biotin, 75 ^g. 
^Supplied per kilogram of diet: dl-a-tocopheryl acetate, 12 IU for LLD, VHI, and 
VHW treatments; 46, 81, and 115 IU for MLD, f\/lHD, and HHD treatments, 
respectively. 
''Supplied 44 mg of virginiamycin per kilogram of diet. 
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mm mesh sieve. Dry matter was determined by drying the samples in a forced 
draft oven at 72 C until constant weight was achieved. Ash was determined by 
using a muffle oven at 600 C for 24 h. The macro-Kjeldahl procedure (Association 
of Official Analytical Chemists, AOAC, 1980, section 2.057) was used to determine 
nitrogen concentration. Nitrogen values were multiplied by 6.25 to calculate the 
protein percentage (AOAC, 1980, section 14.068). Fat concentration was 
determined by ether extraction (AOAC, 1980, section 7.056). Tocopherol isomers 
and TACT were extracted from the diets with a mixture of hexane:acetone:ethanol 
(10:7:6), saponified, evaporated to dryness and redissolved in hexane, and then, 
separated and quantitated by high performance liquid chromatography (HPLC) 
(McGeachin and Bailey, 1995). The mobile phase was 3.5% tetrahydrofuran 
(vol/vol) in hexane, with a flow rate of 1 mL/min, changing linearly over 10 min to a 
flow rate of 2 mL/min for 20 min. Calculated and determined analyses of the diets 
are shown in Tables 5.2 and 5.3, respectively. 
Water consumption was monitored for poults in the VHW treatment from 
Day 3 to Day 10 of the experiment. For that purpose, .946 L (1 qt) jars were used 
during the 7-cl period, to minimize both evaporation of the drinking water, and 
oxidation of d-aTOC. Disappearance of water (consumption) was measured daily 
by change in weight in comparison with a spare .946 L-jar placed in the room in 
the same conditions as the others. Each gram of water disappearance was 
assumed to represent 1 mL. 
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TABLE 5.2. Nutrient composition of the corn-soybean meal diets 
Calculated analysis Basal 
Dry matter, % 90.30 
MEn, kcal/kg 2850.00 
Protein, % 28.50 
Ether extract, % 5.30 
Total sulfur amino acids, % 1.05 
Methionine, % .61 
Lysine, % 1.70 
Calcium, % 1.20 
Available phosphorus, % .60 
Sodium, % .12 
Chloride, % .22 
Potas?4um, % 1.20 
Selenium, mg/kg .22 
Zinc, mg/kg 73.00 
Iron, mg^g 570.00 
Vitamin A, lU/kg 5040.00 
Cholecalciferol, lU/kg 1500.00 
Vitamin E^, !U/kg 18.00 
Riboflavin, mg/kg 5.00 
Pantothenic acid, mg/kg 24.00 
Niacin, mg/kg 96.00 
Choline, mg/kg 2.141.00 
Linoleic acid, % 2.10 
^Basal corn-soybean meal diet, to which vitamin E was added as 12 (LLD, VHI 
and VHW), 46 (MLD), 81 (MHD), and 115 (HHD) lU of dl-a-tocopheryl acetate. 
^Calculated analysis for vitamin E: 18 lU for treatments LLD, VHI, and VHW; 52 
lU for treatment MLD; 87 lU for treatment MHD; and 121 lU/kg of diet for treatment 
HHD. 
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TABLE 5.3. Determined composition of the corn-soybean meal diets^ 
LLD MLD MHD HHD VHI VHW 
Dry matter, % 89.46 89.95 89.38 89.40 89.51 89.46 
Protein, % 28.40 28.77 29.99 28.70 27.83 27.72 
Ether extract, % 4.50 4.99 5.06 4.70 4.73 4.86 
Ash, % 7.27 7.35 7.24 7.27 7.34 7.28 
Vitamin E, lU/kg 17.11 54.49 87.13 112.41 17.10 17.10 
^Basal corn-soybean meal diets, to which vitamin E was added as 12 (LLD, VHI 
and VHW). 46 (MLD), 81 (MHD). and 115 (HHD) lU of dl-a-tocopheryl acetate. 
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Body weight (BW) and feed intake (Fl) of the poults were monitored at 1, 5, 
7, 10, 14, and 21 d of age. Feed efficiency (FE) was calculated as the Fl to BW 
gain ratio for each of the periods studied. At 1 d of age, twelve poults were 
randomly selected for sampling to obtain baseline data. Subsequently, two poults 
were selected at random from each pen for sampling at 5, 10, 14, and 21 d of age. 
Blood was obtained by jugular venipunture by using two different sets of 
syringes, one of them containing an anticoagulant heparin solution (200 U/mL), 
and the second one containing an anticoagulant EDTA solution (1 mg 
NagEDTA/mL). The heparinized blood samples were subsequently separated into 
three subsamples. The first subsample, consisting of 1 mL of whole blood, was 
used to determine the susceptibility of the erythrocytes to oxidative stress. 
Hemolysis of the red blood cells (RBC) was induced by using t-butyl hydroperoxide 
(BHP), at a concentration of 400 nM, as the oxidative agent (Smith et aL, 1988). 
The second subsample consisted of 2 mL of whole blood and was used to collect 
RBC for aTOC determination. For that purpose, blood was centrifuged at 1,500 x 
g for 15 minutes, plasma was separated, and the packed RBC were washed three 
times with isotonic buffer (pH 7.4)(Hassan and Hakkarainen, 1990), and stored 
frozen at -20 C until RBC oTOC analysis. The third subsample was stored in 
crushed ice (4 C) until centrifugation. Then, this sample was centrifuged at 1,500 x 
g for 15 minutes and the plasma aspirated with a Pasteur pipette, transferred to 
tubes, and frozen at -20 C for subsequent aTOC determination. 
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Blood that had been obtained with the EDTA-coated syringes was also kept 
in crushed ice until centrifugation. Then, plasma was centrifuged at 1,500 x g for 
15 minutes, aspirated with a Pasteur pipette, and processed immediately for 
fractionation of the plasma lipoproteins; very low density lipoproteins (VLDL), low 
density lipoproteins (LDL), and high density lipoproteins (HDL), and subsequent 
aTOC determination. 
Plasma lipoproteins were separated by repeated ultracentrifugations after 
progressively increasing the solvent density using the method described by Havel 
ef a/. (1955). Solvents were prepared by mixing different volumes of solutions A 
and B. Solution A was .015 M NaCI (d= 1.005) in distilled, deionized water and 
solution B was 2.61 M NaCI and 2.97 r\/l KBr in distilled, deionized water (d = 
1.346). To obtain a solvent solution of d = 1.063, 250 mL of solution A were mixed 
with 51.2 mL of solution B. To obtain a solvent solution of d = 1.177, 500 mL of 
solution A were mixed with 51.2 mL of solution B. To obtain a solvent solution of 
d = 1.210, 165.9 mL of solution A were mixed with 250 mL of solution B. 
Lipoproteins of less than solvent density (VLDL< 1.005, LDL< 1.063, HDL< 1.21) 
were successively concentrated in a layer at the top of the ultracentrifuge tube 
according to the density of the solvent used. A specific fixed amount of the top 
layer containing the target lipoprotein fraction was carefully removed with a Pasteur 
pipette after each centrifugation (VLDL, 1.5 mL; LDL, 2.1 mL; HDL, 1.8 mL), 
transferred to vials, and stored in a freezer at -20 C until analyzed for qTOC. 
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Total plasma otTOC concentration, RBC aTOC concentration, and the qTOC 
concentration of plasma lipoproteins (VLDL, LDL, HDL) were determined by the 
method described by Cort et al. (1983). Plasma (2 mL), RBC (2 mL), and plasma 
lipoproteins (2 mL) were deproteinized with absolute ethanol (3 mL), and 
tocopherols were extracted with hexane (1 mL). Tocopherol concentrations were 
determined by HPLC, with fluorescence retention at 294 nm excitation wavelength 
and 323 nm emission wavelength. The mobile phase was 3.5% tetrahydrofuran 
(vol/vol) in hexane, with a flow rate of 2.2 mL/min. The sample extracted in 
hexane was injected directly into the HPLC. a-Tocopherol was identified and 
quantitated by the comparison of retention times and peak areas with aTOC 
standards. 
After blood samples were taken, turkey poults were killed by Halothane*^ 
inhalation and the following tissues were excised: adrenal glands, bursa of 
Fabricius, lungs, and pancreas at 1, 10 and 21 d of age, and liver at 1, 5, 10, 14, 
and 21 d of age. Also, yolk sac and yolk sac contents were excised and collected 
at 1 d of age. All tissue samples were frozen in liquid nitrogen, weighed, and 
stored at -20 C until prepared for qTOC determination. 
Tissue samples were thawed at room temperature, and .05 to 2 g 
(depending on the age of the poults and the amount of aTOC expected) were 
homogenized in 10 mL (wt/vol) of phosphate-EDTA buffer (pH 7.0). Tissue 
® Halocarbon Laboratories, North Augusta, SC 29841 
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tocopherols were then determined by HPLC by processing 2 mL of the tissue 
homogenate as described earlier for RBC, plasma and plasma lipoproteins. 
Statistical analysis within each age was performed according to the General 
Linear Model (GLM) procedure of SAS" (SAS Institute, 1985) to determine the 
effect of treatment. Single degree of freedom, non-orthogonal contrasts were done 
when significant (P<.05) effects of treatments were observed. Eight of the 
contrasts were done to compare each of the dietary concentrations with the VHI 
and the VHW treatments, respectively. The ninth contrast compared VHI and VHW 
treatments. The GLM procedure of SAS* was also used to monitor the changes 
with the dietary treatments of all the parameters studied, and to test for linear and 
quadratic effects. The arc sine transformation was used before analysis of data 
expressed as a percentage. 
Results 
Supplementation of the diet with increasing concentrations of dl-aTACT did 
not affect (P > .05) BW of the poults throughout the 21-d experiment (Figure 5.1). 
Body weight of the dl-aTACT-fed poults averaged 138.9, 338.9, and 665.4 g/poult 
at 7, 14, and 21 d of age, respectively. However, injection of 1-d-old poults with 50 
lU of d-cfTOC reduced BW at 5 (P < .03) and 7 (P < .001) d of age as compared 
with all other treatments (Table 5.4). The magnitude of the reductions observed 
were 5.5% at 5 d of age, and 6.5% at 7 d of age. By 14, and at 21 d of age, the 
negative effect of the injection on BW was no longer significant, although birds in 
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Figure 5.1. Body weight of poults fed 12, 46, 81, or 115 lU of dl-a-tocopheryl 
acetate/kg of diet. Each bar is the mean of 4 pens 
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TABLE 5.4. Body weight of poults as influenced by vitamin E provided in the 
diet, In the drinking water, or injected subcutaneously 
Age 
Treatment^ 1 d 5 d 7 d 10 d 14 d 21 d 
l9/Pouit; 
LLD 61.1 106.5 141.5 215.2 340.8 658.0 
MLD 61.0 105.0 139.0 208.2 333.5 646.2 
MHD 61.3 106.2 138.0 213.8 340.5 660.2 
HHD 61.2 104.2 137.0 206.2 337.0 657.2 
VHI 61.4 100.2 132.5 205.0 326.5 633.2 
VHW 61.4 106.8 144.5 220.2 352.0 660.8 
SEM^ 1.4 1.6 3.3 7.0 13.7 
Probabilities 
Treatment .03 .001 .03 .24 .68 
LLD vs VHI .004 .001 .04 _ _ 
LLD vs VHW 
MLD vs VHI .02 .009 
MLD vs VHW .02 .02 
MHD vs VH! .006 .02 .08 
MHD vs VHW .009 
HHD vs VHI .05 .06 
HHD vs VHW .003 .008 
VHI vs VHW .003 .001 .004 
Voults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 lU of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VHI), or In the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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the VHI treatment were the lightest at the end of the experiment. In contrast, 
supplementing the drinking water from Day 3 to Day 10 to achieve an intake of 50 
lU of d-aTOC per poult (actual consumption was 68 lU) significantly improved (P < 
.001) BW of the turkeys at 7 and 10 d of age. Poults in the VHW treatment 
continued to be the heaviest at all ages, but differences from the other treatment 
groups were not significant after 10 d of age. 
Water consumption was monitored for poults in the VHW treatment from 
Day 3 to Day 10 of the experiment. During this period, poults in the VHW 
treatment consumed 406 mL of water per poult per week, and this resulted in a 
total consumption of d-aTOC of 68 ID per poult per week. The initial assumption 
was that poults this age would consume 300 mL of water per poult per week, and 
d-aTOC was added in the water so that poults would consume 50 lU per poult per 
week. As a consequence, on the average, poults in the VHW treatment consumed 
18 lU of d-aTOC more than expected. 
Feed intake of the poults was not affected (P > .05) by dietary 
supplementation of dl-aTACT at any of the ages studied (Figure 5.2). But F1 was 
depressed (P < .02) by d-aTOC injection until 7 d of age, the reduction being of 
9% during this period, as compared with Fl of poults receiving any other treatment 
(Table 5.5). Adding d-aTOC to the drinking water increased (P < .05) Fl from 1 to 
14 d of age. This effect had disappeared by 21 d of age, although poults in the 
VHW treatment consumed more food than any other group of poults throughout 
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Figure 5.2. Feed intake of poults fed 12. 46, 81 or 115 lU of dl-a-tocopheryl 
acetate/kg of diet. Each bar is the mean of 4 pens 
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TABLE 5.5. Feed intake of pouits as influenced by vitamin E provided in the 
diet, in the drinking water, or injected subcutaneously 
Period 
Treatment^ 1 to 7 d 7 to 14 d 14 to 21 d 1 to 21 d 
(g/pouitj 
LLD 82.8 242.8 429.0 754.6 
MLD 80.9 232.7 415.2 736.9 
MHD 82.0 242.6 422.2 746.8 
HHD 79.8 241.1 434.2 755.0 
VHl 75.8 237.5 415.2 728.4 
VHW 85.2 251.8 425.4 762.4 
SEM^ 1.7 3.9 6.8 11.6 
Probabilities 
Treatment .02 .05 .33 .35 
LLD vs VHl .01 _ _ _ 
LLD vs VHW 
MLD vs VHl .05 
MLD vs VHW .09 .003 
MHD vs VHl .02 
MHD vs VHW 
HHD vs VHl 
HHD vs VHW .04 
VHl vs VHW .001 .02 
Voults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 ID of d-a-tocopherol, either by 
subcutaneous injection {Day 1)(VHI), or in the drinking water (Days 3 to 10)Cv'HW). 
^Means of four pens per treatment. 
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the experiment. 
Feed efficiency, expressed as the feed:gain ratio, was not affected (P > .05) 
by any of the treatments at any of the periods studied (Table 5.6). Cumulative data 
show that poults receiving d-aTOC by injection or in the drinking water utilized feed 
as efficiently as those receiving increasing concentrations of dl-aTACT in the diet, 
FE averaging 1.26 across all treatment groups for the 21-d period. 
Susceptibility of erythrocytes to hemolysis varied with the age of the poults. 
Thirty eight per cent of the RBC were susceptible to hemolysis at 1 d of age (Table 
5.7). This susceptibility decreased markedly by 5 d of age (average 15%), 
irrespective of VE supplementation, and then, increased (in most cases) to 21 d of 
age, depending on the route and concentration of VE supplemented. The effect of 
the treatments differed according to the age of the poults. 
Changes in susceptibility of RBC to hemolysis with the dietary VE treatments 
were significant (P < .002) from 10 to 21 d of age, and the patterns of change with 
increasing concentrations of dl-aTACT are shown in Figure 5.3. These data show 
that susceptibility of erythrocytes of the poults to hemolysis was decreased by 
increasing concentrations of dl-aTACT from 12 to 115 lU/kg of diet. Erythrocytes 
of poults in the HHD treatment were very well protected against oxidative damage 
by 14 d of age (9% of the RBC susceptible to hemolysis), and hemolysis values 
were still fairly low for this treatment by 21 d of age. Changes in susceptibility to 
hemolysis of erythrocytes with increments of dietary concentrations of dl-aTACT 
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TABLE 5.6. Feed efficiency (feedigain) of poults as influenced by vitamin E 
provided in the diet, in the drinking water, or injected subcutaneously 
Period 
Treatment^ 1 to 7 d 7 to 14 d 14 to 21 d 1 to 21 d 
(g/g) 
LLD 1.04 1.22 1.35 1.26 
MLD 1.03 1.20 1.32 1.26 
MHD 1.07 1.20 1.32 1.25 
HHD 1.06 1.21 1.36 1.27 
VHl 1.04 1.22 1.36 1.27 
VHW 1.04 1.21 1.37 1.27 
SEM^ .01 .03 .03 .02 
Probabilities 
Treatment .33 .97 .77 .86 
^Poults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 lU of d-a-tocopiierol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10) (VHW). 
^Means of four pens per treatment. 
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TABLE 5.7. Susceptibility to hemolysis of red blood cells of poults as 
influenced by vitamin E provided in the diet, in the drinking 
water, or injected subcutaneously 
Age 
Treatment' 1 d 5 d 10 d 14 d 21 d 
(n/ \ 
LLD 37.9 19.5 
{/v) 
99.6 98.8 100.0 
MLD 37.9 18.2 62.2 55.4 88.8 
MHD 37.9 20.0 60.2 48.9 68.3 
HHD 37.9 19.3 39.7 9.0 28.6 
VHI 37.9 7.1 18.8 47.3 92.9 
VHW 37.9 8.2 9.8 33.8 100.0 
SEM^ 5.8 9.4 14.8 13.6 
Probabilities 
Treatment .11 .001 .001 .001 
LLD vs VHI .001 .002 
LLD vs VHW .001 .001 
MLD vs VHI .003 
MLD vs VHW .001 
MHD vs VHI .001 .07 
MHD vs VHW .001 .02 
HHD vs VHI .1 .05 .001 
HHD vs VHW .01 .001 
VHI vs VHW 
Voults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 lU of d-a-tocopheroi, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatnnent. 
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Figure 5.3. Changes in susceptibility to hemolysis of erythrocytes of poults with 
dietary concentration of dl-a-tocopheryl acetate (dl-csTACT). Each bar 
is the mean of 4 pens. Changes with dietary dl-aTACT were best 
described by a linear model (P < .001) at 10, 14, and 21 d of age. 
Susceptibility of erythrocytes to hemolysis (y) at dietary dl-aTACT 
concentration x was y=2.09-.69x (r^=.63), y = 1.98-.56x (r^=.63), and 
y=1.58+.06x (r^=.68) at 10, 14, and 21 d of age, respectively 
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were best described by a linear model (P < .001) at 10, 14, and 21 d of age 
[susceptibility of RBC to hemolysis (y) at dietary dl-aTACT concentration x was 
y=2.09 -.69x, r^ = .63; y = 1.98 -.56x, r^=.63: and y = 1.58 + .06x, r^=.68 at 10, 14, 
and 21 d of age, respectively]. 
Although not statistically significant, susceptibility of RBC of the VHI- and 
VHW-poults to hemolysis was less than that of the dl-oTACT-fed poults at 5 d of 
age (Table 5.7). By 10 d of age, supplying d-aTOC by subcutaneous injection (50 
IU)(VHI) or in the drinking water (68 IU)(VHW) markedly decreased (P < .001) the 
susceptibility of the RBC of the poults to hemolysis. This effect had partly 
disappeared by 14 d of age. At this time, VHI and VHW treatments were more 
effective (P < .002 and P < .001, respectively) than LLD treatment in decreasing 
erythrocyte susceptibility to hemolysis. By 21 d of age, RBC of poults in the VHI 
and VHW treatments were more susceptible to hemolysis, compared with those of 
the poults in the MHD (P < .07 and P < .02, respectively), and HHD (P < .001 and 
P < .001, respectively) treatments. 
Red blood cells of the 1-d-old poults carried an average of .44 /xg aTOC/mL 
(Table 5.8). Data show that the concentration of aTOC in RBC of 5-d-old poults 
increased slightly, irrespective of the concentration of dl-aTACT supplied in the diet 
(Figure 5.4). After that, RBC aTOC concentration of the poults in the LLD 
treatment (12 lU of dl-aTACT/kg of diet) decreased to 21 d of age, reaching values 
as low as .25, .23, and .19 /xg/mL at 10, 14, and 21 d of age, respectively. In 
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TABLE 5.8. Concentration of a-tocopherol in red blood cells of poults as 
influenced by vitamin E provided in the diet, in the drinking 
water, or injected subcutaneously 
Age 
Treatment^ 1 d 5 d 10 d 14 d 21 d 
(/iQ/mg 
LLD .44 .49 .25 .23 .19 
MLD .44 .65 .58 .60 .69 
MHD .44 .50 .82 1.15 1.06 
HHD .44 .58 1.01 1.42 1.34 
VHI .44 3.24 1.50 .88 .52 
VHW .44 2.06 3.29 1.13 .40 
SEM^ .10 .36 .05 .12 
Probabilities 
Treatment .001 .001 .001 .001 
LLD vs VHI .001 .03 .001 .05 
LLD vs VHW .001 .001 .001 
MLD vs VHI .001 .09 .001 
MLD vs VHW .001 .001 .001 .09 
MHD vs VHI .001 .002 .004 
MHD vs VHW .001 .001 .001 
HHD vs VHI .001 .001 .001 
HHD vs VHW .001 .001 .001 .001 
VHI vs VHW .001 .003 .002 
^Poults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 lU of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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Figure 5.4. Changes in red blood ceil a-tocopherol concentration of poults with 
dietary concentration of dl-a-tocopheryl acetate (dl-aTACT). Each bar 
is the mean of 4 pens. Changes with dietary dl-aTACT were best 
described by a linear model (P < .001) at 10, 14, and 21 d of age. 
Red blood cell a-tocopherol concentration (y) at dietary dl-aTACT 
concentration x was y=.i4+.43x (r^=.96), y=-.31 +.54x (r^=.95), and 
y=--42+.66x (r^=.76) at 10, 14, and 21 d of age, respectively 
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contrast, otTOC content in RBC of poults fed the MLD, MHD, and HHD treatments 
increased steadily to 21 d of age. Starting at 10 d of age, and until 21 d of age, 
diet had a marked effect on the aTOC concentration carried by the RBC of the 
poults. The increase in aTOC concentration in RBC (y) was significant (P < .001) 
and linear [y=-.14 + .43x, r^ = .96; y=-.31 + .54x, r^ = .95; and y=-.42 + .66x, r^ = .76] 
at 10, 14, and 21 d of age, respectively, in response to increasing dietary dl-aTACT 
concentrations (x). 
Injection of the poults with 50 lU of d-aTOC at 1 d of age increased (P < 
.001) RBC aTOC concentration at 5 d of age (Table 5.8). At Day 10, poults in the 
VHI treatment still had greater RBC aTOC concentration than those of poults in the 
LLD (P < .03) and MLD (P < .09) treatments. Red blood cell concentration of 
aTOC in the injected turkeys at 21 d of age (.52 /xg/mL) was still greater (P < .05) 
than that of poults in the LLD treatment. However, including 81 (MHD) or 115 
(HHD) lU of dl-aTACT/kg of diet resulted in greater concentrations of aTOC in 
RBC at 14 (P < .002) and 21 (P < .004) d of age, as compared with aTOC levels 
found in RBC of poults in the VHI treatment. 
Similar to what it was observed with the injection of d-aTOC, addition of 68 
lU of d-aTOC in the drinking water of poults from Day 3 to Day 10 increased (P < 
.001) RBC aTOC concentration at 5 and 10 d of age (Table 5.8). By 14 d of age, 
poults in the VHW treatment still had greater (P < .001) RBC aTOC concentration 
than those in the LLD, MLD, and VHI treatments. By 21 d of age, this effect had 
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disappeared and poults in the MHD and HHD treatments carried more orTOC in 
their RBC than poults in any other treatment. 
Contrary to what occurred in RBC, aTOC concentrations in plasma 
decreased markedly until 10 d of age, irrespective of the concentration of dl-aTACT 
supplied in the diet (Figure 5.5). From an average of 15.2 /^g/mL at Day 1, plasma 
orTOC values ranged from 2.3 (LLD) to 8.2 (HHD) ng/mL at Day 10. Plasma aTOC 
concentrations of the LLD group remained very low to 21 d of age, but increased 
in varying degrees for poults in the other dietary treatments. Changes of plasma 
aTOC (y) at dietary dl-aTACT concentration x were significant (P < .003) and 
quadratic [y=12.27-6.70x-(-1.43x^, r^ = .54] at 5 d of age, and linear thereafter 
[y=3.59-1.70x, r^=.80 at 10; y=1.55 + .72x, r^=.92 at 14; and y = -.47+2.30x, r^ = .98 
at 21 d of age]. 
Plasma aTOC concentration was increased markedly (P < .001) at 5 d of 
age by d-aTOC injection, reaching values as great as 39.9 ^g/mL (vs an average 
of 7.6 ng/mL for all other treatments)(Table 5.9). By 10 d of age, VHI-treated 
poults still had greater (P < .007) plasma oTOC levels than poults fed 12 (LLD), 46 
(MLD), or 81 (MHD) ID of dl-aTACT/kg of diet. This difference with the MHD-fed 
turkeys had disappeared by 14 d of age (P > .05) and, at the end of the 21-d 
experimental period, the beneficial effect of injecting 50 ID of d-aTOC at 1 d of age 
could be observed only when compared with the LLD treatment. Supplying 68 ID 
of d-aTOC in the drinking water from Day 3 to Day 10 increased (P < .003) plasma 
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Figure 5.5. Changes in plasma a-tocopherol concentration of poults with dietary 
concentration of dl-a-tocopheryl acetate (dl-aTACT]. Each bar is the 
mean of 4 pens. Changes with dietary dl-aTACT were best described 
by a quadratic model (P < .003) at 5 d of age, and by a linear model 
{P < .003) at 10, 14 and 21 d of age. Plasma a-tocopherol 
concentration (y) at dietary dl-aTACT concentration x was y=12.27 
-6.70x+1.43x^ (r^=-54), y=3.59-1.70x (r^=.80). y = 1.55+.72x (r^=.92), 
and y=.47+2.30x (r^=.98) at 5, 10, 14, and 21 d of age, respectively 
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TABLE 5.9. Concentration ot a-tocopherol in plasma of poults as influenced 
by vitamin E provided in the diet, in the drinking 
water, or injected subcutaneously 
Age 
Treatment^ 1 d 5 d 10 d 14 d 21 d 
(/zg/mL; 
LLD 15.22 7.07 2.32 2.61 1.99 
MLD 15.22 4.38 3.79 6.11 4.92 
MHD 15.22 5.28 3.95 8.22 8.01 
HHD 15.22 8.31 8.22 14.07 11.67 
VHl 15.22 39.90 9.53 8.14 4.05 
VHW 15.22 13.00 33.66 8.86 3.26 
SEM^ .97 1.30 .68 .29 
Probabilities 
Treatment .001 .001 .001 .001 
LLD vs VHl .001 .001 .001 .001 
LLD vs VHW .001 .001 .001 .006 
MLD vs VHl .001 .006 .05 .05 
MLD vs VHW .001 .001 .01 .001 
MHD vs VHl .001 .007 .001 
MHD vs VHW .001 .001 .001 
HHD vs VHl .001 .001 .001 
HHD vs VHW .003 .001 .001 .001 
VHl vs VHW .001 .001 .07 
Voults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of di-a-
tocopheryl acetate/kg of diet, or received 50 lU of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^IVIeans of four pens per treatment. 
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aTOC concentration at 5 and 10 d of age as compared with any of the dietary 
treatments. At 5 d of age, VHI-treated poults carried more aTOC in plasma (P < 
.001) than those in the VHW group, but this effect was reversed by 10 d of age (P 
< .001). From Day 10 to Day 21, plasma aTOC concentration of poults in the 
VHW group decreased steadily, and only poults in the LLD group had lower (P < 
.006) plasma aTOC concentration than the VHW-poults by the end of the 
experiment. 
The amount of aTOC carried by the VLDL plasma fraction varied with age. 
There was a sharp decrease in aTOC concentration in VLDL between 1 and 21 d 
of age, at which time the minimum concentration occurred for most treatment 
groups. Increasing dl-aTACT in the diet from 12 (LLD) to 115 (HHD) lU/kg of diet 
increased aTOC concentration in VLDL at all ages, although it was statistically 
significant only (P < .001) at 14 and 21 d of age (Table 5.10). Injection of the 
poults with 50 lU of d-aTOC at 1 d of age markedly increased (P < .007) 
concentration of aTOC in VLDL at 5 d of age. This effect was still visible at 10 d of 
age, but gradually disappeared by 21 d of age. At this time, poults in the VHI 
treatment had VLDL aTOC values as low as those of poults in the LLD treatment. 
Addition of 68 lU of d-aTOC in the drinking water significantly increased VLDL 
aTOC concentration at 5 (P < .04) and 10 (P < .001) d of age. However, after 
this time, poults in the VHW group had VLDL aTOC values similar to those of 
poults in the LLD and VHI groups, and these values were lower (P < .004) than 
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TABLE 5.10. Concentration of a-tocopherol in the very low density 
lipoprotein fraction of plasma of poults as influenced by 
vitamin E provided in the diet, in the drinking water, 
or injected subcutaneously 
Age 
Treatment^ 1 d 5 d 10 d 14 d 21 d 
(/ig/mg 
LLD 5.38 1.59 .28 .14 .02 
HHD 5.38 2.14 .31 .87 .53 
VHi 5.38 6.33 .65 .50 .12 
VHW 5.38 3.53 1.38 .32 .09 
SEM^ .61 .12 .10 .08 
Probabilities 
Treatment .001 .001 .002 .004 
LLD vs HHD _ .001 .001 
LLD vs VHI .001 .06 .03 
LLD vs VHW .04 .001 
HHD vs VH! .001 .07 .02 .004 
HHD vs VHW .001 .002 .003 
VH! vs VHW .007 .001 
Voults were fed 12 (LLD) or 115 (HHD) lU of dl-a-tocopheryl acetate/kg of 
diet, or received 50 IU of d-a-tocopiierol, either by subcutaneous injection (Day 
1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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those of poults in the HHD treatment group. 
As was observed for the VLDL fraction of the plasma, the amount of aTOC 
carried by the LDL plasma fraction varied with the age of the poults, and the 
pattern of change from 5 to 21 d of age was markedly influenced by treatments. 
a-Tocopherol in LDL decreased in most instances to 21 d of age (Table 5.11), 
although not so drastically as had been observed with the VLDL fraction. Poults in 
the HHD treatment kept relatively high levels of aTOC in LDL at all ages, a-
Tocopherol in LDL for this group (HHD) decreased from 1 to 5 d of age, increased 
to a maximum at 14 d of age, and decreased again to 21 d of age. Supplementing 
the poults with 115 lU of dl-aTACT/kg of diet resulted in numerically greater aTOC 
concentrations in LDL at 5 and 10 d of age, as compared with those of poults fed 
12 ID of dl-aTACT/kg of diet, and this difference was significant (P < .001) at 14 
and 21 d of age. Injection at 1 d of age with 50 lU of d-oTOC increased (P < 
.001) LDL aTOC levels at 5 d of age, but this effect gradually disappeared by 21 d 
of age (Table 5.11). At this time, VHi-treated poults still had greater (P < .003) 
aTOC concentration in LDL than those in the LLD group. Supplementing the 
drinking water with 68 lU of d-aTOC from Day 3 to Day 10 markedly increased (P 
< .001) LDL aTOC values at 5 and especially at 10 d of age. At this time, poults in 
the VHW treatment group carried 40.4 ^g of aTOC/mL in the LDL fraction of the 
plasma, vs an average of 4.4 /xg/mL carried by poults of the other treatments. 
However, this value had declined 9-fold by 14 d of age, and 49-fold at the end of 
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TABLE 5.11. Concentration of a-tocopherol in the low density lipoprotein 
fraction of plasma of poults as influenced by vitamin E provided in 
the diet, in the drinking water, or injected subcutaneously 
Age 
Treatment^ 1 d 5 d 10 d 14 d 21 d 
l/ig/mLj 
LLD 6.57 3.07 1.41 1.22 .50 
HHD 6.57 3.70 5.42 7.52 2.92 
VHI 6.57 9.67 6.25 3.76 1.08 
VHW 6.57 7.90 40.42 4.74 .83 
SEM^ .33 5.27 .50 .11 
Probabilities 
Treatment .001 .001 .001 .001 
LLD vs HHD .001 .001 
LLD vs VHI .001 .004 .003 
LLD vs VHW .001 .001 .001 .05 
HHD vs VHI .001 .001 .001 
HHD vs VHW .001 .001 .002 .001 
VHI vs VHW .002 .001 . -
^Poults were fed 12 (LLD) or 115 (HHD) lU of d!-a-tocopheryl acetate/kg of 
diet, or received 50 IU of d-a-tocopherol, either by subcutaneous injection (Day 
1)(VH1), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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the experimental period. At 14 and 21 d of age, poults in the HHD treatment 
carried greater (P < .001) amounts of aTOC in the LDL fraction than poults in any 
other treatment. 
The aTOC carried by the HDL fraction of plasma also varied with the age of 
the poults, in an almost identical manner as did the aTOC carried by the LDL 
fraction. o-Tocopherol in HDL decreased markedly from 1 to 21 d of age for 
poults in the LLD treatment (Table 5.12). It decreased from 1 to 5 d of age for 
poults in the HHD treatment, increased to a maximum to 14 d of age, and 
decreased again by the end of the experiment. The beneficial effect of increasing 
dl-aTACT from 12 (LLD) to 115 (HHD) lU/kg of diet was evident at all ages, but 
was significant (P < .001) only at 14 and 21 d of age. Injection of d-aTOC at 1 d 
of age increased HDL aTOC to a maximum at 5 d of age. At this time, VHl-poults 
carried more aTOC (P < .05) in the HDL fraction than poults in any other treatment 
group, but this effect of d-aTOC injection declined gradually to 21 d of age. 
Adding d-aTOC in the drinking water increased (P < .001) HDL aTOC 
concentration at 5 and 10 d of age (to values of 46.5 /xg/mL at 10 d of age)(Table 
5.12). By 14 d of age, aTOC concentration carried by HDL of poults in the VHW 
group had decreased drastically, and, by 21 d of age, poults in the VHI and VHW 
groups had greater (P < .05) HDL aTOC values than LLD-fed poults, but markedly 
lower (P < .001) values than poults fed 115 ID of dl-aTACT (HHD)/kg of diet. 
The percentage of aTOC carried by the different lipoprotein fractions varied 
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TABLE 5.12. Concentration of a-tocopherol in the high density lipoprotein 
fraction of plasma of poults as influenced by vitamin E provided in 
the diet, in the drinking water, or injected subcutaneously 
Age 
Treatment^ 1 d 5 d 10 d 14 d 21 d 
iMg/fTiL) 
LLD 9.47 6.18 2.02 1.54 .80 
HHD 9.47 6.48 6.36 10.46 4.95 
VHI 9.47 11.93 9.02 4.99 1.81 
VHW 9.47 10.66 46.52 6.59 1.46 
SEM^ .41 3.02 .74 .21 
Probabilities 
Treatment .001 .001 .001 .001 
LLD vs HHD - _ .001 .001 
LLD vs VHI .001 .007 .006 
LLD vs VHW .001 .001 .001 .05 
HHD vs VHI .001 .001 .001 
HHD vs VHV^ .001 .001 .003 .001 
VHI vs VHW .05 .001 
^Poults were fed 12 (LLD) or 115 (HHD) ID of dl-a-tocopheryl acetate/kg of 
diet, or received 50 lU of d-a-tocopherol, eitiier by subcutaneous injection (Day 
1)(VH1), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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with the age of the poults fPable 5.13). At Day 1, VLDL carried 20.74% of the 
aTOC present in plasma, whereas the percentages carried by LDL and HDL at the 
same age were 35.46 and 43.81, respectively. a-Tocopherol in VLDL decreased 
markedly from 1 to 10 d of age (average 3.10%), and then, it seemed to plateau 
until 21 d of age. Instead, aTOC in LDL increased until 10 d of age (46.00%), and 
remained at approximately the same level until the end of the experiment (39.70% 
by 21 d of age). The HDL fraction of the plasma carried most of the aTOC at all 
ages studied. From 43.81% at 1 d of age, percentage of aTOC in HDL increased 
steadily until 21 d of age, the average across treatment groups being 48.97, 50.87, 
51.64, and 57.19% at 5, 10, 14, and 21 d of age, respectively. 
Data presented in Tables 5.14 to 5.19 show the weight of adrenal glands, 
bursa of Fabricius, and lungs of poults, expressed either in grams (Tables 5.14, 
5.16, and 5.18, respectively), or as percentages of BW (Tables 5.15, 5.17, and 
5.19, respectively). None of the treatments affected the weight of these tissues 
during the 21-d experimental period (P > .05). 
Pancreas weight, as well as relative pancreas weight, were slightly affected 
by treatments at 10 d of age (Tables 5.20 and 5.21). At this time, changes in 
pancreas weight (y)(Table 5.20) and relative pancreas weight (2)(Table 5.21) were 
significant [P < .006, and P < .005, respectively) and quadratic [y = .98-.21x+.04x^, 
r^=.46: and z=.11+ .006x-.002x^, r^=.47] in response to dietary dl-aTACT (x) 
concentration. The effect of d-aTOC, injected and supplied in the drinking water, 
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TABLE 5.13. Percentage of a-tocopherol transported by each plasma 
lipoprotein fraction of poults as influenced by vitamin E provided 
in the diet, in the drinking water, or injected subcutaneously 
Age 
Treatment 1 d 5 d 10 d 14 d 21 d 
/O/ \1 
VLDL^ 
^/oj 
LLD 20.74 11.93 5.98 3.79 1.19 
HHD 20.74 14.18 2.00 3.63 5.02 
VHI 20.74 18.52 3.21 4.25 3.15 
VHW 20.74 12.89 1.21 2.15 2.99 
SEM^ 1.46 1.04 .45 .78 
LDL 
LLD 35.46 32.32 42.18 46.24 41.67 
HHD 35.46 34.32 48.85 43.95 38.71 
VHI 35.46 39.60 43.26 44.79 39.75 
VHW 35.46 40.39 49.73 44.64 38.65 
SEM 1.98 1.92 .48 .70 
HDL 
LLD 43.81 55.76 51.79 50.04 57.14 
HHD 43.81 51.52 49.13 52.40 56.25 
VHI 43.81 41.88 53.51 50.95 57.10 
VHW 43.81 46.72 49.06 53.19 58.27 
SEM 3.00 1.09 .71 .41 
^Alpha-tocopherol carried by each plasma lipoprotein fraction (VLDL, LDL, or 
HDL), expressed as a percentage of the total a-tocopherol present in the three 
lipoprotein fractions. 
^Poults were fed 12 (LLD) or 115 (HHD) lU of dl-a-tocopheryl acetate/kg of 
diet, or received 50 ID of d-a-tocopherol, either by subcutaneous injection (Day 
1)(VH!), or in the drinking v/ater (Days 3 to 10)(VnW). 
^Means of four pens per treatment. 
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TABLE 5.14. Weight of adrenal glands of poults as influenced by vitamin E 
provided in the diet, in the drinking water, or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
(g/adrenal) 
LLD .009 .035 .10 
MLD .009 .041 .13 
MHD .009 .034 .09 
HHD .009 .034 .11 
VHI .009 .032 .10 
VHW .009 .044 .09 
SEM^ .004 .02 
Probabilities 
Treatment .34 .52 
^Poults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocophery! acetate/kg of diet, or received 50 lU of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.15. Weight of adrenal glands relative to body weight of poults as 
influenced by vitamin E provided in the diet, in the drinking water, 
or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
(% of BW) 
LLD .013 .017 .017 
MLD .013 .020 .022 
MHD .013 .017 .013 
HHD .013 .017 .017 
VHI .013 .015 .015 
VHW .013 .021 .014 
SEM^ .002 .003 
Probabilities 
Treatment .55 .42 
^Poults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 ID of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VH!), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.16. Weight Of bursa of Fabricius of poults as influenced by vitamin 
E provided in the diet, in the drinking water, or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
(g/bursa) 
LLD .065 .32 1.17 
MLD .065 .28 1.11 
MHD .065 .28 1.12 
HHD .065 .33 1.19 
VHl .065 .32 1.24 
VHW .065 .34 1.19 
SEM^ .03 .10 
Probabilities 
Treatment .47 .93 
Moults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) iU of dl-a-
tocophery! acetate/kg of diet, or received 50 IU of d-a-tocopheroi, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.17. Bursa of Fabricius weight relative to body weight of poults as 
influenced by vitamin E provided in the diet, in the drinking water, 
or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
{% of BW) 
LLD .094 .15 .19 
MLD .094 .13 .18 
MHD .094 .14 .17 
HHD .094 .16 .19 
VHI .094 .15 .19 
VHW .094 .18 .18 
SEM^ .01 .02 
Probabilities 
Treatment .39 .93 
Voults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) iU of di-a-
tocopheryl acetate/kg of diet, or received 50 IU of d-a-tocoplierol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.18. Weight of lungs of poults as Influenced b vitamin E provided in 
the diet, in the drinking water, or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
(g/lung) 
LLD .43 1.52 4.24 
MLD .43 1.44 3.90 
MHD .43 1.51 4.49 
HHD .43 1.51 4.40 
VHI .43 1.41 4.39 
VHW .43 1.43 4.56 
SEM^ .07 .37 
Probabilities 
Treatment .83 .84 
Voults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 iU of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.19. Lung weight relative to body weight of poults as influenced by 
vitamin E provided in the diet, in the drinking water, 
or subcutaneously injected 
Age 
Treatment^ 1 d 10 d 21 d 
(% of BW) 
LLD .62 .73 .70 
MLD .62 .69 .63 
MHD .62 .74 .68 
HHD .62 .73 .68 
VHI .62 .66 .68 
VHW .62 .67 .70 
SEM^ .03 .05 
Probabilities 
Treatment .44 .93 
^Poults were fed 12 (LLD), 46 (MLD). 81 (MHD). or 115 (HHD) lU of dl-a-
tocophery! acetate/kg of diet, or received 50 lU of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VH1), or in ti^e drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.20. Weight of pancreases of poults as influenced by vitamin E 
provided in the diet, in the drinking water, or injected 
subcutaneously 
Age 
Treatment"" 1 d 10 d 21 d 
(g/pancreaSj 
LLD .095 .81 1.93 
MLD .095 .70 1.97 
MHD .095 .72 2.10 
HHD .095 .78 1.92 
VHI .095 .70 2.07 
VHW .095 .79 2.12 
SEM^ .03 .84 
Probabilities 
Treatment .09 .36 
LLD vs VHI .02 
LLD vs VHW 
MLD vs VHI 
MLD vs VHW .08 
MHD vs VHI 
MHD vs VHW 
HHD vs VHI .1 
HHD vs VHW 
VH! vs VHW .06 
^Poults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 lU of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.21. Pancreas weight relative to body weight of poults as influenced 
by vitamin E provided in the diet, in the drinking water, 
or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
(% of BW) 
LLD .14 .39 .32 
MLD .14 .34 .32 
MHD .14 .35 .32 
HHD .14 .38 .30 
VHI .14 .33 .32 
VHW .14 .37 .33 
SEM^ .10 .14 
Probabilities 
Treatment .02 .88 
LLD vs VHI .003 _ 
LLD vs VHW 
MLD vs VHI 
MLD vs VHW .06 
MHD vs VHI 
MHD vs VHW 
HHD vs VHI .01 
HHD vs VHW 
VHI vs VHW .02 
^Poults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 IU of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatnnent. 
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on pancreas weight was inconsistent at 10 d of age, and had disappeared by 21 d 
of age. 
Liver weight (Table 5.22) and relative liver weight (Table 5.23) of poults were 
not affected by treatment during the 21-d period. By 21 d of age, however, there 
was an indication that weight of the livers was Increased with Increasing dietary 
concentrations of dl-aTACT. 
Adrenal glands of 1-d-old poults contained 14.4 /xg of aTOC/g for a total of 
.12 /xg/gland (Tables 5.24 and 5.25). By 10 d of age, aTOC in adrenal glands had 
Increased markedly, irrespective of amount or route of VE used. By 21 d of age, 
aTOC in adrenal glands had decreased, although concentrations remained high as 
compared with those found at 1 d of age. There was no effect of dietary 
treatments on aTOC concentration (Figure 5.6) and total aTOC (Figure 5.7) stored 
In adrenal glands at 10 d of age, but increasing dietary dl-aTACT (x) concentration 
from 12 to 115 lU/kg of diet Increased (P < .001) oTOC concentration (y) and total 
qTOC (z) in adrenal glands at 21 d of age, and this increase was linear in both 
instances [y=-87.25+ 146.27x, r^=.83: and z=-7.20+13.70x, r^ = .75]. Giving d-
oTOC to the poults (VHI and VHW treatments) increased aTOC concentration (P < 
.002) and total aTOC (P < .008) in adrenal glands at 21 d of age, but only when 
compared to the LLD-treated poults (Tables 5.24 and 5.25). 
The bursa of Fabricius of poults was very responsive to VE supplementation. 
At 10 d of age, and unlike what had been observed in the adrenal glands, aTOC 
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TABLE 5.22. Weight of livers of poults as Influenced by vitamin E provided in 
the diet, in the drinking water, or Injected subcutaneously 
Age 
Treatment^ 1 d 5 d 10 d 14 d 21 d 
(g/iiverj 
LLD 1.83 3.88 6.63 9.52 13.83 
MLD 1.83 3.84 6.11 9.39 13.28 
MHD 1.83 3.96 6.74 10.05 15.87 
HHD 1.83 3.76 6.44 9.63 15.72 
VHI 1.83 4.01 6.85 9.35 15.59 
VHW 1.83 3.58 6.52 9.85 15.08 
SEM^ .16 .30 .47 .79 
Probabilities 
Treatment .33 .59 .89 .15 
Voults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-o-
tocophery! acetate/kg of diet, or received 50 lU of d-a-tocopheroi, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.23. Liver weight relative to body weight of poults as influenced by 
vitamin E provided in the diet, in the drinking water, 
or injected subcutaneously 
Age 
Treatment^ 1 d 5 d 10 d 14 d 21 d 
(% of BW) 
LLC 2.62 3.78 3.18 2.82 2.28 
MLD 2.62 3.62 2.92 2.85 2.16 
MHD 2.62 3.85 3.28 2.94 2.41 
HHD 2.62 3.85 3.12 2.97 2.49 
VHI 2.62 3.82 3.22 2.92 2.41 
VHW 2.62 3.52 3.08 2.83 2.32 
SEM^ .42 .31 .39 .34 
Probabilities 
Treatment .62 .30 .95 .32 
^Poults were fed 12 (LID), 46 (MLD), 81 (MHD), or 115 (HHD) lU of di-a-
tocopheryl acetate/kg of diet, or received 50 ID of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.24. Concentration of a-tocopherol of adrenal glands of poults as 
influenced by vitamin E provided in the diet, in the drinking 
water, or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
/ 1 \ vMg/g) 
LLD 14.4 428.8 42.5 
MLD 14.4 521.6 114.0 
MHD 14.4 336.9 181.5 
HHD 14.4 525.7 172.5 
VHI 14.4 205.8 123.1 
VHW 14.4 445.4 150.9 
SEM^ 102.9 15.2 
Probabilities 
Treatment .27 .001 
LLD vs VHI .002 
LLD vs VHW .001 
MLD vs VHI 
MLD vs VHW 
MHD vs VHI .01 
MHD vs VHW 
HHD vs VHI .03 
HHD vs VHW 
VHI vs VHW 
^Poults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 ID of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.25. Total a-tocopherol of adrenal glands of poults as Influenced by 
vitamin E provided in the diet, in the drinking water, 
or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
LLD .12 14.66 4.14 
MLD .12 23.21 14.42 
MHD .12 11.28 15.76 
HHD .12 18.55 18.68 
VHI .12 6.63 12.45 
VHW .12 19.82 14.55 
SEM^ 4.72 2.34 
Probabilities 
Treatment .20 .008 
LLD vs VHI _ .02 
LLD vs VHW .006 
MLD vs VHI 
MLD vs VHW 
MHD vs VHI 
MHD vs VHW 
HHD vs VHI .08 
HHD vs VHW 
VHi vs VHW 
Voults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 lU of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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Figure 5.6. Changes in adrenal glands or-tocopherol concentration of poults with 
dietary concentration of dl-o;-tocopheryl acetate (dl-aTACT). Each bar 
is the mean of 4 pens. Changes with dietary dl-aTACT were best 
described by a linear model (P < .001) at 21 d of age. Adrenal 
glands Q-tocopherol concentration (y) at dietary dl-oTACT x was 
y = 87.25+ 146.27 (r^ = .83) at 21 d of age 
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Figure 5.7. Changes in adrenal glands total a-tocopherol of poults with dietary 
concentration of dl-a-tocopheryl acetate (dl-aTACT). Each bar is the 
mean of 4 pens. Changes with dietary dl-oTACT were best described 
by a linear model (P < .001) at 21 d of age. Adrenal glands total a 
-tocopherol (y) at dietary dl-aTACT x was y=-7.20+13.70x (r^ = .75) at 
21 u of age 
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concentration (Figure 5.8) and total aTOC (Figure 5.9) in the bursa of Fabricius of 
poults varied accordingly to the dl-aTACT supplied in the diet. At 10 d, changes in 
otTOC concentration (y) and total amount (z) with dietary dl-aTACT (x) 
concentration were significant (P < .001) and linear [y=-3.14 + 7.59x, r^ = .83, and 
z=-.14+1.32x, r^=.87]. By 21 d of age, bursa aTOC concentration had decreased 
for all dietary treatments (Figure 5.8), whereas the total amount of qTOC stored in 
the bursa had increased for most dietary treatments (Figure 5.9). The aTOC 
concentration (y) and the total amount of aTOC (z) in bursa increased (P < .001) 
with each increment in dietary dl-aTACT (x), and this relationship was linear at 21 d 
of age [y = -1.924-2.90x, r^=.80. and z=-1.64+2.67x, r^=.80]. 
Poults receiving 50 lU of d-aTOC by injection at 1 d of age had greater (P < 
.01) concentrations (Table 5.26) and amounts (Table 5.27) of aTOC in the bursa of 
Fabricius than any of the dl-aTACT-fed poults by Day 10. Giving d-aTOC (68 lU) in 
the drinking water from Day 3 to Day 10 increased (P < .001) bursa aTOC 
concentrations of poults as compared with giving the d-aTOC by injection, or 
supplying the dl-aTACT in the diet. By 21 d of age, however, this effect had 
disappeared. The VHI and VHW-treated poults were not different from each other 
(P > .05) in storing aTOC in the bursa of Fabricius. And, although these poults 
had more aTOC (P < .05) stored in bursa than poults in the LLD treatment, giving 
81 or 115 !U of dl-aTACT/kg of diet was most effective (P < .002) in maintaining 
bursa aTOC concentrations through 21 d of age. 
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Figure 5.8. Changes in bursa of Fabricius a-tocopherol concentration of poults 
with dietary concentration of dl-or-tocopheryl acetate (dl-aTACT). 
Each bar is the mean of 4 pens. Changes with dietary dl-aTACT 
were best described by a linear model (P < .001) at 10 and 21 d of 
age. Bursa of Fabricius a-tocopherol concentration (y) at dietary dl-
aTACT X was y = -3.14-(-7.59x (r^=.83) and y = -1.92-h2.90x (r^=.80) at 
10 and 21 d of age, respectively 
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Figure 5.9. Changes in bursa of Fabricius total c-tocopherol of poults with dietary 
concentration of dl-a-tocopheryl acetate (dl-aTACT). Each bar is the 
mean of 4 pens. Changes with dietary dl-aTACT were best described 
by a linear model (P < .001) at 10 and 21 d of age. Bursa of 
Fabricius total a-tocopherol (y) at dietary dl-aTACT x was y=-.14 
+ 1.32x and y=-1.64 + 2.67x (r^ = .80) at 10 and 21 d of age, 
respectively 
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TABLE 5.26. Concentration of a-tocopherol in bursa of Fabricius of poults as 
influenced by vitamin E provided in the diet, in the drinking 
water, or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
LLD 7.09 3.26 .72 
MLD 7.09 9.04 2.62 
MHD 7.09 10.47 4.23 
HHD 7.09 12.51 4.96 
VHI 7.09 24.31 1.91 
VHW 7.09 52.54 2.86 
SEM^ 3.84 .40 
Probabilities 
Treatment .001 .001 
LLD vs VHI .001 .05 
LLD vs VHW .001 .002 
MLD vs VHI .01 
MLD vs VHW .001 
MHD vs VHI .02 .001 
MHD vs VHW .001 .03 
HHD vs VHI .04 .001 
HHD vs VHW .001 .002 
VHI vs VHW .001 
Voults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 ID of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VH1), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.27. Total a-tocopheroi in bursa of Fabricius of poults as influenced 
by vitamin E provided in the diet, in the drinking water, 
or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
(l^Q) 
LLD .46 1.01 .84 
MLD .46 2.51 2.91 
MHD .46 2.90 4.63 
HHD .46 4.12 5.93 
VHI .46 7.86 2.32 
VHW .46 17.52 3.43 
SEM^ 1.39 .50 
Probabilities 
Treatment .001 ,001 
LLD vs VHI .003 .05 
LLD vs VHW .001 .002 
MLD vs VHI .01 
MLD vs VHW .001 
MHD vs VHI .02 .004 
MHD vs VHV/y .001 
HHD vs VHI .07 .001 
HHD vs VHW .001 .002 
VHi vs VHW .001 
^Poults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocophery! acetate/kg of diet, or received 50 lU of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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Lungs of 1-d-old poults stored 8.85 fig aTOC/g for a total of 3.83 ^g/lung 
{Figures 5.10 and 5.11). The concentration (y) and total amount (z) of aTOC in 
lungs of 10- and 21-d-old poults changed (P < .001) linearly [y=-1.27+4.86x, 
r^=.92, and z=-1.54 + 6.80x, r^ = .95 at 10 d of age; and y=-2.22 + 4.44x. r^ = .98, 
and z=-8.30+16.28x, r^=.92 at 21 d of age] in response to dietary dl-aTACT (x) 
concentration. Injection of d-aTOC increased lung aTOC concentration (P < .01) 
and total aTOC in lungs (P < .1) at 10 d of age (Tables 5.28 and 5.29). Giving d-
oTOC in the drinking water was more effective than the injection (P < .001) to 
increase aTOC stores in the lungs of poults at this age. By 21 d of age, however, 
poults in the MHD and HHD treatments had more aTOC in their lungs as 
compared with poults in any other treatment group. The VHI and VHW treatments 
were more effective (P < .005) than the LLD treatment in maintaining aTOC levels 
in lungs by the end of the experiment. 
None of the dietary treatments alleviated the decrease in pancreatic aTOC 
concentration at 10 d of age (Figure 5.12). As compared with 12.28 Mg/g at Day 
1, concentrations in the pancreas ranged from 3.33 to 7.31 |xg/g at 10 d of age 
and from 1.09 to 7.4 /ig/g at 21 d of age. However, at each increasing 
supplemental concentration of dl-aTACT, there was a significant (P < .004) 
increase in pancreatic aTOC, both in concentration (y)(Figure 5.12) and total aTOC 
(z)(Figure 5.13). Changes with dietary dl-aTACT (x) were quadratic at 10 d of age 
[y=-.49+4.46x-.63x^, r^ = .86, and z = .74 + 2.20x-.24x^, r^ = .90], and linear at 21 d of 
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Figure 5.10. Changes in lung a-tocopherol concentration of poults with dietary 
concentration of dl-a-tocopheryl acetate (dl-aTACT). Each bar is the 
mean of 4 pens. Changes with dietary dl-aTACT were best described 
by a linear model (P < .001) at 10 and 21 d of age. Lung a 
-tocopherol concentration (y) at dietary dl-aTACT x was y=-1.27 
+4.a6x (r^ = .92) and y=-2.22+4.44x (r^ = .98) at 10 and 21 d of age, 
respectively 
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Figure 5.11. Changes in lung total a-tocopherol of poults with dietary 
concentration of di-a-tocopheryi acetate (dl-aTACT). Each bar is the 
mean of 4 pens. Changes with dietary (dl-orTACT) were best 
described by a linear model (P < .001) at 10 and 21 d of age. Lung 
total a-tocopherol (y) at dietary dl-aTACT x was y=-1.54 + 6.80x 
(r^=.95) and y=-8.30+16.28x (r^=.92) at 10 and 21 d of age, 
respectively 
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TABLE 5.28. Concentration of a-tocopherol in lungs of poults as influenced 
by vitamin E provided In the diet, in the drinking 
water, or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
LLD 8.85 3.06 2.26 
MLD 8.85 7.14 7.59 
MHD 8.85 9.23 12.07 
HHD 8.85 11.65 17.98 
VHI 8.85 20.60 6.37 
VHW 8.85 68.14 6.68 
SEM^ 2.33 .55 
Probabilities 
Treatment .001 .001 
LLD vs VHI .001 .001 
LLD vs VHW .001 .001 
MLD vs VHI .001 
MLD vs VHW .001 
MHD vs VHI .003 .001 
MHD vs VHW .001 .001 
HHD vs VHI .01 .001 
HHD vs VHW .001 .001 
VHI vs VHW .001 
^Poults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 lU of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.29. Total a-tocopherol in lungs of poults as influenced by vitamin E 
provided in the diet, in the drinking water, or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
[t^Qj 
LLD 3.83 4.64 9.38 
MLD 3.83 10.31 29.74 
MHD 3.83 13.87 53.02 
HHD 3.83 17.46 78.91 
VHl 3.83 28.71 27.72 
VHW 3.83 97.73 30.74 
SEM^ 4.56 4.08 
Probabilities 
Treatment .001 .001 
LLD vs VHl .002 .005 
LLD vs VHW .001 .002 
MLD vs VHl .01 
MLD vs VHW .001 
MHD vs VHl .03 .001 
MHD vs VHW .001 .001 
HHD vs VHl .1 .001 
HHD vs VHW .001 .001 
VHl vs VHW .001 
Voults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 lU of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VH!), or in the drinking water (Days 3 to 10)(VHV\/). 
^Means of four pens per treatment. 
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Figure 5.12. Changes in pancreas a-tocopherol concentration of poults with 
dietary concentration of dl-a-tocophery! acetate (dl-oTACT). Each bar 
is the mean of 4 pens. Changes with dietary dl-aTACT were best 
described by a quadratic model {P < .004) at 10 d of age, and by a 
linear model (P < .004) at 21 d of age. Pancreas a-tocopherol 
concentration (y) at dietary dl-aTACT x was y=-.494-4.46x-.63x^ 
(r^ = .8o) and y=-1.11+2.16x (r^ = .96) at 10 and 21 d of age, 
respectively 
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Figure 5.13. Changes in pancreas total Q-tocopherol of poults with dietary 
concentration of dl-a-tocopheryl acetate (dl-aTACT). Each bar is the 
mean of 4 pens. Changes with dietary dl-aTACT were best described 
by a quadratic model (P < .004) at 10 d of age and by a linear model 
(P < .004) and 21 d of age. Pancreas total a-tocopherol (y) at 
dietary dl-aTACT x was y=.744-2.20x-.24x^ (r^=.90) and y=-3.53 
-I-5.70X (r^=.93) at 10 and 21 d of age, respectively 
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age [y=-1.11 + 2.16x, r^ = .96, and z=-3.53 + 5.70x, r^ = .93]. Injection of 1-d-old 
poults with 50 lU of d-aTOC was as effective as supplying 68 lU of d-aTOC in the 
drinking water from 3 to 10 d of age for increasing (P < .001) pancreatic qTOC 
concentration of poults at 10 d of age, as compared with the dietary 
supplementation of dl-aTACT (Table 5.30). By 21 d of age, however, VHI-treated 
poults had a pancreatic aTOC concentration (P < .01) that exceeded that of only 
poults in the LLD and MHD treatments. In contrast, the VHW treatment was as 
effective as the HHD treatment in maintaining greater (P < .05) otTOC 
concentrations in pancreas of poults, as compared with all other treatments. The 
total amount of aTOC in the pancreas increased from 1 to 21 d of age, irrespective 
of route and amount of VE supplementation (Table 5.31). However, poults given 
the VHI treatment had greater (P < .002) pancreatic aTOC concentrations at 10 d 
of age than poults fed any concentration of dl-aTACT. And those in the VHW 
treatment had more aTOC (P < .05) stored in pancreas than those in any other 
treatment group. At the end of the experimental period, as observed with other 
tissues, poults receiving the MHD and HHD treatments had greater reserves of 
pancreatic qTOC than poults in any other treatment group. 
The concentration of liver aTOC varied with the age of the poults. Livers of 
1-d-old poults contained 176.6 ^g/g for a total of 322.3 /ig/liver (Figures 5.14 and 
5.15). Liver aTOC concentration decreased markedly to 14 d of age, irrespective 
of dietary dl-aTACT, and continued to decrease to 21 d of age, depending on the 
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TABLE 5.30. Concentration of a-tocopherol in pancreases of poults as 
influenced by vitamin E provided in the diet, In the drinking 
water, or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
LLD 12.28 3.33 1.09 
MLD 12.28 5.92 3.05 
MHD 12.28 7.23 5.50 
HHD 12.28 7.31 7.44 
VHI 12.28 31.04 4.82 
VHW 12.28 37.62 6.14 
SEM^ 3.60 .44 
Probabilities 
Treatment .001 .001 
LLD vs VHI .001 .001 
LLD vs VHW .001 .001 
MLD vs VHI .001 .01 
MLD vs VHW .001 .001 
MHD vs VHI .001 
MHD vs VHW .001 
HHD vs VHI .001 .001 
HHD vs VHW .001 .05 
VHI vs VHW .05 
^Poults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 lU of d-or-tocopheroi, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.31. Total a-tocopherol in pancreases of poults as influenced by 
vitamin E provided in the diet, in the drinking water, 
or injected subcutaneously 
Age 
Treatment^ 1 d 10 d 21 d 
LLD 1.17 2.71 2.10 
MLD 1.17 4.15 6.02 
MHD 1.17 5.19 11.58 
HHD 1.17 5.66 14.31 
VHI 1.17 21.26 9.93 
VHW 1.17 29.91 12.98 
SEM^ 2.95 .98 
Probabilities 
Treatment .001 .001 
LLD vs VHI .001 .001 
LLD vs VHW .001 .001 
MLD vs VHi .001 .01 
MLD vs VHW .001 .001 
MHD vs VHI .001 
MHD vs vyHW .001 
HHD vs VHI .002 .005 
HHD vs VHW .001 
VHI vs VHW .05 .04 
Voults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 lU of d-a-tocopherol, either by 
subcutaneous injection (Day 1)(VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatnnent. 
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Figure 5.14. Changes in liver a-tocopherol concentration of poults with dietary 
concentration of dl-a-tocopheryl acetate (dl-aTACT). Each bar is the 
mean of 4 pens. Changes with dietary dl-aTACT were best described 
by a linear model (P < .001) at 10, 14, and 21 d of age. Liver a 
-tocopherol concentration (y) at dietary dl-aTACT x was y = -1.95 
-t-5.71x (r^ = .95). y=3.30+5.73x (r^ = .94), and y = -3.13+4.96x (r^ = .95) 
at 10, 14, and 21 d of age, respectively 
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Figure 5.15. Changes in liver total a-tocopherol of poults with dietary concentration 
of dl-a-tocopheryl acetate (dl-«TACT). Each bar is the mean of 4 
pens. Changes with dietary (dl-aTACT) were best described by a 
linear model (P < .001) at 10, 14, and 21 d of age. Liver total 
a-tocopherol (y) at dietary dl-oTACT x was y = 12.74+36.65 (r^=.95), 
y=-35.23 + 58.02X {r^=.91), and y=-49.01+69.97x (r^ = .92) at 10. 14. 
and 21 d of age, respectively 
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dietary concentration of dl-aTACT (Figure 5.14). Total liver aTOC decreased 
markedly by 10 d of age, and then, increased slightly for most dietary treatment 
groups between 14 and 21 d of age (Figure 5.15). Starting at 10 d of age, and 
until 21 d of age, dietary dl-aTACT had a marked effect on the aTOC levels stored 
in the livers of the poults. Changes in liver aTOC concentration (y) and total aTOC 
in liver (z) were significant (P < .001) and linear [y=-1.95+5.71x, r^=.95, and z=-
12.74+36.65X, r^ = .95] at 10, [y = -3.30+5.73x, r^=.94, and z =-35.23+ 58.02x, 
r^ = .91] at 14, [y=-3.13-i-4.96x, r2=.95, and z=-49.01+69.97x, r^=.92] and at 21 d 
of age in response to dietary dl-aTACT (x) concentration. Injection of poults with 
50 lU of d-aTOC at 1 d of age increased (P < .01) liver aTOC concentration (Table 
5.32) and total liver oTOC (Table 5.33) at 5 d of age. By Day 10, and until the end 
of the experiment, VHI-treated poults stored more aTOC (P < .07) in their livers 
than poults in the LLD treatment group. However, including 81 (MHD) or 115 
(HHD) lU of dl-aTACT/kg in the diet of poults resulted in greater concentrations (P 
< .001) and total amounts (P < .001) of aTOC in liver at 14 and 21 d of age, 
compared with aTOC levels found in livers of VHI-treated poults. Giving 68 lU of d-
aTOC in the drinking water from Day 3 to Day 10 numerically increased liver aTOC 
concentration (Table 5.32) and total amount (Table 5.33) at Day 5 compared with 
most other groups. By 10 d of age, poults in the VHW treatment had more oTOC 
(P < .001) stored in liver than poults in any other treatment group. But, by 14 d of 
age, and at 21 d of age, aTOC concentrations in livers of VHW-treated poults had 
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TABLE 5.32. Concentration of a-tocopherol in livers of poults as influenced 
by vitamin E provided in the diet, in the drinking water, 
or injected subcutaneously 
Age 
Treatment^ 1 d 5 d 10 d 14 d 21 d 
1/^9/9) 
LLD 176.60 101.32 3.49 2.31 1.77 
MLD 176.60 80.47 8.66 6.09 5.87 
MHD 176.60 82.26 13.00 11.48 10.69 
HHD 176.60 94.46 17.24 13.89 14.19 
VHI 176.60 239.46 19.26 7.19 4.19 
VHW 176.60 179.54 96.30 8.06 3.28 
SEM^ 34.59 5.80 .67 .52 
Probabilities 
Treatment .02 .001 .001 .001 
LLD vs VHI .01 .07 .001 .004 
LLD vs VHW .001 .001 .05 
MLD vs VH! .004 .03 
MLD vs VHW .06 .001 .05 .002 
MHD vs VHI .005 .001 .001 
MHD vs VHW .06 .001 .002 .001 
HHD vs VHI .008 .001 .001 
HHD vs VHW .1 .001 .001 .001 
VHI vs VHW .001 
•^Poults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 lU of d-a-tocopherol, either by 
subcutaneous injection (Day 1){VHI), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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TABLE 5.33. Total a-tocopherol in livers of poults as influenced by vitamin E 
provided in the diet, in the drinking water, or injected subcutaneously 
Age 
Treatment^ 1 d 5 d 10 d 14 d 21 d 
vMQJ 
LLD 322.3 407.3 23.2 22.3 24.5 
MLD 322.3 288.9 53.1 56.5 78.4 
MHD 322.3 326.6 86.7 115.0 170.0 
HHD 322.3 357.7 111.1 134.5 222.8 
VHI 322.3 967.9 129.2 66.5 65.0 
VHW 322.3 654.2 630.3 78.4 49.3 
SEM^ 142.4 40.8 6.5 9.8 
Probabilities 
Treatment .02 .001 .001 .001 
LLD vs VHI .01 .08 .001 .009 
LLD vs VHW .001 .001 .09 
MLD vs VHI .003 
MLD vs VHW .09 .001 .03 .05 
MHD vs VHI .005 .001 .001 
MHD vs VHW .001 .001 .001 
HHD vs VHI .007 .001 .001 
HHD vs VHW .001 .001 .001 
VHI vs VHW .001 
^Poults were fed 12 (LLD), 46 (MLD), 81 (MHD), or 115 (HHD) lU of dl-a-
tocopheryl acetate/kg of diet, or received 50 lU of d-a-tocopiierol, eitlier by 
subcutaneous injection (Day 1)(VH1), or in the drinking water (Days 3 to 10)(VHW). 
^Means of four pens per treatment. 
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decreased considerably. By the end of the experiment, total aTOC of livers of 
poults in the VHW treatment group exceeded (P < .05) that of only the LLD 
treatment group. Poults of the MHD and HHD treatment groups stored greater 
concentrations (Table 5.32) and total amounts (Table 5.33) of aTOC in their livers 
than did poults of any other treatment group. 
Discussion 
Increasing dietary concentration of VE from 12 to 46, 81, or 115 lU/kg of 
diet did not affect BW, Fl, or FE at either measurement period, or for the overall 21-
d trial. The responses from this experiment to dietary VE were consistent with 
those previously reported by Sell etal. (1994) and Applegate (1995), demonstrating 
that supplemental VE (12 lU of VE/kg or more) does not improve posthatching 
performance in young poults. Sell et al. (1994) supplemented turkey diets with 0, 
12, 50, 150, or 300 lU of VE/kg of diet, and reported no effect of dietary VE on 42-
d BW, FE, or liveability of poults. Applegate (1995) did not observe any difference 
in performance of 22-d-old turkeys after supplementing diets with 0 or 150 ID of 
VE/kg of diet. In contrast, Soto-Salanova (1991) and Mallarino (1992) reported an 
improvement in weight gain and FE of 1- to 21-d-old poults when diets were 
supplemented at VE concentrations higher than 12 lU/kg, the NRC (1994) 
recommended concentration for young poults. Mallarino (1992) fed 12 or 800 lU of 
VE/kg of diet to poults of the same age as those used in the present experiment. 
The use of a therapeutic dose of VE (800 lU/kg) may explain the improved 
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performance of the poults observed in Maliarino's experiment. In chickens, Bartov 
and Frigg (1992) reported that increasing concentrations of VE from 12 to 150 
lU/kg in the diet did not affect BW, Fl, or FE of the chicks during a 7 wk-period. 
Similarly, Bartov et al. (1991) found that performance of laying hens did not change 
when the dietary VE increased from 5 to 125 mg/kg of diet. In contrast, after 
feeding sunflower oil-based diets containing 200 mg of VE/kg for different periods 
of time, Lin et al. (1989) reported that VE supplementation increased BW and 
improved FE of chickens from 1 to 7 wk of age, compared with giving the VE only 
during the last 10 d of the experiment. 
In other species, results have also been divergent. Performance of weanling 
pigs was improved (Asghar et al., 1991a) when dietary VE was increased from 10 
to 100, or 200 lU/kg of diet, but it was not affected by VE supplementation (Chung 
et al., 1992) when diets were supplemented with 16, 48, or 96 lU of VE/kg of diet. 
No changes in performance with high dietary supplementation of VE have been 
reported for channel catfish (Gattlin ill et al., 1992), mink (Tyopponen et al., 1984), 
Chinook salmon (Thorarinsson et al., 1994), and trout (Furones et al., 1992). On 
the other hand, dietary VE deficiency impaired performance of shrimp (He and 
Lawrence, 1993), blue tilapia (Roem et al., 1990), and trout (Frigg et al., 1990), but 
did not affect performance of channel catfish (Bai and Gatlin III, 1993), chicks 
(Fuhrmann et al., 1994), rats (Mino et al., 1981), and sheep (Fry etal., 1993). 
Subcutaneous injection of 1-d-old poults with 50 lU of d-orTOC decreased 
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BW and Fl of poults during the first week posthatch, compared with 
supplementation of VE in the diet or in the drinking water. The reduction in BW 
with VE injection observed in the current experiment was 5.5% at 5 d of age, and 
6.5% at 7 d of age, and the decrease in Fl was 9% during the first week after 
hatching. Previously, in Experiment 1, poults subcutaneously injected with the 
equivalent to 12 or 300 lU of VE/kg of diet (9 or 225 lU of dl-oTOC, respectively) at 
Days 1, 7, and 14 had shown an 18% depression in BW and Fl by the end of the 
21-d experimental period. In that experiment, the volume of dl-aTOC injected per 
poult had been .15 mL at Day 1, .25 mL at Day 7, and .50 mL at Day 14. In 
contrast, performance of injected poults in Experiment 2 was not affected by 
injection at any of the ages studied. In Experiment 2, poults had been 
subcutaneously injected once with .05 mL (25 lU) of d-aTOC/poult at Day 1. In 
the current trial, poults were subcutaneously injected with .10 mL (50 lU) of d-
aTOC/poult at Day 1. Differences in sources and volumes of VE injected in the 
three experiments may have been responsible for the differences in performance 
observed in the trials. To the author's knowledge, there is no information available 
about parenteral administration of VE to turkeys at any age, but results reported by 
Judson et al. (1991) for sheep, and by Carrion and Soto-Salanova (1993, ISU, 
Ames, lA 50011, personal communication) for pigs did not show the negative effect 
of VE injection observed in the current experiment. From the three experiments 
reported herein, the response of poults to VE injection seems to be mostly volume-
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related. More research is needed to determine whether volume and/or 
composition of injectable VE can be modified to avoid the adverse effects on poults 
observed in the current study. 
The consumption of 68 IU of d-aTOC per poult in the drinking water 
increased BW at 7 and 10 d of age, and Fl from 1 to 14 d of age. Waibel et al. 
(1994) did not observe any effect of the addition of 60 ID of d-orTOC/kg of drinking 
water on performance of 1- to 26-d-old poults. The disagreement in results may 
be related to the different concentration of VE used. Waibel et al. (1994) used 60 
lU/kg of drinking water, whereas 68 lU/poult, or 166.6 lU/kg of drinking water, 
were used in the current trial. Wills and Rodick (1993) added 71.3 lU of dl-aTACT 
or l-aTOC, or 35.6 ID of l-aTOC/L of drinking water of broiler chicks from 2 to 14 d 
of age. However, these authors reported no effect of the added VE to drinking 
water on performance of the chicks during a 2 wk-trial. 
In the present experiment, the explanation for the lack of effect on 
performance of poults with increasing dietary VE supplementation (12, 46, 81, or 
115 lU/kg), and for the improved performance when the VE was supplemented in 
the drinking water could have been a different efficiency in the mechanism of 
absorption in the gastrointestinal tract for the two sources used, dl-aTACT and d-
qTOC. Because of its strong lipid solubility and extreme hydrophobic nature, dl-
aTACT (used as dietary VE in the current trial) requires micellar solubilization by 
intraluminal bile acids, and hydrolysis of the ester before intestinal absorption 
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(Gallo-Torres, 1970; Sokol et al., 1987). The source of VE used to supplement the 
drinking water of poults during the present experiment was a micellized, water-
dispersible solution of d-aTOC. Thus, neither micellar solubilization nor ester 
hydrolysis were required before d-aTOC could be absorbed. Given the poor 
development of the digestive tract of poults during the first week of life (Sell et al., 
1991), it seems likely that the micellized form of d-orTOC was absorbed more 
easily, resulting in an enhanced utilization of d-aTOC by the poult. This could have 
translated into an improved performance during the first 10 d of life. Thereafter, 
once the digestive system of the poult was fully developed, no further differences in 
performance were detected. 
Vitamin E is the major natural lipid-soluble antioxidant responsible for 
protecting biological membranes against lipid peroxidation (Tappel, 1965). Vitamin 
E increases erythrocyte membrane fluidity, decreasing susceptibility to oxidative 
hemolysis, in two possible ways; by intercalating aTOC molecules between the 
fatty acyl chains in the hydrocarbon region of the membrane bilayer and through 
interactions involving the chroman ring of the aTOC molecule (Berlin et al., 1992). 
In both instances, aTOC would become strongly bound to the phospholipids in the 
fluid region of the membrane, where it would diffuse due to its high diffusion 
coefficient (Aranda et al., 1989). This easy movement across the membrane 
suggests that a small amount of VE would be highly available, and could function 
adequately as an effective antioxidant in vivo. When an animal becomes marginal 
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or deficient in VE, RBC show increased sensitivity to oxidant-induced hemolysis in 
vitro, resulting in an increased oxidative damage to the erythrocyte membrane. As 
a consequence, erythrocyte survival is reduced (Rose and Gyorgy, 1950). In the 
current experiment, 37.9% of RBC of 1-d-old poults were susceptible to in vitro 
hemolysis and this susceptibility decreased, irrespective of treatment, until 5 d of 
age. These results disagree with those observed in Experiment 2, and with those 
reported by Applegate (1995). In Experiment 2, only 9.5% of the RBC of 1-d-old 
poults were susceptible to hemolysis by BHP, and susceptibility increased (45% 
average), irrespective of treatment, until Day 5. Similarly, Applegate (1995) 
reported an increase in RBC hemolysis from 1 to 7 d of age. Reasons for these 
discrepancies are unknown, but they could be attributed to the initial RBC status of 
the poults, and most likely, to the VE status of the hens from which poults of these 
experiments were obtained. 
Starting at Day 10, and until Day 21, erythrocyte susceptibility to hemolysis 
of poults in the current trial was inversely related to dietary VE supplementation. 
Similar responses of RBC hemolysis to supplemental VE were observed in 
Experiment 2, where feeding poults diets containing 80 or 150 lU of dl-aTACT or d-
aTOC/kg of diet reduced RBC hemolysis, compared with the use of 12 ID of 
dietary VE/kg. However, percentage of hemolysis of RBC (100%) of poults fed the 
low VE diet (12 lU of VE/kg of diet) in the current experiment was greater than that 
reported in Experiment 2 (74%), suggesting a lesser response of the erythrocytes 
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to dietary VE supplementation in the present trial. Applegate (1995) fed 1 -d-old 
turkeys diets supplemented with 0 or 150 lU of VE/kg, and obsen/ed 100% 
hemolysis when no supplement of VE was included in the diet. Similarly, Jakobsen 
et al. (1993) found that chicks fed diets without VE were more susceptible to 
hemolysis (94%) than chicks fed increasing concentrations of VE (8 to 50 mg/kg of 
feed) (80%). Fuhrmann et al. (1994) also reported a decreased hemolysis of RBC 
of 2- or 3-wk-old chicks fed diets containing between 22 and 1,400 mg of dl-
aTACT/kg of diet, compared with that of chicks fed no supplemental VE. The 
relatively high susceptibility to hemolysis of RBC of poults fed the low VE diet in the 
present experiment shows that 12 iU of dietary VE/kg was not enough to protect 
RBC membrane from oxidative damage. Moreover, the linear decrease in RBC 
susceptibility to hemolysis as dietary concentrations of VE increased (12, 46, 81, 
and 115 lU/kg) observed at 10, 14, and 21 d of age, showed that additional dietary 
VE was effective in decreasing RBC hemolysis. 
Supplementing 50 IU of d-oTOC to poults by subcutaneous injection (Day 1) 
or in the drinking water (from Day 3 to Day 10) promoted a rapid decrease in the 
susceptibility of poult erythrocytes to hemolysis. Red blood cells of these poults 
were very well protected against hemolysis by BHP until 10 d of age. However, 
this response decreased gradually with age, and RBC of 21-d-old poults that had 
received VE by injection or in the drinking water were as susceptible to hemolysis 
as those of poults fed 12 lU/kg of VE. Stevenson and Jones (1989) observed that 
288 
RBC hemolysis of VE-deficient sheep decreased markedly after the administration 
of a single subcutaneous injection of 300 lU of VE (dl-otTACT), and that low 
hemolytic responses were maintained for at least one week after VE administration. 
No information is available in the literature about the effect of VE supplementation 
in the drinking water on RBC susceptibility to hemolysis of any species. From the 
results obtained in the current trial, it seems that VE administered through this 
route is highly available for young turkeys, resulting in very low in vitro hemolysis 
values at 5 and 10 d of age. 
The beneficial effect of VE supplementation on erythrocyte susceptibility to 
hemolysis has been reported for different species. In chickens, Fuhrmann et al. 
(1994) observed that dietary VE supplementation between 22 and 1400 mg/kg (as 
dl-orTACT) decreased RBC susceptibility to hemolysis, compared with 
supplementation of the diets with 0 to 11 mg of dl-aTACT/kg of diet. A direct 
relationship between VE deficiency and RBC susceptibility to hemolysis has been 
reported in rats (Rose and Gyorgy, 1950; Brownlee ei al., 1977; Lehmann, 1981; 
Mino et al., 1981; Hamada et al., 1982; Eicher et al., 1994). Hamada et al. (1982) 
demonstrated that susceptibility to hemolysis of erythrocytes of VE-deficient goats 
decreased when their diets were supplemented with 150 mg of dl-aTACT/kg of 
feed. These authors also reported a greater fragility of rat erythrocytes, compared 
with that of goats in the conditions studied, the difference most likely being related 
to a different lipid composition of the cell membrane. 
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Plasma aTOC concentration and/or oxidative fragility of the RBC have been 
recognized as the most useful methods to assess the aTOC status of different 
species (Rose and Gyorgy, 1950; Hassan et ai, 1985). However, it is becoming 
more and more important to know the aTOC level in biological membranes, with 
regard to functional impairment in case of deficiency. In this sense, aTOC 
concentration of RBC has been used as an index of physiologically available aTOC 
localized in biomembranes (Mino et al., 1985). In the present experiment, 
concentration of aTOC in RBC of poults averaged .44 iig/mL at 1 d of age, and 
increased for all treatment groups by 5 d of age. This increase was most likely 
due to the utilization of the aTOC from the egg yolk remaining in the abdominal 
cavity at hatch (Sell et al., 1991). In Experiment 2, the decrease observed in RBC 
aTOC from 1 to 5 d of age might be attributed to the high aTOC concentration 
detected in RBC of poults at Day 1 (.83 /ig/mL). Probably, RBC of 1-d-old poults 
had enough aTOC to satisfy their early needs, and aTOC from the egg yolk was 
being utilized by some other metabolically active tissues that needed a supply of 
aTOC. 
Starting at 10 d of age, and until 21 d of age, there was a linear response of 
RBC aTOC to dietary VE supplementation. Increasing dietary VE from 12 to 46, 
81, or 115 lU/kg of diet resulted in an increased incorporation of aTOC in RBC of 
poults, indicating that RBC were not saturated at the supplemental concentration 
used, and that RBC of turkey poults were sensitive to changes in dietary aTOC. A 
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similar response of RBC aTOC of turkeys to increasing dietary concentration of VE 
had been observed in Experiment 2. In Experiment 2, poults were fed diets 
supplemented with 12, 80, or 150 lU of VE/kg of diet, and each increment in 
dietary VE resulted in an increase in RBC aTOC from 5 to 21 d of age. Hassan 
and Hakkarainen (1990) reported similar changes in RBC aTOC of chickens when 
their diets were supplemented with increasing concentrations (5 to 30 mg) of dl-
aTACT/kg of diet. The linear response of RBC aTOC to dietary VE 
supplementation (r=.63) observed in the current trial agrees with the report of 
Hassan and Hakkarainen (1990) with chicks (r=.89), of Lehmann (1981) with rats 
(r=.96), and with results published for cattle (Roquet et a!., 1992; Sconberg et a!., 
1993), guinea pigs (Kelly etal., 1992), rats (Behrens and Madere, 1990), and 
sheep (Fry et al., 1993). Behrens and Madere (1990) found that RBC of rats 
retained least aTOC in VE deficiency, compared with other tissues, but responded 
quickly to VE supplementation. Similarly, Fry et al. (1993) reported that RBC and 
liver v;ere the tissues most susceptible to VE deficiency in sheep, and that they 
responded more quickly to VE supplementation than plasma, muscle, heart, 
adrenal glands, or adipose tissue. Due to the sensitivity exhibited by RBC to VE 
supplementation in different species, some authors (Lehmann, 1981; Lehmann et 
al., 1988) have suggested that RBC aTOC would be a good indicator of VE intake. 
Lehmann (1981) measured oTOC of platelets, RBC, and plasma of rats, and 
reported that any of them would be an accurate indicator of VE intake. In humans, 
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Lehmann et al. (1988) indicated that both platelets and RBC were very responsive 
to changes in dietary VE. 
In the present experiment, subcutaneous injection of d-aTOC at Day 1 was 
very effective in increasing RBC aTOC during the first 10 d after hatching. The 
efficacy of using a single subcutaneous injection in inducing a response in RBC 
aTOC had been observed previously in Experiment 2. In that experiment, 
parenteral administration of 25 lU of d-aTOC at Day 1 (by subcutaneous injection) 
had produced an immediate response in RBC, plasma, and liver aTOC. Injected 
poults had greater aTOC concentrations in RBC that their counterparts fed VE 
during the first 10 d of life. These results agree with those published by Mino et al. 
(1979) with humans and by Ogihara et al. (1985) with rats. Mino et al. (1979) 
administered a single dose of dl-aTACT (600 mg) by intramuscular injection to 
healthy human adults, and measured aTOC in plasma and RBC 3 and 5 d after VE 
administration. These authors observed that RBC aTOC concentration increased 
markedly 3 d after VE injection, and remained high 5 d after intramuscular 
administration of VE. Ogihara et al. (1985) supplemented VE-deficient rats with 10 
mg of VE (dl-aTACT or d-aTOC) orally or by intravenous injection. Irrespective of 
route, there was a marked increase in RBC aTOC 6 h after VE administration, 
especially when the source of VE used was d-aTOC. These authors suggested a 
rapid incorporation of aTOC into the biological membranes, including those of 
RBC, during aTOC circulation in plasma. The faster incorporation of d-aTOC into 
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RBC, compared with dl-aTACT, irrespective of route of administration, was 
probably due to the fact that d-aTOC does not need to be hydrolyzed by tissue 
esterases, allowing a rapid incorporation of the ciTOC to the tissues. 
The use of a micellized form of d-aTOC to supplement the drinking water of 
poults from Day 3 to Day 10 resulted in a marked increase of aTOC in RBC of 
poults during the first 10 d after hatch. The response of RBC aTOC to VE 
supplementation by this route was observed at 5 d of age, indicating that there 
was rapid digestion, absorption, and utilization of the vitamin. As has been 
mentioned early in this discussion, the use of a micellized form of d-aTOC avoids 
the necessity of hydrolysis of the ester form (as it occurs with dl-aTACT), and may 
bypass the need for bile salts, emulsification, and micelle formation (Gallo-Torres, 
1980). Waibei et al. (1994) used the same source of VE to supplement the 
drinking water of 1- to 26-d-old poults. These authors reported increases in aTOC 
of plasma and liver of poults similar to those observed in the current study. 
Plasma aTOC of poults varied with the age of the poults. Contrary to what 
had been observed for RBC aTOC, aTOC concentrations in plasma of poults 
decreased markedly until 10 d of age, irrespective of concentration of dl-aTACT 
supplied in the diet. This decrease in plasma aTOC early in life is similar to 
decreases observed in Experiments 1 and 2, and to those reported for young 
turkeys (Mallarino, 1992; Soto-Salanova et al., 1993; Sell ef al., 1994; Waibei et al., 
1994; Applegate, 1995), chickens (Dudin and Dvinskaya, 1983; Mezes, 1988), and 
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pigs (Chung et al., 1992). Among the factors that might contribute to these 
decreases in plasma aTOC early in life of turkeys are the poor ability of turkeys to 
accumulate aTOC in their tissues (Sklan et al., 1982), a poor absorption of VE 
early in life concurrent with a high oxidation of otTOC to a-tocopheryl quinone in the 
tissues (Dudin and Dvinskaya, 1983), and the poor development of the 
gastrointestinal tract of young turkeys during the first 5 or 6 d posthatch (Sell et al., 
1991). 
a-Tocopherol concentration in plasma of poults fed 12 lU of dl-aTACT/kg of 
diet decreased continuously until 21 d of age, indicating that dietary 
supplementation of VE at the NRC (1994) recommended concentration (12 lU/kg 
of diet) was not capable of maintaining plasma aTOC levels during the first 3 wk of 
life, if circulating levels of aTOC in plasma are the combined result of VE 
absorption from the diet and utilization by the different tissues, the decrease 
observed during this period indicates that the uptake of aTOC by the tissues 
exceeded dietary supply for poults fed 12 lU/kg. In contrast, plasma aTOC of 
poults receiving 46, 81, or 115 lU of dl-aTACT/kg of diet increased from 10 to 21 d 
of age, the increase being directly related to dietary VE supplementation. The 
linear relationship observed in the current experiment between plasma aTOC and 
dietary VE was observed in Experiment 2, when poults were fed diets 
supplemented with 12, 80, or 150 lU of VE/kg of diet. Similar results have been 
published for turkeys (Sell eta!., 1994), chickens (Hassan and Hakkarainen, 1990), 
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and pigs (Chung et a/., 1992). This linear response not only indicated that plasma 
aTOC was sensitive to changes in dietary VE, but also that plasma qTOC had not 
reached saturation at the highest dietary VE concentration used in the current trial 
(115 lU/kg). This supposition is reinforced when we compare plasma aTOC 
concentrations measured in this experiment, and in Experiment 1. Plasma aTOC of 
poults at Day 1 were similar in both experiments (15.22 and 15.02 ng/mL, 
respectively). At Day 21, poults fed 12 lU of VE/kg of diet in the current trial and in 
Experiment 1 had aTOC concentrations in plasma of 1.99 and 1.96 /ig/mL, 
respectively, whereas those of poults fed 115 and 300 lU of dl-oTACT/kg of diet 
was 11.67 and 28.12 Mg/mL, respectively. 
The response of plasma aTOC to dietary VE supplementation varies with the 
different species. Hassan and Hakkarainen (1990) reported a strong positive 
correlation between oTOC concentration in plasma of chickens and dietary VE (0 
to 30 mg dl-aTACT/kg). In contrast, Hidiroglou and Charmley (1990) observed 
that plasma aTOC did not increase linearly with increasing dietary concentration of 
dl-aTACT (0 to 600 mg of dl-aTACT/sheep). These authors stated that in 
ruminants, plasma aTOC was not a reliable indicator of VE intake or status. In the 
current trial, the linear relationship observed between dietary VE intake and plasma 
and RBC aTOC implies that both plasma and RBC aTOC were good indicators of 
VE intake in young turkeys. Moreover, the low concentrations of aTOC measured 
in plasma and RBC of poults fed 12 ID of dl-aTACT/kg of diet strongly suggest the 
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need for higher dietary VE concentrations. a-Tocopherol is carried by plasma and 
distributed widely to most tissues (Astrup, 1979). If availability of oTOC from 
plasma becomes low, especially at times of high metabolic activity (such as the first 
few days after hatch), health of the turkeys might be impaired, resulting in an 
increased susceptibility to lipid peroxidation (Combs and Scott, 1977; Csallany et 
al., 1988; Gattlin III et al., 1992) or a decreased disease resistance due to a 
decreased immune response (Tengerdy and Brown, 1977; Tengerdy, 1992). 
In the current trial, subcutaneous injection of 50 lU of d-aTOC at Day 1 was 
effective in increasing plasma aTOC from 1 to 14 d of age. The maximum 
response to d-aTOC injection was observed at Day 5, but plasma aTOC 
concentration of injected poults remained fairly high until 21 d of age. The rapid 
response observed at Day 5 could be expected and agrees with results in 
Experiment 1 and 2, in which an early dose of injected dl- or d-aTOC markedly 
increased plasma aTOC, which peaked 48 h after injection. Parenteral 
administration of VE has been widely used for a variety of species. Intravenous 
(Ogihara etai, 1985; Hidiroglou, 1986; Hidiroglou and Karpiski, 1987, 1988), 
intramuscular (Mino et ai, 1979; Hidiroglou and Karpinski, 1987; Dierenfeld and 
Citino, 1989; Carrion and Soto-Salanova, 1993, ISU, Ames, lA 50011, personal 
communication), and intraruminal (Hidiroglou, 1986; Hidiroglou and Karpinski, 
1987) administration of VE compounds have been successfully used to induce a 
rapid increase in plasma and tissue aTOC. Isolated cases (Experiment 1; Judson 
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et a/., 1991) of inefficient tissue distribution of VE after subcutaneous Injection of 
VE compounds seem to be more related to an error at the time of injection than to 
the inefficacy of the parenteral administration of the vitamin per se, and must be 
interpreted cautiously. 
Consumption of 68 lU of d-aTOC/poult in the drinking water from Day 3 to 
Day 10 induced a similar response in plasma aTOC to that reported for RBC 
aTOC. Plasma oTOC concentration of WHV-pouits was markedly increased at 5, 
and especially at 10 d of age, compared with that of poults supplemented with the 
greatest concentration of dietary VE. Once the water treatment stopped (Day 10), 
plasma aTOC decreased gradually until 21 d of age. The rapid response of 
plasma aTOC to d-aTOC in the drinking water observed in the present experiment 
agrees with results published by Waibel et al. (1994) with turkeys of the same age. 
Waibel et al. (1994) supplemented 1-d-old poults with 60 IU of d-aTOC/kg of 
drinking water for 26 d. Although the amount of d-aTOC used by these authors 
was lower than that used in the current trial (68 lU/poult, or 168.6 lU/kg of drinking 
water), the fact that they supplemented it for the whole experimental period 
extended the VE effect, resulting in higher plasma aTOC concentrations from 1 to 
26 d of age, compared with dietary supplementation of 17 or 25 lU of VE/kg of 
diet. In an experiment with chickens, Wills and Rodick (1993) compared the 
efficacy of dl-aTACT and l-aTOC in the drinking water to increase plasma aTOC of 
7- and 14-d-old chicks. Chicks receiving either source of VE in the drinking water 
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had higher plasma aTOC concentrations than controls at 7 d of age, but, at Day 
14, concentrations of aTOC in plasma of l-aTOC-supplemented chicks were higher 
than those of dl-aTACT-supplemented chicks. 
Results from the current trial indicate that supplementation of VE as d-aTOC 
in the drinking water or by subcutaneous injection was very effective to increase 
plasma aTOC between 1 and 14 d of age. Given the low plasma aTOC 
concentrations obsen/ed consistently in turkeys during this period (Soto-Salanova, 
1991; Mallarino, 1992; Soto-Salanova etal., 1993; Sell et al., 1994; Waibel et al., 
1994; Applegate, 1995; Soto-Salanova and Sell, 1995), and the increased 
susceptibility to disease observed in animals with marginal concentrations of aTOC 
(Tengerdy and Nockels, 1975, QureshI et al., 1993), further attention should be 
given to determine the adequate dosage and time of administration of VE through 
these two routes. 
a-Tocopherol is transported in blood associated with lipoproteins, and, to 
the author's knowledge, no specific plasma transport proteins for aTOC have been 
described. In the present experiment, plasma aTOC of poults was found in the 
three lipoprotein fractions analyzed, VLDL, LDL, and HDL. Mallarino (1992) 
reported similar results working with turkeys of the same age as those used in the 
current trial. Reports of aTOC being transported by VLDL, LDL, and HDL have 
been published for humans (Behrens and Madere, 1985; Traber and Kayden, 
1989), horses (Petersson et al., 1991), African green monkeys (Carr et al., 1993), 
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and rats (Bjorneboe et al., 1986). 
Plasma aTOC was evenly distributed among the VLDL, LDL, and HDL 
fractions of plasma at Day 1, but thereafter, most aTOC was carried by the LDL 
and HDL lipoprotein fractions. Although the concentration of aTOC in the plasma 
lipoprotein fractions of poults in the current experiment were much higher than 
those reported by Mallarino (1992), the relative changes of aTOC in each 
lipoprotein fraction with age were similar. A shift of aTOC from the VLDL plasma 
fraction towards the LDL and HDL fractions had also been observed in chicks 
(Petersson et al., 1991), horses (Petersson et al., 1991), humans (Traber and 
Kayden, 1989), and rats (Petersson et a!., 1991). 
The concentration of aTOC in VLDL, LDL, and HDL varied with the age of 
the poults. a-Tocopherol concentration in the three lipoprotein fractions decreased 
from 1 to 10 d of age, irrespective of dietary concentration of VE. At 14 and 21 d, 
VLDL, LDL, and HDL aTOC varied according to the concentration of VE in the diet. 
These age-related changes parallelled those reported by Mallarino (1992) for aTOC 
in plasma fractions, and those reported by f^allarino (1992), Sell et al. (1994), and 
Applegate (1995) for aTOC in plasma and livers of turkeys. In humans, the 
published age-related changes in aTOC content among individual lipoprotein 
fractions have been contradictory. Morita et al. (1989) found no age or sex 
differences in qTOC distribution in VLDL, LDL, or HDL. These authors studied 
children ranging from 6 months to 15 years of age. In contrast, Kelly et al. (1990) 
299 
suggested a transient lipoprotein deficiency at birth to explain the low 
concentrations of aTOC measured in plasma and RBC of premature infants. It is 
possible that newly hatched poults undergo a transient lipoprotein deficiency similar 
to that reported in premature infants by Kelly et al. (1990), as suggested by 
Mallarino (1992). However, the substantial concentrations of aTOC carried by the 
VLDL, LDL, and HDL lipoprotein fractions of poults in the present experiment at all 
ages studied do not support this hypothesis. The age-related changes in VLDL, 
LDL, and HDL aTOC observed during this trial seem more related to the rapid 
distribution of oTOC from plasma to all tissues (Astrup, 1979), especially during the 
first weeks of life. 
Increasing dietary concentration of VE from 12 to 115 !U of di-aTACT/kg of 
diet increased aTOC in the three lipoprotein fractions throughout the 21-d trial. 
Mallarino (1992) observed a similar response when feeding 1- to 21-d-old poults 
with 12 or 800 lU of VE/kg of diet. The consistently lower concentrations of aTOC 
in the plasma fractions measured by Mallarino (1992), compared with those 
reported herein, cannot be explained on the basis of differences in age or species 
studied. In both cases, the animals used were 1- to 21-d-old Nicholas Large White 
male turkey poults. One may attribute the differences observed in both 
experiments to a different sensitivity rate in the HPLCs used to measure aTOC in 
plasma fractions in Mallarino's experiment, and in the current trial. 
Supplementation of d-aTOC by subcutaneous injection at Day 1 (50 
300 
lU/poult), or in the drinking water from Day 3 to Day 10 induced changes in the 
aTOC concentration carried by the three lipoprotein fractions similar to those 
observed in plasma and RBC aTOC. a-Tocopherol of injected turkeys peaked in 
the VLDL, LDL, and HDL fractions at 5 d of age, and that of poults receiving the d-
otTOC in the drinking water peaked at 10 d of age. To the author's knowledge, 
there is no information in the literature about the specific transport of parenterally 
administered VE; however, results reported herein suggest a similar mechanism of 
transport to that described for dietary VE (Bjorneboe et a!., 1990; Dutta-Roy et al., 
1994). 
In a few words; once incorporated into chylomicrons, aTOC is secreted into 
the intestinal lymph. The endothelial-bound enzyme lipoprotein lipase hydrolyzes 
the triacylglycerols in chylomicrons, promoting the formation of chylomicron 
remnants. These are taken up by the liver via a specific apolipoprotein E-receptor, 
and then aTOC is secreted from the liver cells associated with VLDL. The VLDL 
are metabolized similarly to chylomicrons by lipoprotein lipase. Some of the aTOC 
associated with chylomicrons and VLDL is transferred to peripheral cells and HDL 
during lipolysis, whereas some ends up in LDL during the metabolism of VLDL. 
This LDL-associated oTOC follows the receptor-mediated uptake of LDL in liver and 
peripheral cells. 
The relative amount of oTOC carried by the three lipoprotein fractions 
determined in the current trial, VLDL, LDL, and HDL varied with age. The HDL 
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plasma fraction carried the highest percentage of otTOC at all ages studied. At Day 
1, 20.7% of aTOC in plasma was carried by VLDL, 35.5% by LDL, and 43.8% by 
HDL. The percentage of aTOC carried by VLDL decreased from 1 to 10 d of age, 
and then remained almost constant until 21 d of age (20.7%, 14.4%, 3.1%, 3.4%, 
and 3.1% at Days 1, 5, 10, 14, and 21, respectively). !n contrast, aTOC 
percentage in LDL increased slightly from 1 to 10 d of age (35.5% at Day 1, 46% at 
Day 10), and then decreased slightly at 14 (44.9%) and 21 (39.7%) d of age. a-
Tocopherol carried by the HDL plasma fraction increased steadily throughout the 
21-d period (43.8%, 48.9%, 50.8%, 51.6%, and 57.2% at 1, 5, 10, 14, and 21 d, 
respectively). Results reported by Mallarino (1992) for young turkeys indicate that 
the LDL and HDL lipoprotein fractions carried most of the aTOC in plasma at all 
ages, as was observed in the current experiment. However, the relative 
percentages of aTOC carried by LDL and HDL differ between these experiments. 
A possible reason for this discrepancy could be a different diet composition of the 
hens from where these poults were obtained. Bartov et al. (1965) demonstrated 
that aTOC concentrations in fresh yolks and in 1-d-old chicks was dependent on 
maternal dietary aTOC levels, as well as on the ability of the individual hen to 
deposit aTOC in the yolks of her eggs. Recently, Piironen et al. (1991) 
demonstrated that there was an effective transfer of aTOC from feeds to eggs. A 
different composition of the diets of the hens, especially in the lipid fraction, would 
result in a different distribution of aTOC within the plasma lipoproteins in those 
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hens, and this difference could be reflected in the lipoprotein aTOC distribution of 
the newly hatched turkey. 
Five tissues were sampled at different ages during the current trial, adrenal 
glands, bursa of Fabricius, liver, lung, and pancreas. Neither weight nor relative 
weight of the adrenal glands, bursa, lung or liver were affected by VE 
supplementation during the 21-d period. Pancreas weight and relative pancreas 
weight (expressed as a percentage of BW) were slightly affected by supplemental 
VE at 10 d of age, but the effect seemed to have been transitory, since no 
differences could be detected by 21 d of age. In young turkeys, reports indicating 
an effect of VE supplementation on tissue weight have been inconclusive. Soto-
Salanova (1991) did not observed any change in the size of livers of 1- to 21-d-
poults after supplementation of 12 or 100 lU of VE to the diet. In another 
experiment, Soto-Salanova (1991) fed 1- to 21-d-old turkeys diets containing 12 or 
100 lU of VE/kg, and 2,000, 5,000, or 8,000 lU of vitamin A/kg, and observed a 
decrease in relative liver weight of poults fed 100 lU of VE/kg, compared with that 
of poults receiving 12 lU of VE/kg. The increased BW of poults fed 100 lU of 
VE/kg of diet reported in the cited experiment may partly explain the differences 
observed in relative liver weight. Mallarino (1992) reported heavier liver weights of 
21-d-old poults that had been fed 800 lU of VE/kg of diet, compared with those of 
poults fed 12 lU of VE/kg. In contrast, Applegate (1995), feeding 1- to 22-d-old 
poults diets containing 0 or 150 lU of VE/kg of diet did not detect any changes in 
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weight or relative weight of liver or cerebellum of poults at any of the periods 
studied. The results of Applegate (1995) agree with data collected recently for 
chickens. Jakobsen et al. (1993) fed broiler chickens either a mixture of natural 
tocopherols, or dl-oTACT, at concentrations ranging from 0 to 50 mg/kg of feed. 
These authors reported no changes in weight or relative weight of liver, heart, 
kidneys, spleen, testicles or cerebellum with source or concentration of dietary VE. 
In fact, most instances of changing tissue weights related to VE nutrition occurred 
when massive amounts of VE were included in the diet (McCuaig and Motzok, 
1970; Nockels et al., 1976). 
Adrenal glands of 1-d-old poults had 14.4 ^ig of oTOC/g, for a total of .12 
/ig/gland. By 10 d of age, the concentration of aTOC in adrenal glands of turkeys 
had increased 30-fold, irrespective of VE supplementation, resulting in a 125-fold 
increase in total aTOC in these glands at this age. By 21 d of age, aTOC 
concentration in adrenal glands had decreased, although aTOC concentrations 
remained high compared with those found in newly hatched poults. Large 
concentrations of oTOC stored in the adrenal gland have been reported in cattle 
(Hidiroglou et al., 1988), dogs (Pillai et al., 1993), rats (Feingold al., 1993), and 
sheep (Hidiroglou, 1986). It has been suggested that the large amounts of aTOC 
found in the adrenal gland protect that tissue during steroid hormone synthesis, but 
little is known about the functional significance or the mechanisms responsible for 
the high adrenal concentrations of aTOC. Recently, Feingold et al. (1993) reported 
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that estrogens and androgens participate in the regulation of aTOC concentration 
in adrenal glands and liver, and that they are responsible for the different 
concentrations of aTOC detected in males and females. The mechanism of action 
suggested by these authors is as follows: androgens and estrogens influence the 
secretion of adrenocorticotropic hormone (ACTH), the major regulator of 
adrenocortical function. Estrogens increase ACTH secretion by the anterior 
pituitary gland, whereas androgens decrease ACTH output. It might be possible 
that gonadal hormone effects on adrenal aTOC are mediated by changes in ACTH 
secretion. It is also possible that adrenal aTOC content is controlled by ACTH, the 
same hormonal factor regulating metabolic activity, and consequently, free radical 
production in the gland. In that way, antioxidant supply would be linked to need. 
This theory is further supported by the results of Donaldson (1995) with newly 
hatched turkeys. Donaldson (1995) linked the effects of hatchery-imposed 
stressors, such as chilling, crowding, feed deprivation, water deprivation, handling, 
injections, surgery, etc, to adrenal-mediated responses. Such responses, i.e., 
increased mobilization of glycogen reserves, elevated blood sugar, increased 
glycolysis, occur in newly hatched turkeys (Donaldson, 1995), and may explain the 
need for high aTOC concentrations in adrenal gland of the turkeys at 10 d of age. 
The concentration of qTOC in adrenal glands changed linearly with dietary 
VE supplementation at 21 d of age. Similar observations have been reported for 
VE depleted and repleted rats (Behrens and Madere, 1990), for VE-deficient sheep 
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(Fry et al., 1993), and for sheep fed graded dietary concentrations of dl-aTACT 
(Hidiroglou and Charmley, 1990). Behrens and Madere (1990) stated that the high 
rate of depletion and repletion of aTOC in adrenal glands of rats could be 
attributed to a high utilization of aTOC in situ, in metabolic roles that have not been 
elucidated yet. Gailo-Torres etal. (1971) gave oral doses of dl-a-tocopheryl 
nicotinate and dl-aTACT to rats, and observed a continuous uptake of qTOC by 
the adrenal glands, even 48 h after administration of the vitamin. 
In the current trial, adrenal glands of VE-injected poults, and of poults 
receiving d-aTOC in the drinking water accumulated similar amounts of aTOC at 10 
d of age as did those of VE-fed poults. By 21 d of age, d-aTOC-supplemented 
poults had more aTOC in their adrenal glands than those fed 12 lU of dl-
aTACT/kg. Single intramuscular injection of 500, 1,500, and 2,500 lU of VE (Batra 
and Hidiroglou, 1994) increased aTOC in adrenal glands of pigs 3 d post-injection, 
and oTOC levels were still relatively high 7 d after injection. Hidiroglou and 
Karpinski (1991) found that kinetics of intramuscular injection of VE were 
characterized by rapid absorption and elimination phases. When administered 
intravenously, adrenal glands accumulated more aTOC than any other tissue 
(Karpinski and Hidiroglou, 1990). Oral (Hidiroglou, 1987) and intraperitoneal 
(Hidiroglou et al., 1990) supplementation of VE increased aTOC in adrenal gland of 
sheep 48 h after administration, and this gland was the tissue with the greatest 
accumulation of aTOC at all times. 
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The bursa of Fabricius is considered as a central lymphoid organ for B-cell 
lymphopoiesis in the chicken (Jeurissen et al., 1994). Its main function is to serve 
as the site for maturation of the B-cell lineage, including the generation of antibody 
diversity (Ratcliffe, 1989). The bursa of Fabricius is located dorsally to the cloaca 
as a hollow, round, or oval sac connected to the cloaca by a short duct, and acts 
as a secondary lymphoid organ, with antigen-specific plasma cells developing after 
immunization. 
In the present trial, the bursa of Fabricius of poults was responsive to VE 
supplementation at 10 and 21 d of age. Concentration of aTOC, and total aTOC in 
the bursa of 10- and 21-d-old poults increased linearly with dietary VE 
supplementation. The bursa was also responsive to parenteral administration of 
VE. Giving VE by subcutaneous injection (50 lU of d-aTOC/poult at Day 1), or in 
the drinking water (68 iU of d-aTOC/poult from Day 3 to Day 10) markedly 
increased aTOC in the bursa at Day 10, and aTOC levels remained fairly high until 
21 d of age. To the author's knowledge, there are no reports in the literature 
indicating changes in the aTOC content of the bursa of Fabricius with VE 
supplementation. However, Likoff et al. (1981) and Lawrence et al. (1985) reported 
that supplementation with 300 IU of VE/kg of diet was very effective in reducing 
prostaglandin levels in the bursa and spleen of chicks during the course of an E. 
CO// infection. Supposedly, VE exerts immunoenhancing effects by altering 
prostaglandin levels in the immune organs, thereby, facilitating greater humoral 
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immunity and phagocytosis. Likoff et al. (1981) also found that VE acted 
synergistically with aspirin, a known inhibitor of prostaglandin synthesis, to 
decrease mortality due to £. coli infection and depress endogenous prostaglandin 
levels in the bursa. Previously, reports by Heinzerling et al. (1974), Tengerdy and 
Nockels (1975), and Tengerdy and Brown (1977) had demonstrated that 
supplemental dietary VE effectively protected chickens from bacterial infection, an 
action associated with increased antibody titers and phagocytosis. If the protective 
effect of VE is connected with its antioxidant inhibitory effect on prostaglandin 
biosynthesis and enhancement of immunity, one can then speculate that the 
increased aTOC content of key tissues would be important for poults that may 
receive challenges to the immune system during early posthatch development. 
As observed with the bursa of Fabricius, aTOC content of lungs of poults in 
the present experiment varied with VE supplementation. Lung aTOC concentration 
of poults fed 12 lU of VE/kg of diet decreased from 1 to 21 d of age, but 
concentration of aTOC in lungs of poults fed 46, 81, or 115 lU of dl-oTACT/kg of 
diet increased with age and increased linearly with dietary VE concentration. 
Generally, total aTOC in lung increased for poults in all treatment groups from 1 to 
21 d of age, indicating that there was a continuous uptake of aTOC by this tissue. 
Increases in lung aTOC with dietary VE supplementation have been described for 
cattle (Arnold etal., 1993), chicks (Sheehy et al., 1991), guinea pigs (Kelly et al., 
1992), monkeys (f\/lachlin and Gabriel, 1982), pigs (Asghar ef a!., 1991a; Chung ef 
308 
a/., 1992), rats (Machlin and Gabriel, 1982), and sheep (Hidiroglou and Charmley, 
1990). Subcutaneous injection of d-oTOC at Day 1 and adding d-aTOC in the 
drinking water increased the concentration of aTOC and the total qTOC in lungs of 
poults at 10 d of age. This response could be expected, since parenteral 
adnninistration of VE had been reported to increase aTOC in lungs of cattle 
(Hidiroglou etaL, 1990), pigs (Batra and Hidiroglou, 1994), rats (Gallo-Torres and 
Miller, 1971), and sheep (Hidiroglou, 1986; Karpinski and Hidiroglou, 1990; 
Hidiroglou and Charmley, 1991; Hidiroglou and Karpinski, 1991). In most reports, 
there was a high degree of accumulation of aTOC by the lung, irrespective of route 
or concentration of supplemental VE. a-Tocopherol is an important antioxidant, 
and might be critical in protecting the lung against oxygen-mediated peroxidation of 
unsaturated cellular lipids, as suggested by Kornsburst and Mavis (1980). A 
reduction in the aTOC content of the pulmonary system would increase the 
susceptibility of the lungs to metabolites that generate intermediates capable of 
peroxidizing membrane lipids. However, the mechanism of uptake and retention of 
aTOC by this tissue is still unknown, and biochemical basis for the high content of 
aTOC in lungs remains to be determined yet. 
Pancreas aTOC concentration of poults in the present experiment decreased 
markedly until 10 d of age, irrespective of dietary VE supplementation, and then, 
remained fairly constant until 21 d of age. Similar changes were observed in 
pancreas aTOC after feeding sheep graded concentrations of dl-aTACT (0, 200, 
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400, and 600 mg/sheep) (Hidiroglou and Charmley, 1990). In contrast, total aTOC 
in pancreas of poults increased from 1 to 21 d of age for most dietary treatments. 
Despite the decrease in pancreas aTOC concentration with age, increasing dietary 
VE from 12 to 46, 81, or 115 lU/kg increased pancreas aTOC at all ages studied. 
Similarly, poults that had been injected with 50 lU of d-aTOC/poults at Day 1, and 
those that received 68 lU of d-aTOC/poult in the drinking water (from Day 3 to Day 
10) had high amounts of aTOC in their pancreases at Day 10, and levels remained 
high until 21 d of age. Pancreas of cattle (Hidiroglou et al., 1990) and sheep 
(Hidiroglou, 1986, 1987; Karpinski and Hidiroglou, 1990; Hidiroglou and Karpinski, 
1991) responded slowly to parenteral administration of VE, suggesting either 
saturation of the tissue, or a slow uptake of the VE by the pancreas. Similar 
results were reported by Batra and Hidiroglou (1994) after intramuscular injection of 
VE to pigs. Pancreases of turkeys are developing rapidly shortly after hatch, with 
changes in the activities of amylase, lipase, and trypsin enzymes occuring during 
the first 4 or 5 d of age (Sell ei al., 1991). This high metabolic activity early in life 
would partly explain the low aTOC concentrations detected in pancreases of poults 
at 10 d of age. 
Concentration of aTOC in liver of 1-d-old poults in the present experiment 
averaged 176.6 ng/g, or 322.3 iig when expressed as total aTOC stored in the 
liver. Liver aTOC concentration decreased markedly until 14 d of age, irrespective 
of dietary concentration of dl-aTACT, and continued to decrease to different 
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degrees until 21 d of age. Total otTOC in liver increased for nnost dietary 
treatments at 5 d posthatch, decreased markedly to 10 d of age, and then, 
increased slightly for most dietary treatment groups between 14 and 21 d of age. 
The results of this study indicate that the high aTOC concentration of liver and yolk 
sac (49.7 ng/g) of 1-d-old poults reflects an efficient transfer of aTOC from the 
feed to the egg yolk (Piironen et a!., 1991). Noble and Cocchi (1990) reported a 
high lipid accumulation in the liver of the chick just before hatching, concurrent with 
a high accumulation of aTOC. The increase in total liver aTOC of 5-d-old poults 
above the amount found in livers of 1-d-old poults may be attributed mainly to 
absorption of aTOC from the yolk sac, rather than to utilization of the aTOC 
present in the diet. Similar results were presented by Bartov et al. (1965) for 
chicks, and by Soto-Salanova (1991) and Mallarino (1992) for turkeys, and 
corroborate the idea that the yolk acts as a nutrient store (Sell et al., 1991; Noble 
et al., 1993) during the first days after hatching. 
Age-related changes in liver aTOC also were observed in Experiments 1 and 
2, and in previous research with turkeys (Soto-Salanova et a!., 1993; Sell et al., 
1994; Applegate, 1995; Soto-Salanova and Sell, 1995) and chickens (Bartov et a/., 
1965; Sklan et a!., 1982; Mezes, 1988). The reasons for this decrease of liver 
aTOC with age are not perfectly understood. On one hand, the liver has been 
proposed as an organ with a large capacity for short-term storage of aTOC (Bieri, 
1972; Jensen et al., 1990; Kelly et al., 1992; Arnold et al., 1993). This would 
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suggest that, in case of any need for the antioxidant properties of aTOC or of its 
ability to stabilize biological membranes, aTOC is going to be mobilized from the 
liver, and be delivered to the specific tissue where needed. This has been 
demonstrated in cases of VE deficiency (Bieri, 1972; Machlin and Gabriel, 1982; 
Behrens and Madere, 1990; Jensen etal., 1990; Fry etal., 1993). Turkey poults, 
as most newborn animals, go through a series of transitional changes early in life, 
trying to adjust to a new metabolic situation. This would suggest a great need for 
aTOC during the first 2 or 3 wk of life. This hypothesis is supported by the 
decrease of liver aTOC and the high uptake of aTOC occurring in adrenal glands, 
bursa, lung and pancreas during the first 10 d of age. Also, turkeys are known for 
their relatively poor ability to accumulate aTOC in their tissues (Sklan et al., 1982). 
During the first days after hatching, there is a poor absorption of aTOC and an 
increased conversion of aTOC to a-tocopheryl quinone and glucuronides (Dudin 
and Dvinskaya, 1983), which would also help explain the low aTOC content stored 
in liver of turkeys during the first 10 to 14 d after hatch. 
Increasing dietary concentrations of dl-aTACT from 12 to 46, 81, or 115 
lU/kg of diet increased aTOC in liver from 10 to 21 d of age. Similar increases 
have been reported for turkeys (Soto-Salanova, 1991; Mallarino, 1992; Csallany et 
al., 1988; Sell etal., 1994; Applegate, 1995), channel catfish (Bai and Gattlin III, 
1993), chickens (Sheehy et al., 1991), mink (Tyopponen etal., 1984), pigs (Asghar 
et al., 1991a; Chung ef al., 1992), chinook salmon (Thorarinsson et al., 1994), 
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sheep (Hidiroglou and Charmley, 1990), and trout (Frigg e^ a/., 1990; Furones et 
a!., 1992). In dogs, Pillai et al. (1993) found that liver was not very responsive to 
dietary VE. It is possible that this latter lack of response is species-related. 
The linear response of liver aTOC to increasing dietary VE from 10 to 21 d 
of age indicates, as was observed with plasma and RBC aTOC. that liver had not 
saturated its storage capacity by 21 d posthatch. 
Parenteral administration of d-aTOC to poults in the current experiment 
induced a marked increase in liver aTOC during the first week of life. Similar 
results were observed in Experiments 1 and 2. As expected, liver of injected poults 
of the current trial accumulated more aTOC at Day 5 that did those of poults of 
Experiment 2. The dose of injection had been increased from 25 lU in Experiment 
2 to 50 ID in the current experiment. No measurements of liver aTOC were done 
between 1 and 5 d of age, but results from the previous trials suggest that aTOC 
concentration peaked in liver of injected poults between 0 and 48 h after 
administration, and that the aTOC found in liver at 5 d of age was in the depletion 
phase. This rapid and efficient uptake of aTOC by the liver supports the 
hypothesis that liver is a target for VE storage, transport, and metabolism. The 
liver has mechanisms for the regulation of aTOC incorporation into lipoproteins, its 
storage and its excretion (Bjorneboe et al., 1990; Dutta-Roy et al., 1994). Murphy 
and Davis (1981) suggested a hepatic cystolic aTOC-binding protein, that recently 
has been shown to exist (Dutta-Roy et al., 1994). Intramuscular injection of VE into 
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pigs (Batra and Hidiroglou, 1994) and sheep (Hidiroglou and Karpinski, 1991), 
intravenous administration of VE to rats (Gallo-Torres and Miller, 1971) and sheep 
(Hidiroglou, 1986), and intraperitoneal injection of VE to sheep (Hidiroglou et a!., 
1990) produced responses in liver of the species studied similar to those reported 
herein. 
Supplementation of 68 IU of d-aTOC/poult in the drinking water from 3 to 10 
d of age increased aTOC in liver of poults at 5 and 10 d of age. Once the 
treatment stopped (Day 10), liver aTOC of poults decreased gradually until 21 d of 
age, although aTOC values did not decrease to concentrations as low as oTOC 
values in livers of poults fed 12 ID of VE/kg of diet. An increase in liver aTOC also 
was reported by Waibel et al. (1994), who supplemented VE in the drinking water 
of young turkeys (1 to 26 d of age) with the same source of VE as used in the 
current trial. Although VE supplementation in the water lasted until 10 d of age in 
the present experiment, the highest liver aTOC concentrations of these poults were 
measured at 5 d of age. This finding further supports the hypothesis that liver is a 
supply organ for the rest of the body, since all other tissues studied in the current 
trial accumulated more aTOC at 10 d than at 5 d of age when VE was being 
supplemented in the drinking water. 
The results of this study concerning the effects of dietary VE 
supplementation on RBC hemolysis and oTOC concentration of key tissues 
indicates that concentrations of VE between 81 and 115 lU/kg of diet are needed 
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to maintain a healtiiy VE status of poults during the first 2 or 3 wk of life. The 
results also show that subcutaneous injection of VE at Day 1, or supplementing a 
micellized form of VE in the drinking water would be appropriate for short-term 
improvements in aTOC status of hatching poults. 
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CHAPTER 6. GENERAL SUMMARY 
Research conducted during the last few years in our laboratory and 
elsewhere has demonstrated that aTOC stores of poults decline drastically during 
the first few weeks of life. This decline occurs despite dietary manipulations to 
increase digestion and/or absorption of supplemental VE. For example, the 
inclusion of a water-soluble VE, a bile salt, or an antioxidant in the diet (Soto-
Salanova et al., 1993) did not affect performance or aTOC status of poults as 
measured by liver and plasma aTOC from 1 to 21 d of age. Similarly, using an 
easily digested fat source, coconut oil, did not affect aTOC status of poults (Soto-
Salanova and Sell, 1995). Increasing dietary VE from 12 to 100 (Soto-Salanova et 
al., 1991), 150 (Sell et al., 1994; Applegate, 1995), 300 (Sell et al., 1994), or 800 
(Mallarino, 1992) lU/kg of diet alleviated the depletion in plasma and liver aTOC 
only to a limited extent. Also, it was observed that increasing dietary VA 
concentration adversely affected the storage of VE in the body of turkey poults 
during the first 3 wk of life (Soto-Salanova, 1991). 
These observations, together with those published by Sklan et al. (1982), 
indicating a relatively poor ability of turkeys to accumulate aTOC in their tissues, 
showed the need of further evaluating effective ways of improving the aTOC status 
of poults early after hatch and the need to reassess the VE requirement of poults. 
Initially, the influence of increasing dietary concentrations of dl-aTACT on 
poults was determined. Growth rate and FE of poults were not affected by dietary 
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concentration of dl-oTACT in any of tlie experiments. All concentrations of di-
qTACT used in the current research, 12, 46, 80, 81, 115, 150, and 300 lU/kg of 
diet, supported performance adequately, as measured by BW, Fl, and FE. This 
research also showed that the natural alcohol form of VE (d-aTOC) was equivalent 
to, but not better than dl-oTACT for supporting performance of the poults to 21 d 
of age, and that feeding a relatively high concentration of VA (15,000 lU/kg) did 
not change responses to dietary dl-aTACT. 
Subcutaneous injection of dl-aTOC negatively affected BW, Fi, and FE of 
poults in Experiment 1. The injection of 25 lU of d-aTOC/poult at Day 1 in 
Experiment 2 did not have any effect on performance, whereas injection of 50 ID of 
d-aTOC/poults at Day 1 in Experiment 3 decreased BW and Fl of the poults until 7 
d of age. From the results presented herein, it seems that the effects of parenteral 
administration of VE to young turkeys are source- and volume-related. 
The addition of d-aTOC in the drinking water of the poults from Day 3 to 
Day 10 resulted in a significant increase in BW at 7 and 10 d of age (Experiment 
3), and in Fl from 1 to 14 d of age. Poults receiving the water treatment were the 
heaviest, and consumed the most food at all ages studied. 
Weight of the tissues studied were not consistently affected by source, 
concentration, or rouia of VE administration. 
increasing dietary concentration of dl-aTACT increased aTOC in ADT, 
adrenal glands, bursa of Fabricius, SI, leg muscle, liver, lung, pancreas, plasma. 
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plasma lipoprotein fractions (VLDL, LDL, and HDL), RBC, and uropygial gland. In 
Experiment 1, liver and uropygial gland had high aTOC stores at Day 1, and these 
stores decreased gradually with age. In Experiment 1, plasma and liver aTOC 
were poorly correlated with ADT otTOC at all ages, but were highly correlated with 
breast muscle, SI, leg muscle, liver and uropygial gland aTOC after 7 d of age. In 
Experiment 3, the increases of tissue aTOC (adrenal glands, bursa of Fabricius, 
liver, lung, plasma, pancreas, and RBC) with increments of dietary dl-aTACT were 
linear, starting at 10 d of age. Adrenal glands accumulated the greatest 
concentrations of oTOC as age increased. 
Subcutaneous injection of dl-aTOC or d-aTOC (any concentration) at Day 1 
markedly increased aTOC concentration in all tissues studied during the first week 
after injection, but this effect decreased gradually with time. Supplementation of 
the drinking water with 50 lU of d-aTOC/poult from Day 3 to Day 10 temporarily 
increased tissue (adrenal glands, bursa of Fabricius, liver, lung, pancreas, plasma, 
and RBC) aTOC, with this effect slowly disappearing after the treatment stopped. 
Susceptibility of RBC to hemolysis was decreased by increasing dietary 
concentration (from 12 to 80, or 150 lU/kg ) of dl-aTACT or d-aTOC in Experiment 
2, or by increasing dietary dl-oTACT from 12 to 46, 81, or 115 lU/kg in Experiment 
3 at all ages. At 21 d of age, only a low percentage of the RBC of the high VE-fed 
poults (150 or 115 lU/kg in Experiments 2 or 3, respectively) were susceptible to 
hemolysis by BHP. 
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Injection of 25 or 50 lU of d-aTOC/poults at Day 1 decreased susceptibility 
of poult RBC to hemolysis, especially during the first week of life. In Experiment 2, 
injected poults had low hemolysis values at Day 21, whereas in Experiment 3, the 
beneficial effect of the injection on RBC hemolysis disappeared gradually after 7 
d of age. Giving d-aTOC in the drinking water from Day 3 to Day 10 also 
decreased RBC susceptibility to hemolysis, but the effect decreased gradually 
between 10 and 21 d of age. 
Liver lipid peroxidation values, as measured by the TEARS assay, were 
affected by the dietary treatments only at 7 d of age. At that time, increasing 
dietary concentration of dl-aTACT or d-aTOC from 12 to 80, or 150 lU/kg 
decreased liver TBARS. However, this effect was transitory and disappeared 
thereafter. There was no effect of the source of dietary VE (dl-aTACT or d-aTOC) 
on liver TBARS. The effect of injecting 25 lU of d-aTOC/poult at Day 1 on liver 
TBARS was inconsistent at 7 and 14 d of age, and had disappeared by 21 d of 
age. 
In Experiment 2, none of the treatments had any effect on plasma CK, 
plasma TG, or the plasma aTOC/TG ratio. 
Results of the present research indicate that increasing dietary concentration 
of VE is an effective method to increase aTOC concentration in most tissues. The 
linear response of tissue oTOC to increasing concentrations of dietary VE indicates 
that the capacity of the tissues to store aTOC was not saturated at dietary 
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concentrations of 115 ID of VE/kg of diet. Moreover, increasing dietary 
concentration of dl-ciTACT decreased susceptibility of RBC to hemolysis at all ages. 
Results obtained in the current research also indicate that relatively high 
concentrations of dietary VA (15,000 lU/kg of diet) can be added to the diet of 
young turkeys without any detrimental effect on performance of the poults. 
Injection of dl-aTOC increased TOC stores of the poults during the first week 
of life, but had little effect thereafter. Injection of d-aTOC at Day 1 increased aTOC 
stores and decreased RBC susceptibility to hemolysis, especially during the first 
week after injection. However, the inconsistent effect of VE injection on 
performance of the poults suggest the need for more research to establish the 
dose needed to improve the health status of poults just after hatch. When d-aTOC 
was added in the drinking water, there was a temporary increase of aTOC in 
tissues, and a decreased susceptibility of RBC to hemolysis. 
Liver and plasma aTOC can be considered as good indicators of aTOC 
status of young turkeys after 7 d posthatch. However, RBC hemolysis was 
relatively more sensitive to changes in VE supplementation. 
Asuming that integrity of RBC membranes is an accurate indicator of tissue 
health in young turkeys, the results of the current research suggest that 
concentrations of 81 to 115 lU of dietary VE are needed by poults, as compared 
with the 12 lU/kg recommended by NRC (1994). 
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APPENDIX. LABORATORY PROCEDURES 
Vitamin E Extraction from Diets and Preparation for Analysis 
Experiments 1 and 2 
[procedure modified from Cort et al., 1983] 
Procedure 
1) Accurately weigh 5.0 g of freshly ground diet into a Whatman^ No. 1 filter 
paper and place in a cellulose extraction thimble. 
2) Place thimble in Soxhiet extraction unit. 
3) Place 75 mL of acetone and 4 to 6 boiling chips into a flat bottomed 
Erienmeyer flask. 
4) Cover Erienmeyer flasks with aluminum foil. 
Note: Light will reduce vitamin E activity. 
5) Turn on condenser water. 
6) Begin extraction heat so the extraction cycle repeats every 5 min. 
7) Extract for 3 h. 
8) Transfer Erienmeyer flask to a rotary evaporator with a 40 C water bath and 
evaporate acetone to dryness. 
9) Dissolve acetone extract in 3 aliquots of hexane totalling 10 mL and place in a 
10 mL volumetric flask. 
10) Bring flask to volume with hexane. 
11) Cap flask and vortex. 
12) Store flask in darkness at room temperature for 24 h. 
13) Filter the sample by using a 10 mL syringe equipped with a .8 nm filter into a 
^Whatman International Ltd., Maidstone, England 
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16 X 125 mm screw-top culture tube. 
14) Transfer sample to amber HPLC vial and cap for HPLC analysis. 
Reagents 
Hexane (HPLC grade) 
Acetone (certified A.C.S.) 
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Vitamin E Extraction from Diets and Preparation for Analysis 
Experiment 3 
[procedure modified from McGeachin and Baiiey, 1995] 
Procedure 
1) Accurately weigh 2 g of finely ground corn and place it in a 100 mL volumetric 
flask. 
2) Add 30 mL of extraction solvent to each flask. 
3) Flush the flask with nitrogen gas, seal it, then swirl 30 s, and store it in the 
dark at 20 C for 24 h with periodic swirling. 
Saponification 
4) Add 2 mL of saturated potassium hydroxide in methanol solution to each 
flask. 
5) Flush with nitrogen, seal, swirl, and store again for 24 h with periodic swirling. 
Extraction 
6) Add 30 mL of hexane to each flask. 
7) Flush with nitrogen and swirl for 30 s. 
8) Fill the flask to about 80% total volume (80 mL) with 10% aqueous sodium 
sulfate solution. 
9) Flush with nitrogen, vortex for 30 s, top off to 100 mL with sodium sulfate 
solution, and put in the dark for 1 h to settle. 
Preparation for Analysis 
10) Transfer 10 mL of the upper phase to an amber screw capped vial. 
11) Evaporate the hexane at 37 C under nitrogen. 
12) Flush with nitrogen. 
13) Store at -10 C until analyzed by HPLC. 
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Reagents 
Extraction Solvent 
Hexane:Acetone:Methanol (10:7:6) plus .05% BHT (Butylated Hydroxytoluene). 
Saturated Potassium Hydroxide in Methanol 
Sodium Sulfate Solution 
10 g Na2S04 
Hexane (HPLC grade) 
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Plasma Lipoprotein Fractionation 
[procedure modified from Havel et a!., 1955] 
Procedure 
1) Add 3 mL of plasma to ultracentrifuge tubes. 
2) Layer .9 mL of Solution A. 
3) Spin 18 h at 39,000 x g at 18 C. 
4) Aspirate carefully with a Pasteur pipette 1.5 mL from the top layer of the 
content of each tube. The portion removed contains the VLDL fraction. 
5) Add 1.2 mL of Solution C and stir. 
6) Layer .3 mL of Solution D. 
7) Spin 22 h at 39,000 x g at 18 C. 
8) Aspirate carefully with a Pasteur pipette 2.1 mL from the top layer of the 
content of each tube. The portion removed contains the LDL fraction. 
9) Add 1.8 mL of Solution B and stir. 
10) Layer .3 mL of Solution E. 
11) Spin 22 h at 39,000 x g at 18 C. 
12) Aspirate carefully with a Pasteur pipette 1.8 mL from the top layer of the 
content of each tube. The portion removed contains the HDL fraction. 
13) The 2.1 mL portion remaining in the bottom of each tube contains the VHDL. 
14) Store VLDL, LDL, and HDL fractions at -20 C for future analysis. 
Reagents 
Sodium Chloride 
Dry overnight, before preparing the salt solutions 
Potassium Bromide 
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Dry overnight, before preparing the salt solutions 
Solution A 
8.775 g NaCI 
in 1 L dd HgO 
(density = 1.CX)5) 
Solution B 
153 g NaCI 
354 g KBr 
in 1 L dd HjO 
(density = 1.346) 
Solution C 
500 mL Solution A 
508.9 mL Solution B 
(density = 1.177) 
Solution D 
250 mL Solution A 
51.2 mL Solution 8 
(density = 1.063) 
Solution E 
165.9 mL Solution A 
250 mL Solution B 
(density = 1.210) 
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Tocopherol Extraction from Red Blood Cells 
[procedure modified from Hassan and Hakkarainen, 1990] 
Procedure 
1) Place 2 mL of heparinized blood in a 13 x 100 mm glass culture tube. 
2) Centrifuge at 1,500 x gf for 15 min. 
3) Aspirate the plasma with a Pasteur pipette and discard. 
5) Wash the RBC with 3 mL of saline solution. 
6) Vortex and centrifuge at 1,500 x g for 15 min. 
7) Aspirate the saline supernate with a Pasteur pipette and discard. 
8) Repeat steps 5 through 7, twice. 
9) Resuspend the RBC in isotonic buffer to achieve the original 2 mL volume. 
10) Transfer the RBC in isotonic buffer to a 12 x 75 mm disposable plastic tubes, 
cap, and store at -20 C for future analysis. 
Reagents 
Saline Solution 
8.9 g NaCI in 1 L dd HgO 
Isotonic Buffer 
8.9 g NaCI 
.6805 g KH2PO4 
in 1 L dd HgO 
(adjust pH to 7.4) 
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Tissue Homogenization and Vitamin E Extraction from Tissues, 
Plasma, Plasma Fractions, and Red Blood Cells 
Procedure 
Tissue Homogenization 
1) Accurately weigh and place the following amount of tissue in a ground glass 
grinding tube; 
Days of age 
Tissue 1 3 5 7 10 14 21 
g 
Adipose tissue .1 .5 .5 .5 .5 .5 
Adrenal glands .010 .015 .05 
Breast muscle .2 .2 1.0 1.5 2.0 2.0 
Bursa of Fabricius .2 .2 1.5 
Leg muscle .05 .2 .2 .4 1.0 1.5 
Liver .2 .2 .2 .5 1.0 1.5 2.0 
Lung 1.0 1.0 1.0 
Pancreas .2 1.0 2.0 
Small intestine 1.0 2.0 2.0 2.0 2.0 2.0 
Uropygial gland .01 .05 .05 .1 .2 .5 
Yolk contents .5 
2) Add 2.5 mL phosphate buffer and homogenize with 15 strokes using a ground 
glass pestle. 
3) Pour into a 10 mL volumetric flask. 
4) Clean and rinse ground glass tube and pestle with 2 successive 2.5 mL 
phosphate buffer, homogenize with 10 strokes each time, and transfer to the 
same volumetric flask. 
5) Bring flask to volume with phosphate buffer, and cap. 
6) Mix flask by inversion and pour contents into a 16 x 100 mm screw top culture 
tube, cap, and store at -20 C for future analysis. 
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Tissue Homogenate, Plasma, Plasma Fractions, and RBC Preparation 
7) Add 3 mL ethanol-ascorbic acid solution to a 16 x 125 mm screw top culture 
tube. 
8) Add 2 mL of homogenate, plasma, plasma fractions, or RBC. 
Note: Smaller quantities of plasma and RBC may also be used. 
9) Vortex tube for 15 s. 
10) Add 1 mL of hexane, cap tube, and vortex for 20 s. 
11) Centrifuge at 2,000 x g for 10 min. 
12) Aspirate hexane layer (top) with a Pasteur pipette and transfer to an amber 
HPLC vial and cap for HPLC analysis. 
Calculation of Multiplier (K) 
For tissue 
K = Total homogenate volume fmLI 
Tissue weight (g) x volume homogenate used (mL) 
For plasma, plasma fractions, and RBC 
K = 1 
Volume plasma used (mL) 
Reagents 
Phosphate Buffer 
13.4 g NaH2(P04).7H20 
1.86 g Na-EDTA 
5.0 g Ascorbic Acid 
in dd H2O 
(adjust pH to 7.0 and dilute to 1 L with dd HgO) 
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Ethanol-Ascorbic Acid Solution 
10 g Ascorbic Acid 
in 1 L Ethanol (distilled, 100%) 
Hexane (HPLC grade) 
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Red Blood Cell Hemolysis Assay 
[procedure modified from Smith et al., 1988] 
Procedure 
1) Before the assay: Begin heating shaking water bath to 37 C. 
2) Place 1 mL of heparinized blood in a 13 x 100 mm glass culture tube. 
3) Centrifuge at 1,500 x g for 15 min. 
4) Aspirate the plasma with a Pasteur pipette and discard. 
5) Wash the RBC with 3 mL of saline solution. 
6) Vortex and centrifuge at 1,500 x g for 10 min. 
7) Aspirate the saline supernatant with a Pasteur pipette and discard. 
8) Repeat steps 5 through 7, once. 
9) Transfer the RBC from the culture tube to a 50 mL glass, round bottom tube 
by mixing three volumes of isotonic buffer totaling 7 mL 
10) Vortex tube and place 2 mL of suspended RBC in a 20 mL glass scintillation 
vial containing 2 mL of 400 nM BHP. 
Note: Vortex the suspended RBC before each transfer. 
11) Incubate at 37 C while shaking (120 oscillations/minute) for 90 min. 
12) Turn on spectrophotometer. 
13) Place (in duplicate) .5 mL of vortexed, incubated RBC suspension in: 
Two 16 x 100 mm glass culture tubes containing 4.05 mL isotonic buffer and 
.45 mL CN solution A (in isotonic buffer), and 
Two 16 x 100 mm glass culture tubes containing 4.05 mL dd HjO and .45 
mL of CN solution S (in dd HjC). 
Note: Vortex the RBC suspension before each transfer. 
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14) Vortex the contents of each tube and centrifuge for 15 min at 1,500 x g. 
15) Set the spectrophotometer wavelength to 540 nm and adjust zero optical 
density with a tube containing 4.05 mL dd H2O and .45 mL of CN solution A. 
16) Determine the optical density of the contents of the tubes at 540 nm. 
Note; Take care not to disturb sedimented RBC while aspirating. 
17) Calculate the percent hemolysis with the following formula: 
% Hemolysis = OP of RBC in buffered CN solution A x 100 
OD of RBC in dd HgO CN solution B 
Reagents 
Saline Solution: 
8.9 g NaCI in 1 L dd Hp 
Isotonic Buffer: 
8.9 g NaCI 
.6805 g KH2PO4 
in 1 L dd Hp 
(adjust pH to 7.4) 
CN Solution A in Buffer 
10 mg NaCN 
30 mg K3Fe(CN)6 
in 100 mL isotonic buffer 
CN Solution B in dd HgO 
10 mg NaCN 
30 mg K3Fe(CN)6 
in 100 mL dd Hp 
t-Butyl Hydroperoxide (BHP) Solution: 
Stock Solution (make weekly): 
130 nL BHP (70% solution) 
in 100 mL of isotonic buffer 
Working Solution (make daily); 
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for 400 fiM BHP use: 
8 mL stock solution 
in 100 mL isotonic buffer 
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TEARS Assay 
[procedure modified from Balasubramanian et al., 1988] 
Tissue Procedure 
1) Homogenize liver with ground glass pestle in 3 volumes of KCI solution to 
achieve 100 mg tissue/mL homogenate (10% homogenate) and place in ice. 
Note: Try to minimize amount of air entering homogenate. 
2) Pipette 30 of homogenate into duplicate 13 x 100 mm glass tubes and 
place in ice. 
3) Add 470 nL of TRIS buffer solution and gently mix. 
4) Incubate at 37 C for 60 min. 
5) Stop reaction by adding 1 mL TCA solution to each tube. 
6) Add 2 mL TBA solution and vortex. 
7) Incubate for 15 min in a 100 C water bath. 
8) Remove tubes from water bath and allow to cool to room temperature. 
9) Centrifuge at 1,500 x g for 15 min to sediment protein. 
10) Determine optica! density at 532 nm on a spectrophotometer after zeroing 
optical density with the 0 nmol MDA standard. 
Note: Make sure not to disturb the sedimented proteins while aspirating. 
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Standard Curve Procedure 
1) A six point calibration solution can be made by adding the following to 
duplicate tubes; 
Tube # uL MDA Solution uL TRIS Buffer Solution nmol MDA 
10 500 0 
2 10 490 4.1 
3 20 480 8.2 
4 30 470 12.3 
5 40 460 16.4 
6 50 450 20.5 
2) Concurrently follow steps 4 through 10 of the tissue assay omitting step 10. 
3) Tube #1 containing 0 nmol MDA should be used to zero the optical density at 
532 nm. 
Calculation of the Results 
1) Linear regression analysis for the standard curve should be used for 
calculation of nmol obtained per tube. 
2) Protein concentration results obtained from Lowry protein determinations 
should be used to standardize results. The Lowry protein assay uses a 1:40 
dilution with dd HgO of the original 10% homogenate. 
3) Final results should be expressed as nmol MDA produced/mg tissue protein. 
Reagents 
KCI Solution (1.15%) 
11.5 g KCI 
in 1 L dd H2O 
TRIS Buffer Solution (200 mM) 
24.22 g TRIS (Sigma 7-9)^ 
in 700 mL ddHjO 
adjust pH to 7.1 with concentrated HCI 
^Sigma Chemical Co., St. Louis, MO 63178 
.2224 g FeSO^.yHgO 
.0528 g Ascorbic Acid 
bring to 1 L-volume with dd HgO 
TCA Solution (20%) 
20 g Trichloroacetic Acid 
in 100 mL dd HjO 
TBA Solution (.67%) 
.67 g Thiobarbituric Acid 
in 100 mL dd HgO 
MDA Stock Solution (.41 mM MDA) 
67.3 mg Malonyl Dialdehyde 
in 1 L 1.15% KCl Solution 
dilute 10x with 1.15% KCl 
